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Summary 
Kindlin-1 belongs to a family of evolutionarily conserved focal adhesion proteins (Kindlin-1, 2 
and 3), which bind β-integrin tails and increase integrin affinity for ligand (also called integrin 
activation). Integrins are a large αβ-heterodimeric cell surface receptor family essential for cell 
adhesion, spreading and migration, but also involved in assembly of the extracellular matrix and 
cell survival. Epidermal keratinocytes express several integrins, most notably β1 integrin 
subfamily members, and Kindlin family members 1 and 2. Kindlin-3 is only expressed in 
hematopoietic cells. Despite their high sequence similarity, Kindlin-1 and -2 cannot compensate 
for each other. Hence, mutations in the Kindlin-1 (KINDLIN-1) gene cause Kindler syndrome (KS) 
in man. In KS, the skin is the main affected organ, displaying blisters, pigmentation defects, 
atrophy, photosensitivity and increased tumor susceptibility. Of note, the increased tumor risk is 
unexpected, as hyperactive integrins are associated with high skin tumor risk and dysfunctional 
integrins prevent skin tumor formation. This discrepancy suggests that the absence of Kindlin-1 
triggers novel, integrin-independent oncogenic function(s) that are sufficient to induce skin 
tumors early in the life of KS patients.  
To analyze the molecular mechanisms of the KS disease, we first constitutively deleted the 
Kindlin-1 gene in mice (Paper II). Besides the expected KS disease symptoms in skin, the 
constitutive Kindlin-1 loss also caused an early lethal ulcerative colitis-like phenotype, which 
prevented investigations on the role of Kindlin-1 in tumor development.  
Thus, in Paper I, I deleted Kindlin-1 conditionally in the skin with a mouse line driving Cre 
recombinase under the control of the keratin5-promoter, enabling for the first time to fully 
recapitulate the human KS skin disease in mice. In addition to the classic KS symptoms - 
blistering, pigmentation defects, skin atrophy and impaired β1 integrin activation - loss of 
Kindlin-1 led to skin area dependent keratinocyte hyperproliferation and a severe and 
unexpected hair follicle phenotype comprising dense packaging of hair follicles and multiple hair 
shafts growing out from a single hair canal. 
To dissect which KS symptoms are caused by impaired β1 integrin function, I compared the 
Kindlin-1 deletion phenotype with a mouse model in which a Kindlin-binding deficient β1 
integrin is expressed in the epidermis. The mutated β1 integrin tail prevents Kindlin induced β1 
integrin activation, while β1-integrin-independent Kindlin functions remain unaffected. 
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Interestingly, while blistering and associated inflammation were present in both models, the 
aberrant hair coat was absent, indicating that this defect is caused by a Kindlin-1-specific and β1 
integrin-independent mechanism. 
I decided to analyze the hair follicle defect in order to unravel novel Kindlin-1 functions. A 
detailed hair follicle and hair cycle analysis revealed that Kindlin-1 loss led to premature anagen 
(hair follicle growth phase) induction after the first hair cycle and to ectopic hair follicle 
development from the interfollicular epidermis as well as from pre-existing hair follicles. These 
findings strongly suggested a severe perturbation in epithelial stem cell homeostasis. I 
established several flow cytometry and immunohistochemistry based techniques that allowed 
analyzing the skin stem cell populations during mouse development. The experiments revealed 
that Kindlin-1 deficiency increased epithelial stem cell proliferation, numbers, mobility and 
compartment size.   
To find an explanation for the disrupted stem cell homeostasis, I started analyzing the integrin 
profile of Kindlin-1 deleted keratinocytes. While the surface levels of most β integrin isotypes 
were only slightly changed, I observed an upregulation of αvβ6 integrin. Besides its role in cell 
adhesion, αvβ6 integrin is essential for transforming growth factor-β (TGFβ) release from the 
latency associated protein (LAP), which in turn suppresses keratinocyte proliferation. I 
performed several adhesion and spreading assays on αvβ6-specific surfaces and TGFβ release 
assays. Although αvβ6 integrin was highly expressed on the cell surface, Kindlin-1 deleted 
keratinocytes were neither able to spread on αvβ6-integrin specific surfaces nor to release TGFβ 
from a matrix. Intriguingly, integrin tail pull-down experiments revealed that while Kindlin-1 and 
-2 were able to bind and activate β1 integrin, only Kindlin-1 but not Kindlin-2 could perform this 
task for αvβ6-integrin. In vivo, the lack of αvβ6 integrin function led to impaired TGFβ signaling, 
especially in the bulge, and thus to a loss of stem cell quiescence. Most importantly, I could 
confirm impaired TGFβ signaling in KS patient biopsies.  
Premature anagen induction, ectopic hair follicle development and expansion of stem cell 
compartments have also been observed in transgenic mice with elevated wingless-type (Wnt)/β-
catenin signaling. In line with this, I observed increased nuclear localization of lymphoid 
enhancer-binding factor 1 (Lef1) and β-catenin as well as increased TOPGal mouse Wnt reporter 
activity in the hair follicle and interfollicular epidermis of Kindlin-1 deleted mice. In collaboration 
with Prof. John McGrath, King's College London, I confirmed increased Wnt signaling in KS 
patients and identified aberrant Wnt ligand expression as a cause of the elevated Wnt signaling 
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in mouse and humans. Indeed, I could prevent premature hair follicle induction and elevated 
Wnt signaling in Kindlin-1 deleted mice and keratinocytes by treating them with the Wnt 
inhibitor IWP-2, which inhibits Wnt ligand secretion, or with IWR-1, which stabilizes the β-
catenin destruction complex. Together with further in vitro experiments these findings 
demonstrated that Kindlin-1 inhibits Wnt/β-catenin signaling in keratinocytes by regulating the 
transcription of Wnt ligands and receptors in a cell autonomous and integrin-independent 
manner. 
I hypothesized that decreased TGFβ and augmented Wnt signaling in KS patients and Kindlin-1 
deleted mice could be responsible for the elevated risk of skin tumors. To test this, I performed 
a two-stage carcinogenesis model with 7,12-Dimethylbenz(a)anthracene (DMBA) and 12-O-
Tetradecanoylphorbol-13-acetate (TPA). Kindlin-1 deleted mice developed tumors earlier and 
obtained more tumors than littermate control mice. Histological analysis revealed that Kindlin-1 
deficient mice developed a higher percentage of tumors associated with deregulated Wnt 
signaling including sebaceous papillomas, trichofolliculoma- and basal cell carcinoma-like 
lesions. Remarkably, I could induce tumors with a single DMBA treatment, indicating that the 
hyperproliferative state of Kindlin-1 deleted keratinocytes is sufficient to promote tumors.  
In summary, my findings assigned Kindlin-1 a novel function for epithelial stem cell homeostasis 
by fine tuning the TGFβ and Wnt signaling pathways. As a result KS is no longer considered 
exclusively a β1 integrin mediated adhesion disease, but rather a disease of skin stem cells 
involving multiple signaling pathways that result in an increased risk for skin tumor 
development.   
In parallel, I started studying the photosensitivity in KS. Therefore, I crossed Kindlin-1 mouse 
model into SKH-hr1 hairless mouse strain, suitable for UV experiments. After detailed 
phenotype characterization, I performed short- and long-term UV experiments in collaboration 
with Dr. Norbert Wikonkál from the University of Budapest. The short-term UV experiment 
revealed that photosensitivity observed in KS patients is reproducible in mice, which displayed 
increased numbers of sun burned cells as compared to wild type littermates at different UV 
dosages. The long-term UV treatment for 48 weeks with a low UV dosage promoted significantly 
more tumors, which developed earlier and progressed to a more malignant phenotype in 
Kindlin-1 deleted mice. The cause for increased photosensitivity is still unclear, and will be 
further investigated by a new PhD student who I am supervising. 
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In addition, I was involved in two other projects (Paper III and IV) during my PhD: In Paper III we 
addressed the role of Kindlin-3 in the regulation and maintenance of hematopoietic stem and 
precursor cells in the bone marrow. Besides helping with sophisticated stem cell experiments, I 
translated epidermal stem cell Kindlin-1 findings to Kindlin-3 and the hematopoietic system. We 
could show that Kindlin-3 deficient hematopoietic stem and precursor cells critically rely on 
Kindlin-3 mediated integrin activation for homing, whereas Kindlin-3 is dispensable for 
hematopoietic stem cell quiescence during homeostasis. Conversely, upon hematopoietic stress, 
impaired retention of activated hematopoietic stem and precursor cells leads to a premature 
exhaustion of Kindlin-3 deficient hematopoietic stem cells, emphasizing the importance of 
Kindlin-3 for maintaining actively proliferating hematopoietic stem and precursor cells in the 
bone marrow. 
For Paper IV, I assisted in the exploration of how the two major fibronectin binding integrin 
classes αv and β1 cooperate in megakaryocyte acute leukemia protein (MAL) / serum response 
factor (SRF) signaling and how newly identified MAL/SRF-target genes control the turnover of 
actin regulatory proteins, adhesome proteins and integrins. Briefly, we found that through 
modulation of the cellular globular (g) / filamentous (f)-Actin composition both integrin classes 
synergize to regulate the expression of MAL/SRF target genes. Furthermore, we identified the 
small ubiquitin-like modifier interferon-specific gene 15 (ISG15) as a novel MAL/SRF target gene. 
Similar to ubiquitin, ISG15 can be conjugated covalently to specific lysine residues of multiple 
MAL/SRF target proteins including Vinculin, Talin and Eplin and thereby preventing their 
ubiquitination and degradation. Thus, we show that these two integrin classes trigger a feed-
forward loop through modulation of  free g-Actin which controls SRF/MAL activity, leading to 
increased transcription of focal adhesion and cytoskeletal genes, which at the same time are 
post-translationally modified and thereby potentially stabilized via ISGylation. Such an 
autoregulatory circuit allows precise and robust activation of the cellular adhesion and motility 
machinery to promote cell migration during cancer metastasis. 
Finally, one of the most prominent interaction partners of Kindlins that links the integrins to the 
actin cytoskeleton is the focal adhesion scaffolding protein integrin-linked-kinase (ILK). In Paper 
V we reviewed the ILK functions, subcellular localizations and structural properties of this 
interesting molecule. 
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Abbreviations 
Å  Angstrom 
ActR-II  Activin type II receptor 
ADP   Adenosine diphosphate  
ADAM A disintegrin and 
metalloproteinase  
ADMIDAS    Adjacent to metal ion- 
dependent adhesion site  
αI        α-inserted 
ALK  Activin receptor-like kinase 
AMHR-II  Anti-Müllerian hormone 
receptor type II 
APC Adenomatous polyposis coli 
gene   
APM  Arrector pili muscle 
ARM  Armadillo  
BCC        Basal cell carcinoma 
BCL B-cell chronic lymphocytic 
leukemia/lymphoma 
βI          β-inserted  
β-TrCP β-transducin repeat containing 
E3 ubiquitin protein ligase 
BM        Basement membrane 
uPA        Urokinase-type plasminogen  
        activator  
BDNF Brain-derived neurotrophic 
factor 
bHLH        Basic helix-loop-helix  
BMP       Bone morphogenetic protein 
BMPR2       BMP type II receptor  
BrdU      5-bromo-2'-deoxyuridine  
Ca2+        Calcium ions 
CAMkII  Ca2+/calmodulin-dependent 
protein kinase II 
CAS      Crk-associated substrate 
CBP       Calcium-binding protein 
CD      Cluster of differentiation 
Cdc       Cell division cycle 
CDKN2B      Cyclin-dependent kinase 
inhibitor 2B 
CK1α       Casein kinase 1α 
COOH       Carboxyl group 
Co-Smad     Common mediator Smad 
CpG  Cytosine-phosphate- guanine      
nucleotide sequence 
CtBP       C-terminal binding protein  
CTS Connective tissue sheath 
CXCR4 Chemokine (C-X-C motif) 
receptor 4, cytein (C), any (X) 
DAAM1 Dishevelled-associated 
activator of morphogenesis 1  
DAG       Diacyl-glycerol 
DAP       Death-associated protein 
Dct       Dopachrome tautomerase 
Dkk       Dickkopf  
DMBA 7,12-Dimethylbenz 
(a)anthracene  
DNA       Deoxyribonucleic acid 
Dvl  Dishevelled 
E-Cadherin          Epithelial cadherin  
e.g.        “Exempli gratia” (for example) 
ECM       Extracellular matrix 
EGF       Epidermal growth factor 
ERK  Extracellular signal-regulated 
kinase 
EMT Epithelial-mesenchymal 
transition 
ER     Endoplasmatic reticulum 
FACS  Flow cytometry 
f-Actin      Filamentous Actin 
FAK     Focal adhesion kinase 
FAP     Familial Adenomatous Polyposis  
FERM Four point one protein, ezrin, 
radixin, moesin domain 
FGF      Fibroblast growth factor 
FoxO     Forkhead box protein O 
Fzd     Frizzled receptor 
g-Actin      Globular (monomeric) actin 
Gadd45b  Growth arrest and DNA-damage 
inducible, beta 
GDF  Growth/differentiation factors  
GDP     Guanosine diphosphate 
GFFKR  Peptide motif glycine (G), 
phenylalanine (F), lysine (K), 
arginine (R) 
GFOGER Glycine (G), phenylalanine (F), 
hydroxyproline (O), glutamic 
acid (E), arginine(R) motif 
Gli1     Glioblastoma 1  
Glu  Glutamine 
GS Glycine (G), serine (S) rich 
domain 
GSK3      Glycogen synthase kinase 3 
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GTP     Guanosine triphosphate 
HDR(R/K)E Peptide motif histidine (H), 
aspartic acid (D), arginine (R), 
lysine (K), glutamic acid (E) 
HAX1     HS1-associated protein X-1 
H&E      Hematoxylin and eosin 
HF     Hair follicle 
h-G-h  Carboxylate binding motif with 
a glycine (G) flanked by two 
hydrophobic residues (h)  
HS  Hair shaft 
HSPG     Heparan sulfate proteoglycan 
ICAM-1     Intercellular adhesion 
molecule-1 
Id     Inhibitor of differentiation 
i.e.  “Id est” (that is) 
I-EGF  Rich integrin epidermal growth 
factor–like  
IFE     Interfollicular epidermis 
IGF      Insulin growth factor  
IKK     IκB kinase 
IL      Interleukin 
ILK     Integrin linked kinase 
IMD    Integrin mediated death  
IPP      ILK-Pinch-Parvin complex 
IP3     Inositol trisphosphate 
IRS  Inner root sheath 
I-Smad     Inhibitory Smad 
ISG15  Interferon-induced 15 kDa 
protein 
JNK     Jun N-terminal kinase 
K5-Cre Keratin5 promoter driven Cre 
line 
kDa      Kilodalton 
Krt15     Keratin 15 
Krt19     Keratin 19 
KGF      Keratinocyte growth factor 
KS     Kindler syndrome 
LAD I, II, III  Leukocyte adhesion deficiency 
type I, II or III 
LAP            Latency-associated protein 
LacZ     β-galactosidase gene 
Lef1 Lymphoid enhancer-binding 
factor 1 
LIMBS  Ligand-induced metal ion–
binding site 
LIMK1     LIM kinase 1  
LDV  Leucine (L), aspartic acid (D), 
valine (V) peptide motif 
Lgr Leucine-rich repeat containing 
G protein-coupled receptor 
LLC     Large latent TGFβ complex  
LRG1 Leucine-rich alpha-2-
glycoprotein 1 
Lrp5/6 Lipoprotein receptor-related 
protein 5 or 6 
LTBP Latent TGFβ binding protein 
MD     Membrane distal 
MET Mesenchymal to epithelial 
transition 
MF     Microfilaments 
MIDAS Metal ion dependent adhesion 
site 
miR200     MicroRNA200  
MAL  Megakaryocyte acute leukemia  
MAPK Mitogen-activated protein 
kinase 
Mg2+     Magnesium ions 
MH1     Mad homology domain 1 
MMP     Matrix metallopeptidase  
Mn2+     Manganese ion 
MP     Membrane proximal 
MRTFA Myocardin related transcription 
factor A 
mTORC  Mammalian target of 
rapamycin  
MTS24 Thymic epithelial progenitor cell 
marker 
NEXT     Notch extracellular truncation 
NFAT  Nuclear factor of activated T-
cells 
NF-κB  Nuclear factor kappa-light-chain 
enhancer of activated B cells 
NICD      Notch intracellular domain 
NMR     Nuclear magnetic resonance 
NPxY  Peptide motif asparagine (N), 
proline (P), any (x), tyrosine (Y) 
NT-3/4     Neurotrophins 3 or 4 
NxxY Peptide motif asparagine (N), 
proline (P), any (x) 
ORS  Outer root sheath 
p130Cas   p130 Crk-associated substrate  
Par6     Partitioning defective 6  
PAT Paralyzed, arrested elongation 
at twofold 
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PCP     Planar cell polarity 
PDGF     Platelet derived growth factor 
PEST     Rich in proline (P), glutamic acid 
    (E), serine (S) and threonine (T) 
PI(4,5)P2   Phosphatidylinositol 4,5-
bisphosphate  
PI(3,4,5)P3  Phosphatidylinositol 3,4,5-
trisphosphate  
PI3K  Phosphoinositide 3-kinase 
Pinch  Particularly interesting Cys-His-
rich protein 
PIPKIγ  Phosphatidylinositol 4-
phosphate-5-kinase type I γ 
PH  Pleckstrin homology 
PkC or PkA Protein kinase C or A 
PLC  Phospholipase C  
PLET1  Placenta-expressed transcript-1 
PLK1  Polo-like kinase 1 
PPM1A Protein phosphatase, Mg2+ / 
Mn2+ dependent, 1A 
PRDM1 PR domain zinc finger protein 1, 
(previously BLIMP1)  
PSI  Plexin/semaphorin/integrin  
PTB  Phosphotyrosine binding site 
Pyro  Pygopus family PHD finger 
qPCR Quantitative polymerase chain 
reaction 
Rab Ras-related in brain 
Rac1 Ras-related C3 botulinum toxin 
substrate 1 
Raf Rapidly accelerated 
fibrosarcoma 
RAM  Rbp-associated molecule 
Rap1  Ras-related protein 1 
Ras  Rat sarcoma 
RIAM Rap1 interacting adaptor 
molecule  
RGD/E Tripeptide motif arginine (R), 
glycine (G), aspartate (D) or 
glutamic acid (E) 
RhoA  Ras homolog family member A  
RNA  Ribonucleic acid 
Rnf43  Ring finger protein 43 
ROCK  Rho-associated kinase 
ROS   Reactive oxygen species  
Ror2 Receptor tyrosine kinase-like 
orphan receptor 2 
R-Smad  Receptor-activated Smad 
Ryk  Receptor-like tyrosine kinase 
SARA Smad anchor for receptor 
activation  
S  Sedimentation coefficient 
SC  Stem cell 
SCC  Squamous-cell carcinoma 
SDL  Specificity determining loop 
sFRP  Secreted frizzled-related 
protein  
SG  Sebaceous gland 
SGSGSG  Serine (S) and glycine (G) rich 
peptide motif 
SH2  Src homology 2 
Shc Src homology containing 
protein  
Shh  Sonic hedgehog 
SHIP SH2 domain-containing 5' 
inositol phosphatase 
SKH-hr1  Hair less mouse strain 
SLC  Small latent TGFβ complex 
Smurf Smad specific E3 ubiquitin 
protein ligase  
Sos1  Son of sevenless homolog 1 
SPR  Surface plasmon resonance 
Src  Proto-oncogene tyrosine-
protein kinase Sarcoma 
SRE   Smad responsive elements  
TAK1  TGFβ-activated kinase 1  
TβRI/II   TGFβ receptor type I or II  
TCF  Transcription factor 
TGFα   Transforming growth factor-α 
TGFβ  Transforming growth factor-β 
THATCH  Talin/HIP1R/Sla2p actin 
tethering C-terminal homology 
TIF  Tubular intestinal fibrosis 
TMD  Transmembrane domain  
TNF  Tumor necrosis factor 
TPA 12-O-Tetradecanoylphorbol-13-
acetate  
TRAF6 Tumor necrosis factor receptor-
associated factor 6  
Unc112  Uncoordinated protein 112  
UV   Ultra violet  
VCAM  Vascular cell adhesion molecule  
VEGF Vascular endothelial growth 
factor 
Wif1  Wnt inhibitory factor 1  
Wnt   Wingless-type
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Nature Medicine Cover Image  
(Issue April 2014 Volume 20 No 4) 
Kindler syndrome (KS) is a skin blister disease 
associated with an increased risk for skin cancer. In this 
issue, Reinhard Fässler and his colleagues have 
developed a new mouse model of KS, which allowed 
them to uncover new insight into the mechanisms of 
the disease. The cover image by Emanuel Rognoni 
illustrates ectopic hair follicles with enlarged hair 
follicle bulges (red) and small hair germs (green) in the 
tail skin of a mouse lacking Kindlin-1 (nuclei in blue).  
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1  Introduction 
1.1  The skin and its appendages  
The skin is the largest organ of the human body that protects from environmental stresses such as 
dehydration, irradiation, mechanical trauma and pathogenic infection (Fuchs, 2008). It has the 
remarkable ability to regenerate in a controlled fashion, including its appendages, hair follicles 
(HF) and sebaceous glands. These regulate body temperature and influence social and 
reproductive behavior.   
Adult skin is composed by approximately 20 different cells types, which are organized in three 
layers arising from different embryonic cell lineages.  The outer most layer (epidermis) is derived 
from neuroectodermal cells that form during embryo development a single layer of 
undifferentiated progenitors, which develop into the multilayered (stratified) epidermis, HFs and 
sebaceous glands, which are separated through a basement membrane from the underlying 
dermis (second layer). The dermis is composed by cells of multiple developmental origins: 
mesoderm-derived cells giving rise to the extracellular matrix (ECM) secreting fibroblasts and 
arrector pili muscle cells, which attach to each HF regulating HF movement; endothelial cells 
forming the dermovascular system essential for skin nutrition; immune cells, which infiltrate and 
reside in the skin (epidermis and dermis). The last skin layer, referred as the sub cutis, comprises 
subcutaneous adipocytes (fat cells) originating from differentiated fibroblasts (Driskell et al., 
2013).  
 
 
Figure1: The structure of the epidermal skin 
layer 
Proliferative keratinocytes are in contact with 
basement membrane forming the stratum 
basale. The overlying stratum spinosum, 
granulosum and corneum are built by the 
delamination and progressive differentiation 
of basal keratinocytes, referred as epidermal 
stratification (modified from (Winograd-Katz et 
al., 2014)). 
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The main cell type of the epidermis are the keratinocytes, which are organized into multiple layers 
(“strata”) thereby establishing together with the basement membrane a physical barrier to the 
outer environment (Figure1). This barrier is frequently renewed. The basal keratinocytes contact 
the basement membrane and harbor the proliferative cell pool of the epidermis as well as 
multiple slow cycling stem cell (SC) populations (discussed in 1.1.2). The turnover rate of basal 
keratinocytes (i.e. the time they are renewed) in mice is estimated to one week, whereas in 
humans it is about 60 days (Ghazizadeh and Taichman, 2001). The process of epidermal layer 
formation (stratification) is characterized by change of keratin expression, downregulation of 
surface adhesion receptor integrin and laminin expression of basal cells undergoing 
differentiation. Consequently, these cells leave the basal layer moving upwards to the stratum 
spinosum and granulosum, withdraw from the cell cycle and denucleate at the end of the 
differentiation program giving rise to a cornified layer (stratum corneum), which eventually sheds 
off the skin surface (Blanpain and Fuchs, 2006). At present, the molecular signals that orchestrate 
cell proliferation, differentiation and patterning in skin, remain incompletely understood. 
 
 
 
In the skin each HF is considered a distinct mini organ composed by up to eight layers organized in 
a concentric manner around the hair shaft (Figure2). The layers from outside to the center are the 
outer root sheath, the inner root sheath, composed of Companion layer, Henle’s layer, Huxley’s 
layer and the inner root sheath cuticle, and finally the hair shaft composed of hair cuticle, medulla 
and cortex. A connective tissue sheath of dermal cells and collagen surround the HF epithelium 
(Figure2D). The HFs are formed during embryonic development (day 14.5 in mice) and 
Figure2: The HF structure and layers 
(A-C) HF in anagen stained by H&E. (A) The 
permanent (infundibulum and isthmus) and 
the cycling (suprabulbar region and hair 
bulb) components of the HF are shown. 
(B,C)  High magnification of the isthmus 
region with the HF bulge indicated by the 
dashed square (B) and the hair bulb (C). (D) 
Schematic illustration of the concentric HF 
layers of the outer root sheath (ORS), inner 
root sheath (IRS) and hair shaft which are 
enclosed by the basement membrane (BM) 
and a connective tissue sheath (CTS). APM, 
arrector pili muscle; DP, dermal papilla; M, 
matrix; HS, hair shaft; SG, sebaceous gland 
(modified from (Schneider et al., 2009)). 
B
M
 
I n t r o d u c t i o n | 17 
 
subsequently the lower part of the HF undergoes repeated cycles of growth, regression and self-
renewal, referred as hair cycle, while the upper part maintains a constant morphology (see section 
1.1.1 and 1.1.3 for details). This cycling of the HF depends on three compartments located in the 
lower area of the HF: the hair bulb, the suprabulbar region and the hair bulge. The upper non-
cycling part consists of the infundibulum and the isthmus (Figure2A-C). The infundibulum forms 
the hair canal opening where the interfollicular epidermis surrounds the hair shaft and ends at the 
duct of the sebaceous gland. Below lies the isthmus region which is connected to the arrector pili 
muscle. At the lower isthmus region follows the HF bulge, required for the maintenance of the 
whole HF, as it forms the main reservoir of epithelial HF and melanocyte SC (see section 1.1.2 for 
details). The hair bulb is composed by the dermal papilla, a densely packed cluster of fibroblasts 
that is enwrapped by matrix keratinocytes (matrix), and harbors the pigmentary unit (see also 
section 1.1.4). The sebaceous gland comprise specialized skin cells, the sebocytes, that produce 
and accumulate lipids (sebum), which can be released to the skin surface and contribute to the 
skin barrier function. 
Interestingly, a recent study has revealed that not only the epidermal keratinocytes but also 
dermal fibroblasts form distinct cell lineages in the skin (Driskell et al., 2013). Transplantation and 
lineage tracing experiments identified two distinct lineages with specialized functions: while the 
upper dermal fibroblast lineage is involved in HF formation giving rise to dermal papilla and 
arrector pili muscle cells, the lower dermal fibroblasts are mainly responsible for ECM synthesis 
and are able to differentiate into preadipocytes and adipocytes of the sub cutis. 
 
1.1.1 Hair follicle morphogenesis 
 
Figure3: HF morphogenesis in mice 
The murine HF development is induced by dermal signals (stage 0), which leads to the hair placode (stage 1) 
in the induction phase. During organogenesis (stage 2-5) extensive dermal-epidermal cross talk promotes 
the hair germ maturation. In the following cytodifferentiation phase (stage 6-8) the distinct HF layers, 
sebaceous gland and HF SC compartments are formed (modified from (Schneider et al., 2009)). 
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During embryonic development HF morphogenesis is initiated by a priming dermal signal (stage 0), 
leading to the condensation of epidermal cells in a regular pattern (discussed below) to form 
epidermal placodes (stage 1), referred as induction phase (Figure 3). Although there are a lot of 
strong evidences that this first initiating dermal signal is based on the release of small 
glycolipoproteins, termed wntless type (Wnt) ligands, the precise source and identity of these Wnt 
ligands remain unknown (Andl et al., 2002). The epidermal placodes then start to signal involving 
Wnt/β-catenin, sonic hedgehog (Shh) and transforming growth factor β (TGFβ) pathway, which 
results in the aggregation of underlying mesenchymal cells to dermal condensates that develop 
into a hair germ (stage 1-2). In response to a second dermal signal, now originating from the 
further developed dermal condensate, epidermal placode cells proliferate, invade the dermis and 
form the dermal papilla by embracing the dermal condensate (stage 2-5) during the organogenesis 
phase. At later stages (stage 6-8) extensive cross talk between epithelial cells of the developing 
hair maintains high proliferation levels and leads to differentiation of the inner root sheath and 
hair shaft of the mature HF (cytodifferentation phase). The dominant role of the Wnt/β-catenin 
pathway for hair morphogenesis is underlined by the fact that deletion of β-catenin or its co-factor 
Lef1 in skin abolishes HF development (Huelsken et al., 2001; van Genderen et al., 1994). 
Conversely, increased Wnt signaling through stabilized β-catenin or overexpressed Wnt ligands is 
sufficient to direct epidermal cells to an appendage fate, leading to de novo HF formation (Gat et 
al., 1998; Widelitz et al., 1999).  
In mouse back skin, HFs emerge at an angle of approximately 40 degree to the epidermis aligned 
from anterior to posterior direction (Paus et al., 1999). It has been speculated that this polarity is 
regulated by the Wnt target gene Shh since it is asymmetrically expressed in the HF bulb in a small 
patch of cells at the side of the matrix closest to the skin surface (Bitgood and McMahon, 1995; 
Gat et al., 1998).  
  
During morphogenesis the HF spacing is established by the patterning of the placode array which 
is suggested to be governed by the “turing reaction diffusion model” (Sick et al., 2006), which was 
previously described for feather development (Jiang et al., 1999). In this model Wnt signaling 
Figure4: Turing reaction diffusion model for HF patterning  
In the HF morphogenesis induction phase simultaneous secretion 
of low distance diffusing inductive Wnt ligands and faster diffusing 
Wnt inhibitor Dickkopf (Dkk) establish a regular array of elevated 
Wnt signaling nodes which eventually develop into HFs (modified 
from (Lim and Nusse, 2013)). 
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activators (Wnt ligands) and inhibitors (e.g. Dickkopf (Dkk)4) are secreted by the placodes and 
diffuse into the extracellular space (Figure4). The large, hydrophobic Wnt ligands diffuse only for a 
short range in the aqueous extracellular environment, while the Wnt inhibitors such as Dkks travel 
a longer range due to smaller size and better solubility. Through this mechanism, placodes can 
only persist in discrete interdistances: placodes at too close interdistances will cancel out Wnt 
ligand induced induction through high Dkk levels, whereas empty spaces with low Dkk levels 
promotes placode induction. At the end of HF morphogenesis (stage 6-8) the sebaceous gland and 
the multiple HF SC compartments start to form, which will be discussed below. 
 
1.1.2 Skin stem cells 
 
Throughout life skin homeostasis relies on epidermal SCs, which are able to self-renew or 
differentiate into all epidermal lineages (Fuchs, 2008). The adult skin is maintained by multiple SC 
populations which develop during HF morphogenesis and reside in different locations within the 
tissue (Figure5). Under normal homeostatic conditions, SCs in these distinct locations maintain 
associated cell lineages: HF SCs maintain HF linages, sebaceous gland SCs produce differentiated 
sebocytes and SCs in the interfollicular epidermis renew epidermal cells. But upon injury, genetic 
manipulations or transplantation different SC populations are able to reprogram and to give rise 
to multiple lineages (Ito et al., 2005; Taylor et al., 2000). One key pathway for SC fate 
determination is the Wnt/β-catenin pathway. In mice, Wnt signaling disruption inhibits embryonic 
HF formation, whereas ectopic epidermal activation results in de novo formation of sebaceous 
Figure5: The epithelial SC populations in the 
murine skin 
The HF bulge can give rise to all epidermal 
lineages and harbors different HF SC 
subpopulations enwrapped by nephronectin 
characterized by the partially differing 
expression pattern of CD34, Sox9, Krt15 and 
Lgr5. Gli1 positive HF SCs can be found in the 
bulge and isthmus region, whereas Lgr6 and 
Lrig1 / PLET1 expressing cells are restricted to 
the isthmus and junctional zone. The 
unipotent Blimp1 positive SCs are located 
close to the sebaceous gland. SC in the 
interfollicular epidermis seems to express 
high level of integrins and Axin2, but their 
organization is still unclear (modified from 
(Arwert et al., 2012)). 
Nephronectin 
Axin2 
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gland and HF from existing HF and interfollicular epidermis in a dose dependent manner (Gat et 
al., 1998; Huelsken et al., 2001; Silva-Vargas et al., 2005). 
In murine skin the main SC compartment is the bulge, first identified by the long-term retention of 
a DNA label, such as 5-bromodeoxyuridine (BrdU) (Cotsarelis et al., 1990; Lyle et al., 1998). The 
first molecular marker of the bulge to be identified was keratin-15 (Krt15), followed by CD34, Sox9 
and leucine-rich repeat-containing G protein-coupled receptor 5 (Lgr5) (Jaks et al., 2008; Lyle et 
al., 1998; Trempus et al., 2003; Vidal et al., 2005). In contrast to cells from other regions of the HF 
and the epidermis, bulge cells display the greatest in vitro growth capacity and clonogenicity and 
can fully reconstitute skin in transplantation experiments, indicating that these cells are 
multipotent (Taylor et al., 2000). In vivo lineage tracing experiments revealed that under 
homeostatic conditions bulge cells give rise to the lower HF, including the outer root sheath, 
matrix and hair shaft, and upon injury migrate upwards to differentiate into epidermal 
keratinocytes (Ito et al., 2005; Taylor et al., 2000). Bulge SCs crucially rely on quiescence for long-
term maintenance and perturbations in the quiescent regulation result in premature SC loss (Arai 
and Suda, 2008).  
Whereas in the past the bulge was believed to be the primary residence of HF SCs, in recent years 
it has become clear that SCs also reside in the isthmus (these cells are positive for Lgr6 and/or 
MTS24) (Nijhof et al., 2006; Snippert et al., 2010) as well as in the junctional zone adjacent to the 
sebaceous glands and infundibulum (these cells are positive for leucine-rich repeats and 
immunoglobulin-like domains 1 (Lrig1)) (Jensen et al., 2009). Lgr6, MTS24, and Lrig1 positive SC 
constitute partially overlapping SCs niches, which can be separated by flow cytometry (Jensen et 
al., 2010). In the upper part, Lrg6 expressing cells partly overlap with unipotent B lymphocyte-
induced maturation protein 1 (Blimp1) expressing cells that are confined to fueling cells to the 
sebaceous gland (Horsley et al., 2006). Of note, when Blimp1 positive cells are lost they are 
replaced by multipotent bulge SC, underlining the SC hierarchy in the HF.  
Although the presence of SC in the interfollicular epidermis has been indicated by linage tracing 
experiments (Clayton et al., 2007), for a long time their molecular identity has remained obscure 
due to lack of specific markers (Watt and Jensen, 2009). Intriguingly, a recent study proposes that 
interfollicular epidermal SC express high levels of Wnt target gene Axin2. These cells require 
Wnt/β-catenin signals to proliferate and do not rely on quiescence for maintenance (Lim et al., 
2013). For HF SCs the niche environment is highly important. One major niche component in the 
HF bulge is the extracellular matrix protein nephronectin which is secreted by bulge SCs (Fujiwara 
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et al., 2011). Within the HF the niche environment of specialized SC compartments influences the 
identity “stemness” and dictates the development of phenotypically and molecularly distinct 
populations of HF SCs. Indeed, in the bulge two subpopulations have been identified with distinct 
transcriptional profiles imposed by the localization within the bulge niche: a basal bulge SC 
subpopulation, which maintain basement membrane contact, and a suprabasal SC subpopulation, 
which arise only after the first hair cycle (Blanpain et al., 2004). Further sensory neurons in contact 
with the HF cultivate a perineural niche microenvironment in the bulge and isthmus. The induced 
secretion of Shh results in a specialized subset of bulge cells characterized by high Glioblastoma 1 
(Gli1) expression and activated Hedgehog pathway, which are able to become epidermal SCs 
(Brownell et al., 2011). For interfollicular epidermal SCs, however, it remains unclear if they also 
rely on dermal and basement membrane niche factors forming interfollicular epidermal SC niches. 
It is conceivable that many more specialized SC subpopulations, maintained and defined by a 
complex array of niche factors, will be discovered in the near future.  In human HF, specific hair SC 
markers remain to be identified. So far human bulge SC could be best described by high KRT15, 
keratin-19 (KRT19) and CD200 expression and absence of CD34 (which is high in mouse SCs), 
nestin and connexin 43 (Kloepper et al., 2008). Interestingly, comparative transcriptional profiling 
of human and mouse bulge cells have revealed similarities in upregulation of Wnt signaling 
inhibitors, TGFβ signaling components and CD200 expression, but also discrepancies such as the 
CD34 expression pattern (Ohyama et al., 2006). This indicates that besides the divergences in SC 
compartments between mouse and humans, also phenotypic and molecular differences in similar 
SC populations exist, which will be a challenge to characterize in the future.  
 
1.1.3 The postnatal hair cycle 
 
Figure6: The hair cycle 
HF periodically cycle from anagen (growth phase), 
through catagen (regression phase) and into telogen 
(resting phase) (modified from (Alonso and Fuchs, 2003)). 
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The postnatal hair cycle is initiated with a phase of  regression and controlled cell death (catagen), 
followed by a resting phase (telogen) and ends in a phase of HF growth (anagen), which then is 
followed by further rounds of catagen, telogen and anagen (Figure6). The HF is governed by an 
autonomous, intrafollicular oscillator system, referred as “hair cycle clock” (Paus and Foitzik, 
2004). During each hair cycle a new hair shaft is formed during anagen and the old club hair is 
shed off after catagen. In mice, the first hair cycle is synchronized for all HFs and occurs in a wave 
from the venter dorsally and posteriorly (Plikus and Chuong, 2008). The postnatal hair cycle starts 
at 17 days after birth after completion of HF morphogenesis with the first catagen, which has been 
shown to be induced by a plethora of growth factor signals such as fibroblast growth factor 
(FGF)5, TGFβ1, the neurotrophins (NT)-3 and NT-4, brain-derived neurotrophic factor (BDNF), 
bone morphogenetic protein (BMP)2/4 and tumor necrosis factor (TNF)α (Stenn and Paus, 2001). 
During catagen the HF matrix, inner root sheath and outer root sheath keratinocytes of the cycling 
HF part undergo a controlled apoptosis, while bulge HF SCs are protected and remain quiescent. 
Consequently, the cycling part of the HF regresses in the shape of a thin epithelial strand towards 
the epidermis, which brings the dermal papilla in close proximity to the bulge (Muller-Rover et al., 
2001; Stenn and Paus, 2001). 
The following telogen phase lasts only several days during the first HC and usually more than three 
weeks during the second telogen. Although the telogen phase is considered as a stage of low 
proliferation, it coincides with major changes in gene activity (Lin et al., 2004). During this resting 
phase the bulge and the dermal papilla in very close proximity, providing proliferation inhibitory 
signals to the bulge leading to their quiescence.  It is generally believed that during telogen little or 
no Wnt/β-catenin signaling occurs. Indeed, during telogen the bulge expresses multiple Wnt 
inhibitors, such as secreted frizzled-related protein (sFRP)1, Wnt inhibitory factor 1 (Wif1) and 
Dkk3 (discussed in section 1.4.7) (Morris et al., 2004; Tumbar et al., 2004) as well as the 
transcription factor (Tcf)3, which is believed to repress Wnt/β-catenin signaling in the absence of 
nuclear β-catenin (discussed in section 1.4.3) (Lien et al., 2014; Wu et al., 2012). This refractory 
phase of the telogen is further supported by high expression of BMP2/4 and TGFβ from the 
dermal papilla and bulge cells (Plikus et al., 2008; Woo and Oro, 2011). At the end of the telogen, 
bulge SCs become highly sensitive for anagen inducing factors which promotes hair regeneration. 
This induction appears to result from the antagonistic interplay between BMP, TGFβ, FGF and 
Wnt/β-catenin signaling in follicular SCs (Greco et al., 2009; Plikus et al., 2008). However, the 
molecular details how Wnt signaling is switched on at anagen onset remain poorly understood. A 
I n t r o d u c t i o n | 23 
 
recent study using live cell imaging demonstrates that constitutive activation of Wnt/β-catenin in 
a small pool of HF SCs is sufficient to induce hair growth independent of dermal papilla niche cell 
signals (Deschene et al., 2014). These Wnt signaling high SCs are able to activate Wnt signaling in 
neighboring cells via Wnt ligand secretion resulting in a coordinated tissue growth. Interestingly, 
during this phase most bulge SCs remain quiescent and only a small number of cells becomes fully 
activated, starts proliferating and migrate out of the bulge forming a new (secondary) hair germ. 
In these cells, Lef1 is upregulated, binds to β-catenin forming an active transcription factor 
complex, which replaces the inhibitory Tcf3 from the promoters regions of Wnt target genes (Lien 
et al., 2014). Because Lef1 is a β-catenin target gene itself, Wnt signaling is amplified in a positive 
feedback loop (Wu et al., 2012). Indeed, studies with Wnt signaling reporter mice showed that in 
the secondary hair germ and hair matrix the high Lef1 expression correlates with the strongest 
Wnt signaling activation (DasGupta and Fuchs, 1999). 
Interestingly, expression of constitutively stable β-catenin in basal epidermal keratinocytes leads 
to hyperactive Wnt/β-catenin signaling and is sufficient to induce anagen onset (Silva-Vargas et 
al., 2005; Van Mater et al., 2003), whereas β-catenin loss-of-function blocks entry into anagen 
when induced postnatally (Huelsken et al., 2001), placing Wnt/β-catenin upstream of hair cycle 
regulation.  
During full anagen, the upper matrix cells stop proliferating and differentiate into the various cell 
linages of the hair shaft and inner root sheath. Conversely, the relatively undifferentiated outer 
root sheath originates from epithelial progenitor cells derived from a small and distinct bulge 
population. Linage tracing experiments has revealed that these cells form a very narrow 
proliferative zone between the lower bulge and the hair bulb (Rompolas et al., 2013). At the end 
of the anagen, dermal BMP signaling and TGFβ2 in the hair bulb have been suggested to mediate 
catagen induction (Plikus et al., 2008; Soma et al., 2002). Subsequently the HF enters the telogen 
phase. Nevertheless, although many key players have been identified, the molecular mechanism 
driving hair cycling remains obscure. 
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1.1.4 Hair pigmentation 
 
Skin pigmentation plays an important physiological and evolutionary role by protecting animals 
against mutagenic ultra violet (UV) irradiation as well as allowing camouflage, mimicry, and social 
communication. Pigmentation of the HF is important for skin UV protection, thermoregulation, 
camouflage and sexual signals. Hair pigment melanin is produced by melanocytes arising from 
neural crest-derived melanoblasts (Rawles, 1947), which reside in the hair matrix and along the 
outer root sheath of anagen HFs (Figure7A,B). In adult mouse back skin, melanocytes are located 
exclusively in HFs, while in human skin melanocytes are maintained in the interfollicular epidermis 
as well. In contrast to the continuous epidermis melanogenesis, in HF the melanin production by 
melanocytes is strictly coupled to the hair cycle where it exclusively occurs during anagen 
(Slominski et al., 2005). During catagen most melanocytes in the HF undergo apoptosis and will be 
replenished during the next anagen by melanocyte SCs residing in the bulge and secondary hair 
germ (Sharov et al., 2005) (Figure7A,B). Intriguingly, their homeostasis and activation is 
synchronized with and directly dependent on the keratinocytes of the bulge, involving Wnt, TGFβ 
and Notch signaling from the bulge SCs (Moriyama et al., 2006; Nishimura et al., 2010; Rabbani et 
al., 2011). Hair pigment production occurs only in the HF pigmentary unit located in the hair bulb. 
There, melanocytes synthesize melanin in melanosomes (lysosome related organelles), which are 
actively exported and transferred to receiving HF keratinocytes leading to the formation of a 
pigmented hair shaft (Nishimura et al., 2002; Slominski et al., 2005). The melanocytes and 
melanoblasts in the outer root sheath normally do not engage in pigment production but can 
replace lost epidermal melanocytes. Graying of hair cavities in mice as well as humans is the direct 
consequence of a loss of active melanocytes in the HF pigmentary unit, which results from a 
depletion of the melanocyte SC reservoir in the bulge. Why HF melanocytes seem to age faster 
compared to the epidermal counterparts, is still a mystery.   
Figure7: Localization of melanocyte stem  and 
precursor cells in the HF  
(A) Melanocyte SCs reside in the bulge in close 
contact with HF bulge SCs, whereas diffe-
rentiated melanocytes are located in the hair 
matrix forming the pigmentary unit. (B) 
Melanocytes can be easily visualized with a LacZ 
reporter gene under control of the tyrosinase 
dopachrome tautomerase (Dct-LacZ) promoter 
(modified from (Osawa, 2008)). 
Dct- 
LacZ 
A    B 
Differentiated 
melanocytes Dermal papilla 
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1.2 Integrin receptor family and adhesion structures 
 
Integrins constitute a major family of cell surface receptors, which recognize as ligand ECM 
proteins such as collagen, laminin and fibronectin, expressed together with integrins in all 
metazoans. Integrins form obligate heterodimers composed of non-covalently associated α and β 
subunits, each being a transmembrane glycoprotein, where the majority of the domains of both 
subunits reside in the extracellular space and are required for ligand interaction (Humphries et al., 
2006; Hynes, 2002).  In mammals there are 18 α and 8 β subunits, which give rise to 24 distinct 
integrins heterodimers with specialized function and ligand binding activity (Figure8). Some 
integrin subunits like β1 form heterodimers with several different α subunits, whereas others such 
as β4 or β6 form only single heterodimers. Integrins can be grouped into four classes: first, RGD 
peptide recognizing integrins that bind molecules like fibronectin, vitronectin and others including 
latent TGFβ binding protein (LTBP) (see section 1.3.6) through an RGD motif; second, laminin 
binding receptors where the binding mode is still unknown; third, collagen receptors binding to a 
GFOGER peptide motif; forth, the LDV peptide recognizing integrins that bind fibronectin and 
other ligands such as vascular cell adhesion molecule (VCAM)1 (Humphries et al., 2006). 
Integrins are regarded as molecular switches as they can reversibly change from a low to a high 
ligand affinity conformation, referred as integrin activation. Integrin activation, connection to the 
intracellular cytoskeleton and signaling is mediated by binding of multiple cytoskeletal and 
adaptor proteins to the rather short cytoplasmic tail of the β and less frequently to the α subunit. 
This allows reversible anchoring of the cellular actin cytoskeleton to the ECM and other cells. 
Figure8: Integrin heterodimer family 
The integrin heterodimers can be 
grouped into several subclasses 
according to their ligand specificity for 
collagen, laminin or RGD motif 
containing ligands as well as their 
leukocyte restricted expression. All gray 
plaid and striped α subunits harbor α-
inserted (αI) domains in the headpiece 
(modified from (Hynes, 2002)). 
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Altogether, stable extracellular ligand binding stimulated upon intracellular signals (inside-out 
signal) results in recruitment of further intracellular signaling proteins to the integrins (outside-in 
signal), which therefore serve as signaling platform for bidirectional signaling  across the plasma 
membrane. Thus, integrins control a variety of vital cell functions, such as adhesion, polarity, 
differentiation, migration and cell division, which are all critical for tissue morphogenesis and 
homeostasis. Indeed, deregulations in integrin signaling are hallmarks of many pathological 
conditions including adhesion related diseases such as junctional epidermolysis bullosa, Kindler 
syndrome (KS), Leukocyte adhesion deficiency type (LAD) I and III as well as cancer (see section 
1.5.3 and 1.6.3) (Janes and Watt, 2006; Wilhelmsen et al., 2006; Winograd-Katz et al., 2014).  
The expression pattern of integrins differs between tissues and cell types, where they exert 
distinct functions. Whereas β1 integrin heterodimers are expressed in almost all mammalian cells, 
others are highly restricted such as integrin β2 and β7 (only present on cells of the immune 
system) or β6 and β4 (limited to epithelial cells). The adhesive complexes also differ between the 
different integrin subtypes (see also section 1.2.5): β4 integrin anchors the intermediate filament 
to laminin in hemidesmosomes, allowing stable adhesion of the epithelia (Wilhelmsen et al., 
2006). The integrins β1, β2 as well as β3 can form focal adhesion complexes and podosomes 
important for cell migration and tissue remodeling, respectively (Humphries et al., 2006; Linder 
and Kopp, 2005). The fact that integrins exert many non-redundant functions in vivo is reflected 
by the highly diverse mouse phenotypes upon deletion of individual integrin subunits: for 
example, β1 subunit deletion blocks embryo development already during the peri-implantation 
state, whereas β4 or αv loss lead to perinatal lethality and β2 or β7 deletion result in viable 
animals with defects in immune cells such as leukocytes (Bader et al., 1998; Fassler and Meyer, 
1995; Scharffetter-Kochanek et al., 1998; van der Neut et al., 1996; Wagner et al., 1996).  
 
1.2.1  Integrins in the skin 
In skin integrin expression is largely confined to the basal layer of the epidermis and is down 
regulated during terminal differentiation. Also within the basal layer expression levels of the 
integrins vary, depending on their differentiation status; a hallmark of epithelial SC is their high 
level of β1 integrin heterodimer expression (Zhu et al., 1999). The most abundant integrins in skin 
are α2β1, α3β1 and α6β4, recognizing components of the basement membrane such as collagens 
and laminins. They are all highly expressed in the basal skin layer and mediate firm adhesion of the 
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kerationcytes to the basement membrane as well as to neighboring cells. Indeed, deletion of 
either complete β4 or skin specific β1 leads to severe skin blistering defects and barrier function 
(Piwko-Czuchra et al., 2009; Raghavan et al., 2000; van der Neut et al., 1996). While β4 null mice 
completely lose hemidesmosoms, in β1 deleted mice their stability is severely impaired. In 
addition, β1 deleted mice show an aberrant HF morphogenesis, due to impaired hair matrix cell 
adhesion and migration (Brakebusch et al., 2000; Raghavan et al., 2000).  
In contrast, αvβ5 can be detected only at low levels in the skin and the αvβ5 null mice display no 
obvious phenotype (Huang et al., 2000). Thus, its function for skin homeostasis is still unclear.  
Interestingly, the expression of αvβ6 is restricted to epithelial cells, where it regulates epithelial 
remodeling during development, tissue repair and neoplasia. While during embryo development 
αvβ6 is highly expressed in the whole developing epidermis, in adult epithelial cells it is strongly 
downregulated with the exception of HF (Breuss et al., 1995; Breuss et al., 1993). There, αvβ6 
integrin is highly expressed in the bulge (Tumbar et al., 2004) and the expression level correlates 
with the hair cycle, showing the highest expression in the early anagen and the lowest in telogen 
(Xie et al., 2012). During wound repair, the expression of αvβ6 is highly upregulated in the 
interfollicular epidermis and maintained until wound closure is completed (Eslami et al., 2009). 
Indeed, loss of β6 integrin leads to an accelerated wound closure (Xie et al., 2009). Although 
normal hair morphogenesis and hair cycle are not affected in β6 integrin null mice, after depilation 
keratinocyte proliferation is enhanced and hair cycle induction is accelerated, indicating an 
aberrant HF bulge SC activation (Xie et al., 2012). In addition, the β6 integrin null mice have 
revealed an unexpected role for this epithelial integrin in the downregulation of local 
inflammations, as they display increased numbers of macrophages in the skin and persistent 
accumulation of activated lymphocytes in the lung (Huang et al., 1996).  
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1.2.2 Integrin structure and activation 
 
Both integrin subunits are composed of multiple, extended extracellular domains (~800 amino 
acids each) referred to as ectodomain, a 20 amino acids single pass transmembrane domain (TMD) 
and a short unstructured cytoplasmic “tail“ domain, which generally ranges from 20-70 amino 
acids in length. The only exception is the β4 cytoplasmic tail being much larger (∼1000 amino 
acids). Crystal structure analysis have revealed that the α subunit consists of several modules, 
subdivided into the more membrane proximal leg domain and the more distal, ligand-binding 
head domain (Figure9A,B). The most N-terminal β-sheet structure of the α ectodomain folds into a 
seven-bladed β-propeller domain. The α subunit leg contains three extended β-sandwich domains, 
the thigh domain in the upper and the two calf-1 and -2 domains in the lower leg. The thigh and 
Extrinsic ligand 
Extrinsic ligand 
A 
B 
Figure9: Integrin activation  
The scheme depicts the integrin structure in 
the low (1),  intermediate (2) and high affinity 
state (3) and illustrates the domain re-
arrangement during activation of integrins 
that lack (A) or contain (B) an αI domain. The 
proposed predominant orientation of the 
flexible β subunit lower legs is shown, 
whereas the less predominant is indicated 
with dashed lines. (C) Communication 
between αI and βI domains. It has been 
proposed that a glutamine residue (Glu) in the 
αI domain acts as an intrinsic ligand that binds 
to the activated βI domain MIDAS leading to 
the subsequent activation of the αI domain 
MIDAS (modified from (Luo et al., 2007)). 
 
C 
Intrinsic 
ligand 
Extrinsic ligand 
active MIDAS 
inactive MIDAS 
Glu residue 
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calf-1 domain are connect by a small Ca2+ binding loop, which serves as a flexible joint, termed 
“genu”, for switchblade extension (discussed below).   
Conversely, the structure of the β subunit is more complex. The headpiece of the β domain is 
formed by a plexin/semaphorin/integrin (PSI) domain that is interrupted by a β sandwich hybrid 
domain containing the β-inserted (βI) domain. In the folded β subunit headpiece the PSI domain is 
located below the hybrid-βI domain and bound to the lower headpiece by a disulfide bond. In 
addition, the βI domain contains two segments: the first allows forming the interface with the β-
propeller and the second is essential for specific ligand binding, known as the specificity 
determining loop (SDL). One part of the βI domain directly binds to the β-propeller of the α 
subunit and both together form the ligand binding head of the integrin, which structurally shows 
strong similarity to the Gα/Gβ complex formation in G proteins. The lower β subunit leg part is 
built by four cysteine-rich integrin epidermal growth factor-like (I-EGF)1-4 domains and a short 
disulfide-bonded β-sheet tail (β-tail). The β leg pivot is located between the I-EGF domains 1 and 2 
in close proximity to the α leg genu allowing the unbending of the integrin headpiece, which is an 
important prerequisite for ligand binding.  
Integrins can exist in an equilibrium between two (β1 heterodimers) or three (αv, β2 and β3 
heterodimers) different conformations with different ligand affinity (Luo et al., 2007; Nishida et 
al., 2006): a bent low-affinity (not bent in β1 heterodimers), half extended intermediate-affinity 
and an upright high-affinity state. The shift of this equilibrium from the first to the last 
conformation (i.e. integrin activation) can be induced either by the binding of extracellular ligands 
to integrin ectodomains or by the binding of integrin activatory proteins Talin and Kindlin to the 
cytoplasmic β tails (i.e. inside-out signaling, see section 1.2.4). In the bent conformation the 
headpiece is facing away from potential ligands and in close proximity to the plasma membrane 
with the hybrid domain deeply buried in the integrin leg interface. This low affinity state is 
stabilized by a close association of the integrin legs in the TMD and cytoplasmic tail region, 
forming hydrophobic and electrostatic interactions between the GFFKR and HDR(R/K)E sequence 
motifs in the membrane proximal region, which are highly conserved between all cytoplasmic 
integrin tails (De Melker et al., 1997; Hughes et al., 1996). It is proposed for some heterodimers 
that a salt bridge is formed between the arginine in the α and the aspartate in the β subunit and 
that disruption of this salt bridge can induce integrin tail separation and thus integrin activation 
(Hughes et al., 1996). For the intermediate-affinity state it is proposed that the integrin extends 
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the ectodomain while the headpiece is still closed and the integrin tails are not separated. In the 
high-affinity state the integrin headpiece is fully extended and open, placing the ligand binding site 
150-200 Å away from the cell surface facing towards the ECM and thus increasing the ligand 
accessibility. Moreover, in the TMD the inhibitory salt bridge and the other interaction sites are 
disrupted allowing the integrin legs to separate by up to 70 Å. The equilibrium between the 
different conformations is integrin heterodimer dependent and could partially explain the 
different susceptibility of integrins to activation (Bazzoni et al., 1998).  
Interestingly, nine of the α subunits contain an additional inserted αI domain, a 200 amino acid 
insertion into the 2 and 3 β-sheet of the β-propeller, also known as von Willebrand factor A 
domain. The αI domain is highly homologue to the βI domain but lacks the two additional 
segments (β-propeller interface and SDL). In these integrin heterodimers the αI domain provides 
the major integrin ligand interface and, similar to βI domain, it can switch between different 
conformations (Shimaoka et al., 2000). Upon ligand binding to the αI domain, it is proposed that a 
pseudo-substrate loop, harbored in the α subunit, binds to the β subunit βI domain which 
transmits the conformational change to the hybrid domain, leading to integrin activation 
(Figure9B,C).  
Both I-domains harbor a highly conserved metal ion-dependent adhesion site (MIDAS) for divalent 
cation binding important for ligand binding (the integrin conformation regulation). Under 
physiological conditions the MIDAS is occupied by Mg2+. In addition, the βI domain MIDAS is 
flanked by two Ca2+ binding sites which influence integrin-ligand affinity. One is termed ligand-
induced metal ion–binding site (LIMBS), because this site is only formed in the ligand bound state 
and therefore stabilizes ligand binding. The other is known as adjacent to metal ion–dependent 
adhesion site (ADMIDAS) and has a rather inhibitory effect (Xiao et al., 2004). Because of these 
sites, integrin activation is influenced by divalent cations: Mg2+ has an activatory influence, high 
concentrations of Ca2+ are inhibitory and Mn2+ can induce a high affinity state of integrins through 
replacement of Ca2+ at the ADMIDAS site of the βI domain.  
For integrin activation two models have been proposed: the ‘switchblade’ and the ‘deadbolt’ 
model. However, the exact mechanism remains elusive. In the first model the integrin headpiece 
is bended at the genu towards the plasma membrane in a ligand low-affinity state. The transition 
to a high ligand affinity state occurs by a switchblade-like opening of the ectodomain into an 
extended conformation with separated subunit legs, which allows adaptor protein recruitment. In 
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this model, integrin extension and subsequent leg separation are coupled with the swing-out of 
the hybrid domain.   
The second model suggests that upon initial ligand binding the integrin remains V-shaped bended 
(low-affinity state) and only a piston-like movement of the TMD disrupts the locked orientation of 
the headpiece and β subunit, allowing full integrin extension (high-affinity state) (Arnaout et al., 
2005; Xiong et al., 2003). Hence, transduction of outside-in signaling could already occur without 
ectodomain extension. However, mutations studies on the deadbolt region of the β tail domain 
have highly questioned this model, showing that bended integrin are resistant to inside-out 
activation and that the headpiece extension is essential for full length fibronectin accessibility (Zhu 
et al., 2007a).  
Interestingly, integrin mutants with blocked TMD separation have revealed that tail separation is 
not necessary for full ectodomain extension, ligand binding and cell adhesion, but crucial for the 
propagation of outside-in signaling shown by impaired cell spreading, actin stress fiber and focal 
adhesion formation as well as focal adhesion kinase (FAK) activation (Zhu et al., 2007b). Thus the 
TMD separation is essential for outside-in signal transduction but not for integrin activation.  
 
 
1.2.3 Integrin clustering and catch-bond mechanisms 
The integrin adhesion to the ECM can be strengthened by lateral, non-covalent association of 
integrins at an adhesion site, referred to as integrin clustering (Cluzel et al., 2005; Shattil et al., 
2010). The coordination of multiple weak binding integrin allows the formation of a strong 
adhesion bond in an additive manner. Besides integrin mediated adhesion, integrin clustering 
seems to be also essential for efficient integrin signaling (Bunch, 2010; Zhu et al., 2007b). But how 
clustering is mechanistically regulated, remains largely unclear. For example, it has been proposed 
that during the adhesion process the binding of one integrin to ECM can bring the cell surface 
closer to the ECM facilitating the association of further integrins which promote the formation of a 
cluster (Boettiger, 2012). But it is also possible that integrins form little clusters already in 
suspension which facilitate a stable adhesion formation upon initial contact with the ECM. 
Furthermore, Talin is proposed to play an important role for the integrin clustering process as a 
molecular lattice, due to its dimerization capacity and second integrin binding site (see section 
1.2.4). Because α-Actinin and Filamin harbor multiple integrin binding sites, they could contribute 
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to integrin clustering as well. Finally, a recent study suggests that Kindlin could be more important 
for integrin clustering than integrin activation, but the molecular mechanism remains undefined 
(Ye et al., 2013).  
Recent data underline a more important role for the integrin-actin-cytoskeleton-connection for 
integrin activation than previously assumed (Kong et al., 2009). It has been suggested, that 
integrin ligand interaction of at least certain heterodimers (α5β1, probably not αvβ3) might not 
follow normal kinetics of classical interactions. Usually, when a force is applied between two non-
covalently interacting molecules, the half-life time of these bonds is decreased (slip-bond). For 
α5β1 integrin, it has been shown that instead the half-life time reaches a maximum between 10-
30 pN force (catch-bond) before decreasing at higher force (slip-bond) (Kong et al., 2009). In a 
further publication, it has been shown that a second mechanism different from catch-bonding can 
be observed for α5β1 integrin (Kong et al., 2013): Here the integrin appears to retain a memory of 
a previously applied force, and thus will retain a prolonged half-life time of the ligand interaction 
after a cycle of contraction and relaxation (cyclic-mechanical reinforcement). However, how catch-
bonds and cyclic-mechanical reinforcement are transmitted on the molecular level of the integrin, 
and which adaptor molecules are essentially required, remains to be elucidated.  
 
1.2.4 Integrin activation is mediated by Talin and Kindlin 
For integrin inside-out activation the key players are the cytoskeletal linker proteins Talin and 
Kindlin (Figure10) which are both essentially required for integrin activation and will be discussed 
below. 
 
 
 
Figure10: Talin and Kindlin structure 
Talin consists of a large rod and a head domain 
containing a four point one protein, ezrin, 
radixin, moesin (FERM) domain composed of 
three subdomains (F1-3) and a small F0 domain. 
In the inactive state the Talin rod domain is 
supposed to cover the integrin binding site in the 
F3 subdomain. Kindlins consist of a small N-
terminal domain and a FERM which is highly 
similar to Talin but in addition harbors a 
pleckstrin homology (PH) domain in the F2 
subdomain (modified from (Moser et al., 
2009b)). 
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1.2.4.1 Talin 
 
 
 
Talin is a  large cytoplasmic adaptor protein (~270 kDa) consisting of a N-terminal 47 kDa head 
domain with a four point one protein, ezrin, radixin, moesin (FERM) domain and a 220 kDa C-
terminal flexible rod domain, which is composed of consecutive helical bundles with multiple 
binding sites for filamentous (f)-Actin binding protein Vinculin (Figure10) (Critchley and Gingras, 
2008).  
The FERM domain consists of three subdomains (F1, F2 and F3) and shares considerable sequence 
homology with the FERM domain of Kindlin. The F3 subdomain harbors a phosphotyrosine binding 
(PTB) fold that can directly bind to the membrane proximal NPxY motif in the cytoplasamtic β 
subunit tail (Wegener et al., 2007). Structural analysis of the β3 tail Talin head complex have 
revealed that the initial PTB NPLY binding only leads to separation of the integrin legs if Talin also 
binds to a more membrane proximal region of the β3 tail, leading to disruption of the inhibitory 
salt bridge (Figure11) (Wegener et al., 2007). 
In addition, the Talin rod domain contains a second integrin binding site and a Talin/HIP1R/Sla2p 
actin tethering C-terminal homology (THATCH) domain at the very end, allowing Talin proteins to 
dimerize as well as to bind f-Actin directly (Senetar et al., 2004; Smith and McCann, 2007). The 
dimerization of two Talin molecules is proposed to promote integrin clustering. In support, calpain 
protease induced Talin head cleavage results in focal adhesion disassembly (Franco et al., 2004).   
 
Figure11: Structural model of Talin 
induced β3 integrin activation 
(A) In the inactive conformation the 
integrin heterodimers are connected 
via a salt bridge. (B) The Talin F3 
domain binds to the NPLY motif in the 
membrane distal (MD) part of the β3- 
integrin tail resulting in a higher order 
of the cytoplasmic tail. (C) Sub-
sequently, the Talin F3 domain 
electrostatically interacts with acidic 
lipid headgroups in the plasma 
membrane and a membrane proximal 
(MP) region of the cytoplasmic β tail, 
inducing the destabilization of the salt 
bridge, separation of the integrin tails 
and integrin activation (modified from 
(Wegener et al., 2007)). 
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1.2.3.2 Kindlin 
  
Kindlin are cytosolic proteins with a length of around 680 amino acids and a size of  ~75 kDa and 
will be discussed in details in section 1.5. In contrast to Talin, the Kindlin FERM domain is divided 
by a pleckstrin homology (PH) domain in the F2 subdomain (Kloeker et al., 2004; Shi and Wu, 
2008). The PH domain of Kindlin interacts with multiple phosphoinositides, especially with 
phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P3), important for its membrane localization and 
to sustain integrin meditated adhesion and fibronectin deposition (Qu et al., 2011). Because 
Kindlins lack any rod domains, actin cytoskeleton linkage is mediated through direct binding to 
integrin-linked-kinase (ILK) and the filamin-binding protein Migfilin (Mackinnon et al., 2002; Tu et 
al., 2003). Also Kindlins have been shown to form dimers, however the function and physiological 
relevance remain unclear (Lai-Cheong et al., 2008).  
Using integrin tail pull down assays, Kindlin has been shown to bind directly to the cytoplasmic 
tails of β1, β2, β3 β5 as well as β6 integrins. Interestingly, the Kindlin F3 FERM subdomain seems 
to interact with three distinct motifs in the cytoplasmic integrin tail (Figure12) (Bandyopadhyay et 
al., 2012; Fitzpatrick et al., 2014; Harburger et al., 2009; Moser et al., 2009a; Moser et al., 2008; 
Ussar et al., 2008). While Talin binds to the membrane proximal NPxY motif, Kindlin interacts with 
the membrane distal NxxY motif in the cytoplasmic β tail (Harburger et al., 2009). In addition, 
Kindlin interacts with a serine/threonine motif present between the NPxY and NxxY motifs of the 
β integrin cytoplasmic tail (Bottcher et al., 2012). A recent study revealed a third interaction site, 
where a carboxylate binding motif (h-G-h) in the Kindlin F3 region binds the COOH-terminus of the 
β integrin tail, which seems to have a crucial role for the Kindlin affinity to different integrin tails 
(Fitzpatrick et al., 2014).  
Mutation of these critical residues in the cytoplasmic integrin tails leads to impaired Kindlin 
localization at adhesion structures as well as integrin activation defects, indicating that integrin 
binding is important for Kindlin localization and integrin mediated functions (Bandyopadhyay et 
al., 2012; Bottcher et al., 2012; Fitzpatrick et al., 2014; Moser et al., 2008). 
Figure12: Model for Kindlin binding to the cytoplasmic integrin tail  
Kindlin is proposed to bind with its PH domain to phosphoinositides 
in the  plasma membrane and with the FERM F3 subdomain to three 
distinct motifs in the cytoplasmic integrin β tail: a serine/threonine 
motif (1), the membrane distal NxxY motif (2) and COOH-terminus of 
the β integrin tail (modified from (Karakose et al., 2010)). 
(1) 
(2) 
(3) 
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1.2.4.3 Kindlin and Talin at the integrin tail  
 
Figure13:  Models for cooperatively of Kindlin-Talin binding to the integrin tail during integrin activation 
(A) Sequential binding model: Kindlin binds first to the membrane distal NxxY motif and facilitates the 
recruitment of Talin, which leads to the displacement of Kindlin; (B) Cis co-operation model: Kindlin and 
Talin bind to their  integrin tail binding sites and form a ternary complex, which induces integrin activation; 
(C) Trans co-operation model: Here Talin and Kindlin bind different integrin tails and upon clustering 
facilitate integrin activation (modified from (Moser et al., 2009b)). 
 
How Kindlin and Talin interact with the cytoplasmic β integrin tail at the plasma membrane is still 
unclear and three binding models have been proposed: First, Kindlin binding could facilitate 
subsequent Talin recruitment, which in turn may leads to the Kindlin displacement (sequential 
binding model). Second, nuclear magnetic resonance (NMR), size-exclusion chromatography, 
surface plasmon resonance (SPR) experiments and ultracentrifugation studies indicate that both 
activators can bind simultaneously to β integrin cytoplasmic tails (Bledzka et al., 2012; Yates et al., 
2012). Thus formation of a ternary complex could induce integrin activation (cis co-operation 
model). Third, Kindlin and Talin could be engaged at different integrin tails and cooperate in trans 
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in integrin nanocluster (trans co-operation model). In a recent study this model, however, has 
been excluded genetically (Meves et al., 2013). 
The inside-out integrin activation seems to be tightly controlled at the level of integrin and 
activator interaction: First, structural analysis have revealed that Talin binding to β3 integrin tail is 
blocked upon phosphorylation of the NPxY tyrosine residue by sarcoma (Src) family kinases (Datta 
et al., 2002; Oxley et al., 2008).  Similarly, phosphorylation of the NxxY motif of β tails has been 
shown to inhibit Kindlin binding (Bledzka et al., 2010). However, this seems to be integrin specific 
since mice that possess a double tyrosine-to-phenylalanine mutation in β1 tails display no 
phenotype characteristic for β1 integrin activation defects (Czuchra et al., 2006). Second, Talin 
exists in an auto-inhibited (closed) conformation in the cytoplasm with an intramolecular 
interaction between its head FERM and tail domain (Goksoy et al., 2008), masking several binding 
regions including the integrin β tail-binding sites. So far the activation mechanism of Talin remains 
elusive. However, it has been proposed that Talin binding to phosphatidylinositol-4,5-
bisphosphate (PI(4,5)P2) promotes a conformational change exposing the Talin head integrin 
binding site at the plasma membrane (Martel et al., 2001). Furthermore, the rat sarcoma (Ras)-like 
small GTPases Ras-related protein-1 (Rap1) has been shown to form an activating complex with its 
effector Rap1-interacting adapter molecule (RIAM) at the plasma membrane. This complex is able 
to recruit Talin and unmask its integrin binding site allowing integrin activation (Han et al., 2006b). 
It is still unclear if Kindlins needs to become activated in vivo, as well. A recent study in C. elegans 
proposes that when Kindlin binds to ILK a conformational change is induced, allowing Kindlin to 
bind to the cytoplasmic integrin tail (Qadota et al., 2012). It is currently unknown, if this 
mechanism holds true also for the mammalian Kindlin orthologues.  
Taken together, a cell is only able to spread when integrins engage their ligand, become fully 
activated and stabilized in the high-affinity conformation and the integrin legs are separated 
through Kindlin and Talin interaction, allowing efficient FAK recruitment and activation and 
subsequently stable adhesion formation.  
  
I n t r o d u c t i o n | 37 
 
1.2.5 From integrin activation to mature integrin adhesions 
 
 
The activation and clustering of integrins is able to induce a vast array of signaling events, termed 
outside-in signaling, which eventually results in the development of a nascent adhesion. 
Depending on the tissue, cell type, cellular context and environment, these nascent adhesion 
mature into focal adhesions, fibrillar adhesion, podosomes or invadopodia. All these integrin 
adhesion structures exert different functions in adhesion-mediated signaling, ECM remodeling as 
well as cell migration and invasion. Because the short cytoplasmic integrin tails lack any catalytic 
activity, integrins completely rely on the recruitment of effector proteins, termed focal adhesion 
proteins, to generate these distinct adhesion classes/types. In the last years multiple approaches, 
including proteomics, bioinformatics and immunohistochemistry, have identified 232 focal 
adhesion proteins which define the integrin adhesome (Schiller et al., 2013; Zaidel-Bar et al., 
2007). These focal adhesion proteins can be further divided in 148 intrinsic (remain in the focal 
adhesion upon formation) and 84 transiently associated components. Functionally, they comprise 
various actin regulators, adaptor proteins that link cytoskeletal structures to the cytoplasmic tails 
of integrins and multiple signaling molecules (Winograd-Katz et al., 2014). Many of these focal 
adhesion proteins have been shown to bind the integrin tail directly serving as scaffolds for 
different sets of effector proteins. Thus, a differential recruitment of focal adhesion proteins 
allows transduction of highly diverse signals.  
Figure14: Integrin outside-in signaling 
Integrin outside-in signaling can be grouped in 
three temporally distinct phases: the 
immediate effects upon activation are the 
activation of lipid kinases and phosphorylation 
of specific protein substrates assisting focal 
adhesion maturation. Subsequent short term 
effects result in the activation of multiple 
signaling pathways and Rho family GTPases, 
which in concert with other actin regulatory 
proteins induce actin cytoskeleton remodeling 
influencing spreading, migration and cell 
polarity. The long term effects induce 
multiple signaling pathways influencing gene 
expression, proliferation, differentiation and 
survival    (adapted from (Legate et al., 2009)).  
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During adhesion formation the recruitment of focal adhesion proteins can be divided in three 
phases which differ in timing (Figure14): upon integrin activation, FAK and Src are activated and 
recruited to the integrin tail. In this priming phase within milliseconds the activated kinases start 
to phosphorylate multiple specific targets such as Paxillin as well as other kinases, which become 
activated themselves leading to signal amplification and propagation. Interestingly, in this phase 
the phosphorylation of integrin bound proteins can create new binding sites and promote the 
recruitment of further adaptor proteins like Crk and p130 Crk-associated substrate (p130Cas), 
generating highly divers signaling platforms (Zaidel-Bar et al., 2007). Moreover an enrichment of 
lipid second messengers, such as PI(4,5)P2 and PI(3,4,5)P3, is observed probably induced by the 
lipid kinase phosphatidylinositol 4-phosphate-5-kinase type I γ (PIPKIγ), which becomes recruited 
to focal adhesions by Talin (Di Paolo et al., 2002). Subsequently, the PI(4,5)P2 rich plasma 
membrane facilitates the binding of further focal adhesion proteins, such as Numb, Src homology 
containing protein (Shc), Tensin as well as Talin, suggesting a positive feedback loop (Martel et al., 
2001). Conversely, increased presence of PI(3,4,5)P3 leads to rearrangement of focal adhesion 
bound α-Actinin and Vinculin. As a short term effect (within minutes), these signals translate into 
rearrangement of the actin cytoskeleton and myosin mediated force generation induced by the 
activation of Ras homolog (Rho) family GTPases and other actin regulatory proteins. Consequently, 
activation of rapidly-accelerated fibrosarcoma (Raf)/ extracellular signal-regulated kinase (ERK)/ 
mitogen-activated protein kinase (MAPK), Jun N-terminal kinase (Jnk) and Akt signaling pathways 
(long term effect), in concert with growth factor signaling such as TGFβ, epidermal growth factor 
(EGF), insulin growth factor (IGF) or platelet derived growth factor (PDGF), induces changes in 
gene transcription and cell behavior, and at the same time modulates cell survival, proliferation 
and differentiation (see also section 1.6.3).   
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1.3 TGFβ signaling 
1.3.1  TGFβ superfamily members 
TGFβ is part of a growth factor superfamily which modulates cell growth, differentiation, 
adhesion, migration, ECM synthesis and apoptosis (Massague, 1998; Siegel and Massague, 2003). 
Currently, it comprises 34 family members subcategorized into the groups of activins, inhibins, 
nodal, myostatin, BMPs and growth/differentiation factors (GDF). These different ligands are 
recognized by specific transmembrane type I and type II serine/threonine kinase receptors which 
form distinct heteromeric complexes upon ligand binding and subsequently activate distinct signal 
transducing Smad complexes in the cell (discussed below).  
The TGFβ pathway seems to have developed in metazoans with the emerging need to control 
multicellular processes and thus is highly conserved in organisms ranging from C. elegans, 
Drosophila melanogaster, Xenopus laevis to mammals (Massague, 1998). 
During embryo development, signaling of TGFβ family members is essential for tissue growth and 
morphogenesis such as vasculogenesis and angiogenesis, whereas in adult tissue it controls 
proliferation of epithelial, endothelial, immune cells and fibroblasts assuring tissue homeostasis  
(Guasch et al., 2007; Siegel and Massague, 2003; ten Dijke and Arthur, 2007). The number of 
target genes for a given TGFβ family member can range from just a few in embryonic SC to many 
hundreds in differentiated cells (Mullen et al., 2011). The strong cellular context dependency and 
apparent multifunctionality of TGFβ signaling was very puzzling in the early characterization: e.g. 
TGFβ is able to inhibit cell proliferation in many epithelial cells but can also enhance proliferation 
in fibroblast and cell growth in endothelial cells (Guasch et al., 2007; Xiao et al., 2012); it enhances 
SC pluripotency, but promotes differentiation in other cells (Park, 2011); in cancer development it 
suppresses pre-malignant cell proliferation, but at the same time promotes conversion to a 
metastatic phenotype (Chaudhury and Howe, 2009).  All these different, partly opposing effects of 
TGFβ signaling indicate that the outcome of the TGFβ response is more dictated by the cellular 
context than by a determinate TGFβ signaling pathway. This multilayered signaling complexity of 
TGFβ in homeostasis and diseases only starts to be unraveled.  
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1.3.2 TGFβ receptors and ligands 
 
 
Members of the TGFβ superfamily bind to two distinct receptor types, known as type II and type I 
receptors, which contain serine / threonine kinase domains in their intracellular part, required for 
signal transduction (Wrana et al., 1994). In mammalians, five type II receptors and seven type I 
receptors are known (Figure15). TGFβ receptor type II (TβRII), BMP receptor type II (BMPRII) and 
anti-müllerian hormone receptor type II (AMHRII) are specific for TGFβ-, BMP- and AMH-type 
ligands, respectively. In contrast, the activin type II and type IIB receptors (ActRII and ActRIIB) bind 
activins, but can also recognize other TGFβ-ligand superfamily members, including nodal and 
BMPs. The type I receptors can be grouped in the TGFβ specific TβR-I (activin receptor-like kinase 
(ALK)5) and ALK1, the BMP type I receptors BMPR-IA (ALK3), BMPR-IB (ALK6) and ALK2 as well as 
the activin, inhibin and nodal recognizing ALK4 and Alk7. 
The access of ligands to the receptors is regulated by a large family of extracellular ligand trap 
proteins which retain ligands in the ECM, such as latency associated protein (LAP) for TGFβ, 
follistatin for activin and noggin for BMP as well as by cell surface proteins which act as co-
receptors, including betaglycan (also known as TGFβ type III receptor) and endoglin (Figure15). 
The LAP-TGFβ ligand trap complex will be discussed in detail below (see section 1.3.5 and 1.3.6.2). 
The type II receptor kinases are constitutively active and upon ligand binding the recruitment of 
type I receptor into hetero-tetrameric complexes is facilitated. The constitutively active type II 
receptor kinases subsequently phosphorylate the type I receptor kinases at the C-terminal GS 
domain, a highly conserved 30 amino acid sequence with a characteristic SGSGSG sequence 
directly upstream of the kinase domain (Wieser et al., 1995). This phosphorylation leads to a 
Figure15: TGFβ superfamily 
signal transduction 
The scheme illustrates the TGFβ 
superfamily ligands and their 
associated ligand trap proteins 
recognizing different TGFβ type I 
and II receptors heterodimers. 
Some ligands require an 
accessory receptor for receptor 
binding. Activation of different 
TGFβ heterodimers can lead to 
highly diverse signal transduction 
through recruitment of different 
Smad transcription factors 
(modified from (Shi and 
Massague, 2003)).  
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conformational change resulting in type I receptor kinase activation and phosphorylation of 
intracellular targets. Thus, in the TGFβ signaling pathway, type I receptors act as downstream 
components of type II receptors and determine the specificity of the intracellular signals induced 
by TGFβ family cytokines. 
 
 
1.3.3 Canonical Smad TGFβ signaling 
 
 
Smads are the major signaling molecules downstream of the serine/threonine kinase receptors 
which can be divided in to three functional subgroups: the receptor-activated Smads (R-Smads), 
common mediator Smad (Co-Smad) and the inhibitory Smads (I-Smads). Structurally, all Smads are 
characterized by two conserved regions, the N-terminal Mad homology (MH)1 domain and the C-
terminal MH2 domain which are joined by a short linker region of poorly conserved amino acid 
composition. While both MH domains play a role in gene transcription regulation, MH1 mediates 
direct DNA binding and nuclear import and MH2 Smad oligomerization. The R-Smads (Smad1, 
Smad2, Smad3, Smad5, and Smad8) are directly phosphorylated by the type I receptors on their C-
terminal serine-serine-x-serine (SSXS) motif, leading to a conformational change in the MH2 
domain which allows oligomerization with Co-Smad. The TGFβ superfamily cytokines can be 
classified into two subfamilies depending on the Smad signaling pathways they activate: while 
Smad2 and Smad3 are phosphorylated in response to the TGFβs and activin, Smad1, Smad5, and 
Figure16: The canonical TGFβ signal transduction 
TGFβ binds the constitutive active type II receptor kinase leading 
to the recruitment and activation of type I receptor kinase, 
whereby the type II kinase phosphorylates and activates type I 
receptor. Subsequently, type I receptor phosphorylates receptor-
bound R-Smad (Smad2/3) transcription factors at the C-terminal 
SSXS motif, inducing their release, association with the Co-Smad 
(Smad4) in the cytoplasm and translocation into the nucleus. I-
Smad (Smad7) promote TGFβ receptor dephosphorylation and 
degradation, inhibiting TGFβ signal transduction. In the nucleus 
activated Smad complex interact with multiple co-activators and 
repressors generating distinct transcriptional responses (modified 
from (Massague and Gomis, 2006)).  
Smad7 
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Smad8 are phosphorylated in response to BMP. The Co-Smad, Smad4, assists the signal 
transduction from both the activin/TGFβ as well as BMP signaling pathways by oligomerizing with 
activated R-Smads, allowing nuclear translocation. In the nucleus the complex binds to Smad 
responsive elements (SRE) and cooperates with other transcription co-factors to either activate or 
repress target gene transcription (Feng and Derynck, 2005).   
Smad6 and Smad7 function as I-Smads. They are induced by BMP and/or TGFβ/activin, 
respectively, and inhibit activation of R-Smads through competition for binding to activated TβR-I 
(Massague, 1998). Smad7 has been shown to promote dephosphorylation of activated type I 
receptor as well as its proteasomal degradation by recruiting Smad specific E3 ubiquitin protein 
ligase (Smurf) after endocytosis (Kavsak et al., 2000; Shi et al., 2004). In addition, attenuation of 
TGFβ signaling is mediated by either ubiquitination and subsequent proteasomal degradation of 
Smad2/3 (Lin et al., 2000) or dephosphorylation of the R-Smad/Co-Smad complex via the 
phosphatase PPM1A (Lin et al., 2006). The dephosphorylated Smads have been shown to 
translocate back into the cytoplasm to await the next round of signaling.  
Interestingly, the TGFβ signaling does not only occur at the plasma membrane, but it is further 
regulated by endocytosis. TGFβ receptors belong to the family of serine/threonine kinase 
receptors that are rapidly internalized after ligand binding. Recent studies have shown that 
activated TGFβ receptors can follow two distinct internalization pathways which dictate 
downstream signal attenuation or activation (Di Guglielmo et al., 2003). First, the endocytosis via 
clathrin-coated vesicles and recruitment of Smad anchor for receptor activation (SARA) and 
Smad2 in early endosomes promote further signaling to the nucleus (TGFβ signaling 
enhancement), and second, the TGFβ receptor can be engulfed into caveolin-positive vesicles 
which further engage Smurf and Smad7 leading to rapid receptor degradation and TGFβ signaling 
attenuation.  
Taken together, TGFβ signal transduction is regulated on multiple levels and most likely more will 
be identified in the near future. The expression pattern of different inhibitory and activatory 
Smads, TGFβ receptor subtypes and transcriptional co-factors are most likely determining the cell 
type specific response. However, how these different modes of TGFβ pathway regulation 
cooperate and influence each other leading to a cell context dependent specificity, are still open 
questions in the field. 
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1.3.4 Non-canonical Smad TGFβ signaling  
In addition to the Smad depended signaling, TGFβ receptor activation is able to induce multiple 
signaling pathways such as phosphoinositide 3-kinase (PI3K), Ras, partitioning defective 6 (Par6), 
and Jnk/p38/ MAPK, referred to as non-canonical TGFβ pathway (Mu et al., 2012). 
 
 
 
 
 
It has been shown that activated TGFβ receptor is able to directly phosphorylate the planar 
polarity protein Par6, a regulator of epithelial cell polarity and tight junction assembly (Figure17). 
Phosphorylated Par6 recruits the E3 ubiquitin ligase Smurf1 to tight junctions where it targets 
RhoA GTPase for degradation, thereby causing loss of tight junctions and polarized migration 
(Ozdamar et al., 2005). The C-terminal domain of BMPRII binds and promotes the activity of LIM 
kinase 1 (LIMK1), an inhibitor of the actin-depolymerizing factor Cofilin, thereby stabilizing actin 
filaments and inducing a loss of epithelial identity (Foletta et al., 2003).  
In addition, TGFβ receptor activation induce MAPK and PI3K pathway involving tumor necrosis 
factor receptor-associated factor 6 (TRAF6), mammalian target of rapamycin (mTORC) and other 
mediator; however, detailed mechanistic insights are mostly missing. On the one hand, it has been 
proposed that TRAF6 in a complex with Smad7 bind to the TGFβ receptor, leading to the activation 
of TGFβ-activated kinase 1 (TAK1) and subsequently induction of the Jnk/p38/MAPK and IκB 
kinase (IKK)/ nuclear factor kappa-light-chain enhancer of activated B cell (NF-κB) pathway (Mao 
et al., 2011). On the other hand, TGFβ and BMP receptors can activate several other signal 
transducers such as mTORC, PI3K, ERK or RhoA.  But whether these pathways are regulated 
through a direct TGFβ receptor induced activation or if it is the result of a collateral activation of 
other receptors upon TGFβ signaling, is currently unknown (Mu et al., 2012).  
 
Figure17: The non-canonical TGFβ signal transduction 
Activated TGFβ receptor type II (TGFBR2) can directly 
phosphorylate Par6 to recruit Smurf1 and target RhoA 
for degradation leading to disassembly of tight 
junctions in epithelial cells. BMP receptor type II 
(BMPR2) contains a long C-terminal tail that binds and 
activates LIMK1, thereby inhibiting Cofilin and 
stabilizing actin filaments. In addition, recruitment of 
TRAF6 and Smad7 to activated TGFβ receptors results 
in the activation of TAK1, which induces p38, JNK and 
IKK signaling. Furthermore, TGFβ and BMP receptors 
are proposed to activate several other signal 
transducers such as mTORC, PI3K, Shc, ERK and Rho 
(modified from (Massague, 2012)).  
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1.3.5 TGFβ synthesis and storage  
After the identification of TGFβ1 in 1980s, two additional isoforms of TGFβ have been identified in 
mammals, TGFβ2 and TGFβ3, which show similar functions in vitro. However, in vivo mouse 
studies revealed that isoform specific complete deletion had very different influence on the HFs, 
indicating that each isoform has specific and non-redundant functions: TGFβ1 seems to promote 
catagen induction and its deletion results in increased epidermal proliferation and accelerated HF 
development. In contrast, TGFβ2 loss has no effect on epidermal cell proliferation, delays HF 
morphogenesis and inhibits bulge cell activation during anagen induction, whereas TGFβ3 null 
mice display no HF defects (Foitzik et al., 2000; Foitzik et al., 1999; Glick et al., 1994; Oshimori and 
Fuchs, 2012).  
 
The three isoforms are all encoded by separate genes and produced as an inactive complex (pro-
TGFβ), consisting of a 25 kDa N-terminal pro-peptide, termed LAP and a covalently bound 12.5 kDa 
TGFβ at the C-terminus (Figure18). Because all LAP have sequence variations between the three 
TGFβ isoforms, they are grouped accordingly in LAP1, 2, 3. TGFβ is synthesized as a pre-pro-
protein, which undergoes proteolytic processing in the rough endoplasmic reticulum. 
Subsequently, two TGFβ monomers dimerize through disulfide bonds and are then cleaved by 
Furin protease in the Golgi leading to the small latent TGFβ complex (SLC), in which LAP and TGFβ 
 
 Figure18: Schematic model of synthesis, secretion and matrix deposition 
of TGFβ 
TGFβ is synthesized as a pre-pro-protein, which undergoes proteolytic 
processing in the rough endoplasmic reticulum (1). Two monomers of 
TGFβ dimerize through disulfide bonds (2). The pro-TGFβ dimer is then 
cleaved by Furin convertase generating the small latent TGFβ complex 
(SLC), where LAP and TGFβ are connected by non-covalent bonds (3). 
Within secretory vesicles the large latent TGFβ complex (LLC) is formed by 
covalent attachment of LTBP through a disulfide bond (4). After secretion 
the N-terminal and hinge region of LTBP interact with ECM components 
such as fibronectin to which they can be covalently cross linked by 
transglutaminases. The C-terminal region of LTBP interacts non-covalently 
with the N-terminal region of Fibrillin-1 (modified from (ten Dijke and 
Arthur, 2007)).  
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are non-covalently connected through salt bridges and hydrophilic as well as hydrophobic 
interactions (Shi et al., 2011). In the subsequently secreted SLC, TGFβ is buried in the structure of 
LAP, preventing recognition of TGFβ by its high affinity receptor TβRI. In order to become 
biological active, TGFβ needs to be liberated (Annes et al., 2003), allowing a tight control of this 
potent cytokine in time and location.  
Furthermore, in the majority of cases cells secrete TGFβ bound to the carrier protein LTBP as part 
of a large latency complex (LLC) important for association of TGFβ to the ECM. Only very few cells 
have been reported to produce and secrete a diffusible form of SLC, however the physiological 
relevance is unclear (Dallas et al., 1994). The LCC is stabilized through a covalent disulfide bond 
between the SLC and LTBP formed within secretory vesicles (Saharinen and Keski-Oja, 2000). LTBP 
is part of the superfamily of fibrillin-like ECM components that bind to several ECM proteins, such 
as Fibrillin-1 (ten Dijke and Arthur, 2007), fibronectin (Taipale et al., 1994) and vitronectin 
(Schoppet et al., 2002). The C-terminus and the hinge region of LTBP can be covalently cross linked 
to the ECM by transglutaminases (Nunes et al., 1997). In mammals, four isoforms with different 
features are expressed (LTBP1-4). Besides LTBP2, all other LTBPs can bind to all isoforms of TGFβ 
(Saharinen and Keski-Oja, 2000). A proper incorporation of LLC into the matrix is essential for an 
efficient TGFβ function as deletion of the N-terminal ECM binding motif of LTBP abolishes TGFβ 
liberation (Annes et al., 2004).  
 
1.3.6 TGFβ release mechanisms 
Although TGFβ can be released from the matrix by huge number of processes including heat, pH, 
reactive oxygen species (ROS) or various proteases (see section below), under physiological 
conditions RGD binding αv-class integrins represent the key activators for TGFβ activation in vivo. 
So far αvβ3, αvβ5, αvβ6 and αvβ8 have been shown to liberate TGFβ, while other RGD binding 
integrins, such as α5β1 or α8β1 cannot release TGFβ (Asano et al., 2005a, b; Mu et al., 2002; 
Munger et al., 1999). Furthermore, the observation that receptor-bound TGFβ induces αvβ3, αvβ5 
and αvβ6 integrin expression suggests a positive feedback loop (Pechkovsky et al., 2008). 
1.3.6.1 Integrin independent TGFβ release mechanisms 
Conversion of TGFβ1 into its biologically active form can be mediated through proteolytic cleavage 
by plasmin, elastase and a variety of matrix metalloproteinases (MMPs) such as MMP-9 or MMP-2 
I n t r o d u c t i o n | 46 
 
(Taipale et al., 1994; Yu and Stamenkovic, 2000) as well as through destabilization of the LAP-
TGFβ1 complex induced by ROS or harsh pH conditions (Barcellos-Hoff and Dix, 1996; Lyons et al., 
1988). In addition, interaction between LAP1 and thrombospondin-1 (Murphy-Ullrich and 
Poczatek, 2000) and the mannose-6-phosphate receptor (Dennis and Rifkin, 1991) promote TGFβ1 
activation independently of proteolytic cleavage. However, detailed mechanistic insights are still 
missing and the physiological relevance remains to be determined.  
Surprisingly, in platelets a secreted furin-like proprotein convertase appears to activate TGFβ1 
independently of any known mechanisms (Blakytny et al., 2004), suggesting that further and 
probably highly cell type specific TGFβ release mechanisms will be discovered in the near future. 
1.3.6.2 Integrin mediated TGFβ release 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure19: Integrin mediated TGFβ release of different αv-class integrins 
The LLC is tethered to the ECM on the surface of cells. TGFβ can be released by integrins via protease-
independent and protease-dependent mechanisms. To unmask TGFβ, αv-class integrins bind to the RGD 
tripeptide motif in the LAP region. The interaction with αvβ3, αvβ5 or αvβ6 integrin induces a 
conformational change in the latent complex by generating an actin cytoskeleton depended pulling force, 
allowing TGFβ to access its receptors. Conversely, the αvβ8 integrin binds LAP, enabling the membrane 
bound protease MT1-MMP to cleave LAP and free TGFβ (modified from (Worthington et al., 2011)). 
 
One key prerequisite of αv-class integrins is their ability to bind to the RGD integrin-binding motif 
in the LAP of the SLC and consequently, point mutations of LAP-RGD to LAP-RGE abolish integrin 
Protease-independent  
release mechanism 
Protease-dependent 
release mechanism  
Only αvβ8 αvβ3, αvβ5 and 
αvβ6 
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mediated TGFβ liberation (Ludbrook et al., 2003; Munger et al., 1998; Munger et al., 1999). 
Although all TGFβ-releasing integrins interact with the RGD motif in the LAP, the release 
mechanism between the integrins differs (Figure19): for αvβ3, αvβ5 and αvβ6 integrin the TGFβ 
release is spatially restricted and controlled by cell contraction as well as dependent on an intact 
actin cytoskeleton (Munger et al., 1999; Wipff et al., 2007). Consequently, when cell contraction is 
enhanced by Thrombin, TGFβ release is increased. Collectively, these results propose a model for 
the TGFβ activation where integrin binds to and pulls on the LLC, inducing a conformational 
change in the LAP rendering the TGFβ now accessible for its high affinity receptor. Indeed, the 
recently solved crystal structure of the SLC of TGFβ confirmed that LAP-TGFβ is not accessible for 
TGFβ receptor and that mechanical force transmitted by αvβ6 integrins promotes a 
conformational change, required for TGFβ release (Shi et al., 2011). On the other hand, the 
intracellular signals required for αvβ6 integrin activation were not known so far.  
Conversely, the αvβ8 integrin induced TGFβ release does not depend on actin-mediated cell 
contractility (Mu et al., 2002). Instead, the αvβ8 integrin release mechanism crucially depends on 
the proteolytic cleavage of LAP by cell surface metalloprotease MT1-MMP (also known as 
MMP14), leading to the release of TGFβ which then might act at more distant sites as well. 
Because the αvβ8 release mechanism has only been investigated in epithelial cells, further studies 
in αvβ8 expressing cells (e.g. brain or immune system) are required to test if this is a general 
mechanism for protease mediated TGFβ activation and which other proteases may be involved. 
Taken together, the integrin mediated TGFβ release represents a very elegant mechanism for 
specific and locally restricted TGFβ release and signaling activation.  
The relevance of integrin mediated TGFβ release for in vivo development and homeostasis is 
further underlined by the observation that mice with the integrin-binding deficient LAP proteins 
(RGD motif mutated to RGE) recapitulate all major phenotypes of TGFβ1 null mice, including multi-
organ inflammation and defects in vasculogenesis (Shull et al., 1992; Yang et al., 2007). This 
striking phenotype overlap with TGFβ deficient mice and phenotypes of mice lacking αv-class 
integrins (Aluwihare et al., 2009; Bader et al., 1998) demonstrates an essential interconnection of 
integrins with TGFβ signaling in vivo, while the role of non-integrin mediated release mechanisms 
remains less clear. Nevertheless, it is still possible that integrin dependent and independent TGFβ 
release mechanisms influence each other and potentially synergize during certain disease 
conditions. In line, in contrast to TGFβ1 and 3, TGFβ2 lacks an RGD site, thus other release 
mechanisms must be responsible for its activation. 
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1.4 Wnt signaling pathways 
 
Figure20:  Wnt signaling pathways 
Simplified scheme displaying the canonical Wnt (B) and two main non-canonical Wnt pathways (A,C) 
induced by specific Wnt, Frizzled (Fzd) and Wnt co-receptors. (A) Planar cell polarity (PCP) signaling triggers 
activation of the small GTPases RhoA and Ras-related C3 botulinum toxin substrate (Rac1), inducing Rho-
associated kinase (ROCK) and JNK, respectively, leading to actin polymerization and regulation of cell 
polarity and motility. (B) In the absence of Wnts β-catenin is constantly degraded via the destruction 
complex (comprising glycogen synthase kinase 3 (GSK3), casein kinase Iα (CKIα), Axin and adenomatosis 
polyposis coli (APC)) leading to repression of Wnt target gene transcription. Upon Wnt signaling, the 
destruction complex is inactivated, allowing β-catenin to accumulate in the nucleus and induce target gene 
transcription in complex with TCF. (C) The Wnt/Ca
2+
 pathway activate Ca
2+ 
release, leading to the activation 
of calmodulin-dependent kinase II (CAMKII), protein kinase C (PKC) and Calcineurin. Calcineurin activates 
nuclear factor of activated T cells (NFAT), which regulates the transcription of genes controlling cell fate and 
cell migration. PCP and Wnt/Ca
2+
 pathways antagonize β-catenin signaling at various levels (modified from 
(Niehrs, 2012)). 
 
One of the fundamental pathways directing cell proliferation, polarity, cell fate determination and 
SC maintenance in embryonic development as well as tissue homeostasis are the Wnt pathways 
(Logan and Nusse, 2004). In particular the fate of skin cells appears to be very sensitive to the 
precise levels of Wnt/β-catenin signaling: High Wnt/β-catenin signaling instructs keratinocytes to 
form hair, whereas intermediate to low levels of Wnt/β-catenin signaling specify the sebocyte and 
interfollicular epidermis lineages (Silva-Vargas et al., 2005). When this fine balance of Wnt/β-
catenin signaling is deregulated, skin cells are promoted to form particular lineages, leading to 
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developmental defects as well as cancer (Lim and Nusse, 2013; MacDonald et al., 2009). There are 
several Wnt signaling pathways which depend on the specific surface receptors as well as Wnt 
ligands and mediate canonical Wnt signaling, non-canonical planar cell polarity signaling or non-
canonical Wnt/Ca2+ signaling (Figure20). While the canonical pathway regulates gene transcription 
through the multifunctional adaptor protein β-catenin, the non-canonical planar polarity pathway 
modulates the actin cytoskeleton inducing cell shape changes and Wnt/Ca2+ pathway controls 
calcium levels in the cell (see section 1.4.5 and 1.4.6 for details).  
 
1.4.1 Wnt ligands  
  
Almost 30 year ago the first Wnt protein was identified and up today 19 Wnt genes have been 
described in the human and mouse genome mediating complex and specific Wnt signaling. While 
canonical Wnt signaling is induced by Wnt ligands such as Wnt1, 3, 3a, 8a, 8b, 10a or 10b, non-
canonical Wnt signaling is mediated by Wnt4, 5b, 6, 7a, 7b, or 11. Interestingly, some Wnt ligands 
like Wnt5a are able to promote β-catenin dependent and independent Wnt signaling contingent 
on the receptor binding (see section 1.4.2) (Mikels and Nusse, 2006). All Wnt family members are 
glycolipoproteins with a size of ~40 kDa (350–400 amino acids) containing many conserved 
Figure 21: Wnt ligand synthesis and secretion  
In the endoplasmatic reticulum (ER) Wnt 
ligands are glycosylated and lipid modified 
involving Porcupine. In the Golgi Wnts are 
escorted to the plasma membrane for 
secretion by Wntless, which is retrieved from 
endocytic vesicles and recycled  back to the 
Golgi by the retromer complex. After 
secretion mature Wnts either bind to heparan 
sulfate proteoglycans (HSPGs) and lipoprotein 
particles or form multimers, which can 
modulate Wnt gradients and facilitate long-
range Wnt signaling (modified from 
(MacDonald et al., 2009)).  
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cysteines and an N-terminal glycosylated signal peptide for secretion. The post-translational lipid 
modification and glycosylation of Wnt ligands is crucial for the secretion process (Takada et al., 
2006). The multipass transmembrane O-acyltransferase Porcupine has been shown to 
palmitoylate and glycosylate Wnt proteins in the endoplasmatic reticulum (Figure21). For the 
subsequent Wnt transport from the Golgi to the plasma membrane, the seven-transmembrane 
domain protein Wntless is essential. Wntless is proposed to bind to Wnts and sort them to plasma 
membrane from where it is recycled via endocytic vesicles back to the Golgi by the retormer 
complex (Belenkaya et al., 2008). Of note, inhibition of Porcupine by chemical compounds such as 
IWP-2 abolishes Wnt ligand secretion and thus inhibits all Wnt signaling pathways (Chen et al., 
2009).  
Since single cell organisms are lacking Wnt genes, it has been speculated that they have been 
crucial for the development and evolution of multicellular organisms, as they are conserved in all 
metazoan animals including cnidarian and sponges (Kusserow et al., 2005; Petersen and Reddien, 
2009). Indeed, Wnt proteins function as morphogens that can mediate short- and long-range 
signaling in tissues. The presence of lipid anchors in Wnt proteins appears contradictive for a role 
in long-range signaling, as lipid interaction would tether and trap Wnt proteins to the lipid 
membrane of the secreting or a neighboring cell. Thus, it has been speculated that after secretion, 
Wnt proteins either form diffusion competent micelle-like multimeric structures with the help of 
the membrane microdomain protein reggie-1/flotillin-2 (Katanaev et al., 2008) or bind to 
lipoprotein particles allowing long-range signaling (Panakova et al., 2005). However, the relevance 
of Wnt as a long-range spreading morphogen has been recently questioned by a study in 
Drosophila, showing that a membrane-trapped version of Wingless (the main Wnt in Drosophila) 
can also control development, without forming a secreted instructive gradient. Wingless fused to 
the transmembrane protein Neurotactin was expressed under the endogenous promoter leading 
to viable flies that produced normally patterned appendages of almost normal size (Alexandre et 
al., 2014). For short-range signaling, the heparan sulfate proteoglycans (HSPGs) low affinity Wnt 
co-receptors Dally and Dally-like protein have been proposed to regulate Wnt ligand diffusion, 
degradation as well as endocytosis/transcytosis (Baeg et al., 2001).  
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1.4.2 Wnt ligand receptors 
 
 
After secretion and diffusion to the signal receiving cell, Wnt ligands bind to subtype specific Wnt 
receptors, leading to the different types of signaling (see section 1.4.5 and 1.4.6). The core 
receptor complex is composed by a seven-pass transmembrane-domain class Frizzled (Fzd) protein 
and its single-pass transmembrane co-receptor, the low-density lipoprotein receptor-related 
protein 5 or 6 (Lrp5/6) (Figure22) (Pinson et al., 2000; Tamai et al., 2000). Mammals have ten 
different Fzd genes which belong phylogenetically to the large family of G protein-coupled 
receptors (Bjarnadottir et al., 2006). They all contain large extracellular N-terminal cysteine-rich 
domain providing the primary binding platform for distinct Wnt ligands (Dann et al., 2001; Janda 
et al., 2012). If also the co-receptor Lrp5/6 can bind Wnts directly is still controversial (Tamai et al., 
2000; Wu and Nusse, 2002). Of note, a single Wnt can interact with multiple Fzd proteins and at 
the same time several Fzd can interact with a specific Wnt. In addition, some Wnt ligands have 
been shown to bind to the receptor tyrosine kinase-like orphan receptor (Ror)2 and receptor-like 
tyrosine kinase (Ryk) (Figure22) (Hikasa et al., 2002; Lu et al., 2004). Thus, a particular Wnt may 
activate β-catenin and/or non-canonical pathways, depending on the receptor complex (van 
Amerongen et al., 2008).  
 
1.4.3 β-catenin and Plakoglobin 
 
Figure22: Wnt signaling receptor complexes 
The scheme illustrates different Wnt receptor 
complexes inducing canonical Wnt/β-catenin 
signaling (β-catenin) or non-canonical planar 
cell polarity signaling (PCP) or Wnt/Ca
2+
 
signaling (Ca
2+
)  (modified from (Niehrs, 
2012)).  
Figure23: Schematic β-catenin structure   
The most important domains of β-catenin are indicated with 
associated function. The central β-catenin ligand binding site 
interacts with cadherin tails, Axin, APC as well as Tcf (Beta-
catenin-structure by Bubus12 used under CC BY 3.0).  
I n t r o d u c t i o n | 52 
 
The central event during canonical Wnt signaling is the nuclear translocation of β-catenin, a 
member of the armadillo protein family. The central part of β-catenin harbors an armadillo (ARM) 
domain consisting of 40 very characteristic ARM repeats, whereas the N- and C-terminal parts are 
unstructured and flexible (Figure23) (Xing et al., 2008). The ARM repeats fold into a curved 
structure where the inner surface serves as ligand binding site for various interaction partners 
including the cytoplasmic cadherin tails, Axin, adenomatosis polyposis coli gene product (APC) and 
the transcription factors of the Tcf/Lef1 family (Behrens et al., 1996; Huber and Weis, 2001; Xing 
et al., 2003). Since the surface of the ARM domain can accommodate only one peptide motif at 
any given time, all these proteins compete for the same cellular pool of β-catenin molecules, 
which is a key feature of the canonical Wnt signaling pathway regulation.  
While the C-terminal part mediates recruitment of transcriptional co-activators when β-catenin is 
bound to DNA, the N-terminal part is responsible for β-catenin turnover as it contains a short 
linear motif with several conserved sites, which bind to the β-transducin repeat containing E3 
ubiquitin protein ligase (β-TrCP) when they are phosphorylated, inducing β-catenin degradation 
(see below).  Notably, the deletion of the N-terminal part of β-catenin impairs the degradation, 
leading to its nuclear accumulation and increased Wnt/β-catenin signaling (Gat et al., 1998). 
Conversely, when the short C-terminal fragment is artificially fused to the β-catenin co-factor 
Tcf/Lef1, it can mimic the consequences of active Wnt signaling, indicating that the other β-
catenin domains are not essential for target gene activation such as c-myc, Axin2 and Jagged1 
(Vleminckx et al., 1999).  
How increased cytoplasmic levels of β-catenin are translated into transcriptional changes in Wnt 
target genes, is incompletely understood. It has been proposed that the cytoplasmic-nuclear 
shuttling of β-catenin is partly mediated by a microtubule mediated active transport; however, the 
molecular mechanism remains elusive (Sugioka et al., 2011).  
 
 
Figure24: β-catenin signaling in the nucleus  
In the absence of Wnt/β-catenin signaling (Wnt OFF), 
Tcf together with the transcriptional co-repressor 
Groucho occupies and represses its Wnt-target genes. 
Upon Wnt signaling (Wnt ON), β-catenin accumulates 
in the cytoplasm, translocates into the nucleus where 
it displaces Groucho from Tcf, and recruits 
transcriptional co-activators as well as histone 
modifiers such as Brg-1, calcium-binding protein 
(CBP), Cdc47, B-cell chronic lymphocytic leukemia/ 
lymphoma (Bcl)9 and pygopus family PHD finger 
(Pygo) to promote target gene expression (modified 
from (Clevers and Nusse, 2012)).  
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In the absence of nuclear β-catenin the co-factor Tcf/Lef1 is bound to the DNA with transcriptional 
co-repressors such as C-terminal binding protein (CtBP), histone deacetylases and Groucho 
(Daniels and Weis, 2005), forming a mutimeric complex which inhibits Wnt target gene 
transcription (Figure24). Upon Wnt signaling activation nuclear β-catenin-Tcf/Lef1 complex 
facilitates the recruitment of additional transcriptional co-activators, such as the histone 
acetytransferase calcium-binding protein (CBP), B-cell chronic lymphocytic leukemia/lymphoma 
(Bcl)9 and pygopus family PHD finger (Pygo), leading to a multimeric complex with high 
transcriptional activation potential (Hecht et al., 2000; Stadeli and Basler, 2005). Intriguingly, it 
seems that not the absolute levels of β-catenin in the cell, but rather the fold changes activate 
Wnt signaling in the cell, indicating that very low level of β-catenin would be sufficient for Wnt 
activity modulation (Goentoro and Kirschner, 2009). 
Of note, the β-catenin homologue Plakoglobin (also called γ-catenin) shares strikingly similar 
protein-domain architecture. Not only does their ARM domain resemble each other in both 
composition and ligand binding capacity, but also the N-terminal β-TrCP-binding motif is highly 
conserved in Plakoglobin, implying shared regulation and function with β-catenin in cell-cell 
adhesion and signaling (Sadot et al., 2000). Conversely, the sequence of the C-terminal segment 
differs, probably explaining the weaker transactivation activity of Plakoglobin towards classic β-
catenin targets when bound to DNA (Maeda O et al., 2004). Indeed, Plakoglobin might act as a 
negative regulator of β-catenin, as it attenuates the expression of several Wnt target genes 
including c-myc (Williamson et al., 2006), and thus it is proposed to behave more as tumor 
suppressor in contrast to β-catenin (Zhurinsky et al., 2000).  
 
1.4.4 Cell-cell adhesion in the context of β-catenin signaling 
 
 
 
Figure25: β-catenin and Plakoglobin in 
adherens junctions  
E-cadherin forms extracellular interactions 
with E-cadherin molecules on neighboring 
cells. Intracellular, β-catenin (β-cat) and 
Plakoglobin (PG) bind to cadherin tails 
mutually exclusive and engage α-catenin (α-
cat) thereby connecting cadherins to actin 
microfilaments (MF). In addition, E-
cadherins recruit p120-catenin which 
promotes cadherin dimerization   (modified 
from (Aktary and Pasdar, 2012)).  
MF 
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In addition to its key role in the Wnt pathway, β-catenin as well as Plakoglobin are essential 
components of the cell-cell adherens junctions, necessary for the creation and maintenance of 
epithelial cell layers and barriers. Indeed, the majority of the β-catenin molecules in epithelial cells 
are retained at cell-cell junctions. β-catenin and plakoglobin bind in a mutually exclusive manner 
to the cytoplasmic domain of various cadherins, which constitute the core component of adherens 
junctions (Figure25) (Zhurinsky et al., 2000). Cadherins are single-pass transmembrane receptors 
that form homotypic interactions with cadherin proteins on neighboring cells through their 
extracellular cadherin repeat domains in the presence of Ca2+. When bound to cadherin, β-catenin 
or Plakoglobin subsequently interact with the actin binding protein α-catenin at a different site 
linking the cadherins to the actin cytoskeleton. Another catenin family member p120 binds to a 
membrane more proximal domain of cadherin cytoplasmic tail, promoting cadherin dimerization 
and stability at the membrane (Meng and Takeichi, 2009). 
Interestingly, in contrast to the short half-life of cytoplasmic β-catenin (minutes), referred to as 
signaling pool, the β-catenin engaged at cell-cell contacts is highly stable (adherens junction pool). 
It is still unclear how these two pools depend on and influence each other under physiological 
conditions. Of note, in many cancers and during wound healing loss of cadherin mediated 
adhesion during EMT leads to an increased β-catenin release and signaling (Heuberger and 
Birchmeier, 2010).  
 
1.4.5 Canonical Wnt signaling pathway 
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Figure26: The β-catenin destruction complex in the presence and absence of Wnt 
In the absence of Wnt (Wnt OFF), the destruction complex resides in the cytoplasm where it binds, 
phosphorylates and ubiquitinates β-catenin by β-TrCP. Degradation of β-catenin by the proteasome is 
required to liberate β-catenin from the complex and thus “recycle” it. Consequently, cytosolic β-catenin 
levels are low and target gene expression is repressed. Wnt (Wnt ON) induces the association of the intact 
destruction complex with phosphorylated Lrp. After binding to LRP, the destruction complex still captures 
and phosphorylates β-catenin, but ubiquitination by β-TrCP is blocked. Newly synthesized β-catenin now 
accumulates in the cytoplasm and promotes Wnt signaling target gene expression (modified from (Li et al., 
2012)).  
 
Downstream of ligand bound-Wnt-receptor complex a destruction complex, which regulates the 
stability of cytoplasmic β-catenin, is considered as the core component of the canonical Wnt/β-
catenin pathway (Figure26). This complex is composed by the scaffolding protein Axin, tumor 
suppressor APC, casein kinase 1 (CK1) and glycogen synthase kinase 3 (GSK3). As Axin interacts 
directly with all components, it is the central scaffold of the destruction complex and was shown 
to dictate its activity. The Axin turnover is mainly regulated by the poly-ADP-ribosylating enzyme 
Tankyrase, which targets Axin for proteasomal degradation (Huang et al., 2009). Of note, 
Tankyrase has emerged as a suitable target for Wnt signaling inhibition, as inhibition of its activity 
through chemical compounds such as IWR-1 enhances the stability of the destruction complex 
(Chen B et al., 2009).   
In the absence of Wnt ligands, cytoplasmic β-catenin protein is constantly recruited to the 
destruction complex and sequentially phosphorylated by CK1 and GSK3 at specific serine residues 
in the N-terminal region. Phosphorylated β-catenin is subsequently recognized and ubiquitinated 
by the E3 ubiquitin ligase β-TrCP, and targeted for rapid destruction by the 26S proteasome 
(Aberle et al., 1997). This continuous degradation of cytosolic β-catenin prevents its accumulation 
in the nucleus. Upon Wnt-Fzd-Lrp5/6 complex formation the scaffold protein Dishevelled is 
recruited to the Fzd tail and starts to polymerize, promoting the clustering of several Wnt-Fzd-
Lrp5/6 complexes, and thereby generating a dynamic scaffold for destruction complex recruitment 
and Lrp5/6 phosphorylation by GSK3 and CK1 (Schwarz-Romond et al., 2007). While it has been 
believed for a long time that the Axin recruitment to phosphorylated Lrp5/6 tails leads a 
disassembly of the destruction complex and thus inhibits the β-catenin phosphorylation and 
degradation (Roberts et al., 2011), new data demonstrate that the whole destruction complex is 
sequestered to the membrane. This re-localization inhibits the ubiquitination of β-catenin and 
subsequently leads to a saturation of the complex with phosphorylated β-catenin (Li et al., 2012). 
Newly synthesized cytoplasmic β-catenin is now able to accumulate in the nucleus where it 
induces target gene expression. 
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1.4.6 Non-canonical Wnt signaling pathways  
In addition to the β-catenin dependent signaling pathways, in vertebrates β-catenin-independent 
(non-canonical) signaling pathways have been described. They control processes including inner 
ear planar cell polarity or tissue boundary formation, or dorsal-ventral patterning during 
gastrulation as well as cancer (Komiya and Habas, 2008). Non-canonical Wnt signaling can be 
activated by specific combinations of Wnt ligands and Fzd receptors in the absence of co-receptor 
Lrp5/6, or by specific receptors like Ror2. In the planar cell polarity pathway, Wnt5a specifically 
interacts with Ror2 inducing the recruitment of Dishevelled and Dishevelled-associated activator 
of morphogenesis 1 (DAAM1) (Figure20). This complex leads to the activation of the small G-
protein Rho and Ras-related C3 botulinum toxin substrate (Rac1), promoting actin remodeling via 
Rho-associated kinase (ROCK) and JNK (Komiya and Habas, 2008). Of note, Wnt5a can also bind to 
the Wnt receptor complex Fzd4-Lrp5, promoting canonical Wnt signaling (Mikels and Nusse, 
2006). 
The Wnt/Ca2+ pathway instead regulates calcium release from the endoplasmic reticulum. 
Dishevelled activation upon Wnt ligand binding to Fzd receptor not only influences β-catenin 
stability (see section 1.4.5), but also induces phospholipase C (PLC) mediated cleavage of 
membrane bound PI(4,5)P2 in diacyl-glycerol (DAG) and inositol trisphosphate (IP3). When IP3 
binds its receptor on the endoplasmic reticulum, calcium is released which subsequently activates 
Ca2+/calmodulin-dependent protein kinase (CAMkII) and protein kinase C (PkC). Subsequently, PkC 
can activate Cdc42, a regulator of the ventral patterning, and CAMkII induces activation of the 
transcription factor nuclear factor of activated T cells (NFAT), which regulates cell adhesion, 
migration and tissue separation (Figure20) (Komiya and Habas, 2008). The planar cell polarity 
pathway as well as the Wnt/Ca2+ pathway are able to antagonize canonical Wnt signaling although 
the mechanisms remain still poorly defined (MacDonald et al., 2009).  
In addition, new non-canonical Wnt pathways seem to emerge recently. Upon Wnt ligand binding 
to the RYK, Dishevelled can be recruited to its cytoplasmic tail, leading to the protease mediated 
cleavage of the C-terminal tail of RYK which then translocates to the nucleus and induces neuronal 
differentiation (Lyu et al., 2008). So far it remains elusive, how the intracellular RYK fragment 
influences the transcriptional machinery in the nucleus. 
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1.4.7 Soluble Wnt agonists and antagonists: 
 
Lately, an increasing number of soluble Wnt ligand binding proteins have been identified, which 
act as Wnt signaling agonists or antagonists. The first identified Wnt antagonists were the sFRP 
comprising a whole family of Wnt binding proteins (sFRP1-5). Because their structure is highly 
homologous to the extracellular cysteine-rich domain of Fzd receptors, they compete with Wnt-
Fzd complex formation (Figure27). Interestingly, some sFRPs exhibit a biphasic effect on Wnt 
activity in a concentration dependent manner: whereas at low concentrations sFRP1 enhances 
Wnt signaling activity, at high concentration it has an inhibitory effect; however the mechanism of 
these opposing functions remain unclear (Uren et al., 2000).  Further known secreted Wnt 
antagonists are the structurally distinct Wif1 and the Dkk family (Dkk1-4) proteins (Fedi et al., 
1999; Hsieh et al., 1999). Wif1 inhibits Wnt receptor interaction through direct interaction with 
Wnt ligands through its WIF domain. In contrast, Dkk family members inhibit canonical Wnt 
signaling by two different mechanisms: first, Dkk binding to Lrp5/6 prevents its interaction with 
Wnt-Fzd complexes and second, binding to the membrane-anchored Dkk receptor Kremen 
triggers the internalization of Lrp5/6 (Mao et al., 2002).  
 
 
Figure27: Soluble Wnt antagonists  
While Wif and sFRP bind directly to secreted Wnt ligands and/or 
Fzd competing for the Wnt receptor binding, Dkk and Wise (SOST) 
proteins interact with Lrp5/6 to prevent FZD-LRP complex 
formation (modified from (MacDonald et al., 2009)).  
Figure28: Fine tuning Wnt signaling 
by Lgr and R-spondin proteins 
Secreted R-spondin ligands can bind 
to Lgr receptors and facilitate Wnt-
Lrp5/6-Fzd complex formation, 
amplifying Wnt signals. Conversely, 
Lgr bound R-spondin recruits the E3 
ubiquitin ligase Rnf43 which ubiqui-
tinates Fzd and promotes its degra-
dation, dampening Wnt signaling. In 
addition, Troy was shown to 
associate with Lgr proteins and to be 
recruited to the Wnt receptor 
complex where it destabilizes Lrp, 
attenuating Wnt signaling (modified 
from (Barker et al., 2013)).  
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Among the agonists with a stimulatory influence towards canonical Wnt signaling, the growth 
factor R-spondins are most prominent (Figure28). It is currently unclear whether R-spondins are 
secreted locally, or whether they are delivered via the circulatory system from more distant 
sources (de Lau et al., 2012). Affected cells recognize R-spondin with leucine-rich repeat-
containing G-protein-coupled receptors (Lgr) 4–6, a group of SC associated seven transmembrane 
domain surface receptors involved in progenitor and SC maintenance in multiple tissues (Barker et 
al., 2013; Carmon et al., 2011). The current model proposes that binding of R-spondin to Lgr 
recruits the E3 ubiquitin ligase ring finger protein 43 (Rnf43), which has been demonstrated to 
ubiquitinate Fzd receptor proteins, thereby targeting them for degradation (Koo et al., 2012). The 
Lgr-Rnf43 complex is rapidly cleared from the plasma membrane, which results in inhibition of 
Wnt receptor turnover and thus enhanced Wnt signaling (Hao et al., 2012).  In addition, a further 
Wnt receptor stabilizing mechanism for Lgr-R-spondin function was described recently. In the 
absence of R-spondin, the tumor suppressor Troy directly interacts with Lgr and is recruited to a 
Wnt-Lgr receptor complex, leading to destabilization of Lrp co-receptor at the cell surface and 
reduced canonical Wnt signaling (Fafilek et al., 2013). Thus, Lgr proteins appear to be facultative 
components of the Wnt receptor complex that bind secreted R-spondin proteins to boost existing 
canonical Wnt signals selectively on responding cells. This might explain the restricted expression 
of Lrg5 on intestinal SC and Lrg6 on skin SC (see section 1.1.2), leading to a tightly controlled 
canonical Wnt signaling above threshold ensuring SC homeostasis in vivo.   
 
 
1.4.8  Wnt and TGFβ signaling cross talk 
TGFβ and Wnt/β-catenin signaling are interconnected at several levels through Smad proteins. In 
particular the TGFβ inhibitory protein Smad7 can promote and inhibit Wnt/β-catenin signaling 
through multiple pathways, and Smad7 is regulated at the same time by components of the 
Wnt/β-catenin signaling pathway. On the one hand, Smad7 in skin has been shown to promote 
degradation of β-catenin and consequently Wnt signaling inhibition through direct interaction and 
recruitment to the E3 ubiquitin ligase Smurf2, which also targets TGFβ receptor for degradation 
(Han et al., 2006a). Furthermore, in tumor cells Smad7 seems to promote β-catenin-E-cadherin 
complex formation and cell-cell adhesion, thereby inhibiting nuclear translocation of cytosolic β-
catenin (Tang et al., 2008).  
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On the other hand, it has also been shown that Smad signaling can enhance Wnt signaling, as the 
Smad7 dependent E3 ubiquitin ligase Smurf2 also fosters the degradation of Axin and thus 
decreases the destruction complex activity (Kim and Jho, 2010). Conversely, Axin assists in the 
ubiquitin mediated degradation of Smad7 through serving as a scaffold for the E3 ligase Arkadia, 
indicating a negative feedback of Wnt signaling to Smad7 (Liu et al., 2006). Furthermore, a 
complex of β-catenin, Smad4 and its R-Smad was shown to protect β-catenin from degradation in 
the cytoplasm (Zhang et al., 2010). Phosphorylation of β-catenin at tyrosine 654 through 
activation of Src kinase(s) is induced by TGFβ, decreasing β-catenin binding to E-cadherin in cell-
cell contacts and promoting its accumulation in the cytoplasm (Ulsamer et al., 2012). Besides 
influencing the protein stability of the respective other pathway, also direct cross talk at the level 
of gene transcription has been observed. In the nucleus Smad7 interacts with the β-catenin-
Tcf/Lef1 complex, enhancing its transcriptional activity and inducing apoptosis in a TGFβ 
dependent manner (Edlund et al., 2005). 
 
1.4.9 Wnt and Notch signaling are highly interconnected in skin 
 
Figure29: Notch signaling pathway  
(A) Notch is translated as a single polypeptide, which 
is fucosylated by the fucosyltransferase O-FUT in the 
endoplasmic reticulum (ER), facilitating Notch protein 
shuttling to the Golgi. (B)  There, Notch is cleaved by a 
furin-like protease at the S1-cleavage site to generate 
the non-covalently linked Notch heterodimer, 
consisting of the extracellular portion and the 
intracellular portion. (C) Subsequently the 
heterodimer is glycosylated by several Fringe 
glycosyltransferase family members. (D) At the plasma 
membrane, Notch becomes available to interact with 
Notch ligand (Jag/Serrate and DLL) on a ligand-
expressing cell. The interaction induces proteolytic 
cleavage of the Notch receptor by ADAM family 
metalloprotease at the S2 cleavage site, generating 
the intermediate Notch substrate NEXT. (E) NEXT is 
then cleaved by the γ-secretase complex, resulting in 
the release of the intracellular Notch fragment, which 
translocates to the nucleus, where it associates with 
the transcription factor RBP-J and other 
transcriptional co-activator and repressors (F) 
(modified from stem cell signaling pathway, Novus 
Biologicals).  
Nucleus 
(A) 
(B) 
(C) 
(D) 
(E) 
(F) 
Hes1  
Hey 
n 
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Notch signaling controls a number of cellular processes including cell fate decision, proliferation, 
differentiation and survival/apoptosis (Andersson et al., 2011). In skin the Notch pathway plays an 
important role in regulating epidermal differentiation of HF, sebaceous gland and interfollicular 
epidermal lineages, reminiscent of the influence of Wnt/β-catenin signaling (Rangarajan et al., 
2001). Genetic ablation or activation of the pathway reveals that Notch act as an epidermal tumor 
suppressor (Dotto, 2008). Mammals express four Notch proteins (Notch1- 4) and five Notch 
ligands, named Delta-like (DLL) 1, 3, 4, and Jagged (Serrate) 1 and 2. All four Notch proteins are 
highly similar in their structure: the extracellular domain of Notch possesses many EGF-like 
repeats which participate in ligand binding. The N-terminal EGF-like repeats are followed by 
cysteine-rich Notch/Lin12 repeats that prevent signaling in the absence of the ligand. The 
cytoplasmic region of Notch transduces the signal to the nucleus and contains a Rbp-associated 
molecule (RAM) domain, ankyrin repeats, nuclear localization signals, a transactivation domain 
and a PEST degradation sequence (Andersson et al., 2011). Although Notch is synthesized as a 
single precursor protein, it is cleaved in two parts during export to the cell surface and thus exists 
as a heterodimeric receptor (Blaumueller et al., 1997). All Notch ligands are single transmembrane 
domain proteins, presented on neighboring cells. Consequently, Notch signaling is transmitted by 
direct cell to cell contact, allowing distinct groups of cells to organize themselves into larger 
structures.  
Notch signaling is initiated by a receptor ligand interaction between two neighboring cells, which 
leads to two successive proteolytic cleavage reactions (Figure29). The first is mediated by a 
disintegrin and metalloproteinase (ADAM) family metalloprotease at the extracellular part of the 
Notch receptors, generating an intermediate Notch extracellular truncation (NEXT), which is a 
substrate for the second proteolytic event mediated by the presenilin γ-secretase protein complex 
(Brou et al., 2000; Saxena et al., 2001). As a result of the second event, the Notch intracellular 
domain (NICD) is liberated from the membrane and translocates to the nucleus where it 
associates with the transcription factor RBP-J.  Subsequently, the co-activators Mastermind and 
histone acetyltransferases are recruited to the complex and activate transcription of target genes, 
including Hes and Hey (Andersson et al., 2011; Mumm and Kopan, 2000). Interestingly, while the 
core signaling pathway of Notch is rather simple, there is considerable complexity in the 
regulation of the Notch receptor and ligands through post-translational modifications. For 
example the glycosyltransferase Fringe, resident in the Golgi, was shown to add carbohydrate 
chains to the extracellular domain of Notch, thereby altering the ability of ligands to activate the 
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receptor (Haines and Irvine, 2003). Similar to the Notch receptors, the ligands undergo controlled 
proteolysis, and there are indications that the cleaved ligand intracellular domains also participate 
in signaling (D'Souza et al., 2008). These diverse signal propagation modes, leading to 
simultaneous generation of distinct signals in the receiving and sending cells, qualify DLL-Notch 
signaling for patterning processes. 
In adult skin all Notch proteins are expressed in the interfollicular epidermis and HF, especially in 
the hair bulb. Notch receptors become upregulated in the suprabasal keratinocyte layer and HF 
matrix, coinciding with cells that are initiating or are undergoing terminal differentiation. The 
Notch ligands Jagged1 and Jagged2 are detected in adult skin (Powell et al., 1998). While Jagged2 
is restricted to the basal layer, Jagged1 is predominantly expressed in the suprabasal layers and 
only present in some basal cells. Similarly, in the HF Jagged2 is detected in the outer root sheath 
and basal hair bulb cells close to the dermal papilla, whereas Jagged1 is present in the more 
differentiated cells of the pericortex (Estrach et al., 2006). The highest Notch signaling activity is 
observed in the suprabasal interfollicular epidermis layer, HF pre-cortex and inner root sheath 
progenitor cells.  
Due to multiple Notch receptor and ligands expressed in the epidermis, complete Notch 
inactivation is only achieved by targeting common Notch pathway components, such as γ-
secretase, RBP-J or Mastermind. These studies have revealed that in the skin Notch activity is not 
required for embryonic HF morphogenesis and patterning, whereas in postnatal skin loss of Notch 
signaling leads to hyperproliferation of basal cells in the interfollicular epidermis, impaired 
sebaceous gland differentiation and conversion of cells from HF keratinocytes into cysts with 
interfollicular epidermis-like cells (Pan et al., 2004; Proweller et al., 2006; Yamamoto et al., 2003). 
Conversely, over activation of Notch signaling can be induced by overexpressing NICD in different 
epidermal layers. Overexpression of NICD in the suprabasal layers of the interfollicular epidermis 
and the HF inner root sheath leads to disturbed differentiation of HF lineages and hair loss as well 
as expansion of the differentiated cell compartment of the interfollicular epidermis (Uyttendaele 
et al., 2004). If NICD is overexpressed in the basal layer of the skin, the cell differentiation is 
severely impaired, leading to expansion of the interfollicular epidermal spinous layer, sebaceous 
glands and hair bulb base. In addition, HFs start to form abnormal clusters (Figure30) (Blanpain et 
al., 2006; Estrach et al., 2006). 
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Figure30: Overexpression of NICD in the basal skin layer 
Increased activation of NICD induces aberrant HF cluster formation, loss of spacing (left and middle) and to 
expansion of the sebaceous glands (asterisk) and hair bulb base (arrow). No ectopic HF formation can be 
observed (modified from (Estrach et al., 2006)).  
 
In skin the Notch and Wnt pathway are highly interconnected. On the one hand, several Notch 
pathway genes are upregulated by β-catenin activation in the epidermis (Ambler and Watt, 2007); 
on the other hand the transcription of various Wnt ligands is regulated by Notch (Devgan et al., 
2005; Hu et al., 2010). Intriguingly, Jagged1 was shown to be a direct target gene of canonical Wnt 
signaling and deletion of Jagged1 blocks β-catenin-induced ectopic HF formation, but not the 
ability of β-catenin to stimulate epidermal proliferation (Estrach et al., 2006). In line, 
overexpression of NICD promotes differentiation of β-catenin-induced HF; however, it does not 
induce ectopic HF formation alone (Estrach et al., 2006), placing Notch signaling downstream of 
Wnt. While Wnt signaling seems to have largely a positive effect on the Notch pathway, Notch 
activity seems to antagonize Wnt signaling in many cell types. Indeed, Wnt signaling becomes 
activated in tumors overexpressing dominant negative form of Mastermind, suppressing Notch 
signaling (Proweller et al., 2006). Conversely, Notch1 suppresses the expression of Wnt4 (Devgan 
et al., 2005), which inhibits canonical Wnt signaling by promoting the recruitment of β-catenin to 
cell-cell adhesion sites and thus reduces the β-catenin signaling pool (Bernard et al., 2008). In 
dermal papilla cells, Notch1 controls Wnt5a expression, which activates or represses canonical 
Wnt signaling depending on the expression of the Wnt receptor type (see section 1.4.2) (Hu et al., 
2010). But Notch is also able to interfere with β-catenin signaling directly because non-cleaved 
NICD is able to bind β-catenin, serving as a protein trap at the membrane and thus suppressing β-
catenin transcriptional activity (Hayward et al., 2005; Kwon et al., 2011). It is conceivable that 
more interaction points of Notch and Wnt pathway will be discovered in the future. 
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1.5 The Kindlin family 
The Kindlins represent a class of focal adhesion proteins that belong to a family of three 
evolutionary conserved proteins in mammals (Kindlin-1, Kindlin-2 and Kindlin-3), encoded by three 
different genes, namely KINDLIN-1 (chromosome 20p12.3), KINDLIN-2 (chromosome 14q22.1) and 
KINDLIN-3 (chromosome 11q13.1) (Siegel et al., 2003). The Kindlin genes are all composed by 
fifteen exons with the translation start in exon 2. Kindlins share considerable sequence and 
structural similarities. In mammals, Kindlin-2 has ~62% homology with Kindlin-1 and Kindlin-3 
shares ~49% similarity with Kindlin-1 (Lai-Cheong et al., 2010; Siegel et al., 2003; Ussar et al., 
2006). 
Phylogeny analysis of the Kindlin paralogues suggests a single ancestral Kindlin protein present in 
even the earliest metazoan, which then underwent duplication events in insects and also genomic 
duplication in vertebrates, leading to the subfunctionalized Kindlin family with distinct expression 
pattern (Khan et al., 2011). Indeed, Kindlin orthologues can be found in C. elegans (unc112) and in 
Drosophila (Fermitin-1 and -2) (Bai et al., 2008; Rogalski et al., 2000). The Kindlin family members 
highly differ in their expression patters in vivo: Kindlin-3 is considered to be mainly restricted to 
the hematopoietic system, such as platelets and red blood cells, with the highest levels in 
megakaryocytes (Ussar et al., 2006), but expression has also been recently reported in endothelial 
tissues and breast cancer cells (Bialkowska et al., 2010; Sossey-Alaoui et al., 2014). Whereas 
Kindlin-2 is wildly expressed, Kindlin-1 is only present in epithelial cells from the skin, intestine, 
kidney and lung (Ussar et al., 2006). The latter two Kindlin paralogues show the highest sequence 
homology and are co-expressed in keratinocytes, where they seem to share a lot of redundant 
functions (He et al., 2011a; Kloeker et al., 2004; Ussar et al., 2008).  
Functionally, Kindlins have revealed themselves as a novel class of adaptor molecules involved in 
integrin activation, integrin trafficking  and adhesion turnover (Bottcher et al., 2012; Margadant et 
al., 2013; Montanez et al., 2008; Moser et al., 2008; Ussar et al., 2008). Due to the lack of catalytic 
domains, Kindlin function is exclusively mediated by protein-protein interactions. The initial link of 
Kindlins with integrin signaling was provided by studies on C. elegans embryos harboring 
homozygous mutations in unc112. These embryos develop a paralyzed, arrested elongation at 
twofold (PAT) lethal phenotype due to failure of organization of PAT3/β integrin in the body 
muscle wall (Rogalski et al., 2000). Following depletion studies in mouse resulted in integrin-
mediated attachment and integrin activation defects in the affected organs for all three 
paralogues (Montanez et al., 2008; Moser et al., 2008; Ussar et al., 2008). In humans loss-of-
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function mutations in KINDLIN-1 and KINDLIN-3 cause Kindler syndrome (KS) and leukocyte 
adhesion deficiency-III syndrome (LAD III), respectively, whereas no human disease has yet been 
associated with KINDLIN-2 gene pathology (see section 1.5.3). Lately, an increasing number of new 
and homologue specific functions in multiple signaling pathways have been discovered, placing 
Kindlins as central signaling hubs in different cellular compartments, which will be discussed 
below.  
 
1.5.1 Subcellular Kindlin localizations and specificities 
It is still largely unknown, how Kindlins are selectively recruited and trafficked to distinct cell 
compartments. In cell culture Kindlins are strongly enriched at the integrin adhesion site, known 
as focal adhesions, while a large fraction resides in the cytoplasm (Herz et al., 2006; Kloeker et al., 
2004; Lai-Cheong et al., 2008; Siegel et al., 2003). In keratinocytes Kindlin-1 and Kindlin-2 co-
localize in focal adhesion structures, but in contrast to Kindlin-1, Kindlin-2 has been found to 
localize also at cell-cell adherens junctions in cardiac muscle cells (Dowling et al., 2008a; Dowling 
et al., 2008b), colon epithelial cells (Ussar et al., 2008) and keratinocytes (He et al., 2014), but not 
in podocytes (Qu et al., 2011). Kindlin-1 instead has been shown to localize at centrosomes in an 
integrin dependent manner upon phosphorylation, where it is involved in the mitotic spindle 
assembly (Patel et al., 2013). In osteoblasts Kindlin-3 is found predominantly at the sealing zone of 
podosomes, which are integrin mediated adhesion structures essential for bone resorption 
(Schmidt et al., 2011). 
Notably, amongst the Kindlin family members only Kindlin-2 has a nuclear localization signal 
(Ussar et al., 2006) and nuclear localization was reported in various cell types including smooth 
muscle cells (Kato et al., 2004), breast cancer cells (Yu et al., 2012), but not in keratinocytes (Lai-
Cheong et al., 2008). Although more and more nuclear Kindlin-2 functions are discovered, it 
remains elusive how Kindlin-2 nuclear trafficking is regulated and whether other Kindlin family 
members share similar nuclear functions.  
One possible mechanism for Kindlin subcellular localization regulation is a differential binding 
affinity of the different Kindlins to various β tails with conserved NxxY motif. On the one hand, it 
has been shown that for example Kindlin-2 binds to β1 and β3 integrin tail with similar affinity, on 
the other hand binding to β2 is over 100 fold less efficient, indicating an impact of further integrin 
tail residues on Kindlin interaction. Indeed, the last three C-terminal residues in the β tail have 
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been identified to determine the Kindlin binding affinity (Bledzka et al., 2012). Of note, a recent 
study in zebra fish has further been able to show that the Kindlin binding affinity is determined by 
the amino acid spacing and the C-terminal COOH group, rather than by residue entities of the 
integrin tail (Fitzpatrick et al., 2014).  
However, also the Kindlin isoforms can differ in their affinity to a β integrin tail. In contrast to 
Kindlin-2, Kindlin-1 is able to bind the β6 integrins and promotes its functions in TGFβ signaling, 
wound healing and cancer (see section 1.3.6 and 1.6.4) (Bandyopadhyay et al., 2012). But so far it 
remains largely elusive, how the selectivity between the integrin tails and Kindlin paralogues is 
achieved and most likely this has to be addressed with comparative co-crystallization studies of 
different Kindlin and integrin tails.  
Taken together, these differences in Kindlin specificities for certain integrin isoforms appear as a 
reasonable consequence of the evolutionary splitting of the Kindlin family, allowing specific 
regulation of tissue specific integrin classes and associated signaling, and even differential 
regulation of integrins in the presence of different integrin isoforms. Furthermore, the different 
affinities of one Kindlin to the co-expressed integrin isoforms might lead to a differential 
preference of those integrins with higher affinities during early spreading and might allow 
regulation of Kindlin affinity via post-translational modifications.  
 
1.5.2 Post-transcriptional modifications of Kindlins  
The localization and function of Kindlins seem to be strongly regulated by post-transcriptional 
modifications, such as phosphorylation and cleavage. Bioinformatic analysis of the Kindlin 
sequence has predicted multiple highly conserved phosphorylation sites and it has become clear 
that Kindlins are prominent targets of multiple signaling kinases. For example, in keratinocytes a 
fraction of Kindlin-1 becomes phosphorylated by casein kinase-2, a serine/threonine kinase that is 
involved in cytoskeleton regulation (Herz et al., 2006), and in breast cancer cells Kindlin-1 
phosphorylation at threonine 30 by the Polo-like kinase 1 (PLK1) controls Kindlin recruitment to 
centrosomes (Patel et al., 2013).  
In platelets and leucocytes it has been shown that the integrin-Kindlin-3 interaction is regulated by 
calpain cleavage at tyrosine 373 in the N-terminal part of Kindlin-3 PH domain (Zhao et al., 2012).  
Expression of a calpain resistant Kindlin-3 mutant leads to stronger adhesion and inhibits cell 
migration by stabilizing its integrin tail association. Thus, calpain cleavage might promote one 
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process of Kindlin-3 removal from activated integrin to free binding sites for other integrin 
partners and allows reversibility of integrin-matrix interactions. Whether the function of other 
Kindlin isoforms is also controlled by protease mediated cleavage, is currently unknown.  
In summary, although Kindlin proteins seem to be heavily modified in the cell, these post-
transcriptional modifications remain poorly characterized. How these are regulated and which 
further modifications such as sumoylation or ubiquitination are involved in the modulation of 
Kindlin function, trafficking and localization are still open questions. 
 
1.5.3 Kindlin pathogenesis and molecular function and signaling 
1.5.3.1 Kindlin-1 and Kindler syndrome 
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Figure31: KS disease symptoms  
Most common symptoms are displayed (modified from (Arita et al., 2007; Ashton et al., 2004; Fassihi et al., 
2005; Mansur et al., 2007; Penagos et al., 2004)). 
 
Although KS was first described in the year 1954 by Dr. Theresa Kindler as a subtype of bullous 
skin diseases characterized by skin blistering, hyperkeratosis, skin atrophy, and distinguished from 
the other diseases by premature skin aging photosensitivity, poikiloderma in sun exposed areas 
(Figure31), it took almost 50 years until loss-of-function mutations in the KINDLIN-1 gene were 
identified as the cause of KS (Jobard et al., 2003; Kindler, 1954; Siegel et al., 2003). Since its 
discovery only slightly above 120 cases have been reported. However, due to the clinical symptom 
overlap with other skin blistering diseases, the true number might be higher (Intong and Murrell, 
2012). To date, over 40 distinct KINDLIN-1 mutations have been reported including large deletions, 
splice site, nonsense and frame shift mutations; all of them leading to premature termination 
codons and, consequently, to complete lack of Kindlin-1 in epithelial cells (Lai-Cheong et al., 2010). 
Interestingly, although the pathogenesis of the patients varies largely, all attempts to correlate the 
manifestation of a specific symptom or the severity of disease progression with a specific 
mutation in the Kindlin-1 gene, have failed so far. The first KS symptoms during infancy are 
characterized by trauma induced skin blistering, due to impaired integrin activity (Figure31) 
(Fassihi et al., 2005; Lai-Cheong et al., 2009; Penagos et al., 2004). With increasing age, further 
skin homeostasis abnormalities appear, including hyperkeratotic palms and soles, severe 
cutaneous atrophy especially on the dorsal side of hands and symptoms of premature aging such 
as cigarette paper-like wrinkling and webbing between fingers. Especially in sun exposed areas, KS 
patient very often develop poikiloderma (an aberrant hyperpigmentation of the skin) and 
erythema (redness of the skin) due to a photosensitivity (increased sensitivity to UV); however, 
the molecular basis for these pathologies are completely unknown (Ashton et al., 2004; Penagos 
et al., 2004). So far, it has only been described that in poikiloderma, melanocytes are highly 
proliferative and delocalized leading to secretion of melanin into the dermis which is then 
engulfed by resident macrophages, converting them to melanophages (Papa and Kligman, 1965). 
Because of the tight interdependence of bulge SC and HF melanocyte homeostasis, it can be 
speculated that loss of melanocyte hemostasis is due to aberrant bulge SC cross talk. Of note, 
colony-forming efficiency assays with serially cultivated primary keratinocytes isolated from KS 
patients indicate an accelerated depletion of SC and premature senescence, suggesting a SC 
maintenance defect which correlates with loss of SC marker expression in KS patient skin (Lai-
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Cheong et al., 2009; Piccinni et al., 2013). However, the molecular mechanisms were unclear so 
far. 
Intriguingly, despite the known functional redundancy between Kindlin-1 and -2 in KS patients or 
Kindlin-1 null mice, Kindlin-2 is unable to fully compensate for Kindlin-1 deficiency, suggesting that 
both Kindlins have functionally significant differences (He et al., 2011a; Ussar et al., 2008). In 
keratinocytes, depletion of Kindlin-1 leads to abnormal cell shape, increased migration, aberrant 
basement membrane deposition, adhesion and proliferation defects, while β1 integrin activation 
and cell adhesion are only mildly perturbed (He et al., 2011a; Herz et al., 2006; Lai-Cheong et al., 
2009; Ussar et al., 2008). The aberrant cell shape and migration may in part be attributed to 
defective lamellipodium formation, resulting from abnormal signaling via Rho GTPase family (Has 
et al., 2009), as well as a partial loss of the epithelial identity (Qu et al., 2012). Although KS is 
mainly described as a skin fragility disorder, KS patients suffer from mucocutaneous malignancies 
(Wiebe et al., 2008) and ulcerative colitis-like intestinal problems from early on (Kern et al., 2007; 
Ussar et al., 2008), suggesting that this disease affects multiple kinds of epithelia. Unlike in the 
skin, two forms of Kindlin-1, arising from alternative splicing, can be detected in the colon (Kern et 
al., 2007); however, their individual function remains unknown. In addition, Kindlin-1 is also highly 
expressed in the kidney epithelial cells (Ussar et al., 2006), but no defects have been reported in 
KS patients and in Kindlin-1 null mice, suggesting that here Kindlin-1 loss is fully compensated for 
by Kindlin-2 during development. 
Finally, KS patients have a higher risk of developing skin cancer at an early age (particularly 
squamous cell carcinomas (SCC) (Arita et al., 2007; Emanuel et al., 2006; Lotem et al., 2001; 
Mizutani et al., 2012), but how Kindlin-1 loss is able to promote tumorigenesis was unknown. 
Furthermore, the role of Kindlin-1 in carcinogenesis seems to be context dependent, because 
increased KINDLIN-1 mRNA expression has been observed in up to 60% and 70% of lung breast 
and colon cancers, respectively (Sin et al., 2011; Weinstein et al., 2003). In addition, it is highly 
expressed in multiple pancreatic cancer cell lines, where it promotes migration and invasion 
(Mahawithitwong et al., 2013a). In such cancer entities, the oncogenic effect of Kindlin-1 seems to 
be strongly TGFβ signaling dependent, however the molecular mechanism remained unclear (Sin 
et al., 2011).  
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1.5.3.2 Kindlin-2 
Because of its ubiquitous expression, Kindlin-2 seems to be important in multiple cell types and 
tissues, where it is implicated in disease condition such as fibrosis or cancer (discussed below).  
In mice, loss of Kindlin-2 causes peri-implantation lethality before embryonic age 7.5 days, due to 
detachment of the endoderm and epiblast from the basement membrane because of severe 
adhesion defects (Dowling et al., 2008a; Montanez et al., 2008). Interestingly, Kindlin-2 is rapidly 
emerging as an important molecule in cardiac and muscle development, where it is highly 
expressed (Dowling et al., 2008a; Ussar et al., 2006). In these cells Kindlin-2 is not only involved in 
muscle elongation and fusion in an integrin dependent manner (Bai et al., 2008; Dowling et al., 
2008a; Dowling et al., 2008b), but it also triggers cell differentiation by regulating myogenic 
regulatory factor Myogenin expression. Mechanistically, Kindlin-2 forms a complex with β-catenin 
and Tcf4 and binds to the Myogenin promoter in the nucleus to enhance its expression during 
myogenic differentiation (Yu et al., 2013a).  
In skin Kindlin-2 seems to be important for the dermal fibroblast adhesion as well as for the 
keratinocytes cell-cell contact formation. During wound healing, Kindlin-2 becomes highly 
expressed in activated myofibroblasts, where it seems to be crucial for focal adhesion formation, 
organization of α-smooth muscle actin into stress fibers and force transmission (He et al., 2011b). 
Despite its low expression in the epidermis, a recent study using human keratinocytes organotypic 
cultures has revealed that Kindlin-2 contributes to cell–cell junctions formation and maintenance 
through RhoGTPase dependent regulation of the actin cytoskeleton at cadherin adhesion sites (He 
et al., 2014). Nevertheless, these results should be confirmed by conditional skin deletion of 
Kindlin-2 in vivo, in order to further elucidate why Kindlin-1 is not able to compensate for at cell-
cell adhesion sites.  
The disease kidney tubular intestinal fibrosis (TIF) is characterized by massive expansion of the 
cortical interstitium, activation of fibroblasts to myofibroblasts and progressive EMT of tubular 
epithelial cells (Bielesz et al., 2010). In affected mouse and human tubular epithelial cells, Kindlin-2 
is highly expressed and promotes EMT by enhancing Erk1/2, Akt and TGFβ signaling: first, Kindlin-2 
induces Ras activation through recruitment of son of sevenless homolog 1 (Sos1), which 
subsequently activates Erk1/2 and Akt signaling (Wei et al., 2014). Second, Kindlin-2 is able to 
activate the TGFβ pathway by binding C-terminally via the FERM domain with TβRI and N-
terminally with Smad3 (Wei et al., 2013). How these distinct Kindlin-2 functions are regulated and 
influence each other in tubular epithelial cells, remains elusive. 
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In contrast to most other polarized cells, endothelial cells only express Kindlin-2 where it is 
essential for angiogenesis and blood vessel homeostasis. Besides controlling integrin mediated cell 
adhesion and migration during angiogenesis, Kindlin-2 triggers endocytosis and recycling of cell 
surface receptors, such as CD39 and CD73 via interaction with the clathrin complex, thereby 
modulating platelet responses and homeostasis (Pluskota et al., 2011; Pluskota et al., 2013).   
For tumor development and progression, the role of Kindlin-2 seems to be tumor type dependent. 
Kindlin-2 expression was found to correlate with tumor invasion, lymph node metastasis and poor 
patient outcome in breast cancer (Gozgit et al., 2006), pancreatic ductal adenocarcinomas  
(Mahawithitwong et al., 2013b), malignant mesothelioma (An et al., 2010) and  bladder cancer 
(Talaat et al., 2011). One major oncogenic effect of Kindlin-2 seems to be the promotion of EMT by 
activating the signaling pathways as described for TIF. In addition, Kindlin-2 was shown to trigger 
EMT and invasion in breast cancer by promoting Wnt signaling and target gene transcription 
through association with active β-catenin and Tcf4 (Yu et al., 2012) as well as by silencing 
microRNA200 (miR-200) family member miR-200b expression through CpG island 
hypermethylation in the nucleus  (Yu et al., 2013b). Interestingly, in esophageal SCC Kindlin-2 has 
been shown to be a miR-200b target itself and decrease Kindlin-2 levels seems to be responsible 
for the tumor suppressive effect of miR-200b for cell invasion (Zhang et al., 2014).  
Besides promoting proliferation, Kindlin-2 is also able to increase cell survival by stimulating 
Hedgehog signaling through interaction with Gli1 as well as expression of anti-apoptotic Bcl2 
proteins (Gao et al., 2013; Gong et al., 2010; Shen et al., 2013). Interestingly, Kindlin-2 seems to 
enhance genome instability, a hallmark for cancer formation; however the molecular mechanism 
remains elusive (Zhao et al., 2013).  
In sharp contrast, high Kindlin-2 expression in mesenchymal cancer cells seems to suppress 
invasion by inhibiting the secretion of the highly oncogenic urokinase-type plasminogen activator 
(uPA) (Shi and Wu, 2008). Furthermore, Kindlin-2 has been shown to impair tumor progression in 
serous epithelial ovarian cancer where it promotes mesenchymal to epithelial transition (MET) 
partly through upregulation of estrogen receptor and thus inhibits tumor cell dissemination (Ren 
et al., 2014).  
Thus, similar to Kindlin-1, Kindlin-2 shows variable expression patterns in many human cancers 
with context dependent tumor promoting or suppressive effects. However, the involved signaling 
pathways and molecular mechanisms seem to highly differ between the two Kindlin paralogues.    
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Furthermore, many tumor types express more than one Kindlin isoform. A recent study indicates 
that Kindlin-1 and -2 have opposing function for lung cancer progression: while Kindlin-1 seems to 
inhibit EMT and to correlate with the differentiation status of non-small-cell lung cancer cells, high 
Kindlin-2 expression correlates with invasiveness and poor patient prognosis (Zhan et al., 2012). 
Whether comparable interdependencies occur in other epithelial cancer entities, and how 
deregulation of one isoform influences the other, has to be analyzed in comparative studies in the 
future. 
Besides the expression in tumor cells, Kindlin-2 seems to be highly upregulated in the tumor 
stroma (Talaat et al., 2011). Consequently, dissecting the mutual influence of Kindlin family 
members in the tumor cell – tumor stroma cross talk will be an exciting challenge in the future.  
 
1.5.3.3 Kindlin-3  
Kindlin-3 is the most studied family member and its depletion affects the integrin function in all 
hematopoietic linages. In humans, pathogenic mutations in KINDLIN-3 gene cause a rare 
hematopoietic disease known as  LAD III, which results from the combined defects in β1, β2, and 
β3 integrin activation in platelets, neutrophils, lymphocytes as well as osteoclasts (Kuijpers et al., 
2009; Malinin et al., 2009; Svensson et al., 2009).  In addition, two other LAD subtypes (LAD I and 
II) have been described with different defects in the leukocyte adhesion cascade: while LAD I is 
due to structural defects in β2 integrin preventing firm adhesion, LAD II is caused by defects in a 
specific Golgi GDP-fucose transporter that lead to a loss of selectin ligands on the cell surface and 
a defective leukocyte rolling. However, the LAD I, II and III disease symptoms are very similar, as all 
patients suffer from impaired wound healing, marked leukocytosis, osteopetrosis and recurrent 
bacterial infections due to compromised inflammatory response (Hanna and Etzioni, 2012).  
Kindlin-3 null mice die shortly after birth because of severe gastrointestinal, cutaneous, cerebral 
and bladder hemorrhages, caused by the defective platelet adhesion (Moser et al., 2008). Further 
analysis of Kindlin-3 deficient mice has been able to show that osteopetrosis is due to severe 
adhesion and spreading defects of osteoclasts leading to strongly reduced bone resorption 
(Schmidt et al., 2011). The defects in the inflammatory response upon Kindlin-3 loss are due to 
impaired β2 integrin activation in leukocytes (Moser et al., 2009a), essential for leukocyte 
adhesion to vessel wall endothelial cells and subsequent transmigration into tissues (Ley et al., 
2007). Here, it has been shown that Kindlin-3 mediates firm arrest of leukocytes on the vessel wall 
I n t r o d u c t i o n | 72 
 
by fully activating β2 integrin (headpiece opening) from a Talin mediated intermediate active 
conformation (Lefort et al., 2012), which is especially important when integrin ligand expression is 
low (Moretti et al., 2013; Morrison et al., 2013). In addition, Kindlin-3 can increase adhesion 
stability by promoting a complex with β2 integrin and calcium selective ion channel Orai1 which 
induces a local Ca2+ influx at focal adhesion sites, leading to increased integrin clustering (Dixit et 
al., 2012). Although Kindlin-3 depleted leukocytes show severe adhesion and migration defects, 
Kindlin-3 seems not to be essential for contact dependent T-cell (Morrison et al., 2013) nor for 
natural killer cell activation and polarization (Gruda et al., 2012).   
To date, there are only few reports pointing to a role of Kindlin-3 in cancerogenesis. A proteomic 
screening has revealed that Kindlin-3 is highly expressed in various B-cell malignancies including B-
cell lymphoma, chronic lymphocytic leukemia and Hodgkin lymphoma (Boyd et al., 2003). 
However, the consequences of deregulated Kindlin-3 expression are elusive. Furthermore, a 
recent report indicates that in human breast tumors elevated Kindlin-3 levels increase β1 integrin 
activity and Twist induced vascular endothelial growth factor (VEGF) expression, promoting 
primary tumor growth, angiogenesis and lung metastasis formation (Sossey-Alaoui et al., 2014). 
Taken together, while the role of Kindlin-3 in LAD III is well described, its involvement in other 
hematologic diseases remains unclear. In light of the recent findings that Kindlin-3 is also 
expressed outside the hematopoietic system (Bialkowska et al., 2010; Sossey-Alaoui et al., 2014), 
it will be intriguing to investigate its function in these cells and whether Kindlin-3 interferes with 
other Kindlin isoforms as well.   
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1.6 Skin cancer  
1.6.1 Comparison of wound healing and cancer in the skin  
 
Figure32: Comparison of wound healing and invasive tumor growth  
(A) Normal tissue is highly organized, where the basal keratinocytes are separated by the basement 
membrane from the dermis. Upon wounding activated platelets promote the formation of a fibrin clot and 
release cytokines and growth factors which facilitate the recruitment of immune cells and fibroblast, which 
become activated. These start to remodel the ECM and repair the dermal tissue before the keratinocytes 
start to re-epithelize the wound by a tightly controlled EMT-like process. After wound closure the increased 
cell proliferation, growth factor secretion and immune response are terminated and dermal fibroblasts are 
inactivated. (B) Invasive tumors are less organized. Neoplastic cells lose basement membrane and cell-cell 
contact in an uncontrolled manner and produce an array of cytokines and chemokines that attract and 
stimulate immune cells, fibroblasts and endothelial cells, promoting aberrant ECM remodeling and 
angiogenesis. In return, activated fibroblasts and infiltrating inflammatory cells secrete proteolytic enzymes, 
cytokines and chemokines, promoting neoplastic cell proliferation and invasion. In contrast to the wound 
healing response, signaling pathways controlling proliferation, ECM remodeling and angiogenesis remain 
constitutively active during tumor formation (modified from (Coussens and Werb, 2002)). 
 
Wound healing is a highly dynamic process involving multiple interactions of epidermal cells, 
dermal fibroblasts and immune cells leading to a rapid wound closure and subsequent tissue 
repair. On the cellular level it involves de-differentiation, differentiation, migration, proliferation 
and apoptosis of various cell types to create the multilayered tissue that constitutes the skin. 
The wound healing response starts immediately after injury with the development of a blood clot 
and a local inflammation, where immune cells prevent infection and remove debris (Figure32A). 
Subsequently, underlying dermal fibroblasts become activated to proliferate and to secret and 
A B 
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remodel the ECM. The fibroblasts of the hypodermis are mainly responsible for the ECM secretion 
for the early wound closure, whereas the upper dermal papillary fibroblast are only recruited 
during the later re-epithelialization step and are required for de novo HF formation (Driskell et al., 
2013). For the re-epithelialization step keratinocytes at the periphery of the wound start migrating 
and proliferating in response to several growth factors, such as EGF, TGFα and keratinocyte 
growth factor (KGF). In an EMT-like process, migrating keratinocytes undergo several subcellular 
modifications including disassembly of hemidesmosomal links between epidermis and basement 
membrane, upregulation of fibronectin-binding integrins, rearrangement of the keratin filaments 
and dissolution of most desmosomes as well as cell polarization towards the wound, forming 
lamellipodia and focal contacts (Santoro and Gaudino, 2005). Once the overlaying keratinocytes 
have proliferated and migrated to repair the epidermis, they together with fibroblasts synthesize 
ECM proteins that are incorporated into the basement membrane. Further angiogenesis is 
stimulated locally to restore skin blood supply. Key signaling pathways during wound healing are 
Wnt/β-catenin, TGFβ, Hedgehog and Notch. After wounding, expression of multiple Wnt ligands is 
induced in the epithelium (Okuse et al., 2005). During the repair process Wnt/β-catenin signaling 
plays an important role in the construction of epithelial structures, particularly the HF as well as 
reconstitution of the dermal compartment, where it strongly influences fibroblast behavior 
(Cheon et al., 2002; Cheon et al., 2006; Ito et al., 2007). Of note, a recent study has shown that 
upon wounding recruited γδT cells activate Wnt signaling in dermal fibroblast, which is essential 
for the HF regeneration (Gay et al., 2013). The authors speculate that the low number of γδT cells 
in human skin compared to mice could explain why human skin scars but does not regenerate HFs. 
A prolonged or aberrant β-catenin activity in dermal fibroblast contributes to excessive fibrosis 
and scar formation (Cheon et al., 2005; Cheon et al., 2002). Similarly, prolonged TGFβ signaling is 
associated with hypertrophic scar formation and fibrosis. During cutaneous wound repair TGFβ 
signaling is highly activated and crucial in mediating the fibrotic mechanisms needed to restore 
the dermis as well as in modulating keratinocyte proliferation (Denton et al., 2009). Because TGFβ 
induces fibroblast contraction it is also proposed to promote wound closure (Martinez-Ferrer et 
al., 2010). The Hedgehog pathway and Notch pathway seem to participate in wound repair at 
multiple levels, such as angiogenesis, matrix production, and inflammation; however, molecular 
insights are largely missing (Bielefeld et al., 2013).  
Whereas the wound healing process is a self-limiting process, tumor cells develop the capacity to 
expand, evolve and spread, promoted by a continuous inflammation (Figure32B). Tumors lose the 
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ability to respond to normal physiological regulatory feedback loops. Instead, tumors hijack and 
constitutively activate signaling pathways that are only transiently induced for wound repair, 
leading to striking similarities between the growth factors, cytokines and chemokines induced in 
healing wounds, and tumors (Chang et al., 2004). The similarities between the microenvironment 
of a healing wound and tumors, led the conclusion that “tumors are wounds that do not heal” 
(Dvorak, 1986). Indeed, chronic wounds are associated with increased risk for cancer (Coussens 
and Werb, 2002).  Similarly, Wnt/β-catenin, TGFβ, Hedgehog and Notch are also key pathways in 
tumor formation and their deregulation give rise to distinct tumor entities, which will be discussed 
below.  
 
1.6.2 Skin tumor entities 
 
 
In skin the tumor entity is mainly determined by the origin of the initiating cell: papillomas are 
derived from interfollicular epidermis or suprabasal cells, sebaceous adenoma arise from 
sebaceous gland and skin squamous-cell carcinoma (SCC) as well as trichofolliculomas originate 
from HF cells (Figure33A-D) (Perez-Losada and Balmain, 2003). While it has been assumed for a 
long time that basal cell carcinomas (BCCs) arise from HF cells, a recent study indicates that BCCs 
originate rather from interfollicular epidermis cells that are reprogrammed into an embryonic HF 
progenitor-like state (Youssef et al., 2012). In humans BCC and SCC are the most common non-
melanoma skin cancers (Diepgen and Mahler, 2002), which will be discussed shortly below.  
Figure33: Skin tumor entities  
Mouse tissue H&E stainings of (A) 
normal skin, showing interfollicular 
epidermis (IFE), hair follicle (HF) and 
sebaceous gland (SG); (B) squamous-
cell carcinoma, showing IFE 
differentiation; (C) trichofolliculoma, 
showing aberrant HF differentiation; 
(D) sebaceous adenoma, with 
numerous differentiated sebocytes. 
(A-D) scale bar: 100 m; (modified 
from (Owens and Watt, 2003)). 
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SCC is a malignant epidermal neoplasm that frequently manifests as a rough keratotic papule, a 
wart-like growth, or a fast growing tender protuberance, mostly with a central keratinous core. 
SCCs arise from multilayered epithelial cells, such as epidermis, oesophagus, cervix and the lining 
of the mouth leading to tumors with different frequency, entity and prognosis. The two major 
proto-oncogens or tumor suppressor genes responsible for SCC formation are K-ras and p53 
respectively (White et al., 2011). Loss of the DNA damage sensor p53 and constitutive activity of K-
ras, lead to uncontrolled proliferation and increased genome instability. P53 is mutated in more 
than 50% of all SCCs and mutations in p53 are frequently induced by UV exposure. Consequently, 
SCCs usually develop on sun exposed sites in the skin (Giglia-Mari and Sarasin, 2003).  
BCC occurs more frequently than SCC (in a ratio 4:1) and thus is one of the most prevalent forms 
of skin cancer. BCCs can be superficial, nodular or morphoeic, which is associated with a more 
aggressive infiltrating growth pattern. These locally invasive skin tumors occur most commonly in 
sun exposed skin and are driven by UV induced mutations of genes encoding proteins in the Shh 
pathway. The most common mutations result in inactivation of Patched, which is the membrane 
receptor for Shh. In the absence of Shh ligand Patched inhibits signaling through smoothened, 
thus Patched inactivating mutations increase Shh signaling. Similar to SCC, also p53 is frequently 
mutated in BCC due to photo damage. However, p53 inactivation does not appear to be necessary 
for BCC formation in either mouse or human models (Fan et al., 1997; Grachtchouk et al., 2000). 
 
1.6.3 Integrins and cancer 
Due to the high similarity in many aspects of wound healing and tumor development, it is 
conceivable that integrins are crucial in both conditions. Indeed, loss of β1 integrin severely 
impairs wound repair in skin (Grose et al., 2002), and prevents the induction and maintenance of 
mammary tumors (White et al., 2004). In line, hyperactive integrins are associated with high skin 
tumor risk and dysfunctional integrins prevent skin tumor formation (see below).  
Functionally, integrins are implicated in tumor cell proliferation, migration, adhesion and survival.  
In several tumor types, the expression of particular integrins correlates with increased disease 
progression and decreased patient survival. In tumors originating from epithelial cells, integrin 
expression pattern is often retained although the expression levels may be altered significantly 
between normal and tumor tissues. Most notably, the fibronectin receptors αvβ3, α5β1 and αvβ6, 
are usually expressed at very low levels in most adult epithelia, but can be highly upregulated in 
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some tumors, assisting adhesion, cell survival and proliferation on fibrotic tissue during invasion 
(see also section 1.6.4). Also switching of integrin heterodimer expression is frequently observed 
during tumor progression. In SCCs αvβ6 upregulation seems to correlate with αvβ5 
downregulation, promoting cell survival (Janes and Watt, 2004). 
Besides their expression, the integrin activity can be altered and indeed, several mutations in β1 
integrin have been found in human SCC, influencing integrin activity and tumor development 
(Evans et al., 2004). Most prominently, a mutation in the β1 integrin I-like domain (T188I) was 
shown to constitutively activate β1 integrin, inducing sustained Erk-MAPK signaling independent 
of cell spreading and suppressing cell differentiation (Evans et al., 2003). In a chemical 
cancerogenesis mouse model, overexpression of T188I mutant β1 integrin in skin promotes tumor 
susceptibility and conversion of benign to malignant skin tumors (Ferreira et al., 2009). In addition 
to integrin activity, integrin recycling was revealed to have profound effects on tumor cell 
invasion. Ras-related in brain (Rab) GTPases direct integrins to the leading edge of invading 
tumors and coordinately regulate integrin and growth factor receptor recycling, enhancing growth 
factor signaling and invasiveness (Caswell et al., 2008; Caswell et al., 2007). 
Not only integrins on the surface of tumor cells, but also the expression on tumor-associated cells 
can profoundly influence the malignant potential of a tumor, promoting ECM remodeling, 
angiogenesis and immune cell infiltration. Especially the cross talk of integrins and growth 
factor/cytokine receptors between tumor cell and tumor stroma is vital for many aspects of tumor 
progression. Integrins are able to directly or indirectly associate with growth factor or cytokine 
receptors, modulating the surface expression, ligand affinity and signaling of the receptors. A 
cooperative signaling occurs between integrins and members of the EGF receptor family: on the 
one hand, integrin ligand binding can induce EGF receptor phosphorylation independently of EGF, 
resulting in increased ERK-MAPK activation, tumor cell proliferation and survival (Moro et al., 
2002). On the other hand, EGF has been suggested to increase integrin αvβ5 mediated migration 
by inducing Src kinase dependent phosphorylation of p130Cas and subsequent activation of 
GTPase Rap1 which increases Talin activation (see section 1.2.4.3) (Ricono JM et al., 2009). 
Furthermore, integrins can regulate the release of growth factor ligands from the ECM. The 
instrumental role of αv-class integrins in the activation of TGFβ, a well characterized promoter of 
tumor progression, is discussed in section 1.3.6.2.  
Integrins and growth factor/cytokine receptor can also reciprocally regulate the surface 
expression and activity of one another. For example, the chemokine receptor CXCR4 increases cell 
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adhesion to fibronectin and collagen by promoting the activity of various β1 class integrins in small 
cell lung cancer cells (Hartmann et al., 2005). Moreover, activation of CXCR4 on various tumor 
cells increases the expression of integrins, such as α5β1 and αvβ3, increasing cell adhesion and 
invasion (Engl et al., 2006; Sun et al., 2007). Besides influencing growth factor/cytokine receptor, 
integrins have been shown to regulate the localization and activity of matrix-degrading proteases, 
such as MMP2 and uPA, important for tumor progression (see section 1.6.4). 
One major hallmark for cancer cell progression is the loss of adhesion dependent growth control. 
Interestingly, integrins can have a profound influence on tumor survival, both in the presence and 
absence of ligands. In adherent cells, both β1- and αv-class integrin induce FAK and Src kinase 
activity and subsequent p130Cas phosphorylation, promoting survival signals through the Akt and 
Erk pathway. Furthermore, ligand bound integrins prevent pro-apoptotic signaling cascades 
initiated in detachment induced apoptosis (anoikis) (Frisch and Screaton, 2001), as well as integrin 
mediated death (IMD). In contrast to anoikis, IMD can also be induced in adherent cells by a 
subset of unligated integrins (shown for β1 and β3 integrin), which then bind and activate 
Caspase8, leading to apoptosis (Stupack et al., 2001). However, recent evidences also point to an 
anti-apoptotic role for unligated integrins in tumor cells. Unligated αvβ3 is able to induce cell 
survival signals by recruiting and activating Src and p130Cas in a FAK-independent manner 
(Desgrosellier et al., 2009). Also unligated αvβ6 integrin is able to promote survival signaling by 
suppressing anoikis in SCC cells (discussed below). Thus, increasing the expression of particular 
integrin heterodimers is an elegant strategy for tumor cells to be able to adapt to novel ECM 
environments during invasion or even escape adhesion dependent growth control.  
 
1.6.4 αvβ6 integrin and cancer 
Intriguingly, integrin αvβ6 is highly upregulated in various carcinomas of the lung, breast, 
pancreas, stomach, colon, ovary, salivary gland as well as oral and skin SCC (reviewed in 
(Bandyopadhyay and Raghavan, 2009)). In these cancers an increased expression of αvβ6 is often 
associated with a poor patient prognosis and enhanced cell invasion, cell survival, protease activity 
and EMT (Ahmed et al., 2002; Thomas et al., 2006). Mechanistic insights of how αvβ6 integrin 
promotes tumor progression and metastasis, only start to emerge recently.  
On the one hand, αvβ6 integrin enhances spreading and migration of keratinocytes on fibronectin, 
tenascin C and vitronectin, all of which are components of the early wound matrix and often 
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upregulated in the tumor stroma. The αvβ6 integrin mediated cell motility was shown to be 
regulated by its interaction with HS1-associated protein X-1 (HAX1), which promotes αvβ6 
clathrin-dependent endocytosis and invasion in SCC (Ramsay et al., 2007). 
On the other hand, αvβ6 seems to play a role in the activity control of proteases, such as MMP9, 3 
and uPA in various cancers, promoting ECM degradation as well as cell detachment from the 
basement membrane (Li et al., 2003; Thomas et al., 2001). Indeed, at the invading edge of colon 
cancer high αvβ6 levels are accompanied by the elevated expression of the pro-enzyme form of 
type IV collagenase and MMP9 (Yang GY et al., 2008). Interestingly, the MMP9 activity is 
modulated through direct ERK binding to the cytoplasmic β6 integrin tail, whereas activity of 
MMP3 has been reported to be modulated indirectly through binding of the Src family kinase FYN 
and subsequent FAK recruitment upon fibronectin binding. The induced activation of the ERK-
MAPK pathway enhances MMP3 transcription (Li et al., 2003). But also a direct binding of uPA to 
the cytoplasmic tail of αvβ6 in ovarian cancer cells, but not in normal ovarian cells, has been 
shown to promote ECM degradation and to correlate with elevated TGFβ signaling (Saldanha et 
al., 2007).  
How increased αvβ6 expression triggers EMT in different cancers is not fully understood. In colon 
carcinoma cells and oral SCC the EMT promoting effect of αvβ6 seems to be partly due to 
increased TGFβ1 release (see also section 1.6.5) (Bates et al., 2005; Ramos et al., 2009). 
Interestingly, deletion of the last 11 amino acids of the cytoplasmic β6 integrin tail abolishes the 
EMT promoting effect as well as the invasive activity of αvβ6 but not the αvβ6-dependent 
adhesion or migration (Morgan et al., 2011). A screening study for specific interaction partners to 
this unique terminal 11 amino acids β6 tail sequence has revealed that psoriasin (also known as 
S100A7) directly binds to it. The psoriasin-β6 tail interaction seems to be crucial for αvβ6 
dependent invasiveness of carcinoma cells; however the molecular mechanism remains elusive 
(Morgan et al., 2011).  
Upregulation of αvβ6 integrin is also able to generate adhesion independent survival signals, 
which are crucial for tumor cell invasion and subsequent metastasis formation. By switching the 
integrin profile from αvβ5 to αvβ6 high expression, oral SCC cells are able to upregulate Akt 
signaling independent of ligand binding, protecting them from anoikis (Janes and Watt, 2004). 
Whether non-transformed keratinocytes, which transiently upregulate αvβ6 integrin during 
wound healing, also become more resistant to apoptosis, is still an open question. 
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Taken together, αvβ6 promotes cancer progression on various levels ranging from enhanced 
adhesion and migration on various substrates to control of protease activity, EMT and cell survival. 
The selective expression in many types of cancer and reversion of oncogenic effects upon 
inhibition, by blocking antibody, shRNA or small peptides (Hsiao et al., 2010; Weinreb et al., 2004), 
positions αvβ6 as a suitable target for the development of cancer therapies. 
 
 
1.6.5 The paradoxical role of TGFβ signaling in cancer  
 
Figure34: The effect of TGFβ signaling on tumor initiation and progression  
(A) TGFβ signaling via Smad transcription factor regulates multiple cytostatic genes and genes involved in 
homeostasis in normal epithelial cells. (B) Furthermore in pre-malignant epithelial cells, TGFβ signaling 
promotes apoptosis, thus acting as a tumor suppressor. During tumor progression, cells need to accumulate 
additional alterations to overcome the suppressive effect of TGFβ. (C) Tumor cells have been shown to 
acquire inactivating mutations in TGFβ receptor and/or Smad4 genes. As a consequence tumor cells are able 
to grow in a TGFβ-rich tumor stroma environment and at the same time benefit from pro-tumorigenic 
effects, such as TGFβ induction of stroma-derived cytokines promoting cell survival. (D) Alternatively, tumor 
cells can acquire mutations in TGFβ target genes, leading to loss of TGFβ mediated growth control, while 
retaining intact Smad signaling machinery. Thus cancer cells not only survive in a TGFβ-rich 
microenvironment, but also respond to TGFβ, resulting in canonical and non-canonical TGFβ signaling 
transduction promoting EMT and an invasive tumor cell behavior (modified from (Massague, 2012)). 
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TGFβ is a multifunctional cytokine which is produced by many different cell types and a loss of 
balance in TGFβ signaling has been implicated in the pathogenesis of many diseases including 
cancer, fibrosis autoimmune and vascular diseases (Blobe et al., 2000; Massague, 2008). 
The effects of TGFβ during tumor development are paradoxical since it is a powerful tumor 
suppressor in the context of pre-malignant cells, but an enhancer of invasion and metastasis in the 
context of more advanced cancer cells (Massague, 2008). The tumor suppressive effect of TGFβ is 
based on its cytostatic pro-apoptotic and cell differentiation effect in a large variety of cell types. 
During the early stages of tumorigenesis when cells acquire oncogenic mutations, TGFβ inhibits 
cell cycle progression and triggers apoptosis (Bardeesy et al., 2006; Guasch et al., 2007). Key 
effector of the growth control in tumors is c-myc which is repressed through the canonical TGFβ 
pathway. Mechanistically upon TGFβ receptor activation, a preexisting complex of R-Smad and the 
transcription factors E2F4/5 and DP1 associate with Smad4 and translocate in the nucleus where it 
binds to a proximal element of the c-myc promoter suppressing its activation (Chen et al., 2002).  
At the same time, R-Smad and Smad4 are able to complex with forkhead box protein O (FoxO) 
transcription factors. In the nucleus these complexes bind to the promoters of several cyclin-
dependent kinase inhibitors, including p15 and p21, promoting their transcription (Figure34A) 
(Gomis et al., 2006). Thus, activated R-Smad can act as a transcriptional repressor or activator, 
depending on the binding partner.   
A detailed mechanism of how premalignant cells become programmed for apoptosis through 
TGFβ is still missing. The pro-apoptotic effect of TGFβ seems to involve multiple pathways 
including the induction of the death-associated protein (DAP)-kinase (Jang et al., 2002), the 
signaling factor growth arrest and DNA-damage inducible, beta (Gadd45b) (Yoo et al., 2003), the 
death receptor FAS (Kim et al., 2004) and the pro-apoptotic effector BIM (Ramesh et al., 2008). In 
addition, TGFβ inhibits the activation of the PI3K-Akt pro-survival pathway by inducing the 5′ 
inositol phosphatase Src homology 2 (SH2) domain-containing 5' inositol phosphatase (SHIP) 
(Valderrama-Carvajal et al., 2002).  
Besides promoting EMT (discussed below), TGFβ signaling can inhibit tumor progression by 
inducing cell differentiation and driving precursor cells into a less proliferative state (Derynck R 
and Akhurst RJ, 2007). For example, TGFβ modulates differentiation through inhibition of inhibitor 
of differentiation (Id) proteins that negatively regulate cell differentiation by interfering with pro-
differentiation transcription factors, such as basic helix-loop-helix (bHLH) (Ruzinova and Benezra, 
2003). 
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In many different tumor entities, such as skin cancer, breast cancers or head or neck SCC, loss of 
TGFβ induced proliferation control is one prominent feature (Massague, 2008). 
In line, transgenic mice expressing a dominant negative TβRII or lacking TβRII in the epidermis or 
mammary glands show increased tumor formation and metastatic progression (Bottinger et al., 
1997; Go et al., 1999; Guasch et al., 2007). Furthermore, deletion of TGFβ1 in the skin leads to 
increased tumor susceptibility and promotes malignant conversion metastasis formation, while 
TGFβ1 overexpression suppresses initial tumor formation but is able to promote the progression 
and invasiveness in chemical cancerogenesis mouse models (Cui et al., 1996; Glick et al., 1994; 
Mohammed et al., 2010). 
Once pre-malignant cells eliminate the sensitivity to the tumor suppressive effect of the TGFβ 
pathway, cancer cells can benefit from a TGFβ-rich microenvironment that favors tumor 
progression through EMT promotion, deregulated inflammation as well as enhanced fibroblast 
activation in the tumor stroma (Figure34B-D) (Yang et al., 2010). Indeed, loss of TGFβ tumor 
suppressive responses has been shown to occur by inactivating mutations in TβRII and Smad4, 
leading to a complete inactivation or more downstream by mutation of essential tumor 
suppressive Smad target, such as cyclin-dependent kinase inhibitor 2B (CDKN2B) and c-myc, 
whereas the potentially remaining Smad signaling capacity is able to promote EMT (Figure34) 
(Massague, 2008). In contrast to the spatially and temporally tight controlled EMT during 
embryonic development or wound healing, this process is more disorganized in advanced cancer. 
TGFβ induces EMT by canonical as well as non-canonical TGFβ signaling. R-Smad activation 
promotes expression of the zinc-finger binding proteins Snail and Slug which promote EMT by 
inhibiting E-cadherin transcription (Vincent et al., 2009). Independent of Smad signaling, EMT is 
promoted by the TGFβ induced activation of the p38/MAPK pathway (Bakin et al., 2002), RhoA 
signaling (Bhowmick et al., 2001), PI3K activity (Kattla et al., 2008) or phosphorylation of Par6 
through the activated TGFβ receptor kinase (Ozdamar et al., 2005).  
Taken together under normal physiological conditions or during onset of tumor formation, TGFβ 
exerts cytostatic effects and functions as a tumor suppressor, whereas at later stages of cancer 
progression it functions as a tumor promoter assisting in metastatic progression by inducing EMT 
and modulating the tumor microenvironment.  
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1.6.6 Wnt signaling in cancer 
Mutations in the Wnt pathway are often observed in cancer, especially in tissues which depend on 
Wnt signaling for self-renewal or repair. Indeed, the Wnt pathway has turned out as an essential 
player for tumor growth and progression (Beronja et al., 2013; Malanchi et al., 2008). It has been 
estimated that approximately 10% of all tissue samples sequenced from all cancers display 
mutations in the CTNNB1 gene (Forbes et al., 2011). Most of these mutations are located within 
the β-TrCP binding motif of the N-terminal β-catenin segment in various tissues, leading to 
stabilized β-catenin and increased Wnt signaling (Chan et al., 1999; Morin et al., 1997; Rubinfeld 
et al., 1997). Indeed, sustained activation of canonical Wnt signaling in adult epidermis promotes 
HF derived pilomatricomas (benign skin tumor derived from hair matrix) and trichofolliculomas 
(benign HF tumor) in transgenic mice and humans (Chan et al., 1999; Gat et al., 1998; Lo Celso et 
al., 2004; Silva-Vargas et al., 2005). Also in melanoma oncogenic β-catenin stabilizing mutations 
are frequent found (Rubinfeld et al., 1997). In addition, mutations are also frequently seen in the 
β-catenin recruiting motifs of APC as well as Axin2 (Liu et al., 2000; Morin et al., 1997). Strikingly, 
the majority of colorectal cancers carry inactivating APC mutations resulting in increased β-catenin 
stability (Korinek et al., 1997; Morin et al., 1997; Rowan et al., 2000). Of note, hereditary loss-of-
function mutations of APC cause a condition known as familial adenomatous polyposis (FAP) 
(Groden et al., 1991). Affected individuals develop multiple polyps in the large intestine, which 
eventually progress to malignancy.  
Surprisingly, also the inhibition of Wnt/β-catenin signaling can promote some types of cancers. In 
skin, mutation of the β-catenin binding site in Lef1 induces the formation of sebaceous gland 
tumors in transgenic mice (Niemann et al., 2002) and humans (Takeda et al., 2006). These data 
suggest that an optimal level of Wnt/β-catenin signaling exists that is required for tissue 
homeostasis, and that either hyperactivation or attenuation of signaling can lead to tumor 
formation. 
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2 Aim of the thesis 
 
My PhD project focused on the role of Kindlin-1 in skin homeostasis and tumor development.  
Kindlin-1 belongs to focal adhesion protein family of three members (Kindlin-1, -2 and -3). All 
Kindlins are involved in cell substrate adhesion by regulating the activity of the cell surface 
adhesion receptors integrin and linking them to the actin cytoskeleton via recruitment of adaptor 
proteins such as ILK. In epithelial cells Kindlin-1 and -2 are co-expressed, while Kindlin-3 is only 
expressed in hematopoietic cells. In humans loss-of-function mutations in KINDLIN-1 and KINDLIN-
3 impair the integrin function in the affected organs causing Kindler syndrome (KS) and leukocyte 
adhesion deficiency III syndrome, respectively. KS is a rare skin genodermatosis characterized by 
trauma induced skin blistering, areas of cutaneous atrophy and hyperkeratosis, pigmentation 
defects, photosensitivity, premature skin aging and an increased risk for skin cancer. Especially the 
increased risk for skin cancer in KS patients is highly unexpected, as hyperactive integrins are 
associated with high skin tumor risk and dysfunctional integrins prevent skin tumor formation. 
This contradiction has strongly suggested that the absence of Kindlin-1 triggers novel, integrin-
independent oncogenic function(s) that are sufficient to induce skin tumors early in the life of KS 
patients.  
To explore these novel Kindlin functions in vivo, the first aim was to generate and characterize a 
suitable mouse model for the human KS disease, allowing to monitor the consequences of Kindlin-
1 loss at different developmental stages and especially at older age.   
By comparing the Kindlin-1 mouse model with transgenic mice expressing a Kindlin-binding 
deficient β1 integrin mutants in the skin, the contribution of the major skin integrin to the KS 
phenotype should be dissected as a second aim.  
My third aim was to analyze the impact of Kindlin-1 loss on the different cutaneous epithelial 
stem cell lineages and their homeostasis. Further, the affected molecular skin signaling pathways 
were investigated employing and establishing numerous in vitro and in vivo assays. 
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The forth aim comprised the investigation of whether the increased tumor risk in KS patients 
could be recapitulated in a chemical cancerogenesis mouse model and to thoroughly analyze and 
quantify the developing tumors by histology. In addition, I identified the molecular mechanism 
contributing to the increased skin cancer risk in mice and humans.  
After defining the role of Kindlin-1 in skin stem cell homeostasis and identifying novel Kindlin-1 
regulated signaling pathways in skin, as fifth aim, these findings were compared to the function of 
Kindlin-3 for hematopoietic stem and precursor cells in the bone marrow.  
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3 Short summary of manuscripts 
 
3.1 Kindlin-1 controls Wnt and TGF-β availability to regulate cutaneous stem 
cell proliferation 
Emanuel Rognoni, Moritz Widmaier, Madis Jakobson, Raphael Ruppert, Siegfried Ussar, 
Despoina Katsougkri, Ralph T. Böttcher, Joey E. Lai-Cheong, Daniel B. Rifkin, John McGrath, 
Reinhard Fässler 
Kindlin-1 is an integrin tail binding protein that controls integrin activation, which is important for 
cell adhesion to the extracellular matrix. Mutations in the Kindlin-1 (KINDLIN-1) gene cause Kindler 
syndrome in humans, which is characterized by skin blisters, pigmentation defects, skin atrophy 
and increased skin tumor susceptibility. Of note, the increased tumor risk is highly unexpected, as 
hyperactive integrins are associated with high skin tumor risk and dysfunctional integrins prevent 
skin tumor formation. 
This contradiction prompted us to develop a mouse model for an epidermal specific deletion of 
Kindlin-1, enabling us for the first time to fully recapitulate the human Kindler syndrome disease in 
mice and explore the role of Kindlin-1 in tumor development. Following the progression of Kindler 
syndrome disease during the whole life span of the animals, we were able to show that Kindlin-1 
controls epithelial stem cell homeostasis and consequently loss of Kindlin-1 led to enlarged and 
hyperactive stem cell compartments and aberrant stem cell commitment, resulting in severe hair 
follicle abnormalities. In vivo and ex vivo studies of Kindlin-1 deleted keratinocytes revealed, in 
addition to the expected β1 integrin associated adhesion defect, a severe deregulation of the 
Wnt/β-catenin and TGFβ signaling pathway, both  important for skin epithelial stem cell 
quiescence, self-renewal and differentiation. 
Mechanistically, we identified that (1) Kindlin-1 controls adhesion of epidermal cells primarily by 
β1 integrin and (2) in stem cells Kindlin-1 inhibits proliferation by inducing αvβ6 integrin-mediated 
TGFβ release and (3) triggers cutaneous epithelial stem cell commitment by regulating Wnt ligand 
expression and preventing aberrant Wnt/β-catenin signaling in an integrin independent manner.  
The relevance of our findings is underscored by the fact that we confirmed similar defects in TGFβ 
and Wnt signaling pathways in human Kindler syndrome patients. 
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3.2 Loss of Kindlin-1 causes skin atrophy and lethal neonatal intestinal 
epithelial dysfunction  
Siegfried Ussar, Markus Moser, Moritz Widmaier, Emanuel Rognoni, Christian Harrer, Orsolya 
Genzel-Boroviczeny, Reinhard Fässler 
 
The human disease Kindler syndrome is caused by mutations in the (KINDLIN-1) gene and is 
characterized by skin blistering, pigmentation defects, skin atrophy and cancer. Kindlin-1 belongs 
to a family (Kindlin-1, -2 and -3) of focal adhesion proteins which bind to the cytoplasmic tails of 
several integrins and promote the activation of these cell surface receptors, essential for cell 
adhesion to the extracellular matrix, migration, proliferation as well as survival. 
In this study we generated a constitutive Kindlin-1 null mouse which develops some symptoms of 
the human Kindler syndrome disease including skin blisters and atrophy. Surprisingly, Kindlin-1 
null mice die shortly after birth due to an ulcerative colitis-like intestinal dysfunction. Similar to 
the skin, the intestinal epithelial cells express the Kindlin isoforms Kindlin-1 and -2. 
Mechanistically, loss of Kindlin-1 leads to impaired intestinal epithelial integrin function, which 
cannot be compensated by Kindlin-2, resulting in a shear stress promoted detachment of the 
intestinal epithelium and subsequent induction of a severe inflammatory response in the whole 
intestine. Of note, a recent study reports that also human subjects with Kindler syndrome showed 
ulcerative colitis-like symptoms confirming our mouse findings; however, the human intestinal 
symptoms are less severe.   
In summary, this mouse model enables us to study the development of the ulcerative colitis-like 
intestinal dysfunction in Kindler syndrome disease, underlining that loss of Kindlin-1 affects 
integrin activity in multiple epithelial structures beyond the skin epidermis.  
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3.3 Kindlin-3 mediated integrin adhesion is dispensable for quiescent 
hematopoietic stem cells but required to maintain activated 
hematopoietic stem and precursor cells 
Raphael Ruppert, Markus Moser, Markus Sperandio, Emanuel Rognoni, Martin Orban, Wen-Hsin 
Liu, Ansgar Schulz, Robert A. J. Oostendorp, Steffen Massberg, and Reinhard Fässler 
The Kindlin family consists of three members (Kindlin-1, -2 and -3) which bind to the cytoplasmic 
tail of most integrin β subunits, which compose a family cell surface receptors essential for cell 
adhesion, migration, survival and proliferation.  
Interestingly, the expression of Kindlin-3 is restricted to the hematopoietic system and mutation 
of the KINDLIN-3 gene in human leads to leukocyte adhesion deficiency type III (LAD III), while 
constitutive deletion of Kindlin-3 in mice is embryonic lethal, due to severe hemorrhages in 
multiple organs. Both hematological disorders are characterized by impaired adhesion and 
migration of multiple blood cell linages because of impaired integrin function.  Kindlin-3 is highly 
expressed in hematopoietic stem and precursor cells, but in contrast to mature blood lineages, 
such as leukocytes, platelets and osteoclasts, the influence of Kindlin-3 loss in these 
compartments is unknown.  After embryonic development, all mature blood cell linages are 
generated and maintained by a pool of hematopoietic stem cells residing in specialized niche 
compartments in the bone marrow. Quiescence, retention, restricted activation and 
differentiation of the hematopoietic stem cells is controlled by a complex cross talk between the 
hematopoietic stem cell and multiple niche environment factors including extracellular matrix 
components, adhesion molecules such as integrins, CD44 or selectins, growth factors, cytokines 
and morphogenes.  
In this study, we generated chimeric mice by transplanting fetal liver cells from Kindlin-3 wild type 
and knockout animals into lethally irradiated wild type recipients, circumventing the early 
postnatal lethality of Kindlin-3 null mice. Upon transplantation we show that hematopoietic 
precursor cells depleted for Kindlin-3 are severely impaired in their bone marrow homing ability 
because of attenuated integrin mediated adhesion to the endothelial cells of the vessels. Also the 
homing competent fraction of Kindlin-3 deficient hematopoietic stem cells can only be retained 
for a while. The defective integrin activation leads to premature release of activated Kindlin-3 
deficient hematopoietic precursor cells into the circulation causing a lack of mature effector cells, 
such as platelets, neutrophils and erythrocytes, which in turn leads to a sustained angiopoietic 
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feedback signal fueling stem cell activation. Thus, Kindlin-3 deficient hematopoietic stem cells 
never enter quiescence and are eventually lost due to exhaustion. Interestingly, in the presence of 
unaffected wild type hematopoietic stem cells which guarantee normal blood effector cell 
homeostasis, Kindlin-3 deficient hematopoietic stem cells can enter quiescence and be retained in 
the bone marrow.  
In summary, we conclude that after homing, Kindlin-3 is dispensable to maintain hematopoietic 
stem cell quiescence in the bone marrow niche. In sharp contrast, Kindlin-3 mediated integrin 
activity is absolutely essential for the retention and function of activated hematopoietic stem 
precursor cells in the bone marrow compartment. Of note, a blood sample from a LAD III patient 
revealed a highly increased number of circulating hematopoietic stem precursor cells, indicating 
that Kindlin-3 loss impairs hematopoietic stem cell and precursor cell homeostasis also in humans.   
 
 
 
3.4 Integrins synergistically induce the MAL/SRF target gene ISG15 to 
ISGylate cytoskeletal and focal adhesion proteins necessary for cancer 
cell invasion 
Michaela-Rosemarie Hermann, Emanuel Rognoni, Madis Jakobson, Moritz Widmaier, Assa 
Yeroslaviz, Roy Zent, Guido Posern, Ferdinand Hofstädter and Reinhard Fässler 
 
Integrins are cell surface adhesion receptors important for adhesion and migration. Depending on 
the bound ligand and engaged integrin heterodimer, they mediate different short-term signaling 
effects, involving recruitment of intracellular signaling proteins and long-term changes, resulting in 
actin cytoskeleton rearrangement, gene transcription modulation as well as promotion of cell 
survival and proliferation. How different integrin heterodimers execute individual long-term 
effects and whether they influence each other, is largely unknown. To answer this question for the 
fibronectin binding αv- and β1-class integrins, we generated single integrin class expressing cell 
lines by reconstituting pan integrin knockout fibroblast with similar levels of only αv (αv-cells) or 
β1 (β1-cells), while cells reconstituted with both integrin subtypes  (αv/β1-cells) represented the 
wild type situation.  
In this study, we report that αv- and/or β1-class integrin expressing cells differ in their monomeric 
globular (g)-Actin pool levels correlating with low nuclear megakaryocyte acute leukemia protein 
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(MAL) levels and MAL/ serum response factor (SRF) signaling in αv single, intermediate in β1 and 
high in αv/β1 double expressing cells. The pool of free g-Actin is controlled by numerous actin 
binding proteins such as Thymosin β4 and Cofilin as well as integrin mediated activation of small 
Rho family GTPases, which stimulate g-Actin polymerization into filamentous (f)-Actin structures. 
Free cytosolic g-Actin associates with MAL and inhibits its nuclear translocation and association 
with SRF. Once g-Actin is sequestered into f-Actin structures, free MAL is able to translocate into 
the nucleus and to associate with SRF inducing transcription of MAL target genes, including 
cytoskeletal proteins like actin and multiple integrin associated focal adhesion proteins.    
We show that αv- and β1-class integrins synergistically induce MAL/SRF activity and target gene 
expression through modulation of the free g-Actin pool. Indeed, g-Actin is significantly more 
sequestered and f-Actin less severed in β1-cells and even more αv/β1-cells compared to αv-cells. 
Among the known targets of MAL, we identified the particularly interesting ubiquitin-like 
interferon-stimulated gene 15 (ISG15) to be regulated by integrin-MAL signaling and independent 
of interferon, as previously described. ISG15 binds covalently to specific lysine residues of targets 
proteins influencing their function directly or interfering with protein ubiquitination at multiple 
levels, eventually modulating proteasomal degradation and protein stability. Following mass 
spectrometry analysis of ISG15 modified proteins revealed have ISGylation of many proteins that 
are transcriptionally regulated by MAL/SRF signaling, including multiple integrins, actin, focal 
adhesion and actin binding proteins and the newly identified MAL targets Talin and Eplin.  
The increased ISGylation of these proteins in αv/β1-cells promotes invasiveness of mouse 
fibroblasts and human breast cancer cells and is correlated with poor patient survival. By 
dissecting the fibronectin binding αv and β1 integrin class functions, we have revealed a novel 
autoregulatory feed-forward loop connecting integrin adhesion, MAL/SRF and ISG15, which 
modulates adhesion and actin cytoskeleton remodeling, essential for cell spreading, migration and 
invasion. 
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3.5 Integrin-linked kinase at a glance 
Moritz Widmaier, Emanuel Rognoni, Korana Radovanac, S. Babak Azimifar, Reinhard Fässler 
Integrin-linked-kinase (ILK) is a focal adhesion protein which is ubiquitously expressed and is 
involved in multiple cellular processes including actin rearrangement, cell polarization, spreading, 
migration, proliferation and survival. 
ILK is able to bind to the cytoplasmic tail of the integrin β subunit directly or via Kindlin mediated 
recruitment and in the last years ILK has emerged as a central hub of focal adhesion signaling 
through its interaction with multiple proteins listed in the review. The ILK function is mainly 
influenced by its two most prominent binding partners the adaptor proteins Pinch and Parvin, 
forming a ternary complex termed ILK-Pinch-Parvin (IPP) complex. Because Parvin as well as Pinch 
constitute protein families of two or three members respectively, which differ in functions and 
expression patterns, each IPP complex can execute different functions which are summarized in 
the review.   
Besides the prominent localization of ILK at focal adhesion sites, in different cell types, ILK seems 
to play an important role at cell-cell adherens junctions, influencing the cell-cell contact formation 
and recruitment of tight junction proteins. At centrosomes, ILK controls centrosome function and 
centrosome clustering during mitotic spindle organization, and in the nucleus it has been shown to 
regulate the expression of several genes. Furthermore, in β1 integrin containing nascent adhesion 
sites, ILK is essential for capturing microtubule tips and connecting them to the cortical actin 
network, allowing exocytosis of caveolar carriers at the plasma membrane. In this review, we have 
summarized the novel ILK functions at the different subcellular compartments and illustrated the 
proposed molecular mechanisms. 
Novel insights of the ILK crystal structure as well as transgenic mouse studies targeting critical 
residues of the putative ILK kinase domain, demonstrated that this domain lacks any catalytic 
activity. To illustrate these findings, we compared the kinase center of the structurally related 
bona fide kinase protein kinase A (PkA) with the putative ILK kinase domain highlighting the 
structural hurdles within the ILK kinase domain which inhibit phosphorylation of any substrate.  
Taken together, while an increasing number of new ILK interaction partners, subcellular 
localizations and functions are emerging, mechanistical details for these functions are often 
lacking behind. Now that the kinase function of ILK could be finally ruled out, its prominent role in 
cancer has to be redefined, which we discussed at the end of the review. 
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Kindler syndrome (KS) is an autosomal-recessive disease caused by 
loss-of-function mutations in the FERMT-1 gene, which encodes 
Kindlin-1. The skin is the principal affected organ in individuals with 
KS and displays trauma-induced blisters, photosensitivity, pigmenta-
tion defects and increased risk for malignancies1,2.
The Kindlins belong to a family of evolutionary conserved proteins, 
which are found primarily at cell-matrix adhesion sites, where they 
bind the cytoplasmic tail of β subunit–containing integrins and 
increase integrin affinity for ligands (also called integrin activation)3–5. 
In addition, they are also present at cell-cell adhesion sites, in the 
cytoplasm and in the nucleus, where their functions are unknown6,7. 
Epidermal and hair follicle (HF) keratinocytes express Kindlin-1 
and Kindlin-2. However, despite their striking sequence similarity, 
Kindlin-1 and Kindlin-2 cannot compensate for each other, indicating 
that they have specialized functions3,8.
Epidermal keratinocytes express several integrins, most notably 
members of the β1 subunit–containing subfamily9. Keratinocytes of the 
HF bulge express high levels of β1 and αvβ6 integrin10. The HF bulge 
harbors dormant stem cells (SCs) that periodically become activated 
to sustain the hair cycle11,12. The alternation of bulge SC activation 
and dormancy is regulated by a tight interplay of antagonistic signal-
ing pathways. SC dormancy is achieved by bone morphogenic protein 
(BMP) and TGF-β signaling, whereas SC activation is elicited by shut-
ting down BMP and TGF-β signaling and activating canonical Wnt–
β-catenin signaling. Perturbations of these cell growth–regulating 
signaling pathways or of integrin signaling can profoundly alter 
SC homeostasis and tumor incidence13–16. It has been shown, for 
example, that increased integrin expression or activity is associated 
with an increased risk for squamous cell carcinoma16–18. Conversely, 
loss of β1 subunit–containing integrin expression in skin (M. Sibilia, 
Medical University of Vienna, Austria, personal communication) or 
other tissues such as the mammary gland markedly reduces tumor 
susceptibility19. Moreover, it has been shown recently that Kindlin-2 
can stabilize β-catenin and induce Wnt signaling in certain tumor cell 
lines20. It is therefore enigmatic why patients with KS suffer from an 
increased tumor risk2,21,22 despite Kindlin-1 loss and compromised 
integrin functions in their keratinocytes3,23,24. This discrepancy sug-
gests that Kindlin-1 harbors potent tumor-suppressor function(s) in 
keratinocytes that operate independently of the abundant and onco-
genic β1-class integrins. In this study we identified oncogenic signal-
ing pathways that are tightly controlled by Kindlin-1.
RESULTS
Kindlin-1 loss in epidermis and HFs leads to KS-like defects
To circumvent the lethal ulcerative colitis of a constitutive Fermt-1 
gene ablation3, we efficiently deleted the Fermt-1 gene in keratino-
cytes by breeding mice with floxed Fermt-1 with Keratin-5 (K5)-
Cre transgenic mice25 (resulting in Kind1-K5 mice; Fig. 1a–c and 
Supplementary Fig. 1a–c). Kindlin-1 loss persisted and did not 
affect Kindlin-2 expression in these mice (Supplementary Fig. 1b). 
Heterozygous Kind1-K5 mice or mice with homozygous floxed Fermt-1 
used as control strains had no apparent phenotype. Homozygous 
Kind1-K5 mice were born within the expected Mendelian ratio, were 
fertile and gained weight normally (Supplementary Fig. 1d).
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Kindlin-1 controls Wnt and TGF-β availability to  
regulate cutaneous stem cell proliferation
Emanuel Rognoni1, Moritz Widmaier1, Madis Jakobson1, Raphael Ruppert1, Siegfried Ussar1,  
Despoina Katsougkri1, Ralph T Böttcher1, Joey E Lai-Cheong2,3, Daniel B Rifkin4, John A McGrath3 &  
Reinhard Fässler1
Kindlin-1 is an integrin tail binding protein that controls integrin activation. Mutations in the FERMT-1 gene, which encodes for 
Kindlin-1, lead to Kindler syndrome in man, which is characterized by skin blistering, premature skin aging and skin cancer of 
unknown etiology. Here we show that loss of Kindlin-1 in mouse keratinocytes recapitulates Kindler syndrome and also produces 
enlarged and hyperactive stem cell compartments, which lead to hyperthickened epidermis, ectopic hair follicle development 
and increased skin tumor susceptibility. Mechanistically, Kindlin-1 controls keratinocyte adhesion through b1-class integrins 
and proliferation and differentiation of cutaneous epithelial stem cells by promoting avb6 integrin–mediated transforming 
growth factor-b (TGF-b) activation and inhibiting Wnt–b-catenin signaling through integrin-independent regulation of Wnt ligand 
expression. Our findings assign Kindlin-1 the previously unknown and essential task of controlling cutaneous epithelial stem cell 
homeostasis by balancing TGF-b–mediated growth-inhibitory signals and Wnt–b-catenin–mediated growth-promoting signals.
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The first histologic phenotype emerged at around postnatal day 
(P) 21 in the back skin of Kind1-K5 mice, with basement membrane 
splitting, small blisters at the dermal-epidermal junction and aberrant 
accumulation of F-actin and cell-cell adhesion proteins at the basal 
side of basal keratinocytes (Fig. 1d,e and Supplementary Fig. 1e). We 
also observed the same defects in mice expressing Kindlin binding–
deficient β1 subunits in keratinocytes (Fig. 1a) due to substitutions 
of T788 and T789 to alanine in the β1 subunit cytoplasmic domain 
(TTAA-K5 mice)26, indicating that they are caused by malfunction-
ing β1-class integrins (Fig. 1f). The blisters and basement membrane 
defects triggered a regenerative response with granulocyte, monocyte 
and T cell infiltrates in the dermis of the back skin of Kind1-K5 and 
TTAA-K5 mice (Supplementary Fig. 1f–h).
At P60, Kind1-K5 mice showed progressive melanin deposits, first in 
the tail and then in the entire back skin (Fig. 1g,h and Supplementary 
Fig. 1i), resembling poikiloderma in KS. At around 3 months of age, 
Kind1-K5 mice developed an irregular hair coat with small patches 
of densely clustered hair (Fig. 1b) that increased in size with age and 
appeared as meanders on the shaved back skin (Fig. 1c). At 6–8 months 
of age, Kind1-K5 mice began to lose hair, and patches with dense hair and 
alopecia alternated on their hair coat (Supplementary Fig. 1j). TTAA-K5 
mice developed neither pigmentation defects nor densely packed hairs 
(Fig. 1b,c,e). Kind1-K5 mice also developed areas of atrophy next to 
areas of hyperkeratosis in the tail and back skin, whereas TTAA-K5 mice 
displayed hyperkeratotic areas only (Fig. 1e and Supplementary Fig. 2a). 
Although the number of Ki67-positive cells was higher in the epider-
mis of Kind1-K5 and TTAA-K5 mice compared to control littermates 
(Supplementary Fig. 2b–d), keratinocyte differentiation and apoptosis 
were unaffected in both mouse strains (Supplementary Fig. 2e–i).
These results show that Kindlin-1 deletion in the mouse epidermis 
recapitulates human KS and additionally induces an aberrant hair 
coat, which does not develop in TTAA-K5 mice, indicating that the 
aberrant hair coat is caused by Kindlin-1–specific and β1 class– and 
inflammation-independent mechanisms.
Kindlin-1 loss disturbs the hair cycle and induces ectopic HFs
Back skin histology of 6-month-old Kind1-K5 mice revealed two dif-
ferent HF abnormalities: (i) areas with isolated and densely packed 
HFs (Fig. 1g) separated by 1–15 interfollicullar epithelium (IFE) cells 
compared to the 37 ± 10 (mean ± s.d., n = 4 mice per genotype) IFE 
cells observed between control HFs, and (ii) HFs with multiple hair 
shafts and bulges that clustered together and contained hair strands 
exiting the skin through a single hair canal (Fig. 1h).
A detailed hair cycle analysis revealed that HF morphogenesis and 
the first hair cycle proceeded normally in the skin of Kind1-K5 mice 
(Supplementary Fig. 3a). At P50, HFs from control and Kind1-K5 mice 
entered telogen (resting phase of the hair cycle). Whereas HFs from con-
trol mice remained in a long telogen until P80 before a new hair cycle was 
initiated (Supplementary Fig. 3a), HFs from Kind1-K5 mice immediately 
re-entered anagen (growth phase of the hair cycle) (Fig. 2a–c), which was 
visible by the formation of a hair germ and the expression of the transcrip-
tion factor CCAAT displacement protein (CDP)27. We never observed pre-
mature anagen induction in TTAA-K5 mice (Supplementary Fig. 3b).
Whole-mount staining of the tail epidermis at P80 showed HFs 
from control mice with prominent sebaceous glands, normal-sized 
Keratin-15 (Krt-15)-positive bulges and small hair germs with few 
CDP+ cells (Fig. 2d). The tail skin of Kind1-K5 mice contained small 
ectopic HFs originating from pre-existing HFs and the IFE (Fig. 2d,e). 
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Figure 1 Kindlin-1 controls HF growth. (a) Model of Kindlin-1 and 
β1 integrin functions in mice. Kind1-K5 mice lack Kindlin-1 in 
keratinocytes, and TTAA-K5 mice express a Kindlin binding–deficient  
β1 integrin in which T788 and T789 are substituted with alanines.  
(b) Appearance of 7-month-old control, Kind1-K5 and TTAA-K5 mice. 
(c) View of shaved back skin of 7-month-old control, Kind1-K5 and 
TTAA-K5 mice. (d) Immunofluorescence staining of back skin from  
P21 and 7-month-old mice for LN-332 (red) and α6 subunit (green). 
Nuclei are stained with DAPI (blue). Arrowheads indicate basement 
membrane splitting. (e) H&E staining of back skin from 6-month-old 
mice. Arrowheads indicate areas of hyperkeratosis and blisters at the 
epidermal-dermal junction. (f) Integrin activation index on primary 
keratinocytes from control, Kind1-K5 and TTAA-K5 mice reported  
as mean 9EG7 binding normalized to total β1 subunit level ±s.d.  
(n = 3 technical replicates for each group). ***P < 0.001,  
unpaired two-tailed t test. (g,h) H&E-stained back skin sections  
of 7-month-old Kind1-K5 mice. Scale bars, 5 mm (c); 50 µm (d,e,g); 
100 µm (h).
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Ectopic HF- and IFE-derived HFs were also 
present in the back skin of Kind1-K5 mice 
and expressed the dermal papilla marker alka-
line phosphatase (Supplementary Fig. 3c,d). 
Of note, whereas HF numbers increased after 
P50 in the back skin of Kind1-K5 mice, their 
number began declining after 1 year of age 
(Supplementary Fig. 3i).
These findings show that Kindlin-1 defi-
ciency leads to a premature onset of anagen, the formation of ectopic 
HFs in the IFE and from pre-existing HFs and a decline in HF numbers 
at old age.
Kindlin-1 regulates cutaneous epithelial SC homeostasis
The ectopic HFs in Kind1-K5 mice pointed to a perturbed SC home-
ostasis. The epidermis contains different SC populations that reside 
in different niches11. Whereas bulge SCs express CD34, Krt-15, 
nephronectin (Npnt)28 and high levels of α6 integrin (Fig. 3a), reliable 
mouse IFE SC markers are still missing11,29. Immunostaining revealed 
higher numbers of CD34+ bulge cells in back skin (Supplementary 
Fig. 3e) and enlarged Krt-15+ bulges in tail whole mounts of 
Kind1-K5 mice at P80 compared to controls (Fig. 3b and 
Supplementary Fig. 3f). Krt-15+ cells were also present in the 
infundibulum and IFE of Kind1-K5 mice (Fig. 3b) but were not 
present in control mice. Npnt expression expanded into the seba-
ceous gland, the infundibulum and the outer root sheath (Fig. 3b,c), 
and Npnt mRNA levels were higher in FACS-sorted bulge and 
infundibulum–junctional zone cells of Kind1-K5 mice compared to 
controls (Supplementary Fig. 3h). Also, the leucine-rich repeats and 
immunoglobulin-like domains 1 (Lrig1)-positive SC population of the 
infundibulum–junctional zone30 extended toward the infundibulum 
and lower hair shaft of back and tail skin HFs of Kind1-K5 mice 
(Fig. 3d and Supplementary Fig. 3g).
Despite normal hair cycles and hair counts until P50 (Supplementary 
Fig. 3a,i), FACS quantifications of keratinocytes from mouse skin 
at P40 revealed significantly more SCs in the bulge, upper isthmus 
and infundibulum–junctional zone of Kind1-K5 mice compared to 
controls (Fig. 3e,f). A time-course analysis showed that the expan-
sion of the SC compartments was already visible at P21, peaked at 
P50–P80 and then began declining to become markedly smaller in 
12-month-old Kind1-K5 mice (Fig. 3g and Supplementary Table 1). 
In line with normal hair coat development, SC subpopulations 
were unaffected in TTAA-K5 mice, at least until 1 year of age 
(Supplementary Fig. 3j).
To test whether elevated proliferation caused the enlarged bulges, 
we performed BrdU label-retaining cell (LRC) assays. After 10 days of 
chase, significantly more bulge cells were BrdU+ in tail whole mounts 
of Kind1-K5 mice compared to controls, whereas after 32 days, 
70 days and 5.5 months, significantly fewer bulge cells were BrdU+ in 
Kind1-K5 mice (Fig. 3h,i).
These findings demonstrate that Kindlin-1 deficiency elevates cuta-
neous epithelial SC proliferation, numbers and compartments in a β1 
class–independent manner.
Kindlin-1 triggers avb6 integrin–mediated TGF-b release in skin
To determine whether Kindlin-1 loss alters integrin surface levels, 
we analyzed integrin profiles on primary keratinocytes using FACS. 
The levels of β1 and β4 integrin subunits were slightly lower and the 
levels of β5 and β8 integrin subunits were slightly higher in cells from 
Kind1-K5 mice compared to controls. Detection of β3 integrin subunits 
was not evident in either genotype. We also noted clearly elevated β6 
subunit levels in Kindlin-1–deficient keratinocytes (Fig. 4a), as were 
Itgb6 (encoding the β6 integrin subunit) mRNA levels in FACS-sorted 
cutaneous SCs (Supplementary Fig. 4a). Immunostaining showed β6 
subunit expression extending from the bulge and outer root sheath to 
the infundibulum and IFE of Kind1-K5 mice (Fig. 4b).
Next we investigated β6 subunit–dependent cell spreading and focal 
adhesion formation. Although keratinocytes from Kind1-K5 mice 
spread normally on fibronectin, they displayed severely impaired 
adhesion, spreading, clustering of paxillin in focal adhesion-like 
structures and assembly of F-actin stress fibers when plated on sur-
faces coated with αvβ6-specific antibodies or αv-specific peptidomi-
metic cyclic RGD (cRGD) (Fig. 4c,d and Supplementary Fig. 4b,c), 
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Figure 2 Premature anagen induction and 
ectopic HF development in skin from Kind1-K5 
mice. (a) H&E-stained back skin sections of 
P56 mice. (b) Immunostaining of HFs from P56 
mice for CD34 (red) and CDP (green). Nuclei 
are stained with DAPI (blue). (c) The percentage 
of anagen HFs at the indicated time points 
(mean ± s.d., n = 4 mice per genotype, ≥8 10× 
objective fields were counted). ***P < 0.001, 
unpaired two-tailed t test. (d) Immunostaining 
of tail epidermal whole mounts for CDP (green), 
Krt-15 (red) and DAPI (blue) of P80 mice. Of 
note, there is ectopic HF growth in the IFE of 
Kind1-K5 mice. (e) Ectopic HF outgrowth from 
a pre-existing HF of tail whole mount skin in a 
6-month-old Kind1-K5 mouse stained for CDP 
(green) and DAPI (blue). Scale bars, 50 µm (a,b); 
100 µm (d,e). Bu, bulge; SG, sebaceous  
gland; HG, hair germ; DP, dermal papilla;  
Ec, ectopic HF.
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indicating that αvβ6 integrins in keratinocytes from Kind1-K5 mice 
are nonfunctional. We confirmed the αvβ6 specificity of these defects 
by treating keratinocytes from control mice with the β6-blocking anti-
body 10D5, which phenocopied the spreading defects of Kindlin-1– 
deficient cells on cRGD surfaces (Supplementary Fig. 4d).
Active αvβ6 integrins can release TGF-β from the latency asso-
ciated protein (LAP)31, which in turn suppresses the proliferation 
of bulge SCs10,12,32,33. We tested αvβ6-dependent TGF-β release by 
seeding keratinocytes together with transformed mink lung epithelial 
cells (tMLECs), which are able to report TGF-β–induced luciferase 
on a latent TGF-β binding protein-1 (LTBP-1)–LAP–TGF-β1–rich 
matrix34 (Fig. 4e). Keratinocytes from control mice efficiently 
induced the luciferase reporter, which could be inhibited with the 
αvβ6 blocking antibody 10D5 or the TGF-β neutralizing antibody 
1D11. In sharp contrast, keratinocytes from Kind1-K5 mice were 
unable to release TGF-β, confirming that their αvβ6 integrins are 
nonfunctional (Fig. 4e). In line with this in vitro result, TGF-β signal-
ing was also severely impaired in bulge cells of Kind1-K5 mice in vivo, 
in which phosphorylated Smad2 and Smad3 (pSmad2/3) was detect-
able neither before nor after premature anagen induction (Fig. 4f and 
Supplementary Fig. 4g). Signaling by BMP through phosphorylation 
of Smad1, Smad5 and Smad8 (pSmad1/5/8), which also suppresses 
bulge cell proliferation35,36, was unaffected (Supplementary Fig. 4h). 
Treatment of Kindlin-1–deficient keratinocytes with soluble TGF-β1 
induced robust Smad2 phosphorylation and reduced cell prolifera-
tion (Supplementary Fig. 4e,f), indicating that TGF-β1 signals are 
efficiently transduced. The severe dysfunction of αvβ6 integrins was 
not compensated by Kindlin-2 because of the inability of Kindlin-2 
to bind β6 tails (Fig. 4g). Most notably, subjects with KS showed a 
similar TGF-β defect as Kind1-K5 mice, with elevated expression 
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(b), Npnt (green) and α6 integrin (red) (c) and  
Lrig1 (green) and α6 integrin (red) (d). Arrowheads  
indicate Krt-15–positive cells (b), Npnt deposition  
(c) and Lrig1 expression (d) in Kind1-K5 mice.  
(e) CD34 and Sca1 expression in keratinocytes  
from P40 mice that were separated by FACS into  
those with high and low levels of α6 integrin.  
(f) Quantification of gated populations (1–6)  
represented as mean ± s.d. (n = 5 control mice,  
and n = 3 Kind1-K5 mice). The color code in e and  
f corresponds to the cell population denoted in a.  
NS, not significant. *P < 0.05, unpaired two-tailed  
t test. (g) The relative amounts of SC subpopulations  
over time analyzed by FACS. Data show the average  
fold increase (±s.d.) relative to control mice (n and P values are listed in Supplementary Table 1). (h) BrdU (green)-retaining cells in Krt-15 (red)-
stained tail whole mounts after the indicated chase times. (i) Numbers of LRCs per HF after the indicated chasing periods quantified as boxplots (10 d: 
n = 5 control, and n = 3 Kind1-K5; 32 d: n = 3 control, and n = 4 Kind1-K5; 80 d: n = 4 control, and n = 3 Kind1-K5). The boxplot whisker ends show 
the minimum and maximum distribution, and the middle line reports the median. ***P < 0.001, Mann-Whitney U test. Nuclei are stained with DAPI 
(blue) (b–d,h). Scale bars, 50 µm (b–d); 100 µm (h). UI, upper isthmus; IJ, infundibulum junctional zone.
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of β6 subunits and reduced nuclear pSmad2/3 in large areas of basal 
epidermal keratinocytes (Fig. 4h,i), whereas pSmad1/5/8 was unaf-
fected (Supplementary Fig. 4i).
These findings indicate that Kindlin-1 is essential for β6 subunit–
containing integrin–mediated cell adhesion, cell spreading and TGF-β 
release required for SC quiescence.
Kindlin-1 curbs Wnt–b-catenin signaling in skin
Premature anagen induction, ectopic HF development and expan-
sion of SC compartments also develop in mice with elevated Wnt–β- 
catenin signaling in keratinocytes37–40, and reduced HF spacing and 
aberrant hair orientation occur in mice overexpressing the β-catenin 
cofactor Lef1 (ref. 41) or mice with increased Notch signaling42. In the 
skin of control mice, β-catenin levels were high at cell-cell junctions, 
low in the nucleus and absent at the basal side of basal keratinocytes. 
In contrast, in the epidermis of Kind1-K5 mice, β-catenin also accu-
mulated at basal sides of basal keratinocytes, in the nuclei of a large 
number of IFE cells and in catagen HFs (Fig. 5a and Supplementary 
Fig. 5d). Furthermore, Kind1-K5 mice showed β-catenin 
in the nuclei of developing hair germs during premature anagen 
induction (Supplementary Fig. 5a,b) and extended Lef1 expression 
from the normal site in hair germs to the bulge and IFE at all stages 
analyzed (Fig. 5a and Supplementary Fig. 5a,c,d). Notably, at P50, 
shortly before bulges from Kind1-K5 mice induced premature anagen, 
they showed high nuclear Lef1 levels, indicating a premature onset of 
Wnt signaling. In control mice, Lef1 was absent in telogen bulges and 
became highly expressed in the nuclei of hair germ cells and weakly 
expressed in the cytoplasm of IFE cells (Fig. 5a and Supplementary 
Fig. 5a). The numbers of nuclear Notch effector Notch intracellular 
domain (NICD)-containing cells and NICD-induced Hes1 mRNA 
levels were unaltered in hair germs and the pericortex, but both were 
higher in the IFE of Kind1-K5 mice compared to controls at all time 
points analyzed (Fig. 5b and Supplementary Fig. 5e–g).
Next we determined Wnt–β-catenin signaling by intercrossing 
Kind1-K5 and control mice with TOPgal reporter mice, which express 
β-galactosidase under a TCF-Lef–controlled minimal c-Fos promo-
tor43. In HFs from control mice, TOPgal activities were high in the 
pericortex during anagen, low during catagen and lost in telogen, 
with some residual activity in club hairs. In Kind1-K5 mice, the high 
TOPgal activity in the pericortex and bulb of anagen HFs persisted 
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throughout catagen, decreased in telogen (Fig. 5c and Supplementary 
Fig. 5i) and was strongly re-induced in the following anagen stage 
(Supplementary Fig. 5h). Furthermore, we observed a patch-like dis-
tribution of TOPgal in the IFE of Kind1-K5 mice, which was absent in 
controls (Fig. 5c). Notably, the IFE of humans with KS showed simi-
lar abnormalities in β-catenin–LEF1 expression, with weak nuclear 
β-catenin expression in the basal cell layer and a patch-like distribution 
of nuclear LEF1, whereas normal human skin contained β-catenin 
exclusively in cell-cell contacts and LEF1 in the cytoplasm (Fig. 5d 
and Supplementary Fig. 5j).
These findings demonstrate that loss of Kindlin-1 induces nuclear 
translocation of β-catenin–Lef1 in KS and mouse skin, leading to 
elevated Wnt–β-catenin signaling and premature anagen onset of HFs 
in Kind1-K5 mice.
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Kindlin-1 regulates Wnt ligand expression
To find an explanation for the increased Wnt–β-catenin signaling in 
the absence of Kindlin-1, we compared the skin transcriptome between 
healthy individuals and subjects with KS using microarray analyses. 
As we expected, FERMT-1 expression was absent in skin from subjects 
with KS, and the levels of mRNAs encoding inflammatory proteins were 
high (Fig. 5e; the complete list is given in Supplementary Table 2). 
Unexpectedly, the levels of several Wnt signaling components, most 
notably WNT5A, were high in individuals with KS compared to 
healthy individuals (Fig. 5e). Immunostaining confirmed the aber-
rant expression of WNT5A in basal keratinocytes of individuals with 
KS (Fig. 5f). Quantitative PCR (qPCR) and in situ hybridization of 
tail whole mounts from Kind1-K5 mice corroborated high Wnt5a 
mRNA levels in hair bulbs, ectopic HFs and patches of the IFE, which 
overlapped with high TOPgal activities (Fig. 5g and Supplementary 
Fig. 6a–c). qPCR of all known Wnt ligands and receptors revealed that 
the levels of several canonical (Wnt1, Wnt2b, Wnt3a and Wnt9b) and 
noncanonical (Wnt6 and Wnt2) Wnts were also significantly higher in 
keratinocytes from Kind1-K5 mice compared to controls, whereas the 
levels of Wnt4, Wnt7a, Wnt9a, Wnt10a and Wnt16 were significantly 
lower (Fig. 5g and Supplementary Table 3). The expression of several 
Frizzled (Fzd) receptors was higher in Kind1-K5 mice compared to 
controls, most notably Fzd4 and Fzd5 and to a lesser extent the Fzd 
co-receptor Lrp6. We also performed qPCR of FACS-sorted bulge cells 
and in situ hybridization of tail whole mounts from Kind1-K5 mice 
and confirmed the high Fzd4 mRNA levels and patch-like expression 
of Fzd4 in the IFE (Supplementary Fig. 6d,e).
Transfection of Kindlin-1–deficient keratinocytes with 
SuperTOPFlash reporter revealed that the elevated Wnt signaling 
was cell autonomous (Fig. 5h,i) and that Lef1 was limiting the extent 
of Wnt signaling (Supplementary Fig. 6f). Overexpression of Wnt4, 
which triggers translocation of β-catenin to cell-cell junctions, thereby 
preventing nuclear accumulation of β-catenin and Wnt–β-catenin sig-
naling44, decreased SuperTOPFlash activity in Kindlin-1–deficient 
keratinocytes compared to GFP-transfected controls (Fig. 5h). 
Overexpression of Wnt5a, which together with Lrp5 and Fzd4 effi-
ciently activates the canonical Wnt–β-catenin signaling pathway45, 
further increased the activity of the SuperTOPFlash reporter in 
Kindlin-1–deficient cells but not in control cells in which Fzd4 expres-
sion was low (Fig. 5h and Supplementary Fig. 6d,e).
Re-expression of similar quantities of Kindlin-1–GFP or the 
integrin binding–deficient Kindlin-1Q611A,W612A–GFP but not 
Kindlin-2 attenuated the increased SuperTOPFlash activities and 
levels of Wnt4 and Wnt5a in Kindlin-1–deficient keratinocytes 
(Fig. 5i and Supplementary Fig. 6g–j), indicating that inhibition of 
Wnt–β-catenin signaling is Kindlin-1 specific and does not require 
integrin binding. To exclude a role for nuclear Kindlin-1, we expressed 
Kindlin-1–GFP fused to two SV40 nuclear localization signals (NLSs) 
in Kind1-null cells. Although most of the protein localized to the 
nucleus, the elevated SuperTOPFlash activity was only partially res-
cued (Fig. 5i), probably because of Kind1-NLS-GFP spillovers into 
the cytoplasm (Supplementary Fig. 6j).
To corroborate that elevated Wnt protein secretion and high 
Wnt–β-catenin signaling underlie premature HF anagen induction 
in Kind1-K5 mice, we treated them at P49, shortly before telogen 
onset (Fig. 5j and Supplementary Fig. 7a), with IWP-2, which 
blocks Wnt protein secretion by inhibiting porcupine-mediated 
palmitylation of Wnts46, or with IWR-1, which inhibits tankyrases, 
thereby stabilizing the β-catenin destruction complex46,47. Both com-
pounds efficiently blocked premature anagen induction in Kind1-K5 
mice and decreased SuperTOPFlash activities in vitro (Fig. 5j and 
Supplementary Fig. 7a,b). In line with previous reports42, inhibition 
of Wnt signaling also reduced aberrant Notch activities in Kind1-K5 
keratinocytes in vitro and in vivo, which in turn normalized Wnt4 
levels48 (Supplementary Fig. 7c–g).
Together these findings demonstrate that Kindlin-1 inhibits Wnt–
β-catenin signaling by regulating the transcription of Wnt ligands and 
receptors in a cell-autonomous and integrin-independent manner.
Loss of Kindlin-1 increases skin tumor susceptibility
The low TGF-β levels and augmented Wnt signaling in humans 
with KS and Kind1-K5 mice are oncogenic threats49,50. To test this 
hypothesis, we used the two-stage carcinogenesis protocol and treated 
mice with 7,12-dimethylbenz[a]anthracene (DMBA) and 12-O- 
tetradecanoylphorbol-13-acetate (TPA) for 25 weeks. Kind1-K5 
mice developed tumors earlier and had more tumors than control 
mice (Fig. 6a–c). Of note, tumor sizes were similar between Kind1-
K5 and control mice (Fig. 6d), which could be due to different skin 
lesion subtypes. Indeed, histology of the tumor lesions revealed 
that hyperkeratotic and exophytic papillomas dominated in control 
mice, whereas HF-derived trichofolliculoma-like lesions, sebaceous 
papillomas, mixed papillomas and basal cell carcinoma–like lesions 
dominated in Kind1-K5 mice (Fig. 6e and Supplementary Fig. 8a). 
In line with uncurbed Wnt signaling, we observed more cells with 
nuclear β-catenin and Lef1 expression in tumors from Kind1-K5 mice 
(Supplementary Fig. 8b–d).
Figure 5 Kindlin-1 controls Wnt–β-catenin signaling. (a) Immunofluorescence staining for β-catenin (green) in HFs (P44) (left) and the IFE (P55) 
(middle) and for Lef1 and CD34 (red) in HFs and the IFE (4 months) (right) from control and Kind1-K5 mice. Arrowheads indicate aberrant β-catenin 
(left) or Lef1 (right) localization. (b) IFE immunofluorescence staining for NICD (green) from P44 control and Kind1-K5 mice. (c) TOPgal reporter 
activity in tail HFs (left) and the IFE (right) from 3-month-old control and Kind1-K5 mice. Arrowheads indicate HFs with abnormal TOPgal activity. 
β-gal, β-galactosidase. (d) Immunofluorescence staining of human skin from control individuals and individuals with KS for β-catenin (left) and LEF1 
(right). (e) Skin gene expression profile of NHS (n = 3) and KS (n = 3) assessed with microarray and shown as a volcano plot. Genes with at least twofold 
change in KS were plotted according to the log2 fold change (x axis) and the log10 P value (y axis), unpaired two-tailed t test. (f) Immunofluorescence 
staining for WNT5A (green) in the skin of control individuals and individuals with KS. (g) Volcano plot of the qPCR-determined gene expression profile 
of keratinocytes from control and Kind1-K5 mice. Mean expressions relative to Gapdh of Wnt ligands (circle, red) and receptors (triangle, green) were 
plotted according to the log2 fold change (x axis) and log10 P value (y axis) (n = 3 biological replicates per genotype; the ± s.e.m. values are listed 
in Supplementary Table 3). (h) Transient overexpression of GFP, Wnt4 and Wnt5a in floxed keratinocytes (WT) and Kindlin-1–deficient keratinocytes 
previously treated with adenovirus expressing Cre recombinase (KO) expressing the TOPFlash reporter. Values are corrected for the Renilla control and 
are represented as mean ± s.e.m. fold increase relative to WT cells (n = 5 WT and KO biological replicates). *P < 0.05, **P < 0.01, unpaired two-tailed 
t test. (i) TOPFlash reporter activity in KO cells stably re-expressing Kindlin-1–GFP, integrin binding–deficient Kindlin-1Q611A,W612A–GFP (Kind1-QW/AA-GFP), 
NLS-tagged Kindlin-1–GFP or Kindlin-2–GFP. Values are corrected for the Renilla control, are represented as fold increase relative to WT cells and 
are reported as mean ± s.e.m. (n = 21 WT and KO; n = 13 Kind1-GFP; n = 9 Kind1-QW/AA-GFP; n = 5 Kind1-NLS-GFP and Kind2-GFP; all biological 
replicates). NS, not significant. *P < 0.05, **P < 0.01, ***P < 0.001, unpaired two-tailed t test. (j) H&E staining of control and Kind1-K5 mice at 1 d 
(P50) and after treatment (P56) with the indicated Wnt inhibitor. Nuclei are stained with DAPI (blue) (a,b,d,f). All scale bars, 50 µm.
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A single DMBA treatment induced more 
and slightly larger tumors in Kind1-K5 mice 
compared to controls (Fig. 6f–i), indicating 
that the hyperproliferative state of keratino-
cytes in Kind1-K5 mice was sufficient to promote tumor development. 
Furthermore, the tumors in the Kind1-K5 mice originated primarily 
from HFs and sebaceous glands containing hyperactive SCs.
DISCUSSION
Loss-of-function mutations in the FERMT-1 gene cause KS, which 
is characterized by skin blistering at birth, premature skin aging, 
pigmentation defects and increased incidence of skin cancer. The 
ability of Kindlin-1 to activate integrins and link them to the F-actin 
cytoskeleton explains the development of skin blisters and basement 
membrane splitting followed by an inflammatory response. However, 
the notion that skin tumor development is promoted by hyper-
active integrins and inhibited by compromised integrins indicates 
that Kindlin-1 loss activates oncogenic functions, inhibits tumor- 
suppressor functions or both. The task of this study was to identify 
such pathway(s).
Deletion of Kindlin-1 in skin epithelial cells with the K5-Cre driver 
line leads to small skin blistering, basement membrane defects, 
chronic skin inflammation, progressive pigmentation defects and skin 
atrophy and is hence similar to KS. Unexpectedly, Kind1-K5 mice also 
develop enlarged cutaneous epithelial SC compartments, hyperactive 
bulge SCs, distorted HF cycles and ectopic HFs (Supplementary 
Fig. 8e). In line with high SC proliferation, treatment with both 
DMBA and TPA as well as with DMBA only induces a significantly 
higher tumor incidence and tumor burden in Kind1-K5 mice. 
Moreover, the majority of the tumors are basal cell carcinoma–  
and trichofolliculoma-like lesions, suggesting that the tumors 
originate predominantly from HF bulge SCs.
In search for a mechanistic explanation for the dysregulated SC 
and tumor cell proliferation in Kind1-K5 mice, we identified two 
Kindlin-1–regulated signaling pathways with opposing functions on 
bulge SC quiescence (Fig. 6j). Kindlin-1 binding to the cytoplasmic 
tail of β6 subunit–containing integrin51 triggers αvβ6 integrin bind-
ing to the RGD motif of LAP, thereby liberating TGF-β and inducing 
TGF-β receptor signaling and cutaneous epithelial SC quiescence. 
These findings are supported by a report showing that loss of β6  
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Figure 6 Loss of Kindlin-1 increases skin tumor 
incidence. (a–e) Two-stage carcinogenesis  
(n = 26 control mice and n = 23 Kind1-K5 
mice). (a–c) Tumor incidence (P value by log-rank 
test) (a), burden (P value by Wilcoxon t test) (b) 
and skin lesions per animal (reported as  
mean ± s.d., P value by Mann-Whitney U test)  
after 25 weeks of treatment (c). ***P < 0.001.  
(d) Tumor growth reported by diameter shown 
in a boxplot, where the whisker ends are at the 
1.5-interquartile range, and the middle lines 
represent the median. NS, not significant; 
P values by Mann-Whitney U test. (e) The 
percentage of skin lesion subtypes from 
control (n = 25 lesions) and Kind1-K5 (n = 47 
lesions) mice that were staged by histology and 
immunofluorescence analysis (Supplementary 
Fig. 8a). (f–i) One-stage carcinogenesis with 
DMBA (n = 10 control mice and n = 10 Kind1-
K5 mice monitored as in a–d). (f–i) Tumor 
incidence (P value by log-rank test) (f), skin 
lesion number (P value by Wilcoxon t test) (g), 
frequency (reported as mean ± s.d., P value by 
Mann-Whitney U test) (h) and size (reported 
as boxplot, where the whisker ends are at the 
1.5-interquartile range, and the middle lines 
represent the median; P value by Mann-Whitney 
U test) (i). NS, not significant. *P < 0.05,  
***P < 0.001. (j) Molecular functions of 
Kindlin-1. In normal cells (left), Kindlin-1 
activates β1-class integrins and αvβ6 integrin 
to facilitate adhesion and TGF-β liberation 
from LAP, respectively. Free TGF-β activates 
TGF-β receptors (TβRI/II), leading to nuclear 
translocation of pSmad2/3, which promotes SC 
quiescence. In Kindlin-1–deficient cells (right), 
activation of β1-class integrins and αvβ6 is 
impaired, leading to adhesion defects and loss 
of TGF-β–mediated SC quiescence. In addition, 
dysregulated Wnt ligand expression leading to 
elevation of Wnt5a levels leads to canonical 
Wnt–β-catenin signaling through the Lrp5/6–
Fzd4 complex. Wnt5-Prom, Wnt5 promotor.
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subunit–containing integrin impairs TGF-β signaling and elevates 
bulge SC activity in vivo32.
Despite the sequence similarities of Kindlin-1 and Kindlin-2 
(ref. 52) and their expression in keratinocytes from control and Kind1-
K5 mice, Kindlin-2 can only partially compensate for Kindlin-1 at β1 
subunit–containing integrin adhesion sites. Furthermore, Kindlin-2 
is unable to bind β6 subunit tails, which prevents it from releas-
ing TGF-β1 and suppressing SC proliferation. Interestingly, other 
TGF-β isoforms such as TGF-β2 activate HF stem cells by antagoniz-
ing BMP in the bulge53. In contrast to LAP1, however, LAP2 lacks 
the αvβ6-binding RGD motif54, and hence the release of TGF-β2 and 
BMP signaling are not affected by Kindlin-1 loss.
It is particularly interesting that high Kindlin-1 levels have also been 
associated with high TGF-β1 signaling in metastatic breast cancers55. 
Although it was not investigated how Kindlin-1 regulates TGF-β1 
signaling, this observation, together with our findings, suggests that 
different tumor stages may benefit from different Kindlin-1 levels: 
in early stage tumors, low TGF-β signaling supports tumor growth, 
whereas in late stage tumors, high TGF-β signaling promotes the 
epithelial-to-mesenchymal transition and metastatic progression56. 
If this is the case, subjects with KS suffering from an increased tumor 
risk may be protected from metastasis.
We also found elevated Wnt–β-catenin signaling in cutaneous epi-
thelial cells of Kind1-K5 mice and the epidermis of subjects with KS, 
which is inevitably associated with a high tumor risk and severe SC 
and hair cycle defects13,50. The defect leads to ectopic HF formation 
and aberrant hair cycling and is due to aberrant expression of several 
Wnt ligands, most notably Wnt5a, which probably act in an auto-
crine manner. Notably, chemical compounds that inhibit Wnt protein 
secretion or Wnt–β-catenin signaling prevent the hair cycle and Wnt 
signaling defects in keratinocytes from Kind1-K5 mice.
Wnt5a is best known for the ability to activate the noncanonical 
Wnt signaling pathway. However, Wnt5a can also elicit canonical 
Wnt–β-catenin signaling. The decision of which signaling pathway is 
induced is dictated by the type of cell surface receptor to which Wnt5a 
is binding: Wnt5a binding to the Ror2 receptor tyrosine kinase inhib-
its the transcriptional activity of β-catenin and thus canonical signal-
ing, whereas Wnt5a binding to Fzd4 and the Lrp5/6 co-receptors leads 
to β-catenin stabilization and canonical Wnt signaling45. Interestingly, 
Wnt–β-catenin signaling can activate Notch42, which is also elevated 
in keratinocytes from Kind1-K5 mice and may contribute at least 
in part to the Kind1-K5 mouse phenotype, for example, by suppress-
ing Wnt4 expression48 and the recruitment of β-catenin to cell-cell 
junctions44. Clearly, the dysregulated expression of Wnt proteins and 
their receptors in Kind1-K5 mice strongly suggests that Kindlin-1 
safeguards the skin and HFs against an overshooting activation of 
the important and at the same time potentially harmful canonical 
Wnt–β-catenin signals.
In summary, our results show that Kindlin-1 loss results in a com-
bination of defects caused by the dysregulation of distinct pathways: 
the compromised β1 integrins impair adhesion and induce an inflam-
matory response, the impaired TGF-β liberation from LAP leads to 
HF SC hyperproliferation, and the increased Wnt signaling abrogates 
the resting phase of the hair cycle, expands the SC compartments 
and, together with impaired TGF-β signaling and inflammation, con-
tributes to the increased tumor risk. The high epithelial SC activity 
eventually leads to SC exhaustion and skin atrophy later in life, 
which is another hallmark of KS. It is also conceivable that the abil-
ity of Kindlin-1 to shuttle between integrin sites, where it mediates 
adhesion, migration and TGF-β release, and the cytoplasm, where it 
curbs Wnt–β-catenin signaling, may also contribute to physiologic 
SC homeostasis and hair development (Fig. 6j); mobilization of bulge 
SCs has little or no integrin-ligand engagement and therefore uses 
Kindlin-1 to prevent Wnt–β-catenin signaling and their activation. 
Once activated bulge SCs move to the hair germ, they engage integrins 
to ensure downward growth and therefore have less Kindlin-1 in the 
cytoplasm to inhibit Wnt–β-catenin signaling.
METHODS
Methods and any associated references are available in the online 
version of the paper.
Note: Any Supplementary Information and Source Data files are available in the 
online version of the paper.
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ONLINE METHODS
Mouse strains. The conditional Fermt-1flox/flox mice carry a loxP-flanked 
ATG-containing exon 2 (Supplementary Fig. 1a) and were generated by 
electroporation of R1 embryonic stem cells using standard procedures57. 
Homologous recombination was verified with Southern blots, and positive 
embryonic stem cell clones were used to generate chimeric mice. Mice were 
crossed with transgenic mice carrying a deleter-flp recombinase to remove 
the neomycin cassette and with mice carrying deleter-Cre (to confirm the 
null phenotype) or K5-Cre transgenes, respectively58. For all animal studies, 
transgenic mice were backcrossed eight times to C57BL/6 mice. The TTAA-K5 
transgenic mice were obtained through an intercross of mice carrying alanine 
substitutions of T788 and T789 in the cytoplasmic domain of β1 integrin26 
with Itgb1-floxed mice and K5-Cre transgenic mice. The TOPgal Wnt reporter 
mice43 were intercrossed with Kind1-K5 mice. For all in vivo experiments, gen-
ders were distributed randomly between the genotypes. Mice were housed in a 
special pathogen-free mouse facility, and all animal experiments were carried out 
according to the rules of and approved by the government of Upper Bavaria.
DMBA and TPA tumor experiment. Cutaneous two-stage chemical carcino-
genesis was performed as previously described59 using topical applications of 
100 nmol (25 µg) DMBA (Sigma) in 100 µl of acetone and twice weekly applica-
tions of 10 nmol (6.1 µg) TPA (Sigma) in 200 µl of acetone or only acetone for 
25 weeks. The tumor model was terminated after 25 weeks of TPA promotion 
because of the critical skin health condition of Kind1-K5 mice. For tumor experi-
ments, control animals were treated with acetone or TPA only. For all animal 
studies, 7-week-old mice were randomized after genotyping, and sample size 
was estimated by nonparametric Wilcoxon test (U test). The number and size of 
tumors were recorded once per week after the start of promotion (week 0). All 
mice were euthanized at the end of the experiment. Skin lesions were analyzed 
by histology and graded as described previously59–61.
Subjects with KS. Individuals with KS gave their informed written consent under 
protocols approved by St. Thomas’ Hospital Ethics Committee (COREC number 
06/Q0702/154), and the study was conducted according to the Declaration of 
Helsinki Principles. For immunofluorescence (IF) analysis, biopsies were taken 
from age- and site-matched controls (NHS) and subjects with KS with the fol-
lowing mutations: KS patient 1 (3-year-old Indian girl; homozygous nonsense 
mutation +/+ p.Glu516X) and KS patient 2 (22-year-old Panamanian woman; 
homozygous nonsense mutation +/+ p.Arg271X).
RNA for microarray analysis was isolated from upper-arm biopsies taken 
from three subjects with KS; KS patient A, a 22-year-old Omani woman with the 
homozygous nonsense mutation +/+ p.Arg271X; KS patient B, a 7-year-old Indian 
girl with the homozygous nonsense mutation +/+ p.Try616X; and KS patient C, 
a 19-year-old Omani woman with the nonsense mutation +/+ p.Try616X. Control 
skin RNA was isolated from four age-, site- and sex-matched biopsies.
Gene expression microarray. Total RNA was extracted using the RNeasy 
Fibrous Tissue Mini kit (Qiagen), and quantity and quality were measured 
on a Nanodrop spectrophotometer (Nanodrop, Wilmington, DE, USA). For 
whole-genome Illumina expression analysis, total RNA from each skin biopsy 
was hybridized to an Illumina Human-Ref-6 v2 BeadChip expression array 
(Illumina, San Diego, CA, USA). The Illumina HumanRef-6 v2 BeadChips were 
scanned with an Illumina Bead Array Reader confocal scanner.
The microarray data analysis was performed using Illumina’s BeadStudio 
Data Analysis Software (Illumina). The expression signals for all genes from 
each individual were grouped in KS and NHS and averaged. In order to identify 
statistically significant differentially regulated genes, a prefiltering set was deter-
mined for significantly higher (≥2-fold change) and lower (≤0.5-fold change) 
expression intensity between KS and NHS skin samples. Bonferroni’s correction 
was applied to each P value to obtain an adjusted P value to identify differentially 
expressed mRNAs with high statistical significance (Supplementary Table 2). 
The microarray data have been submitted to NCBI under the GEO accession 
number GSE47642.
FACS analysis. FACS analysis and sorting was performed as previously 
described62. A suspension of primary keratinocytes in FACS-PBS (PBS with 
1% BSA) was incubated for 1 h with primary antibodies on ice and then washed 
twice with FACS-PBS. Cell viability was assessed by 7-aminoactinomycin labeling 
(BD Biosciences) or ethidium monoazide staining (Invitrogen). FACS analysis 
was carried out using a FACSCantoTMII cytometer (BD Biosciences) and cell 
sorting with an AriaFACSII high-speed sorter (BD Biosciences), both of which 
were equipped with FACS DiVa software (BD Biosciences). Purity of the sorted 
cells was determined by post-sort FACS analysis and typically exceeded 95%. 
Integrin surface FACS analysis of primary keratinocytes was carried out as pre-
viously described63. Data analysis was conducted using the FlowJo program 
(version 9.4.10).
Real-time PCR and Notch target gene inhibition. Total RNA from total skin 
or FACS-sorted keratinocytes was extracted with the RNeasy Mini extraction 
kit (Qiagen) following the manufacturer’s instructions. For Notch target gene 
inhibition analysis, cells were plated on  fibronectin- and collagen I–coated six-
well plates (1.2 × 106 cells per well) and were treated the next day with 2.5 µM 
N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT; 
Selleckchem, S2215) in full keratinocyte growth medium (KGM) for 24 h before 
total RNA isolation. cDNA was prepared with an iScript cDNA Synthesis Kit 
(Biorad). Real-time PCR was performed with an iCycler (Biorad). Each sample 
was measured in triplicate, and values were normalized to Gapdh. The PCR 
primers used are listed in Supplementary Table 4.
Antibodies and inhibitors. The following antibodies or molecular probes were 
used at the indicated concentrations for western blot (W), IF, immunohisto-
chemistry (IHC) or flow cytometry (FACS): Kindlin-1 (home made3; W: 1:5,000, 
IF of tissue: 1:1,000), Kindlin-2 (Sigma; K3269; W: 1:1,000), talin (Sigma; 8D4; 
W: 1:1,000), GAPDH (Calbiochem; 6C5; W: 1:10,000), phalloidin–Alexa 488 
(Invitrogen; A12379; IF tissue: 1:500; IF of cells: 1:800), integrin αM (Mac-1) 
(eBioscience; M1/70; IF of tissue: 1:200), GR1 (Ly6g) (eBioscience; RB6-8C5; IF 
of tissue: 1:200), CD4 (PharMing; H129.19; IF of tissue: 1:200), CD19 (PharMing; 
1D3; IF of tissue: 1:200), integrin αx (CD11c) (BD Bioscience; HL3; IF of tissue: 
1:200), desmoplakin (Fritzgerald Industries International; 20R-DP002; IF tissue: 
1:500), integrin α6 (Itga6) (PharMingen; GoH3; IF of tissue: 1:200, FACS: 1:500), 
laminin-332 (a gift from M. Aumailley, University of Cologne, Germany; IF of 
tissue: 1:500), Keratin-10 (Krt-10) (Covance; PRB-159P; IHC: 1:600), Keratin-15 
(Krt-15) (a gift from R. Grosschedl; MPI Immunobiology, Freiburg, Germany; 
IF: 1:500), Lef1 (a gift from R. Grosschedl, MPI Immunobiology, Freiburg, 
Germany; IF of tissue: 1:500), Loricrin (Lor) (Covance; PRB-145P; IF: 1:500), 
Ki67 (Dianova; M7249; IHC: 1:100), cleaved caspase-3 (Asp175, cCaspase3) 
(Cell Signaling; 9661; IF of tissue: 1:200), CD34 (BD Bioscience; RAM34; 
IF of tissue: 1:200, FACS: 1:100), Sca1 (BioLegend; D7; IF of tissue: 1:200, FACS: 
1:200), Lrig1 (R&D Systems, AF3688; IF: 1:500), BrdU (Abcam; ab6326; IF: 
1:500), Keratin-5 (Krt-5) (Covance; PRB-160P; IF: 1:1,000), Keratin-6 (Krt-6) 
(Covance; PRB-169; IF: 1:500), CDP (Santa Cruz; sc-13024; IF: 1:500), integrin 
β1 (BD Biosciences; Ha2/5; FACS: 1:200), integrin β3 (BD Bioscience; 2C3.G2; 
FACS: 1:200), integrin β4 (BD Biosciences; 346-11A; FACS: 1:200), integrin β6 
CH2A1 (Itgb6) (a gift from S. Violette, Biogen Idec; IF of mouse tissue: 1:500), 
integrin β6 (Itgb6) (Chemicon; 10D5; IF of human tissue: 1:200, FACS: 1:200, IF of 
cells: 1:500), integrin β5 (Itgb5) (a gift from D. Sheppard, University of California, 
USA; FACS: 1:200), integrin β8 (Itgb8) (Santa Cruz; sc-25714; FACS: 1:200), pax-
illin (BD Bioscience; 610051; IF: 1:500); pSMAD2/3 (Santa Cruz, sc11769; IF: 
1:200), pSmad2 (Millipore; AB3849; W: 1:2,000), total Smad2/3 (Santa Cruz; 
sc-8332; W: 1:1,000), pSMAD1/5/8 (Millipore; AB3848; IF of tissue: 1:200), Sox9 
(a gift from M. Wegner, University of Erlangen, Germany; IF of tissue: 1:500), 
trichohyalin (AE15) (Abcam; ab58755; IF of tissue: 1:500), activated Notch1 
(NICD) (Abcam, ab8925; IF of tissue: 1:200) and pan-laminin (Sigma; L9393; 
IF of tissue: 1:500). The following secondary antibodies were used: goat anti– 
rabbit Alexa 488 (A11008), goat anti–human Alexa 488 (A11013), goat 
anti–mouse Alexa 488 (A11029), donkey anti–goat Alexa 488 (A11055), goat 
anti–guinea pig Alexa 594 (A11076), goat anti–mouse Alexa 546 (A11003), 
goat anti–rabbit Alexa 546 (A11010) (all from Invitrogen; FACS: 1:500, IF: 1:500), 
streptavidin-Cy5 (Dianova; 016170084; FACS: 1:400), goat anti–rat horseradish 
peroxidase (HRP) (Dianova; 712035150; W: 1:10,000), goat anti–mouse HRP 
(172-1011) and goat anti–rabbit HRP (172-1019) (all from Biorad; W: 1:10,000). 
For mouse monoclonal primary antibodies the M.O.M. (Mouse on Mouse) kit 
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(Vector Labs) was used according to the manufacturer’s protocol. Mast cells were 
stained for mast cell heparin with avidin-FITC (Invitrogen; 43-4411; IF of tissue: 
1:100) as previously described64. Nuclei were stained with DAPI (Sigma).
The Notch signaling inhibitor DAPT (Selleckchem; S2215) was dissolved 
in ethanol at 25 µg µl−1. The Wnt inhibitors IWP-2 (Calbiochem; 681671) 
and IWR-1 (Sigma; I0161) were dissolved in DMSO at 2.5 µg µl−1 (IWP-2) or 
10 µg µl−1 (IWR-1).
BrdU labeling. The LRC assay was performed as previously described27. Briefly, 
10-day-old mice were injected four times with 50 mg kg−1 body weight BrdU 
every 12 h to label mitotic cells, and then mice were maintained for the indicated 
chase periods. To determine LRCs per HF bulge, tail epidermal whole mounts 
were prepared, z projections were acquired using a Leica SP5 confocal micro-
scope (20× objective), and BrdU-positive cells were counted from ≥30 HFs per 
animal from different whole mounts.
Cell culture. The TGF-β reporter cell line tMLEC and LTBP1–TGF-β matrix–
producing CHO-LTBP1 cells were used as described previously34. Primary 
keratinocytes were isolated at P21 or at the indicated time points as described 
previously65. To generate clonal keratinocyte cell lines, primary cells from 
Fermt-1flox/flox mice were spontaneously immortalized, single clones were 
picked, and Kindlin-1 ablation was induced by transient transfection with an 
adenovirus expressing Cre recombinase. Keratinocytes were cultured in KGM 
containing 8% chelated FCS (Invitrogen) and 45 µM Ca2+ in a 5% CO2 humidi-
fied atmosphere on plastic dishes coated with a mixture of 30 µg ml−1 collagen I 
(Advanced BioMatrix) and 10 µg ml−1 fibronectin (Invitrogen).
Inhibition of premature anagen induction and increased Notch signaling. At 
telogen onset (P49), back skin of control and Kind1-K5 mice was shaved, and 
100 µl of 200 µM IWR-1 or IWP-2 (diluted in PBS) was subcutaneously injected 
every 24 h into a marked skin region. 100 µl DMSO diluted in PBS was used 
for control experiments. At P56, the treated back skin was isolated, sectioned 
and stained with H&E. Ten serially sectioned HFs per animal were counted. 
To analyze Notch signaling, back skin sections were stained for NICD, and 
NICD-positive nuclei were quantified.
Constructs and transfections. Wnt4 expression constructs were gifts from 
A. Kispert (University of Hannover, Germany), and the human β-catenin expres-
sion construct was a gift from J. Behrens (University of Erlangen, Germany). Human 
WNT5A (ID18032), LEF1 (ID16709), pHes1-luc (ID43806), SuperTOPFlash 
(ID17165) and FOPFlash (ID12457) reporter plasmids were purchased from 
Addgene. The pEGFP-C1 expression vector was acquired from Clontech.
GFP-tagged Kindlin-1, Kindlin-2 and Kindlin-1–QWAA expression con-
structs were described previously3, and the Kindlin1-NLS construct was gener-
ated by fusing SV40 NLS motifs to the N terminus of Kindlin-1. The expression 
cassettes were driven by a CAG promotor and flanked by two inverted terminal 
repeat sites recognized by sleeping beauty transposase 100× (SB100×)66 and tran-
siently co-transfected with the SB100× vector in a 1:1 ratio using Lipofectamine 
2000 (Invitrogen) following the manufacturer’s instructions. After two passages, 
cells stably expressing the GFP fusion protein were FACS sorted for equal expres-
sion levels, which was further confirmed by western blotting.
Histology and immunostainings. Small pieces from back skin were either fixed 
in paraformaldehyde (PFA) and embedded in paraffin or frozen on dry ice in 
cryo-matrix (Thermo) and sectioned. Tail skin whole mounts were prepared and 
immunostained as described27. Immunohistochemistry (H&E, DAB, Oil Red O, 
alkaline phosphatase (AP) and β-gal) of skin sections and tail whole mounts and 
immunofluorescence staining of tissue sections were carried out as described25. 
To better visualize the blue β-gal stain, the epidermal whole mount was overlaid 
with a grayscale image. Immunostaining of human skin sections for β6 integrin 
followed published protocols67.
HF bulge sizes were quantified in epidermal tail whole mounts stained for 
Krt-15, and z projections were collected with a confocal microscope using 
a 20× objective. The length and diameter of a Krt-15–positive bulge area was 
measured with the ImageJ software (version 1.41n), and bulge volumes were 
calculated using the circular cylinder formula (v = π × r2 × h, where v is the 
volume, r is the radius, and h is the height). The HF numbers were quantified 
in serial sections of comparable back skin regions from at least three mice per 
genotype and the indicated ages. HFs per 10× objective field of H&E-stained 
sections were counted. HFs in anagen and early HF development were staged 
as described previously68,69.
Images were collected by confocal microscopy (DMIRE2 or SP5, Leica) with a 
10×, 20× numerical aperture (NA) 1.4 or 40× oil objective using Leica Confocal 
software (version 2.5 build 1227) or by bright field microscopy (Axioskop, Carl 
Zeiss with a 10× NA 0.3, 20× NA 0.5 or 40× NA 0.75 objective) and DC500 
camera with IM50 software (Leica).
In situ hybridization. Antisense riboprobes for mouse Fzd4 (SpeI-EcoRI frag-
ment of mouse FZD4 3′ untranslated region), Wnt5a (gift from I. Thesleff, 
University of Helsinki, Finland) and Hes1 (gift from R. Kageyama, Kyoto 
University, Japan) were synthesized with T7 RNA polymerase (New England 
BioLabs) and DIG (digoxigenin) RNA Labeling Mix according to the manufac-
turer’s instructions (Roche). Isolated tail skin epidermis was fixed in 4% PFA in 
PBS, washed in PBS for 5 min twice and then washed twice for 15 min in PBS 
with 0.1% active diethylpyrocarbonate followed by 15 min equilibration in 5× 
saline-sodium citrate (SSC). Samples were first prehybridized for 1 h at 58 °C in 
50% formamide, 5× SSC and 40 µg ml−1 salmon sperm DNA, then hybridized 
for 16 h at 58 °C with 400 ng ml−1 of DIG-labeled probe in prehybridization mix 
and washed twice for 30 min in 2× SSC at room temperature, followed by a 60-
min wash at 65 °C in 2× SSC and then a 60-min wash at 65 °C in 0.2× SSC. The 
tissues were washed in Tris-buffered saline (TBS) for 5 min three times, blocked 
in 0.5% blocking reagent (Roche) in 0.1% Tween 20 and TBS (TBST) for 90 min 
at room temperature and then incubated in 1:5,000-diluted anti-DIG AP (Roche) 
in 0.5% blocking reagent in TBST at 4 °C overnight. After three 60-min washes 
in TBST, tissues were incubated in NTMT (100 mM NaCl, 100 mM Tris, 
pH 9.5, 50 mM MgCl2 and 0.1% Tween 20) for 10 min at room temperature. 
Color was developed using BM Purple AP substrate precipitating reagent 
(Roche) at 37 °C. The reaction was stopped for 15 min with TE buffer (10 mM 
Tris and 1 mM EDTA, pH 8.0), and samples were mounted with 70% glycerol.
Peptide pulldowns. Pulldowns were performed with β1 WT tail peptide (HDRR
EFAKFEKEKMNAKWDTGENPIYKSAVTTVVNPKYEGK-OH), β1 scrambled 
peptide (EYEFEPDKVDTGAKGTKMAKNEKKFRNYTVHNIWESRKV 
AP-OH), β6 WT tail peptide (HDRKEVAKFEAERSKAKWQTGTNPLYRGST
STFKNVTYKHREKHKAGLSSDG-OH) and β6 scrambled peptide (KTDHAV
QGDKKLSHKKNRGTSKATFPKVRHYETEEWAALESGYGSRTFKNSR-OH). 
All peptides were desthiobiotinylated. Before use, peptides were immobilized 
on 35 µl Dynabeads MyOne Streptavidine C1 (10 mg ml−1; Invitrogen) for 
3 h at 4 °C.
Keratinocytes were lysed on ice in Mammalian Protein Extraction Reagent 
(Thermo Scientific), and 1 mg of cell lysate was incubated with the indicated 
peptides for 4 h at 4 °C. After three washes with lysis buffer, the beads were 
boiled in SDS-PAGE sample buffer, and the supernatant was loaded on 8%  
SDS-PAGE gels.
Preparation of avb6 antibody–coated coverslips. Antibody coating was carried 
out as described70. Briefly, glass slides (24 mm × 24 mm; Menzel) were sterilized, 
coated with collagen I (Advanced BioMatrix) for 1 h at 37 °C, air dried, covered 
with nitrocellulose dissolved in methanol and air dried again. Slides were incub-
ated with αvβ6-specific antibody (10D5; 10 µg ml−1; Chemicon) diluted in PBS 
overnight at 4 °C in a humidity chamber, washed once with PBS and blocked 
with 1% BSA for 1 h at room temperature.
Generation of dense gold nanoarrays functionalized with cRGD. In a typical 
synthesis, 7 mg ml−1 of polystyrene154-block-poly(2-vinylpyridine)33 (PS154-b-
P2VP33; Polymer Source) was dissolved at room temperature in p-xylene (Sigma) 
and stirred for 2 d. Hydrogen tetrachloroaurate (III) trihydrate (HAuCl4·3H2O; 
Sigma) was added to the block co-polymer solution (1 HAuCl4 per 2 P2VP units) 
and stirred for 2 d in a sealed glass vessel. Glass coverslips (Carl Roth) were 
cleaned in a piranha solution for at least 2 h and rinsed extensively with MilliQ 
water and dried under a stream of nitrogen. Micellar monolayers were prepared 
by dip coating a glass coverslip into previously prepared solutions with a constant 
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velocity equal to 24 mm min−1. The dip-coated glass slides were exposed to 
oxygen plasma (150 W, 0.15 mbar, 45 min; PVA TEPLA 100 Plasma System). To 
prevent nonspecific protein adsorption or cell binding, the glass background was 
covalently modified with silane-terminated polyethylene glycol (PEG; molecular 
weight 2,000) (ref. 71). Thiol-terminated cRGD was synthesized as described 
before72. The gold nanoparticles were then functionalized with this ligand by 
incubating the PEG-functionalized substrates in 100 µl of a 50 µM aqueous 
solution. The substrates were then rinsed thoroughly, incubated overnight with 
water and finally dried with nitrogen.
Spreading assay. A single-cell suspension with 1.0 × 105 cells per well in a six-well 
plate was plated in serum-free KGM (1% BSA and 1% penicillin-streptomycin) 
on fibronectin-coated glass coverslips (10 µg ml−1 fibronectin in PBS for 1 h at 
room temperature) or the indicated substrates for 3 h at 37 °C. Cells were imaged 
by a bright-field Axiovert 40 CFL microscope (20× objective; Carl Zeiss) and a 
CV640 camera (Prosilica) before fixation in 4% PFA-PBS and immunostaining 
with the indicated antibodies. The spreading area was quantified after staining 
with phalloidin–Alexa 488 (Invitrogen) with an AxioImager Z1 microscope 
(20× objective; Carl Zeiss) using the ImageJ software (Version 1.41n).
TGF-β stimulation assays. Keratinocytes were starved for several hours and 
stimulated with 5 ng ml−1 recombinant human TGF-β1 (PEROTech) in serum-
free KGM for the indicated times, lysed and analyzed by western blotting. 
TGF-β–modulated proliferation was determined in 70% confluent kerati-
nocytes that were cultured in six-well plates, incubated for 8 h with 10 µM 
5-ethynyl-2′-deoxyuridine (EdU; Invitrogen) and the indicated concentrations 
of TGF-β1 and analyzed with the Click-iT EdU Alexa Fluor488 Flow Cytometry 
Assay kit (Invitrogen).
TGF-β release assay. TGF-β release was determined as described34. Briefly, 
CHO-LTBP1 cells were seeded (5.0 × 104 cells per well) for 48 h in a 96-well 
plate in triplicates to deposit an LTBP1–TGF-β–rich matrix. Cells were then 
detached with PBS and 15 mM EDTA, and the remaining LTBP1–TGF-β–rich 
matrix was washed twice with PBS and incubated with keratinocytes (2.0 × 104 
cells per well) and tMLEC cells (1.5 × 104 cells per well) in a 100 µl final volume 
either in the absence or presence of αvβ6 integrin–blocking antibody (10D5; 
20 µg ml−1; Chemicon) or TGF-β neutralizing antibody (1D11; 15 µg ml−1; 
BD Biosciences). The amount of released TGF-β was measured after 16–24 h 
using a Bright Glo luciferase kit (Promega).
Wnt and Notch reporter assay. Cells were plated on fibronectin- and collagen I– 
coated 12-well plates (6.0 × 105 cells per well) before transient transfection with 
0.5 µg of pHes1-luc, SuperTOPFLASH or SuperFOPFLASH reporter, the indi-
cated expression plasmid and 50 ng thymidine kinase–driven Renilla (Promega) 
for controlling the transfection efficiency. The total amount of transfected plas-
mid DNA was kept constant at 1.5 µg per well using the pEGFP-C1 expression 
vector as a transfection control (Clontech). After 24 h (Wnt reporter) or 48 h 
(Notch reporter), luciferase activity was analyzed with a Dual Luciferase reporter 
assay system (Promega). To determine the effect of Wnt or Notch signaling, cells 
were treated with the indicated inhibitor 18 h after transfection, and luciferase 
activity was measured 24 h later.
Statistical analyses. Analyses were performed with GraphPad Prism software 
(version 5.00, GraphPad Software). Experiments were routinely repeated at least 
three times, and the repeat number was increased according to effect size or 
sample variation. If not mentioned otherwise in the figure legend, statistical 
significance (*P < 0.05; **P < 0.01; ***P < 0.001; NS, not significant) was deter-
mined by unpaired t test (for biological effects with assumed normal distribu-
tion), Wilcoxon t test or Mann-Whitney U test. In the boxplots, the middle line 
represents the median, the box ends represent the 25th and 75th percentiles, 
the whisker ends show the minimum and maximum distribution or are at the 
1.5-interquartile range, and outliers are shown as dots, as indicated in the figure 
legend. Unbiased and reproducible identification of cells with positive nuclear 
staining for β-catenin, Lef1 and NICD was ensured by quantification of nuclear 
staining intensities with ImageJ tool (version 1.41n).
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Neonatal Intestinal Epithelial Dysfunction
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Abstract
Kindler Syndrome (KS), characterized by transient skin blistering followed by abnormal pigmentation, skin atrophy, and skin
cancer, is caused by mutations in the FERMT1 gene. Although a few KS patients have been reported to also develop
ulcerative colitis (UC), a causal link to the FERMT1 gene mutation is unknown. The FERMT1 gene product belongs to a family
of focal adhesion proteins (Kindlin-1, -2, -3) that bind several b integrin cytoplasmic domains. Here, we show that deleting
Kindlin-1 in mice gives rise to skin atrophy and an intestinal epithelial dysfunction with similarities to human UC. This
intestinal dysfunction results in perinatal lethality and is triggered by defective intestinal epithelial cell integrin activation,
leading to detachment of this barrier followed by a destructive inflammatory response.
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Introduction
Kindler Syndrome (KS; OMIM:173650) is a rare, recessive
genodermatosis caused by mutations in the FERMT1 gene
(C20ORF42/KIND1) [1,2]. KS patients suffer from varying skin
abnormalities that occur at distinct phases of their life [3]. Skin
blisters develop and disappear after birth, followed by skin
atrophy, pigmentation defects and finally skin cancer. The severity
of the individual symptoms varies extensively among individual
patients. FERMT1 mutations are distributed along the entire gene
and can give rise to different truncated Kindlin-1 proteins [4].
Interestingly, the different courses of the KS cannot be linked to
mutations within specific regions of the FERMT1 gene [3]
suggesting that additional environmental and/or genetic factors
contribute to the disease course.
Kindlin-1 belongs to a novel family of cytoplasmic adaptor
proteins consisting of three members (Kindlin-1-3) [5]. Kindlins
are composed of a central FERM (band 4.1, ezrin, radixin,
moesin) domain, which is disrupted by a pleckstrin homology (PH)
domain. They localize to cell-matrix adhesion sites (also called
focal adhesions, FAs) where they regulate integrin function. In line
with the role of Kindlins in integrin function, keratinocytes from
KS patients and Kindlin-1-depleted keratinocytes display impaired
cell adhesion and delayed cell spreading [6,7]. The mechanism
how Kindlin-1 regulates integrin function is not understood and
controversial. Kindlin-2 (Fermt2) and Kindlin-3 (Fermt3) were
shown to bind to the membrane distal NxxY motif of b1 (Itgb1)
and b3 (Itgb3) integrin cytoplasmic domains. This binding, in
concert with Talin (Tln1) recruitment to the membrane proximal
NPxY motif, leads to the activation (inside-out signaling) of b1 and
b3 class integrins enabling them to bind to their ligands. Following
ligand binding, Kindlin-2 and Kindlin-3 stay in matrix adhesion
sites where they link the ECM to the actin cytoskeleton by
recruiting ILK and Migfilin (Fblim1) to FAs (outside-in signaling).
Consistent with this adaptor function of Kindlins, keratinocytes
from KS patients and keratinocytes depleted of Kindlin-1 display
impaired cell adhesion and delayed cell spreading [6,7].
Importantly, however, Kindlin-1 was reported to have different
properties than Kindlin-2 and -3, since it was shown to bind like
Talin to the proximal NPxY motif of b1 integrin tails [6].
The Kindlins have a specific expression pattern. Kindlin-1 is
expressed in epithelial cells, while Kindlin-2 is expressed almost
ubiquitously. They are both found at integrin adhesion sites and/
or cadherin-based cell-cell junctions. Kindlin-3 is exclusively
expressed in hematopoietic cells, where it controls a variety of
functions ranging from integrin signaling in platelets [8] to
stabilizing the membrane cytoskeleton in mature erythrocytes [9].
Although the FERMT1 gene is expressed in epithelial cells of
almost all tissues and organs [5], only abnormalities of the skin and
the oral mucosa are associated with KS. Recently it has been
reported, however, that some KS patients also develop ulcerative
colitis (UC) [4,10,11], which together with Crohn’s disease belongs
to idiopathic inflammatory bowel disease.
UC usually occurs in the second or third decade of life, although
the incidence in pediatric patients is steadily rising [12,13]. UC is
restricted to the colon and is characterized by superficial
ulcerations of the mucosa. It is currently believed that the mucosal
ulcerations are triggered by the release of a complex mixture of
inflammatory mediators leading to severe inflammation and
subsequent epithelial cell destruction [12]. In line with this
paradigm a large number of murine colitis models occur when the
innate or adaptive immune response is altered [12]. Genetic
linkage analysis in man led to the identification of several
susceptibility loci [14,15].
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In line with the UC disease course most of the KS patients
develop their first UC symptoms in adulthood. Interestingly,
however, one of them suffered from a severe neonatal form of UC
and was diagnosed with a null mutation in the FERMT1 gene
after developing trauma-induced skin blistering [10]. Since only a
few KS patients were reported to develop intestinal symptoms, it is
currently debated whether UC development in these patients is
directly linked to FERMT1 gene mutations or secondarily caused
by a microbial infection or an abnormal inflammatory response.
In this study we directly investigated the role of Kindlin-1 in
vivo by generating mice carrying a constitutive null mutation in
the Kindlin-1 gene. We demonstrate that Kindlin-1 deficient mice
develop skin atrophy and a lethal intestinal epithelial dysfunction,
resembling the reported UC in KS patients. The intestinal
epithelial dysfunction is caused by defective intestinal epithelial
integrin activation leading to extensive epithelial detachment
followed by a severe inflammatory reaction.
Results
Loss of Kindlin-1 Leads to a Lethal Intestinal Epithelial
Dysfunction
To unravel the consequences of loss of Kindlin-1 in vivo, we
established a mouse strain with a disrupted Fermt1 gene, leading to a
complete loss of Kindlin-1 mRNA and protein (Figure 1A–C).
Heterozygous Kindlin-1 mice (Kindlin-1+/2) had no phenotype and
were fertile. Kindlin-1-deficient mice (Kindlin-12/2) were born with
a normal Mendelian ratio (29.6% +/+; 44.1% +/2; 26.3% 2/2;
n= 203 at P0) and appeared normal at birth. Two days postnatal
(P2), all Kindlin-12/2 mice analyzed so far were dehydrated
(Figure 1D), failed to thrive (Figure 1E) and died between P3-P5
(Figure 1E). Blood glucose and triglyceride levels of Kindlin-12/2
mice were normal suggesting a normal absorption of nutrients in the
small intestine (Figure S1). Their urine showed an increased
osmolarity and protein content further pointing to severe dehydra-
tion (Figure 1F, Figure S2A and B). Histology of Kindlin-12/2
kidneys at P3 revealed normal morphology of glomeruli and tubular
systems (Figure S2C). Thus, these findings suggest that the peri-natal
lethality is not caused by a renal dysfunction.
Figure 1. Loss of Kindlin-1 results in early postnatal lethality. (A) The Fermt1 gene was disrupted by replacing the ATG start codon
containing exon 2 with a neomycin resistance cassette. (B) Kindlin-1 mRNA levels were determined by PCR from cDNAs derived from P3 kidneys. (C)
Loss of Kindlin-1 protein was confirmed by western blotting in colonic IEC lysates. (D) Pictures from newborn (P0) and two day old mice (P2). Scale
bars represent 5mm. (E) Weight curve of Kindlin-12/2 (n = 8) and control littermates (+/+; n = 8; +/2; n = 9) where a  indicates when mice died. ***
indicates a P-value ,0.0001. Error bars show standard deviations. (F) Osmolarity of P2 Kindlin-12/2 and control (+/+) urine (n = 3 per genotype). Error
bars show standard deviations. *** indicates a P-value ,0.0001.
doi:10.1371/journal.pgen.1000289.g001
Author Summary
Mutations in FERMT1, coding for the Kindlin-1 protein,
cause Kindler Syndrome in humans, characterized by skin
blistering, atrophy, and cancer. Recent reports showed
that some Kindler Syndrome patients additionally suffer
from ulcerative colitis. However, it is unknown whether
this is caused by loss of Kindlin-1 or by unrelated
abnormalities such as infections or additional mutations.
We ablated the Fermt1 gene in mice to directly analyze the
pathological consequences and the molecular mode of
action of Kindlin-1. Kindlin-1–deficient mice develop a
severe epidermal atrophy, but lack blisters. All mutant
mice die shortly after birth from a dramatic, shear force-
induced detachment of intestinal epithelial cells followed
by a profound inflammation and organ destruction. The
intestinal phenotype is very similar to, although more
severe than, the one observed in Kindler Syndrome
patients. In vitro studies revealed that impaired integrin
activation, and thus impaired adhesion, to the extracellular
matrix of the intestinal wall causes intestinal epithelial cell
detachment. Therefore, we demonstrate that intestinal
epithelial cells require adhesive function of integrins to
resist the shear force applied by the stool. Furthermore, we
provide evidence that the colitis associated with Kindler
Syndrome is caused by a dysfunction of Kindlin-1 rather
than by a Kindlin-1–independent event.
Loss of Kindlin-1 Causes IEC Dysfunction
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Next we analyzed whether skin abnormalities caused the
perinatal lethality. Although Kindlin-12/2 mice showed features
of KS like skin atrophy and reduced keratinocyte proliferation
(Figure 2A and B), adhesion of basal keratinocytes to the basement
membrane (BM) was unaltered (Figure 2A and Figure S3).
Histology of backskin sections from different developmental stages
revealed normal keratinocyte differentiation (Figure S4), normal
development of the epidermal barrier (Figure S5A and Figure 2C
and D), and comparable epidermal thickness at E18.5 and P0
(Figure S5B). In line with the progressing proliferation defect
quantified by the number of keratinocytes positive for the cell cycle
marker Ki67 (Mki67), a reduction of the epidermal thickness was
first observed at P1 (Figure S5B). Interestingly despite the mild in
vivo phenotype, Kindlin-12/2 keratinocytes displayed severe
adhesion and spreading defects in culture (Figure S6A and B)
further indicating that Kindlin-12/2 keratinocytes from mouse
and man display similar defects [7].
These results indicated that another defect is responsible for
their perinatal lethality. When the stomach and the intestine of
Kindlin-12/2 mice were examined, they were swollen and filled
with milk and gas (Figure 3A) suggesting severe intestinal
dysfunction might be the cause of death. The presence of milk
in the stomach together with the normal histology of the oral and
esophageal mucosa suggested that the lethality is not caused by
impaired feeding (Figure S7). At P2, the terminal ileum and colon
were shortened and swollen and strictures were evident in the
distal colon, which are signs of acute inflammation (Figure 3B). By
P3, when the majority of mutant mice were dying, more than 80%
of the colonic epithelium was detached (Figure 3C and Figure
S8A–C), became apoptotic (Figure S9) and infiltrated by
macrophages, granulocytes (Mac-1; Itgam staining) and T cells
(Thy staining) (Figure 3D). The shortened colon was neither a
consequence of increased apoptosis, which was only seen in
detached epithelium, nor a result of reduced intestinal epithelial
cell (IEC) proliferation (Figure S9).
The epithelial detachment and severe inflammation extended
into the ileum (Figure 3C). In contrast, the proximal small intestine
(duodenum and jejunum) had no evidence of IEC detachment or
inflammation (Figure 4). The phenotype of Kindlin-12/2 mice for
the most part phenocopied the intestinal disease observed in the
patient with a complete loss of Kindlin-1[10].
Kindlin-1 Is Required for Intestinal Epithelial Cell
Adhesion
To define the cell type affected by loss of Kindlin-1 we localized
Kindlin-1 in the normal intestine by immunostaining. Similar to
the situation in man [4], Kindlin-1 is present throughout the
cytoplasm of IECs of the colon and at the basolateral sites of both
IECs of the colon (Figure 5A) and the small intestine (Figure 5B).
The anti-Kindlin-1 polyclonal antibody produced some weak
unspecific background signals in the intestinal mesenchyme of wild
type and Kindlin-12/2 mice (Figure 5B). Kindlin-2 was
exclusively found in cell-cell contacts and did not change its
distribution in the absence of Kindlin-1 (Figure 5C and D). Focal
adhesion (FA) components such as Talin and Migfilin as well as
Figure 2. Atrophy and reduced proliferation in Kindlin-12/2 skin. (A) H&E stainings from P3 backskin show severe epidermal atrophy in
Kindlin-12/2 mice. The BM is indicated by a dashed line and separates the epidermis (e) from the dermis (d). sc: stratum corneum. Scale bar indicates
50 mm. (B) Percentage of Ki67-positive interfollicular keratinocytes, indicating proliferating cells, at different ages (n = 7 per genotype). Error bars
show standard errors of the mean. (C) Kindlin-2 (red; co-stained with a6 integrin (a6 int; in green) and E-cadherin (green, co-stained with Collagen IV
(Coll IV) in red) staining of P3 backskin sections. Nuclei are shown in blue. Scale bar indicates 10 mm. (D) FITC-Lucifer yellow stain of P3 backskin
overlaid with DIC. Lack of lucifer yellow dye penetration shows normal skin barrier in Kindlin-12/2 mice. Scale bar indicates 50 mm.
doi:10.1371/journal.pgen.1000289.g002
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filamentous actin (F-actin) were expressed normally inKindlin-12/2
colonic epithelium that was still adhering to the BM (Figure 5C and
data not shown).
Next we determined the time point when mutant mice began
developing intestinal abnormalities. At E18.5 the ileum and colon
of Kindlin-12/2 mice were histologically normal and electron
microscopy revealed an intact epithelium and basement mem-
brane (BM) (Figure 6A). Shortly after birth (P0), wild-type and
Kindlin-12/2 mice began to suckle and accumulated milk in their
stomachs. Within the first hours after birth nursed Kindlin-12/2
mice contained colostrum in the intestinal lumen and displayed
extensive epithelial cell detachment (Figure 6B; see Colon P0)
without infiltrating immune cells (Figure 6B and C) in the distal
colon. No epithelial detachment occurred when Kindlin-12/2
mice were delivered by Caesarean section and incubated in a
heated and humidified chamber for up to 7 hours (Figure 6B
Colon CS) indicating that mechanical stress applied by stool
caused IEC detachment. However, inflammatory infiltrates were
clearly visible between the detached epithelial cells and the
underlying mesenchyme at around 12 hours after birth in fed mice
(Figure 6B; see Colon P0.5) and further increased during the
following day (Figure 6D). The steady immune cell infiltrate was
accompanied with increased expression of the proinflammatory
cytokines TNF-a (Tnf) and IL-6 (Il6) and a reduction in goblet cell
mucins (Figure 6D and E). The wide range of TNF-a and IL-6
expression levels in Kindlin-12/2 mice likely reflects the different
severities of inflammation at the time tissues were prepared.
Although inflammation extended into the ileum at P2 and P3
(Figure 3B and C), the epithelial cells of the ileum were never
detached suggesting that Kindlin-12/2 mice develop a so-called
backwash ileitis caused by stool ‘‘washed back’’ from the colon into
the ileum [13]. These analyses revealed that the epithelial
detachment begins at P0 in the distal parts of the colon and
subsequently expands proximally.
Kindlin-1 Controls Activation of Integrins
An important question is how Kindlin-1 deficiency leads to
detachment of intestinal epithelial cells. One potential explanation
could be loss of support by a disrupted BM as reported for skin of
KS patients [1,2,3]. Moreover, it is known that BM digestion and
epithelial detachment in inflammatory bowel disease (IBD) can be
triggered via the secretion of MMPs by epithelial and/or
infiltrating immune cells [17]. This possibility could be excluded,
since Kindlin-12/2 mice at P1 showed a continuous BM with all
major components present, both in areas of the colon where IECs
were still adherent as well as in areas where IECs were detached
(Figure 7A). Interestingly, also the skin of Kindlin-12/2 mice
showed a normal BM distribution by immunostaining (Figure S3).
An alternative explanation for the IEC detachment could be a
reduction of integrin levels, or a dysfunction of integrins, similar to
that reported for Kindlin-3-deficient platelets [8] and Kindlin-2-
deficient primitive endoderm [18]. The normal distribution of b1
integrin (Figure 7B) and the comparable levels of b1 and av (Itgav)
Figure 3. Severe inflammation and epithelial detachment in
Kindlin-12/2 colon. (A) Opened abdomen with intestine from P2
mice. Arrowheads indicate air in the stomach and small intestine of
Kindlin-12/2 mice. bl; bladder. Scale bar represents 5 mm. (B) Whole
gut preparations from P2 mice. Scale bar represents 5 mm. Arrowhead
indicates a stricture in the distal colon. The caecum is highlighted with a
red circle and the colon is marked with a green line. (C) H&E staining of
P3 colon and ileum. Kindlin-12/2 mice show complete absence of
colonic epithelium (e), exposure of the submucosa to the intestinal
lumen (lu) and severe inflammation in colon and ileum. Scale bar
represents 50 mm. (D) Macrophage and granulocyte infiltrations in P3
colon shown with Mac-1 staining in green. T-cell infiltrates in P3 colon
shown with Thy1.2 staining in green. Fibronectin (FN) is stained in red.
Scale bar represents 50 mm.
doi:10.1371/journal.pgen.1000289.g003
Figure 4. Normal duodenum and jejunum in Kindlin-12/2 mice. H&E stainings of (A) P1 and (B) P3 duodenal and jejunal sections reveal a
normal histology of the Kindlin-12/2 small intestine. Scale bar represents 50 mm.
doi:10.1371/journal.pgen.1000289.g004
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integrins (Figure 7C and D and data not shown) excluded a defect
in expression and/or translocation of integrins to the plasma
membrane. Flow cytometry of primary IECs with the monoclonal
antibody 9EG7, which recognizes an activation-associated epitope
on the b1 integrin subunit, showed significantly reduced binding
(Figure 8A) suggesting that loss of Kindlin-1 decreases activation
(inside-out signaling) of b1 integrins. Primary keratinocytes from
Kindlin-12/2 mice also showed normal localization (Figure S10A)
and surface expression of b1 integrins (Figure S10B). Interestingly,
9EG7 staining revealed reduced, although not statistically
significant, activation of b1 integrins in these cells (Figure S10C).
Since it is difficult to culture and maintain primary murine
IECs, we depleted Kindlin-1 in a human colon carcinoma cell line
(HT-29) using RNAi (HT-29siKind1; Figure 8B) to show that
integrin-mediated cell adhesion and shear stress induced detach-
ment were also perturbed in a colon cell line. HT-29siKind1 cells
were unable to adhere to Fibronectin (FN; Fn1) and showed
strongly reduced adhesion to Laminin-332 and Collagen IV
(Figure 8C) and easily detached from FN upon exposure to low
(0,5dyn/cm2) as well as high shear stress (up to 4dyn/cm2; Figure
S11). The remaining adhesion to Laminin-332 and Collagen IV is
likely mediated by other Laminin- and Collagen-binding receptors
on colonic epithelial cells such as a6b4 integrins (Itga6,Itgb4) and
discoidin domain receptors [19,20], which are both known to
function independent of Laminin and Collagen binding b1
integrins [21].
These findings indicate that (i) loss of Kindlin-1 impairs integrin
activation, which compromises adhesion of colonic epithelial cells,
that (ii) Kindlin-2 cannot rescue Kindlin-1 loss in colonic epithelial
cells, and that (iii) the residual IEC adhesion to Laminin and
Collagen is suspended by shear forces exerted for example, by the
feces.
It has been reported that Kindlin-1 associates with the
membrane proximal NPxY motif of b1 and b3 integrins [6]. This
observation, however, is in contrast with observations made with
Kindlin-2 and -3, both of which bind the membrane distal NxxY
motifs of b1 and b3 integrins to trigger their activation [8,18,22].
To explore the mechanism whereby Kindlin-1 induces integrin
activation, we performed pull down experiments with recombinant
GST-tagged cytoplasmic b integrin tails in IEC and keratinocyte
lysates. The results confirmed that Kindlin-1 associated with the
cytoplasmic domains of b1 and b3 (Figure 8D). Since substitutions
of the tyrosine residues in the proximal NPxY motifs with alanine
(b1Y788A; b3Y747A) allowed Kindlin-1 binding, while tyrosine to
alanine substitutions in the distal NxxY motif of b1 and b3 integrin
tails (b1Y800A; b3Y759A) abolished Kindlin-1 binding, we
conclude that the binding and functional properties are conserved
among all Kindlins. This was further confirmed with direct
binding assays, which showed that the recombinant His-tagged C-
terminal FERM domain of Kindlin-1 (aa 471–677) containing the
phosphotyrosine binding (PTB) motif bound GST-tagged b1 but
not the Y800A mutated b1 integrin cytoplasmic tail (Figure 8E).
It is well established that Talin can induce activation of
integrins, and for a long time it was believed that it is sufficient for
the execution of this task. This important function of Talin was
discovered by overexpressing Talin or its FERM domain in CHO
cells stably expressing the human platelet integrin aIIbb3 (Itga2b,
Itgb3) [23], which shifted the inactive conformation of aIIbb3
integrin to a high affinity state, as demonstrated by increased
binding of the PAC1 antibody recognizing activation associated
epitopes on aIIbb3 integrin (Figure 8F). In contrast to Talin,
overexpression of Kindlin-1 failed to trigger activation of aIIbb3
integrin in these cells (Figure 8F). Interestingly, as described for
Kindlin-2 [18,22], overexpression of both the Talin FERM
domain and Kindlin-1 doubled PAC1 binding when compared
with cells expressing only the Talin FERM domain (Figure 8F).
The synergism between Talin and Kindlin-1 depends on a
Kindlin-1 and b integrin tail interaction, as a PTB mutant of
Figure 5. Kindlin-1 localization in mouse intestine. (A) Immunofluorescence staining of Kindlin-1 in neonatal colon. Arrows indicate BM. (B)
Immunofluorescence staining of P1 ileum for Kindlin-1. Arrows indicate the BM. (C) Immunofluorescence staining of P1 colon for Kindlin-2, Migfilin, F-
actin (red), a6 integrin (a6 int; green) and Laminin-332 (LN332; green). (D) Immunofluorescence staining of colon for Kindlin-2 (green) and E-cadherin
(E-cad; red). All scale bars represent 10 mm.
doi:10.1371/journal.pgen.1000289.g005
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Kindlin-1 (QW611/612AA) failed to bind b integrin tails
(Figure 8G) and the synergistic effect with Talin was lost
(Figure 8F). These findings suggest that Kindlin-1 is not sufficient
for integrin activation but is required for inducing Talin-mediated
integrin activation. This notion was confirmed with CHO cells, in
which endogenous Kindlin-2 levels were depleted by RNAi
Figure 6. Progressive epithelial dysfunction in Kindlin-12/2 mice. (A) Normal morphology of IECs and BM at E18.5. Shown are H&E stainings
of the ileum and colon and electron microscopy pictures at 120006 magnification from the colon. The boxed enlargement shows the BM, e:
epithelium. Arrows point to the BM. (B) Colonic IEC (e) detachment at P0 (Colon P0, around 5–6 hours after birth) that becomes infiltrated by immune
cells around 12 hours after birth (Colon P0.5). In mice delivered by Caesarean section (CS) and kept unfed for 7 hours no epithelial cell detachment
can be observed. Arrows indicate blister. (C) IEC detachment but no macrophage (Mac-1) and granulocyte (GR-1) infiltrations at P0 (Mac-1 and GR-1 in
green; Perlecan (Perl) indicating BM in red). Arrows indicate IEC detachment. (D) Immune cell infiltrations in the lumen of the colon and floating
epithelial sheets (e) in the colonic lumen at P1. PAS staining shows reduced goblet cell mucins in Kindlin-12/2 colonic epithelium. Scale bars in A, B
and D represent 50 mm and in C 10 mm. (E) Median of Real Time PCR results from whole colon mRNA at E18.5 (n = 2 per genotype) and P1 (n = 5 per
genotype) for TNF-a and IL-6. Error bars show range. The P value was determined using a Mann-Whitney test.
doi:10.1371/journal.pgen.1000289.g006
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(Figure 8H). Furthermore, overexpressing Talin failed to induce
integrin activation in these cells, but expression of Kindlin-1
restored this function (Figure 8I).
These findings show (i) that Kindlin-1 and -2 require Talin for
integrin activation, (ii) that Talin requires Kindlins for integrin
activation, and (iii) that Kindlin-1 and Kindlin-2 have redundant
functions in vitro as both Kindlin-1 and -2 are recruited to FAs
where they exert similar functions on integrin cytoplasmic tails.
However, in vivo this is not the case as Kindlin-2 is recruited to
cell-cell contacts in IECs and apparently does not compensate
Kindlin-1 loss.
Discussion
In the present study we show that a null mutation in the Fermt1
gene gives rise to skin atrophy and an acute and fulminant,
neonatal intestinal epithelial dysfunction. We demonstrate that the
primary defect is a loss of the intestinal epithelial barrier that
secondarily leads to inflammatory cell infiltrates and the
development of a severe colitis. Furthermore, we show that loss
of the intestinal epithelial barrier is caused by a severe adhesion
defect of intestinal epithelial cells to the underlying BM, which in
turn is caused by the inability of integrins to become activated and
to bind BM components. It is possible that in addition to defective
integrin activation and epithelial detachment, Kindlin-1 exerts
other yet unidentified functions that could contribute to the
phenotype in Kindlin-12/2 mice.
Kindler syndrome (KS) is thought to be primarily a skin disease
with a disease course that is characterized by epidermal atrophy
and followed by epidermal blistering, pigmentation defects and
skin cancer. The complex disease syndrome is difficult to diagnose
at the disease onset due to similarities with other forms of skin
blistering diseases (also called epidermolysis bullosa; EB) that are
caused by mutations in keratin and BM genes [24]. Recent case
reports showed that KS may involve more organs than only the
skin, as several KS patients also suffer from intestinal symptoms.
One patient with a severe form of KS developed a severe postnatal
UC. Interestingly, this patient was diagnosed with a null mutation
in the FERMT1 gene after developing trauma-induced skin
blistering [10]. In line with this severe UC case of KS, we found
that the null mutation of the Fermt1 gene in mice also leads to a
dramatic and lethal intestinal epithelial dysfunction very shortly
after birth. Lethality is usually not seen in KS patients, which is
most likely due to the immaturity of the murine intestine at birth,
making it more vulnerable to injury [25].
The intestinal epithelial dysfunction of Kindlin-1-deficient mice
is characterized by flat and superficial ulcerations in the colon, as
the epithelium detaches from an intact BM. The defects begin in
the rectum and extend along the entire colon finally leading to a
severe pancolitis. The ulcerations and epithelial cell detachments
are restricted to the colon, although the ileum shows signs of a
secondary inflammation at later stages of the disease. In vitro
studies with primary IECs from Kindlin-12/2 mice and Kindlin-
1-depleted HT-29 cells showed that the cell detachment is caused
by impaired activation of integrins leading to weak adhesion of
IECs to the underlying BM. Mechanistically Kindlin-1 requires
direct binding to the b1 and b3 integrin cytoplasmic domains to
promote the activation of the two integrin subfamilies. These
biochemical and functional properties are conserved among the
three members of the Kindlin family. Kindlin-2-mediated binding
and activation of b1 and b3 integrins critically support the
attachment of endoderm and epiblast cells to the underlying BM
in peri-implantation embryos [18], while Kindlin-3 plays a central
role for the activation of platelet integrins [8]. The findings of this
report also demonstrate that Talin function crucially depends on
the activity of Kindlin-1. Depletion of Kindlin-2 (the only Kindlin
expressed in CHO cells) completely prevents overexpressed Talin
from activating integrins. Re-expression of either Kindlin in
Kindlin-2-depleted CHO cells, however, recovers the ability of
Talin to trigger the activation of integrins. It will be important to
next investigate how Kindlins become activated and why Kindlin-
2 is unable to take over the function of Kindlin-1 in Kindler
Syndrome and Kindlin-1-deficient mice.
Figure 7. Normal BM composition and integrin localization in P1 colon. (A) Electron micrograph at 120006 magnification shows
detachment of colonic IECs from the BM at P1. Arrows point to the BM. The boxed enlargement shows the BM, e: epithelium. Cryo-sections from the
colon of P1 Kindlin-1+/+ and Kindlin-12/2 mice stained for Collagen IV (Coll IV), Laminin-332 (LN332) and Perlecan. The staining of them shows a
normal distribution and localization in Kindlin-12/2 colon. Scale bar represents 10 mm. (B) b1 integrin staining of P1 colon. Arrows indicate the BM.
Scale bar represents 10 mm. (C) Western blot from IECs for b1 integrin. (D) b1 and av integrin FACS profile on primary IECs.
doi:10.1371/journal.pgen.1000289.g007
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The conclusion that the observed phenotype is triggered by IEC
detachment rather than by a primary inflammatory defect in
Kindlin-1 deficient mice is based on the observation that epithelial
cell detachment always occurred prior to immune cell infiltration.
We would therefore, argue that the detachment of IECs resembles
an intestinal wound, which secondarily triggers a strong wound
healing response leading to immune cell infiltrates and release of a
cytokine storm. In line with this hypothesis, epithelial cell
detachment and induction of inflammatory reactions can be
completely prevented when Kindlin-1 pups are delivered by
Caesarian section and subsequently incubated in a humidified and
temperature controlled chamber. Mechanical stress applied by the
colostrum is likely inducing the detachment of the weakly adhering
epithelial cells in the colon. The vast majority of mouse models
reported to develop colitis so far have an abnormal immune system
[12,26]. This fact as well as the identification of several susceptibility
loci in human patients [14,15] led to the conclusion that defects in
the immune system are of central importance for UC development.
Severe adhesion defects of IECs leading to a massive wound
response may represent an alternative etiology for UC development.
Although adhesion is severely compromised in the colon of
Kindlin-1-deficient mice, they are born without skin blisters. This
is in line with KS patients, who are also born without skin blisters
even when they are delivered by the vaginal route but develop
blisters postnatally at trauma prone sites. Interestingly, Kindlin-1
deficient mice did not show defective adhesion of basal
keratinocytes to the BM even after application of mechanical
stress. The different severity of the adhesion defect in skin and
Figure 8. Kindlin-1 association with b integrins is required for Talin-mediated integrin activation. (A) Kindlin-1 IECs display significantly
reduced 9EG7 binding (active b1 integrin). The 9EG7 binding was quantified by subtracting background (BG) values from mean fluorescence intensity
(MFI) values and normalized to total b1 integrin expression (n = 8 mice per genotype). Error bars show standard deviations. (B) Western blot from HT-
29 cells expressing a control siRNA or a siRNA directed against hKindlin-1 (siKind1) for Kindlin-1 and Kindlin-2. GAPDH was used to show equal
loading. (C) Adhesion assay of control and Kindlin-1-depleted HT-29 cells on the indicated substrates (n = 5). Shown are mean values, error bars show
standard errors of the mean. Coll IV, Collagen IV; FN, Fibronectin; LN332, Laminin-332; PLL, Poly-L lysine. (D) Kindlin-1 pull-down from IEC lysates using
GST-tagged cytoplasmic b integrin tails. (E) Direct interaction of Kindlin-1 with b1 integrin cytoplasmic tails. His-tagged Kindlin-1 C-terminus was co-
precipitated with GST-tagged b1 integrin cytoplasmic tails, but not with GST alone or an Y800A mutant form of b1 integrin. (F) Quantification of
aIIbb3 integrin activation, as measured by activation specific antibody PAC1 in CHO cells using flow cytometry (n = 9). Shown are mean values, error
bars show standard deviations. (G) Pull-down with GST-tagged cytoplasmic b3 integrin tail from CHO cells transiently transfected with the indicated
EGFP-constructs. (H) Western blot of CHO cells 24 hours after transfection with the indicated siRNAs. (siSCR: scrambled; siKind2_1 and siKind2_2:
Kindlin-2 specific siRNAs) (I) Quantification of aIIbb3 integrin activation in CHO cells transfected with the indicated cDNA constructs and/or siRNAs
(n = 8). Shown are mean values, error bars show standard deviations.
doi:10.1371/journal.pgen.1000289.g008
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colon could be reflected by the functional properties of the distinct
set of integrins expressed in the two organs and the absence of
classical hemidesmosomes in intestinal epithelial cells [27].
Another pronounced skin defect in Kindlin-1-deficient mice as
well as KS patients is skin atrophy, which seems to be due to
reduced proliferation of interfollicular keratinocytes. This finding
raises several questions; first, regarding the mechanism underlying
the molecular control of cell proliferation by Kindlin-1. The
mechanism is unknown and could result from a diminished cross
talk between integrin and growth factor signaling. Second, it is also
unclear how a molecular player that supports proliferation is
giving rise to cancer at a later stage. It is possible that the
localization of Kindlins in different cellular compartments, i.e. cell-
matrix adhesion sites, cell-cell adhesion sites and in certain
instances in the nucleus, equips them with different functions that
become evident at different time points in life.
Kindlin-1 and -2 are co-expressed in epidermal cells as well as
epithelial cells of the colon. Interestingly, we found that Kindlin-2
cannot compensate Kindlin-1 function in vivo, neither in the colon
nor in skin. Since Kindlin-2 normally localizes to cell-cell
adhesions in both cell types and does not translocate to integrin
adhesion sites in mutant intestinal and epidermal epithelial cells, it
is unable to compensate for the loss of Kindlin-1, although both
Kindlins are capable of performing the same tasks at the integrin
tails ex vivo and in vitro [27]. Hence, a therapeutic strategy to
reroute some of the Kindlin-2 from cell-cell to the integrin
adhesion sites may represent a promising approach to prevent
ulceration in KS patients with severe UC.
Materials and Methods
Mouse Strains
The Kindlin-12/2 mice were obtained by replacing the ATG-
containing exon 2 with a neomycin resistance cassette (detailed
information on the cloning of the targeting construct can be
obtained from Faessler@biochem.mpg.de). The construct was
electroporated into R1 embryonic stem (ES) cells (passage 15) and
homologous recombination was verified with southern blots.
Genomic DNA was digested with EcoRV, blotted and then
hybridized with a 59 probe or digested with BglII, blotted and
hybridized with a 39 probe (Figure 1A). Targeted ES cells were
injected into blastocysts and transferred into foster mice. Mice
were housed in a special pathogen free mouse facility. All animal
experiments have been approved by the local authorities.
Histology, Immunohistochemistry, and
Immunfluorescence Stainings
For H&E stainings intestinal segments were either PFA fixed
and embedded in paraffin, or frozen on dry-ice in cryo-matrix
(Thermo). Immunhistochemistry of paraffin embedded sections
was carried out as previously described [5]. Sections of 8 mm
thickness were prepared and stained following routine protocols.
Cryo sections were fixed in 4% PFA/PBS except for the Kindlin-1
staining where sections were fixed with 1:1 methanol/acetone at
220uC. Subsequently tissue sections were blocked with 3% BSA/
PBS, incubated with primary antibodies in a humidity chamber
over night at 4uC, with fluorescently labeled secondary antibodies
for 1 h at RT and finally mounted in Elvanol. Pictures were taken
with a Leica DMIRE2 confocal microscope with a 1006 or 636
NA 1.4 oil objective.
GST-Pull Downs
Recombinant GST-b1, b1Y788A, b1Y800A, b3, b3Y747A,
b3Y759A cytoplasmic tails were expressed and purified from E.coli
under non denaturing conditions. 5 mg of recombinant tails were
incubated with 500 mg IEC lysate (in 50 mM Tris pH 7.4,
150 mM NaCl, 1 mM EDTA, 1% Triton-X-100) overnight.
GST-constructs were precipitated with glutathione beads (Nova-
gen). Subsequent western blots were probed for Kindlin-1 and
GST.
Antibodies
A polyclonal peptide antibody against Kindlin-1 was raised
against the peptide YFKNKELEQGEPIEK as previously de-
scribed [5].
The following antibodies were used at the given concentration
indicated for western blot (W), immunoprecipitation (IP), immun-
fluorescence (IF), immunhistochemistry (IHC): Kindlin-1 (W:
1:5000, IF cells: 1:200, IF tissue: 1:1000), Kindlin-2 (W: 1:1000,
IF cells 1:200, IF tissue: 1:200), E-cadherin (Cdh1; Zymed, W:
1:5000), Migfilin (W: 1:5000, IF cells 1:100, IF tissue: 1:100),
GAPDH (Chemicon; W: 1:10000), phalloidin Tritc (Sigma; IF
cells: 1:800, IF tissue: 1:800), Mac-1 (EuroBioscience; IF tissue:
1:100), GR-1 (Ly6g; eBioscience; IF tissue: 1:100), Thy1.2
(PharMingen; IF tissue: 1:100), GST (Novagen; W: 1:10000),
His (CellSignaling; W: 1:1000), PAC1 (BD; FACS: 1:100), a6
integrin (Itga6; PharMingen; IF tissue: 1:100), CollagenIV (a gift
from Dr. Rupert Timpl; IF tissue: 1:100), Laminin-332 (a gift from
Dr. Monique Aumeilley; IF tissue: 1:200), Perlecan (Hspq2; a gift
from Dr. Rupert Timpl; IF tissue: 1:100), b1 integrin (Chemicon;
WB: 1:3000, IF tissue: 1:600), 9EG7 (PharMingen; FACS: 1:100),
EGFP (Abcam; WB: 1:10000), b1 integrin (PharMingen; FACS:
1:200), av integrin (PharMingen; FACS: 1:200). Keratin10 (Krt10;
Covance; IHC: 1:600 ), Keratin14 (Krt14; Covance; IHC: 1:600 ),
Loricrin (Lor; Covance; IHC: 1:500 ) Ki67 (Dianova; IHC: 1:50),
cCaspase3 (CellSignaling, IHC: 1:100).
Caesarean Section
Pregnant mice were sacrificed by cervical dislocation when
embryos were at E18.5–E19 of gestation. The uterus was removed
and cut open. Embryos were taken out and the umbilical cord was
cut. Mice were subsequently dried and kept in an incubator at
37uC and high humidity.
Real Time PCR
Total RNA from whole colons was extracted with a PureLink
Micro to Midi RNA extraction kit (Invitrogen) following the
manufacturers instructions. cDNA was prepared using the iScript
cDNA Synthesis Kit (Biorad). Real Time PCR using a Sybr Green
ready mix (Biorad) was performed in an iCycler (Biorad). Each
sample was measured in triplicates and values were normalized to
GAPDH. Following primers were used; TNFa fwd: AAAATTC-
GAGTGACAAGCCTGTAGC, TNFa rev: GTGGGTGAG-
GAGCACGTAG. IL-6 fwd: CTATACCACTTCACAAGTCG-
GAGG IL-6 rev: TGCACAACTCTTTTCTCATTTCC. RT-
PCR for Kindlin-1 and GAPDH was performed as previously
described [5].
Isolation of IECs
Neonatal mouse intestine was removed and flushed with 1 ml
PBS. The intestine was longitudinally cut open, rinsed with PBS
and incubated for 40 min. in IEC isolation buffer (130 mM NaCl,
10 mM EDTA, 10 mM Hepes pH 7.4, 10% FCS and 1 mM
DTT) at 37uC on a rotor. The epithelium was shaken off and
pelleted by centrifugation at 2000rpm for 5 min. For WB analysis
cells were washed once with PBS and subsequently lysed. For flow
cytometry cells were washed once with PBS and trypsinized with
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26 trypsin (GIBCO) for 10 min. at 37uC. Trypsin was inactivated
with DMEM containing 10%FCS. A single cell suspension was
prepared by passing cells through a cell strainer (BD).
Isolation of Keratinocytes
Primary keratinocytes were isolated from P3 mice as described
previously [28]. Cells were cultured on a mixture of ColI
(Cohesion) and 10 mg/ml FN (Invitrogen) coated plastic dishes
in keratinocyte growth medium containing 8% chelated FCS
(Invitrogen) and 45 mM Ca2+.
Flow Cytometry
IEC’s and keratinocytes were stained with 9EG7 antibody in
Tris buffered saline [29]. For the PAC1 binding assay CHO cells
were stained for 40 min. at RT as described previously [23]. Cells
were gated for viability by excluding propidium iodide-positive
cells. CHO cells transfected with EGFP-tagged constructs were
additionally gated for highly EGFP-positive cells. Measurements
were performed with a FACS Calibur (BD) and data evaluation
was done with FlowJo software.
Constructs
The EGFP-Kindlin-1 expression plasmid was previously
described [5]. The cDNA encoding His-Kindin-1 C-terminus (aa
471–677) was amplified by PCR and cloned into the pQE-70
vector (Qiagen). The Kindlin-1 PTB mutation QW611/612AA
was introduced with a site directed mutagenesis kit (Stratagene)
following the manufacturers recommendations. All EGFP con-
structs were cloned into the pEGFP-C1 vector (Clontech) and
subsequently sequenced. EGFP-Talin head was previously de-
scribed [8].
Cell Culture
CHO and HT-29 cells were maintained in DMEM containing
penicillin/streptomycin, non-essential amino-acids and 10% or
20% FCS, respectively (GIBCO). Cells were transfected with 2 mg
of each DNA in six well plates using Lipofectamine 2000 following
the manufacturers’ instructions (Invitrogen).
RNAi
To deplete Kindlin-1 constitutively from HT-29 cells, an
shDNA corresponding to the cDNA sequence GTAAGT
CCTGGTTTATACA of hKindlin-1 and a control cDNA with
the sequence AGCAGTGCATGTATGCTTC were cloned into
the pSuperRetro vector (OligoEngine). Viral particles were
prepared as described previously [30]. HT-29 cells were infected
and subsequently selected with 2mg/l puromycin. Transient
knockdown of Kindlin-2 from CHO cells was achieved by
transfection of the siRNAs; Kind2_1: GCCUCAAGCUCUU-
CUUGAUdTdT and Kind2_2: CUCUGGACGGGAUAAG-
GAUdTdT, and a control siRNA (purchased from Sigma) using
Lipofectamine 2000 (Invitrogen), following the manufacturers
instructions. Cells were harvested and assayed 24 hours after
transfection.
Adhesion Assay
The adhesion assays were performed as previously described
[29], using 40000 cells per well in serum free DMEM (HT-29) or
MEM (primary keratinocytes).
Osmolarity
Osmolarity was measured from 50 ml urine using an Osmomat
030 from Gonotec.
X-Gal Barrier Assay
Embryonic skin barrier formation was determined as previously
described [31].
Shear Stress Assay
Slides with a 1 mm diameter (ibidi BioDiagnostics) were coated
overnight with 5 mg/ml FN and then blocked with 1% BSA.
100.000 cells were seeded onto the slides and incubated for
2.5 hours in a cell culture incubator. Cells were subsequently
exposed to increasing amounts of shear force in two minute
intervals (as indicated in the Figure S11) and pictures were taken
every second.
Co-Immunoprecipitation
CHO cells were transiently transfected with the indicated EGFP
constructs. Approximately 1mg of protein lysate was immunopre-
cipitated using the mMACS Epitope Tag Protein Isolation Kit for
EGFP tags (Miltenyi Biotec) following the manufacturers instruc-
tions.
Electron Microscopy
Electron microscopy was performed as previously described
[29].
Statistical Analysis
Analyses were performed with GraphPad Prism. If not
mentioned otherwise in the figure legends, Gaussian distribution
of datasets was determined by a D’Agostino & Pearson omnibus
normality test. If samples were not Gaussian distributed a Mann-
Whitney test was performed. Gaussian distributed samples were
either compared with a one way ANOVA and a Tukey’s multiple
comparison post test or an unpaired two-tailed t-test.
Supporting Information
Figure S1 Normal triglyceride and glucose levels in the blood of
P3 Kindlin-12/2 mice. Triglyceride (n = 7 per genotype) and
glucose (n = 5 per genotype) levels from total blood at P3. The
differences are statistically insignificant. Shown are mean values,
error bars show standard deviations.
Found at: doi:10.1371/journal.pgen.1000289.s001 (0.5 MB TIF)
Figure S2 Normal kidney morphology in Kindlin-12/2 mice.
(A) Coomassie stained gel of 10 ml urine from P2 and P3 control
and Kindlin-12/2mice. (B) Quantification of total protein in urine
from Kindlin-1+/+, Kindlin-1+/2 and Kindlin-12/2 mice at P1
(n= 14/7/6) and P3 (n= 20/20/9). Error bars show standard
deviation. (C) H&E staining of P3 Kindlin-1+/+ and Kindlin-12/2
kidneys. Kindlin-12/2 kidneys do not show altered glomeruli and
collecting duct morphology. Scale bar represents 200 mm.
Enlargements show glomeruli (A1, A3) and collecting ducts (A2,
A4). Scale bar represents 50 mm.
Found at: doi:10.1371/journal.pgen.1000289.s002 (8.6 MB TIF)
Figure S3 Normal BM composition and deposition in P3
Kindlin-12/2 backskin. P3 backskin of wild type and Kindlin-
12/2 mice was stained for the BM components Laminin-332
(LN332; red), Collagen IV (Coll IV; red) and Fibronectin (FN; red)
and co-stained with a6 or b4 integrin marking (green) the basal site
of basal keratinocytes. The stainings reveal no differences in BM
deposition and composition or a6 and or b4 integrin localization
between control and Kindlin-12/2 littermates. Scale bar indicates
30 mm.
Found at: doi:10.1371/journal.pgen.1000289.s003 (9.8 MB TIF)
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Figure S4 Normal skin differentiation. P3 backskin of control
and Kindlin-12/2 mice was stained for epidermal differentiation
markers Keratin14, Keratin10 and Loricrin (red) and co-stained
with a6 integrin (green) to mark basal keratinocytes. The stainings
show no difference in the differentiation pattern of Kindlin-12/2
keratinocytes. Scale bar indicates 10 mm.
Found at: doi:10.1371/journal.pgen.1000289.s004 (8.4 MB TIF)
Figure S5 Normal skin development. (A) Normal X-Gal staining
in E17 Kindlin-12/2 embryos indicating normal barrier formation
during development. Scale bar indicates 5 mm. (B) H&E staining
of back skin from control and Kindlin-12/2 littermates of different
age. In Kindlin-12/2 mice the epidermal (e) thickness at E18.5
and P0 is normal but clear epidermal atrophy is seen at P1. Scale
bar indicates 50 mm. (d): dermis.
Found at: doi:10.1371/journal.pgen.1000289.s005 (8.5 MB TIF)
Figure S6 Altered adhesion and spreading of Kindlin-12/2
keratinocytes. (A) Adhesion assay of control and Kindlin-12/2
keratinocytes on LN332, Laminin-332; Coll IV, Collagen IV; FN,
Fibronectin; PLL, Poly-L lysine (n = 3). Shown are mean values,
error bars show standard error of the mean. (B) Cell area
measured upon spreading on 5 mg/ml Fibronectin at the indicated
time-points using MetaMorph software (n = 30 cells per genotype
from 3 independent experiments). Shown are mean values, error
bars show standard deviation (*** p,0.0001).
Found at: doi:10.1371/journal.pgen.1000289.s006 (0.8 MB TIF)
Figure S7 Oral and oesophageal mucosa in Kindlin-12/2 mice.
Histology of the oral mucosa and the oesophagus of P3 Kindlin-
1+/+ and Kindlin-12/2 mice did not reveal an abnormal
morphology. Scale bar represents 50 mm.
Found at: doi:10.1371/journal.pgen.1000289.s007 (8.1 MB TIF)
Figure S8 Progressive epithelial loss in Kindlin-12/2 colons. (A)
Quantification of the extent of intact colonic epithelium at P1 and
P3 (n= 3 per genotype and age). Error bars show range. (B)
Overview of an H&E picture of a P3 control and Kindlin-12/2
colon. The Kindlin-12/2 colon shows a complete absence of
colonic epithelium (black arrowheads), while the epithelium in the
caecum is still present (white arrowheads). Scale bars show
500 mm. (C) Magnifications of the boxed areas shown in B.
Found at: doi:10.1371/journal.pgen.1000289.s008 (7.7 MB TIF)
Figure S9 Normal IEC proliferation but detachment induced
apoptosis . P1 colons from wild type and Kindlin-12/2 mice were
DAB stained for cleaved Caspase-3 to determine apoptosis and
Ki67 stained to show proliferating IECs. Apoptosis occurs in
detached epithelium of Kindlin-12/2 mice. In areas of still
adhering epithelium the number of proliferating IECs is similar
between wild type and Kindlin-12/2 mice. Scale bar indicates
50 mm.
Found at: doi:10.1371/journal.pgen.1000289.s009 (8.7 MB TIF)
Figure S10 b1 integrin activation in Kindlin-12/2 keratino-
cytes. (A) Immunofluorescence staining for b1 integrin (green) and
Laminin-332 (LN332; red) from P3 backskin shows normal
localization of b1 integrin in Kindlin-12/2 backskin. (B) FACS
quantification of b1 integrin expression of freshly isolated control
and Kindlin-12/2 keratinocytes at P2 shows unaltered b1 integrin
expression on basal keratinocytes. Error bars show range (n= 4)
(C) 9EG7 FACS quantification of these keratinocytes shows no
significant reduction in b1 integrin activation. Error bars show
range (n= 4).
Found at: doi:10.1371/journal.pgen.1000289.s010 (8.0 MB TIF)
Figure S11 Shear induced detachment of Kindlin-1 depleted
HT-29 cells. Control and Kindlin-1 depleted HT-29 (siKind1)
cells were plated on Fibronectin-coated flow chamber slides and
exposed to increasing shear forces as indicated in the figure.
Control cells did not detach from the matrix while Kindlin-1
depleted cells were unable to resist low or high shear forces
(compare lane 1 (0dyn/cm2) with lane 2 (0,5dyn/cm2). Scale bar
indicates 50 mm.
Found at: doi:10.1371/journal.pgen.1000289.s011 (9.0 MB TIF)
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SUMMARY	  Blood	  cell	   lineages	  are	   formed	  by	  dividing	  hematopoietic	  precursor	  cells	   (HPCs).	  HPCs	  originate	  from	  hematopoietic	  stem	  cells	  (HSCs),	  which	  reside	  in	  a	  quiescent	  state	  and	  are	  only	  activated	  when	  the	  HPC	  pool	  is	  decreasing.	  Both,	  hematopoietic	  stem	  and	  precursor	  (HSPCs)	  express	  high	  levels	  of	  the	  essential	  integrin	  activating	  protein	  Kindlin-­‐3,	  which	  is	  mutated	   in	   leukocyte	   adhesion	   deficiency	   type	   III	   (LAD-­‐III)	   in	  man.	  Here	  we	   report	  that	   loss	   of	   Kindlin-­‐3	   in	   HSPCs	   impaired	   bone	  marrow	   (BM)	   homing	   due	   to	   reduced	  integrin-­‐mediated	   adhesion	   to	   the	   microvascular	   endothelium.	   Using	   HSPC	  transplantations	  we	  also	  show	  that	  Kindlin-­‐3	  deficient	  HSCs	  were	  retained	  in	  the	  BM	  and	  became	  quiescent	   only	  when	  wild	   type	  HSCs	  were	  present.	   In	   their	   absence	  Kindlin-­‐3	  deficient	   HSCs	   lost	   quiescence	   and	   eventually	   became	   exhausted	   leading	   to	   reduced	  survival	  of	   transplanted	  recipient	  mice.	  This	   loss	  of	  HSC	  quiescence	  was	  caused	  by	  the	  continuous	  movement	  of	  activated	  HSPCs	  into	  the	  circulation	  because	  their	  retention	  in	  the	   BM	   niche	   requires	   Kindlin-­‐3	   dependent	   integrin	   adhesion.	   Since	   HSPCs	   also	  accumulate	   in	   the	   circulation	   of	   LAD-­‐III	   patients	   we	   conclude	   that	   Kindlin-­‐3	   is	  dispensable	  for	  quiescent	  HSCs	  but	  essential	  for	  the	  maintenance	  of	  activated	  HSPCs	  in	  BM	  compartments	  of	  mouse	  and	  man.	  
INTRODUCTION	  The	  entire	  hematopoietic	  system	  is	  derived	  from	  and	  maintained	  by	  a	  small	  number	  of	  hematopoietic	   stem	   cells	   (HSCs),	   which	   reside	   in	   the	   bone	   marrow	   (BM).	   HSCs	   are	  characterized	   by	   their	   low	   cycling	   rate	   and	   their	   ability	   to	   self-­‐renew	   throughout	   the	  lifespan	   of	   an	   organism.	   After	   hematopoietic	   injury	   (e.g.	   bleeding)	   quiescent	   HSCs	  become	   activated,	   divide	   asymmetrically,	   replenish	   the	   pool	   of	   hematopoietic	   effector	  cells	   and	   then	   return	   to	   the	   quiescent	   state	   (Trumpp	   et	   al.,	   2010).	   To	  maintain	   HSCs	  throughout	   the	   lifespan	   of	   an	   animal,	   the	   oscillation	   of	   HSCs	   between	   quiescence,	  activation,	   self-­‐renewal	   and	   differentiation	   is	   precisely	   regulated	   in	   a	   specific	  microenvironment	   referred	   to	   as	   the	   stem	   cell	   niche	   (Morrison	   and	   Spradling,	   2008).	  The	   oscillation	   of	   HSCs	   is	   regulated	   through	   interactions	   with	   niche	   cells	   (Kiel	   and	  Morrison,	   2008),	   extracellular	   matrix	   (ECM)	   proteins	   (van	   der	   Loo	   et	   al.,	   1998),	   the	  action	  of	  cytokines,	  chemokines	  and	  growth	  factors	  released	  by	  niche	  cells	  (Rizo,	  2006),	  and	  calcium	  gradients	  established	  by	  osteoclasts	  during	  bone	  remodeling	  (Adams	  et	  al.,	  2006).	  Thus,	  an	  impairment	  of	  the	  HSC-­‐niche	  interplay	  can	  result	  in	  loss	  of	  quiescence,	  uncontrolled	  activation	  and	  finally	  exhaustion	  of	  HSCs.	  The	  interactions	  of	  HSCs	  with	  niche	  cells	  and	  ECM	  are	  mediated	  by	  adhesion	  molecules	  such	   as	   integrins	   (Wilson	   and	   Trumpp,	   2006).	   Integrins	   are	   expressed	   on	   all	   cells	  including	   tissue	  stem	  cells,	  where	   they	  mediate	  binding	   to	  ECM	  and	  counter	  receptors	  (Hynes,	   2002).	  The	   composition	  of	   niche	   cells	   and	  ECM	  components	   is	   unique	   in	   each	  organ	  and	  hence	  tissue	  stem	  cells	  express	  specific	   integrin	  profiles	  to	  interact	  with	  the	  niche	  microenvironment.	  The	  integrin	  profile	  of	  HSCs	  includes	  multiple	  members	  of	  the	  
??? ?????	   (?????? ?????? ?????? ?????? ???1),	  ???2	   from	   the	  ?2	   class	   ???? ???3	   from	   the	  
??-­‐class	  (Grassinger	  et	  al.,	  2009).	  In	  vivo	  and	  in	  vitro	  studies	  using	  genetics	  or	  inhibitory	  antibodies	  demonstrated	  that	  integrins	  promote	  hematopoietic	  stem	  and	  precursor	  cell	  (HSPC)	   homing	   to	   the	   BM	   (Potocnik	   et	   al.,	   2000),	   their	   BM	   retention	   (Magnon	   and	  Frenette,	   2008),	   proliferation	   and	   differentiation	   (Arroyo	   et	   al.,	   1999).	   Although	   these	  studies	  identified	  important	  roles	  for	  integrins	  in	  hematopoietic	  precursor	  cells	  (HPCs)	  it	  is	  not	  clear	  whether,	  similarly	  like	  other	  tissue	  stem	  cells,	  HSCs	  also	  require	  integrins	  to	  maintain	  quiescence.	  Integrin	   ligand	   binding	   and	   signaling	   requires	   an	   activation	   step,	   which	   is	   induced	  following	  Talin	   a??????????????????? ??? ???? ???????????????????? ??? ??????????? ?????????and	  associated	  with	  allosteric	  changes	   in	   the	   integrin	  ectodomain	  and	   transmembrane	  
domains	  (Moser	  et	  al.,	  2009a;	  Shattil	  et	  al.,	  2010).	  Kindlins	  are	  evolutionary	  conserved	  and	  consist	  of	  three	  members.	  Hematopoietic	  cells	  express	  Kindlin-­‐3	  (Ussar	  et	  al.,	  2006)	  whose	   deletion	   in	   mice	   abrogates	   integrin	   activation	   resulting	   in	   hemorrhages,	  leukocyte	  adhesion	  defects	  and	  osteopetrosis	  (Moser	  et	  al.,	  2009b;	  2008;	  Schmidt	  et	  al.,	  2011).	  A	  human	  disease	  with	  similar	  abnormalities	  called	  leukocyte	  adhesion	  deficiency	  type	  III	  (LAD-­‐III)	  is	  also	  caused	  by	  null	  mutations	  of	  the	  KINDLIN-­‐3	  gene	  (Kuijpers	  et	  al.,	  2009;	  Malinin	  et	  al.,	  2009;	  Svensson	  et	  al.,	  2009).	  Since	   Kindlin-­‐3	   activates	   all	   integrins	   analyzed	   so	   far,	   it	   is	   perfectly	   suited	   to	   broadly	  abrogate	   integrin-­‐dependent	   functions	   in	   HSCs.	   We	   report	   that	   proliferating	   HSPCs	  require	  Kindlin-­‐3	   for	   their	  maintenance	   in	   the	  BM,	  while	   quiescent	  HSCs	   are	   retained	  independent	   of	   Kindlin-­‐3	   mediated	   integrin	   adhesion.	   In	   a	   situation	   of	   hematopoietic	  stress	   and	   high	   demand	   for	  HPCs,	   however,	   quiescent	  HSCs	   are	   activated	   to	   refill	   the	  decreasing	  pool	  of	  HPCs,	  become	  also	  dependent	  on	  Kindlin-­‐3	  and	  eventually	  exhaust.	  
RESULTS	  
Kindlin-­‐3	  is	  required	  for	  HSC	  engraftment	  Kindlin-­‐3,	   the	   sole	   Kindlin	   family	   member	   expressed	   in	   FACS-­‐purified	   wt	   (K3+/+)	  hematopoietic	   stem	   and	   precursor	   cells	   (HSPCs),	   was	   absent	   in	   Kindlin-­‐3-­‐null	   (K3-­‐/-­‐)	  HSPCs	   (Figure	   S1A-­‐B).	   Since	   FACS	   only	   enriches	   for	   HSCs,	   we	   will	   refer	   to	   the	  populations	   used	   in	   this	   study	   as	   HSPCs	   to	   account	   for	   potential	   progenitor	   cell	  contamination.	   To	   test	  whether	  Kindlin-­‐3	   is	   required	   for	  HSPC	   function	  we	   generated	  fetal	   liver	   (FL)	   chimeras	   by	   transplanting	   5x106	   unfractionated	   FL	   cells	   (C57BL/6;	  CD45.2+)	   from	   K3+/+	   or	   K3-­‐/-­‐	   E14.5	   littermate	   embryos	   into	   lethally	   irradiated	   wt	  congenic	  B6.SJL	   (CD45.1+)	   recipient	  mice	   (Figure	   S1C).	   Lifetime	   analysis	   revealed	   that	  the	  median	  survival	  of	  K3+/+	  FL	  cell	  recipients	  (termed	  K3+/+	  chimeras)	  and	  K3-­‐/-­‐	  FL	  cell	  recipients	  (termed	  K3-­‐/-­‐	  chimeras)	  was	  48.7	  and	  24.6	  weeks,	  respectively	  (Figure	  1A).	  To	  exclude	  that	  the	  diminished	  survival	  of	  K3-­‐/-­‐	  chimeras	  was	  due	  to	  transplantation	  of	  a	  reduced	   total	   number	   of	   HSPCs	   in	   K3-­‐/-­‐	   FLs	   we	   harvested	   mononuclear	   cells	   (MNCs)	  from	  FLs	   and	   determined	   the	   relative	   frequency	   of	   lineage-­‐Mac-­‐1medAA4.1+Sca-­‐1+c-­‐kit+	  (FL-­‐LSK)	  cells	  (Figure	  S1D)	  (Jordan	  et	  al.,	  1990;	  Okada	  et	  al.,	  1992).	  The	  results	  revealed	  that	   the	   total	   number	   of	   MNCs	   was	   2.75-­‐fold	   decreased	   in	   E14.5	   FLs	   of	   K3-­‐/-­‐	   mice	  (Figure	  S1E),	  while	  the	  relative	  FL-­‐LSK	  cell	  number	  was	  significantly	  elevated	  compared	  to	  control	  FLs	  (Figure	  S1D,	  F)	  and	  the	  absolute	  number	  of	  LSK	  cells	  per	  FL	  was	  similar	  between	   K3+/+	   and	   K3-­‐/-­‐	   mice	   (Figure	   S1G).	   Further	   assessment	   of	   committed	  hematopoietic	   precursor	   cells	  with	   the	   colony-­‐forming	   unit-­‐culture	   (CFU-­‐C)	   assay	   and	  more	   immature,	   long-­‐term	   culture	   initiating	   cells	   (LTC-­‐ICs)	   revealed	   that	   the	  frequencies	   of	   CFU-­‐Cs	   as	   well	   as	   LTC-­‐ICs	   were	   increased	   in	   FL-­‐MNCs	   of	   K3-­‐/-­‐	   mice	  (Figure	   S1H,	   S1I).	   Interestingly,	   while	   the	   absolute	   numbers	   of	   CFU-­‐Cs	   per	   FL	   were	  decreased	   (Figure	   S1J),	   the	   absolute	   numbers	   of	   LTC-­‐ICs	   per	   FL	   were	   normal	  (Figure	  S1K).	   Immunohistochemistry	  demonstrated	  a	  normal	  vasculature	  and	  a	  similar	  distribution	   of	   hematopoietic	   effector	   cells	   in	   K3+/+	   and	   K3-­‐/-­‐	   FLs	   (Figure	   S1L).	   FACS	  analysis	   revealed	   changes	   in	   the	   relative	   numbers	   of	   non-­‐hematopoietic	   (CD45-­‐)	   and	  hematopoietic	   cells	   (CD45+	   or	   B220+	   or	   Mac-­‐1+	   or	   Mac-­‐1+Gr-­‐1+	   or	   CD71+and/or	  Ter119+).	  While	   the	  absolute	  numbers	  of	  non-­‐hematopoietic	  and	  all	  hematopoietic	  cell	  types	  were	  reduced	  in	  K3-­‐/-­‐	  FLs,	  the	  absolute	  numbers	  of	  vascular	  (CD31+	  and	  EpCAM+)	  and	   hepatic	   cell	   numbers	   (EpCAM+)	  were	   normal	   (Figure	   S1M-­‐S).	   These	   data	   indicate	  that	  the	  transplantation	  of	   identical	  numbers	  of	  K3+/+	  and	  K3-­‐/-­‐	  FL	  MNCs	  together	  with	  
the	   increased	   frequency	  of	  HSPCs	   in	  K3-­‐/-­‐	   FL	  MNCs	  provides	  K3-­‐/-­‐	  chimeras	  with	  more	  donor	   HSPCs	   than	   K3+/+chimeras	   and	   hence	   excludes	   a	   lack	   of	   HSPCs	   in	   K3-­‐/-­‐	   FLs	   as	  cause	  for	  the	  reduced	  survival	  of	  K3-­‐/-­‐	  chimeras.	  Next,	  we	  tested	  whether	  defects	  in	  lineage	  differentiation	  caused	  the	  diminished	  survival	  of	  K3-­‐/-­‐	  chimeras	  by	  quantifying	  different	  hematopoietic	  lineages	  in	  BM,	  spleen	  (Spl)	  and	  peripheral	   blood	   (PB)	   of	   moribund	   and	   healthy	   chimeras	   3	   to	   4	   months	   after	  transplantation.	  Moribund	  K3-­‐/-­‐	   chimeras	  displayed	  a	  pronounced	  pancytopenia	   in	   the	  BM	  affecting	  B,	  T,	   erythroid	   cells,	  neutrophils	  and	  monocytes/macrophages,	   and	   in	  PB	  and	  Spl	  affecting	  B,	  T	  and	  erythroid	  cells	   (Figure	  1B,	  1C,	  S1T,	  S1U,	  Table	  S1).	  This	  was	  never	   observed	   in	   K3+/+	   chimeras.	   Healthy	   K3-­‐/-­‐	   chimeras	   had	   reduced	   T	   cells	   and	  erythroid	  cells	  and	  increased	  myeloid	  and	  B	  cells	  in	  the	  PB	  (Figure	  S1T,	  Table	  S1).	  The	  increase	  in	  myeloid	  cells	  is	  consistent	  with	  their	  inability	  to	  leave	  the	  vasculature	  (Moser	  et	   al	   2008).	   In	   BM	   and	   Spl	   the	   numbers	   of	   MNCs	   in	   healthy	   K3-­‐/-­‐	   chimeras	   were	   not	  changed,	   while	   cell	   counts	   of	   lymphoid,	   erythroid	   and	   myeloid	   lineages	   were	  differentially	  affected	  (Figure	  1B,	  1C,	  S1U).	  However,	  they	  were	  still	  sufficiently	  high	  to	  exclude	   a	   severe	   differentiation	   defect	   as	   a	   cause	   for	   the	   increased	   lethality	   of	   K3-­‐/-­‐	  chimeras.	   Histology	   and	   immunohistochemistry	   of	   bone	   sections	   from	   K3+/+	   and	   K3-­‐/-­‐	  chimeras	  revealed	  similar	  morphologies	  also	  excluding	  a	  defective	  microenvironment	  as	  cause	  for	  the	  lethality	  (Figure	  S1V).	  To	  avoid	  secondary	  abnormalities	  due	  to	  imminent	  
?????????????????????????????????????????????????????????????????-­‐/-­‐	  chimeras	  that	  had	  a	  normal	  physical	  appearance	  and	  no	  anemia.	  
Kindlin-­‐3	  is	  required	  for	  BM	  homing	  of	  HSPCs	  Homing	  of	  HSPCs	  to	  the	  BM	  requires	  ????????????	  (Magnon	  and	  Frenette,	  2008;	  Potocnik	  et	  al.,	  2000)	  whose	  affinity	  is	  controlled	  by	  Kindlin-­‐3	  (Moser	  et	  al.,	  2009a).	  To	  assess	  the	  role	   of	   Kindlin-­‐3	   in	   homing,	   we	   analyzed	   short-­‐term	   homing	   of	   FACS-­‐isolated	  lineage-­‐Sca-­‐1+c-­‐kit+	   (LSK)	   cells	   from	   the	   BM	   of	   K3+/+	   and	   K3-­‐/-­‐	   chimeras.	   Injection	   of	  fluorescently	  labeled	  LSK	  cells	  into	  lethally	  irradiated	  wt	  recipient	  mice	  and	  their	  FACS	  quantification	  in	  the	  BM	  18	  h	  after	   transplantation	  revealed	  that	  K3-­‐/-­‐	  LSK	  cells	  homed	  about	  5	   times	   less	  efficient	   to	   the	  BM	  than	  K3+/+	  LSK	  cells	   (Figure	  2A).	  These	   findings	  were	  confirmed	  by	  intravital	  2-­‐photon	  microscopy	  imaging	  of	  the	  central	  sinus	  and	  the	  surrounding	  BM	   cavity	   of	   the	  mouse	   calvaria,	  which	   also	   showed	   around	  5	   times	   less	  K3-­‐/-­‐	   LSK	   cells	   within	   the	   BM	   interstitium	   18	  h	   after	   transplantation	   (Figure	   2B,	   C).	  Closer	  analysis	  revealed	  a	  significant	  reduction	  of	  K3-­‐/-­‐	  LSK	  cells	  firmly	  adhering	  to	  the	  
vessel	  surface	  (defined	  as	  adhesion	  to	  the	  same	  spot	  for	  at	  least	  60	  s)	  (Figure	  2D).	  While	  most	  K3-­‐/-­‐	  LSK	  cells	  remained	  at	  the	  same	  spot	  for	  just	  a	  few	  seconds,	  the	  K3+/+	  LSK	  cells	  remained	  at	  the	  same	  spot	  up	  to	  30	  min	  (Figure	  2E,	  F	  and	  Movie	  S1-­‐	  S3).	  The	   similar	   integrin	   expression	   profile	   of	   K3+/+	   and	   K3-­‐/-­‐	   LSK	   cells	   (Figure	   S2A,	  B)	  suggested	  that	  integrin	  function(s)	  rather	  than	  integrin	  levels	  were	  affected	  by	  the	  loss	  of	   Kindlin-­‐3	   expression.	   To	   test	   this	   hypothesis	   under	   flow	   conditions,	   we	   analyzed	  integrin-­‐dependent	   adhesion	   of	   LSK	   cells	   in	   an	   ex	   vivo	   microflow	   chamber	   assay	  (Frommhold	   et	   al.,	   2008).	   Consistent	   with	   previous	   findings	   (Mazo	   et	   al.,	   2011),	   the	  numbers	   of	   adherent	   K3+/+	   LSK	   cells	   from	   the	  BM	  of	   chimeric	  mice	   (Figure	   2G)	   or	   FL	  (Figure	  S2C)	  were	  highest	  on	   surfaces	   coated	  with	   recombinant	  murine	   (rm)	  VCAM-­‐1,	  rmE-­‐selectin	   and	   rmCXCL12.	   Adhesion	   of	   K3+/+	   LSK	   cell	   was	   efficiently	   blocked	   with	  antibodies	  against	  ??	  integrin.	  In	  sharp	  contrast,	  K3-­‐/-­‐	  LSK	  cells	  from	  BM	  (Figure	  2G)	  or	  FL	  (Figure	  S2C)	  adhered	  poorly	  to	  flow	  chambers	  coated	  with	  rmVCAM-­‐1,	  rmE-­‐selectin	  and	   rmCXCL12	   or	  with	   rmVCAM-­‐1	   and	   rmE-­‐selectin,	   suggesting	   that	   loss	   of	   Kindlin-­‐3	  
????????????? ???????????????????-­‐dependent	  LSK	  cell	  adhesion.	  Importantly	  though,	  the	  low	  level	  adhesion	  of	  K3-­‐/-­‐	  LSK	  cells	  was	  still	  sufficient	  to	  enable	  residual	  homing	  to	  the	  BM	  compartment	  (Figure	  2A-­‐C).	  The	  inability	  of	  K3+/+	  and	  K3-­‐/-­‐	  LSK	  cells	  from	  the	  FL	  as	  well	  as	  BM	  to	  adhere	  to	  immobilized	  ICAM-­‐??????????????????????????????????????????????integrin	   is	   the	  predominant	   adhesion	   receptor	   that	   requires	  Kindlin-­‐3	   to	   firmly	   arrest	  LSK	  cells	  under	  flow	  conditions.	  
LT-­‐HSCs	  are	  present	  in	  the	  BM	  of	  K3-­‐/-­‐	  chimeras	  The	  data	  so	  far	  indicate	  that	  a	  reduced	  number	  of	  K3-­‐/-­‐	  HSPCs	  enters	  the	  BM	  but	  fails	  to	  accomplish	   a	   long-­‐term	   reconstitution	   of	   the	   hematopoietic	   system.	   To	   test	   whether	  HSPCs	  were	  indeed	  present	  in	  the	  BM	  of	  K3-­‐/-­‐	  chimeras	  we	  performed	  CFU-­‐C	  and	  LTC-­‐IC	  assays	  with	   donor	   derived	   BM	   cells	   4	  months	   after	   transplantation	   and	   found	   similar	  numbers	   of	   CFU-­‐Cs	   and	   a	   similar	   frequency	   of	   LTC-­‐ICs	   in	   the	   K3+/+	   and	   K3-­‐/-­‐	   BM	  (Figure	  3A,	   B).	   To	   further	   corroborate	   the	   presence	   of	   HSPCs	   in	   the	   K3-­‐/-­‐	   BM	   we	  phenotypically	   identified	   and	   quantified	   them	   with	   FACS	   using	   specific	   antibodies	  against	   CD34	   and	   the	   signal	   lymphocyte	   activating	   molecule	   (SLAM)	   receptors	  (CD150	  and	  CD48)	  (Kiel	  et	  al.,	  2005;	  Morita	  et	  al.,	  2010).	   In	  all	  K3-­‐/-­‐	  chimeras	  analyzed	  the	  total	  number	  of	  K3-­‐/-­‐	  LSK	  cells	  in	  the	  BM	  was	  normal,	  while	  LSK	  subpopulations	  were	  markedly	  altered	  (Figure	  3C,	  D).	  The	  LSK	  CD150+CD48-­‐	  population	  containing	  the	  CD34-­‐	  (enriched	   with	   quiescent	   LT-­‐HSCs)	   and	   CD34+	   (enriched	   with	   more	   actively	   cycling	  
cells)	  subpopulations	  (Wilson	  et	  al.,	  2008)	  were	  significantly	  reduced	  in	  the	  BM	  of	  K3-­‐/-­‐	  chimeras.	  Instead,	  the	  LSK	  CD150+CD48+	  and	  LSK	  CD150-­‐CD48+	  populations,	  containing	  HPCs,	  were	   increased	  (Figure	  3C,	  D)	  suggesting	  a	  shift	   from	  the	  quiescent	  HSCs	   to	   the	  proliferating	  pool	  of	  HSPCs	  in	  K3-­‐/-­‐	  chimeras.	  To	  determine	  whether	  populations	  enriched	  in	  LT-­‐HSCs	  in	  the	  BM	  change	  over	  time,	  we	  analyzed	   the	   chimeras	   1,	   2,	   4	   and	   9-­‐13	   months	   after	   transplantation.	   While	   the	  percentages	   of	   the	   K3+/+	   and	  K3-­‐/-­‐	   LSK	   subpopulations	   to	   total	   LSK	   cells	   was	   reduced	  already	  one	  month	  after	  BM	  transplantation,	  the	  total	  numbers	  of	  LSK	  CD150+CD48-­‐	  and	  LSK	  CD150+CD48-­‐CD34-­‐	   cells	   were	   comparable	   between	   K3+/+	   and	   K3-­‐/-­‐	   chimeras	  (Figure	   3E-­‐G).	   The	   numbers	   of	   LSK	  CD150+CD48-­‐	   and	   LSK	  CD150+CD48-­‐CD34-­‐	   cells	  steadily	   increased	   in	   the	   K3+/+	   BM,	   while	   they	   remained	   low	   in	   the	   K3-­‐/-­‐	   BM	  (Figure	  3E-­‐G).	  These	  results	   indicate	  that	  populations	  enriched	   in	  LT-­‐HSCs	  are	  present	  in	  the	  BM	  of	  K3-­‐/-­‐	  chimeras	  but	  fail	  to	  expand	  with	  age.	  
Kindlin-­‐3	  maintains	  HSC	  quiescence	  and	  BM	  retention	  The	   reduction	   of	   populations	   enriched	   in	   LT-­‐HSCs	   in	   the	   BM	   of	   K3-­‐/-­‐	   chimeras	   could	  result	   from	   an	   increased	   proliferation,	   an	   enhanced	   differentiation	   into	   multipotent	  progenitors	   and/or	   an	   impaired	   BM	   retention,	   which	  would	   lead	   in	   all	   cases	   to	   their	  premature	  exhaustion.	  To	  test	  whether	  LT-­‐HSCs	  are	  hyperactive	  we	  first	  determined	  the	  sensitivity	  of	  K3+/+	  and	  K3-­‐/-­‐	  chimeras	  to	  the	  cytostatic	  drug	  5-­‐Fluorouracil	  (5-­‐FU),	  which	  eliminates	   cycling	   but	   not	   quiescent	   HSCs	   (Essers	   et	   al.,	   2009).	   In	   response	   to	   5-­‐FU	  treatment	  2	  out	  of	  22	  K3+/+	  chimeras	  and	  all	  K3-­‐/-­‐	   chimeras	  died	   suggesting	   that	  HSCs	  are	  actively	  cycling	  and	  quiescent	  LT-­‐HSCs	  are	  absent	  or	  exist	  in	  extremely	  low	  numbers	  in	   K3-­‐/-­‐	   chimeras.	   Pre-­‐treatment	  with	   polyI:C,	   which	   induces	   type	   I	   interferons	   (IFN?,	  IFN?)	   expression	   and	   hence	   drives	   HSCs	   into	   the	   cell	   cycle	   (Essers	   et	   al.,	   2009),	  sensitized	  also	  K3+/+	  chimeras	  to	  5-­‐FU	  (Figure	  4A,	  B).	  The	   increased	  proliferative	  activity	  of	  K3-­‐/-­‐	  HSCs	  was	   confirmed	  with	   the	  BrdU	  uptake	  assay,	   which	   revealed	   that	   3-­‐4	   months	   after	   BM	   transplantation	   the	   percentages	   of	  BrdU+	   LSK,	   LSK	  CD150+CD48-­‐	   and	   LSK	  CD150+CD34-­‐	   cells	   were	   increased	   in	   the	   K3-­‐/-­‐	  BM,	  while	   the	   percentage	   of	   BrdU+	   lineage-­‐Sca-­‐1-­‐c-­‐kit+(LK)	   progenitor	   cells,	  which	   are	  highly	   proliferative,	   was	   similar	   in	   the	   BM	   of	   K3+/+	   and	   K3-­‐/-­‐	   chimeras	   (Figure	  4C).	  Furthermore,	   DNA	   and	   Ki67	   measurements	   in	   LSK	   cells	   also	   revealed	   increased	  numbers	   of	   cycling	   LSK	   cells	   in	   the	   BM	   of	   K3-­‐/-­‐	   chimeras	   (Figure	   4D,	   E),	   and	  quantification	  of	  mRNA	  levels	  of	  the	  cyclin-­‐dependent	  kinase	  inhibitors	  (CKIs)	  p21,	  p27,	  
and	   p57	   in	   LSK	  CD150+	   cells	   demonstrated	   that	   p57,	   which	   is	   required	   to	   maintain	  quiescence	   and	   stemness	   of	   HSCs	   (Matsumoto	   et	   al.,	   2011;	   Zou	   et	   al.,	   2011)	   ,were	  significantly	  decreased	  in	  K3-­‐/-­‐	  LSK	  CD150+	  cells	  (Figure	  4F).	  Finally,	  label-­‐retaining	  cell	  (LRC)	  assays	  (Wilson	  et	  al.,	  2008)	  also	  corroborated	  that	  the	  numbers	  of	  slowly	  dividing	  HSCs	  were	  reduced	  in	  the	  K3-­‐/-­‐	  BM.	  Administration	  of	  BrdU	  for	   16	   days	   labeled	   all	   HSPC	   populations	   in	   K3+/+	   and	   K3-­‐/-­‐	   BM	   (Figure	   4G).	   After	   a	  BrdU-­‐free	  chase	  of	  45	  days	   the	  percentage	  of	  BrdU	   label-­‐retaining	  cells	   (LRCsBrdU)	   in	  the	  LSK,	  LSK	  CD150-­‐CD48+,	  LSK	  CD150+CD48+,	  LSK	  CD150+CD48-­‐	  and	  LSK	  CD150+CD34-­‐	  cells	  were	  significantly	  diminished	  in	  the	  K3-­‐/-­‐	  BM	  (Figure	  4H).	  Despite	  the	  high	  proliferative	  activity	  of	  K3-­‐/-­‐	  HSPCs,	  the	  numbers	  of	  MNCs	  (Figure	  1B)	  or	   LSK	   cells	   (Figure	   3D)	   were	   not	   increased	   in	   the	   BM	   of	   healthy	   K3-­‐/-­‐	   chimeras	  suggesting	   that	   in	   addition	   to	   their	   proliferation	   defect,	   K3-­‐/-­‐	   HSPCs	   are	   not	   properly	  retained	   in	   the	  BM.	   In	   line	  with	  a	   retention	  defect,	  we	  observed	   increased	   frequencies	  and	  total	  numbers	  of	  LK	   in	  PB	  and	  LSK	  cells	   in	  Spl	  and	  PB	  (Figure	  4I,	   J)	  and	   increased	  frequencies	   of	   CFU-­‐Cs	   in	   Spl	   and	   PB	   of	   K3-­‐/-­‐	   chimeras	   (Figure	   S3A).	   Furthermore,	  transplantation	   of	   PB	   MNCs	   together	   with	   rescue	   Spl	   cells	   into	   lethally	   irradiated	  recipients	   demonstrated	   that	   K3+/+	   PB	   MNCs	   hardly	   contributed	   to	   total	   leukocytes,	  myeloid	  and	  lymphoid	  (i.e.	  B	  and	  T	  cells)	   lineages,	  while	  PB	  MNCs	  from	  K3-­‐/-­‐	  chimeras	  readily	  contributed	  to	  a	  multi-­‐lineage	  hematopoietic	  chimerism	  in	  recipient	  mice	  up	  to	  16	  weeks	  after	   transplantation	   indicating	  that	   the	  PB	  of	   the	  K3-­‐/-­‐	  chimeras	  contains	  an	  increased	   number	   of	   circulating	   HSPCs	   (Figure	  4K-­‐N).	   The	   absence	   of	   T	   cells	   in	   K3-­‐/-­‐	  chimeras	   (Figure	  4N)	   is	   due	   to	   an	   extravasation	   defect	   of	   preT	   cells	   into	   the	   thymus	  (manuscript	  in	  preparation).	  To	   corroborate	   the	   BM	   retention	   defect	   of	   HSPCs	  we	   induced	   their	  mobilization	   with	  granulocyte	   colony-­‐stimulating	   factor	   (G-­‐CSF)	   (Figure	   4O,	   S3B).	   G-­‐CSF	   treatment	  increased	  LSK	  cells	  in	  the	  PB	  of	  K3+/+	  chimeras	  to	  the	  same	  extent	  as	  in	  PBS-­‐treated	  K3-­‐/-­‐	  chimeras,	   while	   the	   LSK	   numbers	   rose	   even	   further	   in	   the	   PB	   of	   K3-­‐/-­‐	   chimeras	  (Figure	  4O).	  The	  LSK	   cells	  were	  higher	   in	   the	   Spl	   of	  K3+/+	   compared	   to	  K3-­‐/-­‐	   chimeras	  (Figure	  S3B),	   which	   was	   probably	   due	   to	   the	   reduced	   extravasation	   potential	   of	   K3-­‐/-­‐	  HSPCs.	   Altogether	   these	   data	   demonstrate	   that	   HSCs	   in	   the	   K3-­‐/-­‐	   chimeras	   are	  constitutively	  cycling	  and	  that	  K3-­‐/-­‐	  HSPCs	  are	  less	  efficiently	  retained	  in	  the	  BM.	  
Loss	  of	  Kindlin-­‐3	  leads	  to	  a	  premature	  exhaustion	  of	  HSCs	  Quiescent	   HSCs	   mediate	   multi-­‐lineage	   long-­‐term	   reconstitution	   (Trumpp	   et	   al.,	   2010;	  Wilson	   et	   al.,	   2008).	   Since	   most	   HSCs	   in	   the	   K3-­‐/-­‐	   chimeras	   were	   activated,	   we	  hypothesized	  that	  multi-­‐lineage	  long-­‐term	  reconstitution	  and	  thus	  survival	  of	  recipient	  mice	  exposed	  to	  an	  extreme	  hematopoietic	  stress	  such	  as	  serial	  BM	  transplantations	  or	  weekly	  5-­‐FU	  administration	  will	  be	   severely	   impaired	  without	  Kindlin-­‐3.	  Although	   the	  1st	   generation	   K3-­‐/-­‐	   chimeras	   suffered	   from	   increased	   lethality	   (Figure	  1A),	  approximately	   50%	   of	   them	   maintained	   a	   multi-­‐lineage	   long-­‐term	   reconstitution	   for	  more	   than	   5	  months.	  We	   isolated	   5x106	  whole	   BM	   (WBM)	   cells	   from	   these	  mice	   and	  transferred	   them	   intravenously	   (i.v.)	   into	   lethally	   irradiated	   secondary	   wt	   congenic	  B6.SJL	   recipients.	   As	   shown	   above	   (Figure	   3C,	   D),	   5x106	   K3-­‐/-­‐	   WBM	   cells	   contained	  sufficient	  numbers	  of	  HSCs	  to	  mediate	  long-­‐term	  reconstitution.	  While	  all	  42	  recipients	  transplanted	  with	  K3+/+	  WBM	  cells	  were	  radio-­‐protected	  for	  more	  than	  10	  weeks,	  only	  4	  out	  of	  the	  55	  recipients	  of	  K3-­‐/-­‐	  WBM	  cells	  were	  able	  to	  survive	  for	  10	  weeks.	  We	  next	  transferred	   5x106	   WBM	   cells	   from	   9	   K3+/+	   and	   the	   4	   surviving	   K3-­‐/-­‐	   2nd	   generation	  donors	   to	  5	   tertiary	   recipients	   for	   each	   secondary	  donor	   and	  observed	   that	  within	  10	  weeks	   after	   transplantation	   41	   out	   of	   the	   45	   recipients	   of	   K3+/+	   WBM	   cells	   were	  protected	   against	   lethal	   irradiation,	   while	   all	   20	   recipients	   of	   K3-­‐/-­‐	   WBM	   cells	  succumbed.	   As	   expected,	   K3+/+	   WBM	   cells	   enabled	   long-­‐term	   engraftment	   even	   in	  quaternary	  (Figure	  5A)	  and	  quinary	  recipients	  (data	  not	  shown).	  To	  ensure	  that	  the	  severe	  reconstitution	  defect	  of	  K3-­‐/-­‐	  WBM	  cells	  did	  not	  result	  from	  a	  reduced	  number	  of	  HSPCs	  in	  transplanted	  WBM	  cells	  but	  rather	  from	  HSPC	  dysfunctions	  described	   above,	   we	   performed	   transplantation	   experiments	   with	   1x103	   LSK	  CD150+	  cells	   sorted	   by	   FACS	   from	   BM	   of	   K3+/+	   and	   K3-­‐/-­‐	   primary	   donor	   chimeras	   and	  supplemented	  the	  secondary	  recipients	  with	  5x106	  congenic	  BL6.SJL	  unfractionated	  Spl	  cells.	   The	   experiments	   revealed	   that	   K3+/+	   LSK	  CD150+	   donor	   cells	   induced	   a	   high	  percentage	   of	   donor-­‐derived	   myeloid,	   B	   and	   T	   cells	   in	   the	   PB	   5	   weeks	   after	  transplantation,	   which	   further	   increased	   at	   11	   weeks.	   In	   contrast,	   recipients	   of	   K3-­‐/-­‐	  LSK	  CD150+	  donor	  cells	  showed	  a	  significantly	  lower	  multi-­‐lineage	  reconstitution	  in	  the	  PB	   5	   weeks	   after	   transplantation	   that	   further	   declined	   after	   11	   weeks	   (Figure	   5B).	  Almost	  all	   differentiated	  cell	   lineages	   in	  BM	  and	  Spl	   in	   recipients	  of	  K3+/+	  LSK	  CD150+	  cells	  were	  donor-­‐derived,	  while	   less	   than	  5%	  were	  donor-­‐derived	  cells	   in	  recipients	  of	  K3-­‐/-­‐	  LSK	  CD150+	  cells	  (Figure	  S4A,	  B).	  Furthermore,	  almost	  all	  cells	  in	  the	  different	  HSPC	  populations	   were	   donor-­‐derived	   in	   K3+/+	   LSK	  CD150+	   cell	   recipients,	   while	   the	  
percentage	   of	   donor-­‐derived	   HSPCs	   was	   around	   10%	   in	   most	   K3-­‐/-­‐	   LSK	  CD150+	   cell	  recipients	  (Figure	  5C).	  To	   exclude	   that	   differences	   in	   transplanted	   LSK	  CD150+	   cell	   counts,	   defective	   homing,	  lodgment	   into	   the	   BM	   niche	   and	   engraftment	   properties	   of	   K3-­‐/-­‐	   HSPCs	   lead	   to	   their	  exhaustion,	   we	   disrupted	   the	   Kindlin-­‐3	   allele	   in	   HSPCs	   2-­‐3	   months	   after	   the	  transplantion	  of	  BM	  cells	  from	  mice	  carrying	  floxed	  Kindlin-­‐3	  alleles	  and	  a	  Rosa26Cre-­‐ERT2	  transgene	   into	   congenic	   B6.SJL	   recipients	   (K3fl/flRosa26Cre-­‐ERT2	   chimera).	  Tamoxifen-­‐treated	   K3fl/flRosa26Cre-­‐ERT2	   chimeras	   developed	   defects	   (Figure	   S4C-­‐L)	  resembling	   those	   of	   K3-­‐/-­‐	   FL	   chimeras	   (Figure	  1,	  4I).	   Furthermore,	   weekly	   5?FU	  treatment	   5	   weeks	   after	   tamoxifen	   administration	   caused	   a	   90%	   lethality	   of	  K3fl/flRosa26Cre-­‐ERT2	   chimeras	   within	   20	   days,	   whereas	   almost	   all	   control	   chimeras	  survived	   (Figure	   5D)	   demonstrating	   that	   the	   impaired	   stress	   response	   of	   K3-­‐/-­‐	   HSCs	  operates	   independent	  of	  niche	   lodgment	  and	  number	  of	   transplanted	  HSCs.	  Altogether	  these	  findings	  demonstrate	  that	  the	  long-­‐term	  BM	  reconstitution	  defect	  of	  K3-­‐/-­‐	  chimeras	  is	   due	   to	   an	   impaired	   stemness	   of	   K3-­‐/-­‐	   HSCs	   cells	   within	   the	   BM	   that	   is	   further	  aggravated	  by	  their	  homing	  defects.	  
K3-­‐/-­‐	  HSC	  defects	  are	  cell	  autonomous	  Hematopoietic	   injury	   (e.g.	   blood	   loss)	   activates	  quiescent	  HSCs	  until	   all	   hematopoietic	  cells	   are	   replenished	   (Trumpp	   et	   al.,	   2010).	   Since	   K3-­‐/-­‐	   chimeras	   suffer	   from	   anemia,	  which	  could	  induce	  HSC	  activation,	  we	  performed	  several	  experiments	  to	  define	  whether	  K3-­‐/-­‐	  HSC	  quiescence	  is	  lost	  in	  a	  cell	  autonomous	  or	  non-­‐autonomous	  manner.	  First,	  we	  restored	  the	  anemia	  of	  K3-­‐/-­‐	  chimeras	  (Table	  S1)	  by	  generating	  mixed	  chimeric	  mice	   (mix-­‐chimeras)	   with	   FL	   cells	   from	   E14.5	   K3+/+	   or	   K3-­‐/-­‐	   embryos	  (C57BL/6;	  CD45.2+)	   mixed	   with	   competitor	   FL	   cells	   from	   E14.5	   wt	   congenic	   B6.SJL	  (CD45.1+)	  embryos	  and	  transplanted	  both	  together	  into	  lethally	  irradiated	  F1	  recipients	  (CD45.2+CD45.1+)	   (Figure	   S5A)	   in	   a	   1:1	   ratio	   for	   K3+/+	   and	   1:1	   or	   20:1	   for	   K3-­‐/-­‐	  mix-­‐chimeras,	   respectively.	   Despite	   efficient	   reversal	   of	   the	   anemia	   (Table	   S2),	   K3-­‐/-­‐	  (CD45.2+)	  LK	  and	  LSK	  cell	  numbers	  were	  still	  significantly	  increased	  in	  the	  PB	  compared	  to	  wt	  LK	  and	  LSK	  competitor	  cells	  (CD45.1+)	  (Figure	  6A),	  indicating	  that	  the	  elevation	  of	  K3-­‐/-­‐	  HSPCs	  in	  the	  PB	  occurs	  in	  a	  cell	  autonomous	  manner.	  Second,	  we	  compared	  G-­‐CSF	  induced	   mobilization	   of	   LSK	   cells	   to	   the	   PB	   between	   K3+/+	   and	   K3-­‐/-­‐	   mix-­‐chimeras	  (Figure	  6B)	  and	   found	   that	   the	  high	  basal	   levels	  of	   K3-­‐/-­‐	   LSK	  cells	   in	  PBS-­‐treated	  K3-­‐/-­‐	  mix-­‐chimeras	  further	  increased	  after	  G-­‐CSF	  treatment,	  while	  the	  K3+/+	  and	  the	  congenic	  
competitor	  derived	  LSK	  cells	  in	  K3+/+	  and	  K3-­‐/-­‐	  mix-­‐chimeras	  increased	  after	  application	  of	  G-­‐CSF	  to	  the	  basal	  K3-­‐/-­‐	  LSK	  cell	   level,	  demonstrating	  that	   the	  mobilization	  defect	  of	  K3-­‐/-­‐	  HSCs	   is	  also	  cell	  autonomous.	  Third,	  LRC	  assays	  revealed	  that	  a	  BrdU	  pulse	  of	  18	  days	  labeled	  almost	  all	  HSPCs	  in	  K3+/+	  or	  K3-­‐/-­‐	  mix-­‐chimeras	  (Figure	  6C),	  while	  a	  chase	  period	   of	   45	   to	   50	   days	   decreased	   the	   percentages	   of	   LRCsBrdU	   in	   the	   LSK,	  LSK	  CD150-­‐CD48+	   and	   LSK	  CD150+CD48-­‐	   populations	   significantly	   more	   in	   K3-­‐/-­‐	   than	  K3+/+	  mix-­‐chimeras	   (Figure	  6D),	   indicating	   that	  also	   the	   increased	  proliferation	  rate	  of	  HSPCs	   is	   cell	   autonomous.	   Interestingly,	   the	   reduction	   in	   LRCsBrdU	   in	   the	  LSK	  CD150+CD34-­‐	  population	  was	  not	   significant	   (Figure	  6D),	  which	  may	   indicate	   that	  their	  activity	   is	  diminished	   in	  K3-­‐/-­‐	  mix-­‐chimeras	  compared	  with	  100%	  K3-­‐/-­‐	   chimeras.	  Fourth,	  we	  demonstrate	  that	  hematopoietic	  stress	  induced	  by	  5-­‐FU	  treatment	  of	  K3+/+	  or	  K3-­‐/-­‐	  mix-­‐chimeras	  diminished	  the	  ratio	  between	  K3-­‐/-­‐	  to	  congenic	  competitor	  LSK	  cells	  by	   approximately	   7-­‐fold	   (Figure	  6E),	   while	   the	   ratio	   between	   K3+/+	   and	   congenic	  competitor	  LSK	  cells	  remained	  unaffected	  indicating	  that	  also	  the	  5-­‐FU	  sensitivity	  is	  cell	  autonomous.	  Fifth,	  we	   investigated	   the	   long-­‐term	  reconstitution	  potential	  of	  K3+/+	   and	  K3-­‐/-­‐	  HSPCs	  isolated	  from	  mix-­‐chimeras	  in	  a	  competitive	  repopulation	  assay.	  Around	  450	  FACS-­‐purified	  K3+/+	  or	  K3-­‐/-­‐	  LSK	  CD150+CD45.2+	  cells	  were	  mixed	  with	  5x106	  whole	  Spl	  cells	  from	  congenic	  B6.SJL	  mice	  and	  transplanted	  into	  lethally	  irradiated	  congenic	  B6.SJL	  recipients.	   While	   the	   average	   percentages	   of	   K3+/+	   and	   K3-­‐/-­‐	   donor-­‐derived	   whole	  leukocytes	   were	   similar	   4	   weeks	   after	   transplantation,	   the	   average	   percentages	   of	  myeloid	   cells,	   B	   and	  T	   cells	   differed	   significantly	   in	   the	   respective	   recipient	  mice.	   The	  difference	  of	  K3+/+	  and	  K3-­‐/-­‐	  donor-­‐derived	  cells	  further	  increased	  over	  the	  observation	  period	  of	  8	  and	  12	  weeks	  after	  transplantation	  (Figure	  6F-­‐I).	  Interestingly,	  the	  CD45.1+	  to	   CD45.2+	   ratio	   remained	   constant	  between	  HSPCs	   and	  mature	   effector	   cells	   in	  K3+/+	  mix-­‐chimeras,	  while	  the	  ratio	  diminished	  in	  K3-­‐/-­‐	  mix-­‐chimeras	  (Figure	  S5B,	  C)	  pointing	  to	  an	  additional	  differentiation	  defect	  of	  K3-­‐/-­‐	  HSPCs	  and/or	  a	  decreased	  production	  of	  effector	  cells	  due	  to	  impaired	  BM	  retention	  of	  K3-­‐/-­‐	  HSPCs	  in	  the	  BM.	  Since	  a	  decreased	  formation	   of	   K3-­‐/-­‐	   effector	   cells	   does	   not	   allow	   to	   correlate	   the	   percentage	   of	  donor-­‐derived	  cells	  in	  the	  PB	  with	  the	  percentage	  of	  HSPCs	  in	  the	  BM,	  we	  assessed	  the	  percentage	   of	   donor-­‐derived	   cells	   in	   different	   HSPC	   populations	   in	   the	   BM.	   Twelve	  months	   after	   transplantation,	   K3+/+	   LSK	  CD150+CD45.2+	   donor	   cells	   produced	   nearly	  100%	  of	  all	  HSPC	  populations	  analyzed,	  while	  in	  recipients	  of	  K3-­‐/-­‐	  LSK	  CD150+CD45.2+	  cells	   the	   average	   engraftment	   capacity	   was	   reduced	   to	   around	   50%	   (Figure	   6J),	  indicating	   that	   the	  K3-­‐/-­‐	  HSCs	   reconstitution	  defect	   is	   also	   cell	   autonomous.	  Altogether	  
these	   findings	   demonstrate	   that	   abnormal	   mobilization,	   increased	   proliferation,	  enhanced	   5-­‐FU	   sensitivity	   and	   diminished	   engraftment	   of	   K3-­‐/-­‐	   HSPCs	   are	   cell	  autonomous	  defects.	  
Kindlin-­‐3	  is	  essential	  for	  activated	  HSPCs	  rather	  than	  quiescent	  HSCs	  To	  address	   the	  question	  whether	  Kindlin-­‐3	   is	   required	   for	  quiescent,	   and/or	  activated	  HSCs	  and/or	  formation	  of	  HPCs,	  we	  first	  monitored	  donor-­‐derived	  HSPC	  populations	  in	  the	  BM	  of	  mix-­‐chimeras	  over	  time	  (Figure	  7A-­‐D).	  This	  analysis	  revealed	  that	  the	  average	  percentages	   of	   donor-­‐derived	   LK	   and	   LSK	  CD150-­‐CD48+	   cells	   increased	   in	   K3+/+	   and	  decreased	   in	   K3-­‐/-­‐	   mix-­‐chimeras	   during	   an	   observation	   period	   of	   12	   months	   after	  transplantation	   (Figure	   7A,	   B),	   while	   the	   average	   percentages	   of	   donor-­‐derived	  LSK	  CD150+CD48-­‐	  or	  LSK	  CD150+CD48-­‐CD34-­‐	  cells	  remained	  similar	  and	  stable,	  both	  in	  K3+/+	   and	   K3-­‐/-­‐	   mix-­‐chimeras	   (Figure	   7C,	   D)	   indicating	   that	   Kindlin-­‐3	   is	   required	   to	  maintain	   stable	   LSK	  CD150-­‐CD48+	   cell	   numbers	   but	   not	   for	   maintaining	  LSK	  CD150+CD48-­‐	   and	   LSK	  CD150+CD48-­‐CD34-­‐	   cells.	   This	   conclusion	   is	   further	  supported	   by	   the	   observation	   that	   3-­‐4	  months	   post	   transplantation	   the	   percentage	   of	  donor-­‐derived	   LSK	  CD150-­‐CD48+	   cells	   significantly	   dropped	   in	   comparison	   to	  LSK	  CD150+CD48-­‐	  or	  LSK	  CD150+CD48-­‐CD34-­‐	  cells	  in	  the	  BM	  of	  K3-­‐/-­‐	  mix-­‐chimeras,	  while	  this	  cell	  population	  significantly	  increased	  in	  K3+/+	  mix-­‐chimeras	  (Figure	  7E).	  To	  further	  confirm	  a	  differential	  role	  of	  Kindlin-­‐3	  for	  different	  HSPC	  populations	  and	  to	  exclude	  homing	  defects,	  we	  also	  monitored	  donor-­‐derived	  HSPC	  populations	  in	  the	  BM	  of	  lethally	  irradiated	  mix-­‐chimeras	  (F1	  CD45.2+CD45.1+recipients)	  transplanted	  with	  wt	  BM	  cells	   from	  congenic	  B6.SJL	   (CD45.1+)	  mice	  mixed	   in	  a	  1:1	  ratio	  with	  BM	  cells	   from	  either	  C57BL/6	   (CD45.2+)	  K3fl/flRosa26Cre-­‐ERT2	  or	  wt-­‐Rosa26Cre-­‐ERT2	  mice,	   supplied	  with	  tamoxifen	  three	  months	  after	  transplantation,	  and	  treated	  with	  either	  PBS	  or	  5-­‐FU	  five	  weeks	   later.	   Wt-­‐Rosa26Cre-­‐ERT2	   control	   and	   non-­‐induced	   K3fl/flRosa26Cre-­‐ERT2	  mix-­‐chimeras	   displayed	   similar	   average	   percentages	   of	   donor-­‐derived	   LK,	  LSK	  CD150+CD48-­‐	   and	   LSK	  CD150+CD48-­‐CD34-­‐	   cells,	   while	   the	   percentage	   of	  LSK	  CD150-­‐CD48+	  cells	  was	  increased	  in	  the	  K3fl/flRosa26Cre-­‐ERT2	  mix-­‐chimera	  compared	  control	  chimeras	  (Figure	  7F-­‐I).	  Tamoxifen-­‐induced	  deletion	  of	  Kindlin-­‐3	  diminished	  the	  LK	   and	   LSK	  CD150-­‐CD48+	   populations	   in	   K3fl/flRosa26Cre-­‐ERT2	   mix-­‐chimeras,	   while	   the	  percentages	   of	   donor-­‐derived	   LSK	  CD150+CD48-­‐	   and	   LSK	  CD150+CD48-­‐CD34-­‐	  populations	   remained	   similar	   between	   K3fl/flRosa26Cre-­‐ERT2	   and	   control	   mix-­‐chimeras,	  further	   confirming	   that	   Kindlin-­‐3	   is	   dispensable	   for	   these	   HSC	   populations	   under	  
homeostatic	  conditions	  (Figure	  7F-­‐I).	  Importantly,	  however,	  5-­‐FU-­‐induced	  activation	  of	  HSCs	   further	   decreased	   the	   LK	   and	   LSK	  CD150-­‐CD48+	   populations	   and	   also	   induced	   a	  dramatic	   decrease	  of	   the	   average	  percentages	   of	   donor-­‐derived	  LSK	  CD150+CD48-­‐	   and	  LSK	  CD150+CD48-­‐CD34-­‐	   populations	   in	   tamoxifen	   pretreated	   K3fl/flRosa26Cre-­‐ERT2	  mix-­‐chimeras	  (Figure	  7F-­‐I).	  
Kindlin-­‐3	  maintains	  HSPCs	  in	  the	  BM	  by	  activating	  integrins	  The	  results	  so	  far	  indicate	  that	  Kindlin-­‐3	  is	  essential	  to	  retain	  active/proliferating	  HSPCs	  in	   the	  BM.	  To	   test	  whether	  Kindlin-­‐3	  executes	   this	   function	   through	   integrin-­‐mediated	  
????????? ??? ????????? ???? ????????? ?????? ??? ??? ?????????? ??? ???	  CD150-­‐CD48+	   and	  LSK	  CD150+CD48-­‐	  cells	  from	  100%	  K3+/+	  and	  K3-­‐/-­‐	  chimeras	  by	  determining	  the	  levels	  of	  
???? ????? ????????? ?????? ??? ????? ?????? ??? ??????? ??? ??????????? ???? ???????? ?????significantly	   decreased	   9EG7	   levels	   on	   K3-­‐/-­‐	   LSK	  CD150-­‐CD48+	   and	   LSK	  CD150+CD48-­‐	  cells	   compared	   to	   the	   K3+/+	   control	   populations	   (Figure	   7J).	   To	   further	   confirm	   an	  important	  role	   for	  Kindlin-­‐3	   induced	   integrin	  activation	  on	  HSPCs,	  K3+/+	  and	  K3-­‐/-­‐	  LSK	  cells	   were	   isolated	   from	   the	   BM	   of	   100%	   chimeras	   and	   lentivirally	   transduced	   with	  either	   a	   wt	   or	   an	   integrin-­‐binding	   deficient	   Kindlin-­‐3	   expression	   construct,	   in	   which	  amino	   acid	   residues	   QW597/598	   were	   substituted	  with	   alanines	   (thereby	   preventing	  Kindlin-­‐3	  binding	  to	  the	  NPxY	  motif	  of	  all	  ?????????????????.	  Approximately	  1.5x104	  of	  the	  transduced	   LSK	   cells	   were	   transplanted	   together	   with	   8.8x105	   CD45.2+	   WBM	   cells	  isolated	   from	  a	  K3-­‐/-­‐	  100%	  chimera	   into	   lethally	   irradiated	   congenic	  B6.SJL	   recipients.	  The	  reconstitution	  potential	  of	  K3+/+	  LSK	  cells	  transduced	  with	  GFP	  (K3+/+	  LSK	  with	  GFP;	  positive	   control),	   K3-­‐/-­‐	   LSK	   cells	   transduced	   with	   either	   GFP	   (K3-­‐/-­‐	   LSK	   with	   GFP;	  negative	  control)	  or	  a	  K3-­‐wt	  expression	  construct	  (K3-­‐/-­‐	  LSK	  with	  K3-­‐wt)	  or	  a	  K3-­‐QWAA	  expression	   construct	   (K3-­‐/-­‐	   LSK	   with	   K3-­‐QWAA)	   was	   compared	   by	   monitoring	   the	  survival	  of	  recipients.	  As	  expected,	  recipients	  transplanted	  with	  K3-­‐/-­‐	  LSK	  cells	  with	  GFP	  died	  within	  40	  days	  (Figure	  7K),	  while	  recipients	  transplanted	  with	  K3+/+	  LSK	  cells	  with	  GFP	   showed	   multi-­‐lineage	   long-­‐term	   rescue	   of	   all	   recipients	   (Figure	   7K,	   S6A).	  Importantly,	   only	  one	   recipient	   transplanted	  with	  K3-­‐/-­‐	   LSK	   cells	  with	  K3-­‐wt	   died	   and	  the	  remaining	   four	  survivors	  showed	  a	  multi-­‐lineage	   long-­‐term	  reconstitution,	  while	  4	  out	   of	   5	   recipients	   transplanted	  with	   K3-­‐/-­‐	   LSK	   cells	  with	   K3-­‐QWAA	   died	   from	   severe	  pancytopenia	   (Figure	  7K,	   S6A,	   and	   data	   not	   shown).	   The	   stable	   transduction	   of	   the	  different	  viral	  expression	  constructs	  in	  donor-­‐derived	  blood	  cells	  of	  surviving	  recipients	  was	  confirmed	  by	  different	  PCRs	  (Figure	  S6B	  and	  Table	  S4).	  
The	  reduced	  9EG7	  epitope	  levels	  on	  K3-­‐/-­‐	  LSK	  CD150-­‐CD48+	  and	  LSK	  CD150+CD48-­‐	  cells	  together	  with	  the	  severely	  diminished	  reconstitution	  potential	  of	  LSK	  cells	  expressing	  an	  integrin-­‐binding	  deficient	  Kindlin-­‐3	  indicates	  that	  Kindlin-­‐3	  regulates	  HSPC	  homeostasis	  in	  an	  integrin	  dependent	  manner.	  
Kindlin-­‐3	  in	  human	  HSPCs	  maintenance	  To	   test	   whether	   the	   role	   of	   Kindlin-­‐3	   for	   regulating	   HSPCs	   is	   conserved	   in	   man,	   we	  quantified	   the	  number	  of	  CD45+CD34+,	  CD34+CD38+	  and	  CD34+CD38-­‐	  HSPCs	   in	  PB	  of	  a	  patient	  suffering	  from	  LAD-­‐III	  caused	  by	  a	  null	  mutation	  in	  the	  KINDLIN-­‐3	  gene	  leading	  to	  a	  premature	  stop	  codon	  at	  the	  position	  coding	  for	  amino	  acid	  529	  and	  loss	  of	  protein	  expression	  (Schulz	  et	  al.,	  manuscript	  in	  preparation).	  The	  experiment	  was	  controlled	  by	  determining	  the	  numbers	  of	  HSPCs	  in	  a	  blood	  sample	  from	  a	  healthy	  child	  of	  the	  same	  age	   as	   the	   LAD-­‐III	   patient	   (Figure	   7L).	   The	   results	   revealed	   that	   CD45+CD34+	   and	  CD34+CD38+	  cells	  were	  around	  200	  times	  and	  CD34+CD38-­‐	  cells	  around	  60	  times	  higher	  in	  the	  blood	  of	  the	  LAD-­‐III	  patient	  compared	  to	  the	  healthy	  subject.	  Importantly,	  the	  CFU	  assay	   revealed	   that	   blood	   samples	   from	   the	   healthy	   individual	   as	   well	   as	   from	   the	  LAD-­‐III	  patient	  produced	  similar	  numbers	  of	  CFU-­‐GM	  and	  BFU-­‐E	  colonies	  when	  whole	  leucocytes	   with	   calculated	   100	   CD34+	   cells	   were	   cultured	   (Figure	   7M).	   These	   results	  indicate	   that	   the	   absence	   of	   Kindlin-­‐3	   in	   LAD-­‐III	   patients	   impairs	   the	   homeostasis	   of	  HSPCs	   and	   hence	   is	   perfectly	   in	   line	   with	   the	   observations	   made	   in	   mice	   lacking	  Kindlin-­‐3	  in	  HSPCs	  (Figure	  4I-­‐N).	  
DISCUSSION	  Kindlin-­‐3	   is	   expressed	   in	   all	   hematopoietic	   cells	   including	   HSPCs	   and	   is	   required	   for	  bidirectional	   integrin	   signaling	   (Moser	   et	   al.,	   2009a).	   HSPCs	   express	   several	   integrins	  (Grassinger	   et	   al.,	   2009)	   and	   therefore,	   one	   would	   predict	   that	   Kindlin-­‐3	   serves	  important	   roles	   for	  HSC	   homeostasis.	   To	   test	   this	   hypothesis,	  we	   designed	   a	   range	   of	  experiments,	  which	   assigned	   several	   important	   function(s)	   to	  Kindlin-­‐3	   in	  HSPCs.	   The	  results	   of	   our	   study	   demonstrate	   that	   Kindlin-­‐3	   is	   dispensable	   for	   the	   generation	   of	  HSCs,	  however	  it	  plays	  key	  roles	  for	  several	  important	  HSPC	  properties;	  first,	  Kindlin-­‐3	  supports	   the	  homing	  of	  HSPCs	   to	   the	  BM	  by	   facilitating	   integrin-­‐mediated	  adhesion	   to	  the	   vessel	   wall.	   Second,	   it	   facilitates	   the	   retention	   of	   proliferating	   HSPCs	   in	   the	   BM	  microenvironment.	  Finally,	  the	  retention	  of	  proliferating	  HSPCs	  by	  Kindlin-­‐3	  prevents	  an	  excessive	   activation	   of	   quiescent	  HSCs	   under	   hematopoietic	   stress	   and	   thereby	   averts	  their	  premature	  exhaustion.	  The	   homing	   of	   HSPCs	   to	   the	   BM	   is	   a	   multistep	   process	   that	   commences	   with	   their	  adhesion	   to	   the	   BM	   vessel	   wall	   and	   continues	   with	   their	   transendothelial	   migration	  finally	  leading	  to	  colonization	  of	  the	  stem	  cell	  niches	  (Magnon	  and	  Frenette,	  2008).	  Our	  analysis	   showed	   that	  disruption	  of	   the	  Kindlin-­‐3	   gene	   in	  HSPCs	  diminished	  short-­‐term	  BM	  homing.	  A	   few	  K3-­‐/-­‐	  HSPCs	  assumed	  long	   lasting	  adhesions	  to	  endothelial	  cells	  and	  eventually	  crossed	  the	  vessel	  wall,	  which	  gave	  rise	  to	  significant	  numbers	  of	  K3-­‐/-­‐	  HSPCs	  in	   the	   BM	   of	   recipient	   mice	   1	   month	   after	   transplantation.	   Previous	   reports	   already	  
??????????????????????????????????????????????????????????????? ????????????????????????
????????????????????-­‐1)	  are	  essential	  for	  BM	  homing	  of	  HSPCs	  (Magnon	  and	  Frenette,	  2008;	   Potocnik	   et	   al.,	   2000;	   Taooka	   et	   al.,	   1999)?? ????????? ??????????? ??? ??? ?????????likely	   all	   other	   integrin	   classes	   is	   impaired	   on	   K3-­‐/-­‐	   HSPCs	   there	   are	   still	   sufficient	  integrins	   functional	   to	  permit	  BM	  homing	  of	   K3-­‐/-­‐	  HSPCs,	   although	  at	   a	  much	   reduced	  efficiency.	  Hence,	  the	  ability	  of	  Kindlin-­‐3	  to	  shift	  the	  equilibrium	  of	  integrins	  toward	  high	  activity	  is	  not	  absolutely	  essential	  although	  tremendously	  instrumental	  in	  this	  process.	  Our	   experiments	   also	   revealed	   that	   the	   numbers	   of	   K3-­‐/-­‐	   HSPCs	   were	   significantly	  elevated	   in	   the	   circulation	   and	   Spl,	   of	   both	   100%	   chimeras	   and	   mix-­‐chimeras.	   The	  accumulation	   of	   these	   cells	   in	   the	   periphery	   could	   be	   caused	   by	   a	   spontaneous	  mobilization	   of	  HSPCs	   and/or	   a	   diminished	   re-­‐homing	   of	   circulating	  HSPCs	   to	   the	  BM	  (Massberg	  et	  al.,	  2007;	  Wright	  et	  al.,	  2001).	  The	  defects	  observed	  in	  K3fl/flRosa26Cre-­‐ERT2	  mix-­‐chimeras,	   in	  which	   the	  Kindlin-­‐3	   gene	  was	   deleted	   after	   transplantation,	  makes	   a	  
defective	   rehoming	   rather	   unlikely	   and	   argues	   for	   a	   defective	   retention	   of	   HSPCs.	   A	  defective	   retention	   is	   further	   supported	   by	   the	   increased	   sensitivity	   of	   K3-­‐/-­‐	   HSPCs	   to	  G-­‐CSF	   and	   the	   observation	   that	   the	   K3-­‐/-­‐	   LSK	  CD150-­‐CD48-­‐CD34-­‐	   population	   fails	   to	  increase	  over	  time	  in	  the	  BM	  of	  100%	  chimeras	  despite	  an	  elevated	  proliferation	  rate	  of	  these	  cells.	  The	  hyperproliferative	  state	  of	  K3-­‐/-­‐	  HSCs	  in	  100%	  chimeras	  results	   in	  HSC	  exhaustion	  characterized	  by	  the	  loss	  of	  LT-­‐HSCs	  leading	  to	  pancytopenia	  in	  old	  K3-­‐/-­‐	  chimeras.	  The	  finding	   that	   K3-­‐/-­‐	   LSK	  CD150+CD48-­‐CD34-­‐	   cell	   numbers	   remain	   quiescent	   in	  mix-­‐chimeras	   reconstituted	   with	   wt	   and	   K3-­‐/-­‐	   HSPCs	   while	   the	   proliferative	   K3-­‐/-­‐	  LSK	  CD150-­‐CD48+	   population	   diminishes	   points	   to	   a	   major	   task	   of	   Kindlin-­‐3	   for	  maintaining	  proliferating	  HSPCs	  rather	  than	  quiescent	  HSCs.	  In	  line	  with	  this	  conclusion,	  we	   found	   that	   the	  exposure	  of	  mix-­‐chimeras	   to	  hematopoietic	   stress	   such	  as	  a	  weekly	  5-­‐FU	   treatment,	   which	   triggers	   HSC	   activation	   and	   proliferation,	   gradually	   diminishes	  the	  pool	  of	  K3-­‐/-­‐	  HSCs.	  Their	  reduction	  results	  from	  the	  loss	  of	  K3-­‐/-­‐	  HPCs	  and	  activated	  K3-­‐/-­‐	  HSCs	   into	   the	   circulation	   coupled	  with	   the	   demand	   to	   replenish	   their	   decreasing	  pools.	  In	  5-­‐FU	  treated	  mix-­‐chimeras	  the	  presence	  of	  wt	  HSC	  compensates	  for	  the	  gradual	  decline	  of	  K3-­‐/-­‐	  HSC,	  while	  in	  100%	  chimeras	  the	  loss	  of	  K3-­‐/-­‐	  HSPCs	  into	  the	  circulation	  is	  eventually	  leading	  to	  the	  exhaustion	  of	  the	  quiescent	  HSC	  pool	  and	  to	  the	  death	  of	  the	  animal.	  Since	  untreated	  K3-­‐/-­‐	  mix-­‐chimeras	  are	  not	  exposed	  to	  hematopoietic	  stress,	  wt	  HSCs	   fill	   the	   HPC	   niches	   and	   only	   the	   few	   proliferating	   HSPCs	   derived	   from	   the	   K3-­‐/-­‐	  HSCs	  fail	  to	  retain	  in	  the	  BM	  and	  accumulate	  in	  the	  circulation.	  Kindlin-­‐3	   maintains	   HSPCs	   in	   the	   BM	   in	   a	   cell	   autonomous	  manner,	   although	   factors	  such	  as	  anemia	  contribute	  to	  the	  defect	  in	  100%	  chimeras.	  Mechanistically,	  this	  function	  is	   achieved	   through	   the	   ability	   of	   Kindlin-­‐3	   to	   activate	   integrins.	   In	   line	   with	   this	  
???????????????????????? ????? ???????????????????????? ????????????????????????????????integrins,	   is	   dramatically	   reduced	   in	   K3-­‐/-­‐	   HSPCs.	   Furthermore,	   the	   inability	   to	  reconstitute	   lethally	   irradiated	   recipients	   with	   K3-­‐/-­‐	   LSK	   cells	   expressing	   an	   integrin	  binding-­‐deficient	   Kindlin-­‐3	   indicates	   that	   Kindlin-­‐3	   maintains	   HSPCs	   in	   the	   BM	   by	  
??????????? ??????????? ??????????????? ?????-­‐catenin	   and	   TGF-­‐?? ??????????? ?????? ????essential	  in	  cutaneous	  stem	  cells,	  were	  unaffected	  in	  K3-­‐/-­‐	  HSPCs	  (data	  not	  shown).	  This	  is	  likely	  due	  to	  differences	  in	  the	  niche	  microenvironment,	  the	  different	  properties	  of	  the	  Kindlin	   isoforms	  and	  the	  different	   integrin	  subtypes	  expressed	   in	  different	   tissue	  stem	  cells.	   For	   example,	   cutaneous	   stem	   cells	   express	   high	   levels	   of	   the	   epithelial	   integrin	  
??????????????????????????????????????(Huang	  et	  al.,	  1996;	  Klimmeck	  et	  al.,	  2012),	  and	  hence	  is	  not	  employed	  to	  liberate	  TGF-­‐?	  and	  regulate	  TGF-­‐?	  signaling.	  Why	   is	   Kindlin-­‐3	   only	   required	   in	   activated	   HSPCs	   and	   not	   in	   quiescent	   HSCs?	   It	   is	  possible	   that	   different	   classes	   of	   adhesion	   molecules	   such	   as	   CD44	   or	   selectins	  compensate	   for	   each	   other	   on	   quiescent	   HSCs.	   These	   adhesion	   molecules	   have	   low	  affinities	   for	   their	   ligand,	   which	   is	   sufficient	   to	   retain	   quiescent	   HSCs	   in	   their	   BM	  compartments	   but	   insufficient	   to	   retain	   proliferating	   HSPCs	   that	   round	   up	   during	  mitosis	   and	   loosen	   their	   adhesion.	   Consequently,	   proliferating	  HSPCs	   (and	  most	   likely	  also	  active	  HSCs)	  detach	  and	  accumulate	  in	  the	  circulation.	  Finally,	  it	  is	  also	  conceivable	  that	   activated	   and	  quiescent	  HSCs	   reside	   in	  different	  niches.	  Although	   the	  presence	  of	  different	   niches	   for	   HSPCs	   is	   not	   entirely	   resolved,	   one	   could	   envisage	   that	   different	  niches	  differ	  in	  their	  niche	  components	  and	  hence	  require	  different	  adhesion	  molecules	  for	   cell	   retention.	   In	   line	   with	   these	   hypotheses,	   our	   findings	   indicate	   that	   Kindlin-­‐3	  mediated	  integrin	  adhesion	  is	  essential	  for	  proliferating	  HSPCs	  and	  to	  a	  lesser	  extent	  for	  quiescent	   HSCs.	   Live	   imaging	   microscopy	   of	   HSPCs	   in	   the	   BM	   should	   allow	   to	   see	  whether	   HSPCs	   move	   to	   a	   different	   BM	   compartments	   during	   cell	   division	   and/or	  whether	  they	  round	  up	  and	  detach	  during	  cell	  division	  and	  become	  lost	  when	  they	  lack	  Kindlin-­‐3	  expression.	  In	  summary,	  our	  findings	  assign	  Kindlin-­‐3	  induced	  integrin	  adhesion	  an	  important	  role	  for	  maintaining	   actively	   proliferating	   HSPCs	   in	   the	   BM.	   This	   exquisite	   function	   is	   not	  required	  by	  quiescent	  HSCs,	  although	  stem	  cells	   in	  other	  tissues	  such	  as	  the	  hair	  bulge	  require	   integrin	  adhesion	   for	   their	  maintenance	   (Brakebusch	  et	  al.,	  2000;	  Raghavan	  et	  al.,	  2000).	  Furthermore,	  the	  important	  role	  of	  Kindlin-­‐3	  for	  integrin	  activation	  in	  HSPCs	  is	   conserved	   between	   mouse	   and	   man,	   as	   an	   individual	   suffering	   from	   LAD-­‐III	   also	  demonstrates	  dramatically	  increased	  levels	  of	  circulating	  HSPCs.	  
EXPERIMENTAL	  PROCEDURES	  
Mice	  K3-­‐/-­‐	  chimeras	  have	  been	  described	  (Moser	  et	  al.,	  2008).	  Kindlin-­‐3	  floxed	  mice	  carry	  lox	  P	  sites	  that	  flank	  exons	  3-­‐6	  with	  loxP	  sites	  (manuscript	  in	  preparation).	  Mice	  were	  kept	  under	  specific	  pathogen-­‐free	  conditions	  in	  the	  animal	  facility	  of	  the	  Max	  Planck	  Institute	  of	  Biochemistry.	  All	  mouse	  experiments	  were	  performed	  with	  approval	  by	   the	  District	  Government	  of	  Upper	  Bavaria.	  
LAD-­‐III	  patient	  LAD-­‐III	  patient	  was	  a	  6	  months	  old	  female	  carrier	  of	  a	  homozygous	  nonsense	  mutation	  in	   exon	   13	   of	   the	  KINDLIN-­‐3	   gene	   leading	   to	   a	   premature	   stop	   codon	   at	   the	   position	  coding	   for	   amino	  acid	  529	   and	   loss	  of	   protein	   expression	   (Schulz	   et	   al.,	  manuscript	   in	  preparation).	  All	  tests	  were	  performed	  after	  obtaining	  a	  signed	  informed	  consent	  form	  from	  the	  parents.	  
Flow	  cytometry	  For	  FACS	  analysis	  MNCs	  from	  BM	  (2x	  femur,	  2x	  tibia,	  2x	  pelvis,	  2x	  humerus),	  PB	  or	  Spl	  were	   isolated,	   immunostained	   according	   to	   standard	   procedures	   and	   analyzed	   with	   a	  FACSCalibur	   or	   FACSCantoII	   or	   sorted	   for	   subpopulations	   with	   a	   FACSAriaII	   (BD	  Biosciences).	   HSPC	   subpopulations	  were	   gated	   as	   shown	   in	   Figure	   3C.	   Antibodies	   are	  described	  in	  the	  extended	  experimental	  procedures.	  
Short-­‐term	  homing	  assay	  FACS-­‐sorted	  LSK	   cells	  were	   stained	  with	   cell	   tracker	  CMTMR.	   Short-­‐term	  homing	  was	  assessed	  directly	  after	  injection	  to	  the	  right	  external	  carotid	  artery	  or	  18	  h	  after	  tail	  vein	  injection	  using	  2-­‐photon	  intravital	  microscopy	  (LaVision	  BioTec)	  or	  flow	  cytometry.	  
In	  vitro	  flow	  chamber	  assay	  Microflow	  chambers	  were	  prepared	  as	  previously	  described	   (Frommhold	  et	  al.,	  2008),	  see	  Extended	  Experimental	  Procedures.	  Cells	  were	  perfused	  through	  coated	  capillaries	  for	   12	  min	   under	   shear	   (shear	   stress	   1	  dyne/cm2).	   After	   washing	   and	   fixation	   of	  adherent	  cells	  with	  Türks	  solution	  for	  80	  s,	  adherent	  cells	  were	  quantified	  using	  a	  ZEISS	  Axioskop40	  microscope	  (Zeiss).	  
BM	  and	  PB	  transplantation	  For	  noncompetitive	  serial	  transplantation,	  WBM	  cells	  were	  isolated	  from	  1	  mouse	  of	  the	  previous	   generation	   and	   5x106	   cells	   were	   intravenously	   injected	   each	   into	   5	   lethally	  irradiated	  congenic	  B6.SJL	  wt	  recipients.	  After	  10-­‐12	  weeks	  transplantation	  to	  the	  next	  generation	   recipients	   was	   performed	   using	   the	   same	   conditions.	   For	   competitive	   BM	  HSC	   transplantations	   1000	   FACS-­‐sorted	   BM	   LSK	  CD150+	   cells	   from	   K3+/+	   or	   K3-­‐/-­‐	  chimeras	   or	   450	   FACS-­‐sorted	   BM	   LSK	  CD150+	   cells	   from	   K3+/+	   or	   K3-­‐/-­‐	  mix-­‐chimeras	  together	  with	  5x106	  whole	  Spl	  competitor	  cells	  were	  injected	  to	  the	  tail	  vein	  of	  lethally	  irradiated	  F1	  wt	  recipients.	  The	  percentage	  of	  donor-­‐derived	  cells	  in	  the	  PB	  or	  BM	  and	  Spl	   of	   recipient	   mice	   was	   analyzed	   by	   FACS	   at	   time	   points	   after	   transplantation	   as	  indicated	  in	  the	  figures.	  For	  competitive	  PB	  transplantation,	  3x106	  PB	  MNCs	  were	  mixed	  with	  4x106	  host-­‐type	  whole	  Spl	   cells	   and	   injected	   to	   the	   tail	   vein	  of	   lethally	   irradiated	  congenic	  B6.SJL	  wt	  recipients.	  Percentage	  of	  donor-­‐derived	  lymphoid	  and	  myeloid	  cells	  in	  the	  PB	  of	  recipient	  mice	  was	  analyzed	  5,	  8,	  12	  and	  16	  weeks	  after	  transplantation.	  In	  all	  transplantation	  experiments	  recipient	  mice	  received	  a	  total	  body	  irradiation	  of	  13.5	  Gy	  (7.5	  Gy	  and	  6	  Gy	  4	  h	  apart).	  
Administration	  of	  5-­‐FU	  For	   the	   polyI:C	   (GE	   Healthcare)	   and	   5-­‐Fluorouracil	   (5-­‐FU;	   Sigma-­‐Aldrich)	   double	  treatment,	   polyI:C	   (10	  mg/kg)	   and	   5-­‐FU	   (150	  mg/kg)	   were	   injected	   intraperitoneally	  into	  BM	  chimeras	  (3-­‐4	  months	  after	  transplantation).	  For	  weekly	  5-­‐FU	  treatment,	  5-­‐FU	  was	   injected	   intraperitoneally	   at	   dose	   of	   150	   mg/kg	   for	   first	   two	   injections	   and	  100	  mg/kg	   for	   the	   following	   injections.	   In	   both	   experiments	   survival	   was	   monitored	  daily.	  
Statistical	  analysis	  Unless	  otherwise	  noted,	   all	   values	  are	   reported	   as	  mean	  ±SD.	  Statistical	   tests	  used	   for	  each	  experiment	  are	  described	  in	  the	  figure	  legends.	  Statistical	  significance	  was	  assumed	  at	   p	   <	   0.05.	   Statistical	   analyses	   were	   performed	   using	   Prism	   software	   (GraphPad	  Software)	  or	  MedCalc	  software	  (MedCalc	  Software).	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FIGURE	  LEGENDS	  
Figure	  1:	  Survival	  of	  K3-­‐/-­‐	  chimeras	  and	  distribution	  of	  K3-­‐/-­‐	  HSPCs	  (A)	   Kaplan-­‐Meier	   survival	   curve	   of	   1st	   generation	   K3+/+	   and	   K3-­‐/-­‐	   FL	   chimeras	  (***p<0.0001	  by	  log-­‐rank	  test),	  n=41-­‐47	  per	  genotype.	  (B)	   Total	   number	   of	   MNCs	   from	   BM	   (2x	   femur,	   2x	   tibia,	   2x	   pelvis,	   2x	   humerus)	   and	  whole	   Spl.	   K3+/+	   chimeras	   are	   compared	   with	   healthy	   and	   moribund	   K3-­‐/-­‐	   chimeras	  (***p<	   0.0001	   by	   Kruskal-­‐Wallis	   test	   ???? ??????? ????????? ??????????? ????-­‐test),	  n=10-­‐15	  per	  group.	  Data	  are	  mean	  cell	  counts	  ±SD.	  (C)	  Total	  number	  of	  B	  cells	  (B220+),	  T	  cells	  (CD3e+),	  erythroid	  cells	  (Erythro;	  Ter119+),	  neutrophils	   (Neutro;	   Gr-­‐1hiMac-­‐1+)	   and	   monocyets/macrophages	   (Mono/Macro;	  Gr-­‐1intMac-­‐1+)	   in	   the	   BM	   of	   K3+/+,	   healthy	   and	   moribund	   K3-­‐/-­‐	   chimeras.	   Data	   are	  presented	  as	  box-­‐and-­‐whisker	  plots.	  The	  horizontal	  lines	  inside	  the	  boxes	  represent	  the	  median,	   the	  box	  edges	   show	   the	   lower	  and	  upper	  quartiles,	   and	   the	  whiskers	   indicate	  the	  minimum	  and	  maximum	  (*p<0.05,	  **p<0.01,	  ***p<0001	  by	  Kruskal?Wallis	  test	  and	  
??????? ???????????????????????-­‐test).	  n=10-­‐15	  per	  genotype.	  
Figure	  2:	  BM	  homing	  of	  K3-­‐/-­‐	  LSK	  cells	  (A)	  Short-­‐term	  homing	  assay	  with	   labeled	  BM	  LSK	  cells	   from	  K3+/+	  and	  K3-­‐/-­‐	   chimeras	  quantified	  by	  FACS.	  Shown	  are	  mean	  percentages	  of	  injected	  cells	  in	  BM	  after	  18	  h	  ±SD	  (**p=0.0046	  by	  unpaired	  t-­‐test),	  n=5-­‐6	  per	  genotype.	  (B)	  Quantification	  of	  extravasated	  K3+/+	  and	  K3-­‐/-­‐	  LSK	  cells	  in	  BM	  by	  intravital	  2-­‐photon	  microscopy	  18	  h	  after	  transplantation,	  given	  as	  mean	  value	  ±SD	  of	  the	  absolute	  number	  of	   transmigrated	  cells	  per	  1x105	   injected	  LSK	  cells	  (*p=0.0159	  by	  Mann-­‐Whitney	  test),	  n=4-­‐5	  per	  genotype.	  (C)	   Representative	   images	   illustrating	   transmigration	   of	   K3+/+	   (upper	   panels)	   and	  K3-­‐/-­‐	  LSK	  cells	  (lower	  panels)	  up	  to	  6	  h	  after	  injection	  in	  Col2.3-­‐GFP	  recipients.	  LSK	  cells,	  white	   (CMTMR);	   bone,	   blue	   (second	  harmonic	   signal);	   blood,	   red	   (Q-­‐Tracker	   695	  nm).	  Arrowheads	  indicate	  LSK	  cells	  transmigrating	  across	  endothelium	  (white	  dashed	  lines),	  left	  colum	  before	  and	  right	  colum	  after	  transmigration.	  Scale	  bars	  are	  100	  µm.	  (D)	  LSK	  cells	  of	  either	  genotype	  were	  visualized	  in	  BM	  microvessels	   for	  up	  to	  6	  h	  after	  injection.	  The	  numbers	  of	  adherent	  LSK	  cells	  are	  shown	  as	  percentage	  (mean	  ±SD)	  of	  all	  LSK	  cells	  visualized.	  (***p=0.0006	  by	  unpaired	  t-­‐test),	  n=5	  per	  genotype.	  (E)	  Firm	  adherent	  cells	  shown	  in	  (D)	  grouped	  according	  to	  their	  residence	  time	  on	  the	  BM	  endothelium	  shown	  as	  frequencies	  ±SEM	  of	  the	  absolute	  number	  of	  visualized	  cells	  
(***p<0.0001	  for	  <	  1	  min,	  **p=0.0037	  for	  >1	  min,	  ***p=0.0008	  for	  >10	  min,	  by	  Fisher´s	  test).	  (F)	   Representative	   images	   of	   adherent	   K3+/+	   (upper	   panels)	   and	   K3?/?	   (lower	   panels)	  LSK	   cells	   at	   indicated	   time	   points	   after	   transfer	   (upper	   right	   corner).	   LSK	   cells,	   red	  (CMTMR);	   bone,	   blue	   (second	   harmonic	   signal);	   blood,	   green	   (FITC-­‐dextran).	   Arrows,	  arrowheads	  and	  asterisk	   indicate	  different	   single	  LSK	  cells;	  white	  dashed	   line	  outlines	  endothelium;	  Scale	  bars	  indicate	  100	  µm.	  (G)	   Adhesion	   analysis	   of	   sorted	   K3+/+,	   K3-­‐/-­‐	   and	   K3+/+	   BM	   LSK	   cells	   under	   shear	   in	  microflow	  chambers	  and	  preincubated	  with	  an	  anti-­‐??	  integrin	  blocking	  mAb.	  Microflow	  chambers	   were	   precoated	   with:	   rmE-­‐selectin	   ???	   alone;	   rmE-­‐selectin	   and	   VCAM-­‐1	   or	  rmE-­‐selectin,	   CXCL12	  and	  VCAM-­‐1.	   Scale	   bars	   represent	  mean	  percentage	  of	   adherent	  cells	   to	   total	   LSK	   cells	   ±SEM	   (*p<0.05,	   **p<0.01	   by	   Kruskal???????? ????? ???? ???????multiple	  comparison	  post-­‐test),	  ??4	  per	  group.	  
Figure	  3:	  Kindlin-­‐3	  deficient	  HSCs	  home	  to	  the	  BM	  (A)	  Frequency	  of	   CFU-­‐Cs	   in	   sorted	  CD45.2+	  BM	  cells	   isolated	   from	  chimeras	  4	  months	  after	   transplantation	   (p=0.8857	   by	  Mann-­‐Whitney	   test).	   n=4	   per	   genotype.	   Scale	   bars	  show	  average	  cell	  counts	  ±SD.	  	  (B)	  LTC-­‐IC	  assay	  performed	  by	  limiting	  dilutions	  of	  donor	  derived	  BM	  MNCs	  from	  K3+/+	  and	  K3-­‐/-­‐	   FL	   chimeras	  4	  months	  after	   transplantation.	  The	  percentage	  of	  wells	   in	  each	  experimental	   group	   that	   failed	   to	   generate	   colony-­‐forming	   units	   is	   plotted	   against	   the	  number	  of	  test	  MNCs	  cells.	  The	  frequency	  of	  LTC-­‐ICs	  is	  shown	  at	  the	  bottom.	  (p=0.0965	  by	  Person	  chi-­‐squared	  test),	  n=	  4	  per	  genotype.	  (C)	   Representative	   FACS	   plots	   of	   BM	   cells	   derived	   from	   chimeras	   1-­‐13	   months	   after	  transplantation	  gated	  for	  HSPCs	  using	  SLAM	  markers.	  The	   left	  column	  shows	  c-­‐kit	  and	  Sca-­‐1	   expression	   on	   lin-­‐	   cells.	   Gating	   from	   left	   to	   right	   on	   LSK	   cells,	   LSK	  CD150+CD48-­‐	  cells	   and	   the	   CD34-­‐	   or	   CD34+	   subsets	   of	   this	   population,	   respectively.	  Numbers	   above	  each	   boxed	   gate	   refer	   to	   the	   frequencies	   in	   BM	   (percentages	   of	   live	   leukocytes	   ±SD),	  n=24-­‐27	  per	  genotype.	  (D)	   Quantification	   of	   (C).	   LSK	  CD150-­‐CD48+	   (*p=0.0121	   by	   unpaired	   t-­‐test);	  LSK	  CD150+CD48+	  (***p<0.0001	  by	  unpaired	  t-­‐test);	  LSK	  CD150+CD48-­‐	  (***p<0.0001	  by	  Mann-­‐Whitney	   test);	   LSK	  CD150+CD48-­‐CD34+	   (***p=0.0003	   by	   unpaired	   t-­‐test)	   and	  LSK	  CD150+CD48-­‐CD34-­‐	   (***p<0.0001	  by	  Mann-­‐Whitney	   test)	   cells.	  Mean	  cell	  numbers	  ±SD	  are	  given.	  n=24-­‐27	  per	  genotype.	  
(E)	  Representative	  FACS	  plots	  of	  BM	  LSK	  cells	  from	  K3+/+	  and	  K3-­‐/-­‐	  chimeras,	  gated	  for	  CD150	  against	  CD48.	  FACS	  plots	   show	   the	  distribution	  of	   3	  populations,	  CD150+CD48-­‐	  cells	  (upper	  left	  gate);	  CD150-­‐CD48+	  cells	  (upper	  right	  gate);	  CD150+CD48-­‐	  cells	  (lower	  gate)	  1,	  2,	  4	  and	  9-­‐13	  months	  after	  transplantation.	  Numbers	  next	  to	  each	  gate	  represent	  mean	   percentage	   ±SD	   of	   events	  within	   the	   LSK	   population,	   n=3-­‐11	   per	   genotype	   and	  time	  point.	  (F)	   Quantification	   of	   BM	   LSK	  CD150+CD48-­‐	   cells	   from	   K3+/+	   and	   K3-­‐/-­‐	   chimeras.	  Compared	   are	   the	   K3+/+	   and	   K3-­‐/-­‐	   mean	   cell	   counts	   ±SD	   1,	   4	   and	   9-­‐13	   months	   after	  transplantation	   (1	   month:	   p=0.4	   by	   Mann-­‐Whitney	   test;	   4	   months:	   ***p<0.0001;	   by	  unpaired	  t-­‐test;	  9-­‐13	  months:	  ***p=0.0001	  by	  unpaired	  t-­‐test).	  n=3-­‐8	  per	  genotype.	  (G)	   Quantification	   of	   BM	   CD150+CD48-­‐CD34-­‐	   cells	   from	   K3+/+	   and	   K3-­‐/-­‐	   FL	   chimeras.	  Compared	   are	   the	   K3+/+	   and	   K3-­‐/-­‐	   mean	   cell	   counts	   ±SD	   1,	   4	   and	   9-­‐13	   months	   after	  transplantation	   (1	   month:	   p=0.2	   by	   Mann-­‐Whitney	   test;	   4	   months:	   ***p=0.0005	   by	  unpaired	  t-­‐test;	  9-­‐13	  months:	  **p=0.002	  by	  unpaired	  t-­‐test).	  n=3-­‐9	  per	  genotype.	  
Figure	  4:	  K3-­‐/-­‐	  HSC	  remain	  hyperactive	  and	  accumulate	  in	  the	  PB	  (A-­‐B)	  Poly(I:C)	  and	  5-­‐FU	  double	  treatment	  of	  K3+/+	  and	  K3-­‐/-­‐	  chimeras.	   (A)	  Diagram	  of	  tested	  drug	  combinations	  and	  timing.	  (B)	  Kaplan-­‐Meier	  survival	  curves	  of	  experimental	  groups	   indicated	   in	   (A)	   (***p<0.0001	  by	   log-­‐rank	   test),	   n=16-­‐22	   per	   treatment	   group.	  Data	  are	  combined	  from	  5	  independent	  experiments.	  (C)	  In	  vivo	  BrdU	  uptake	  assay.	  Mean	  percentage	  ±SD	  of	  BrdU+	  cells	  determined	  by	  FACS	  in	   LK	   cells	   (p=0.4078	   by	   unpaired	   t-­‐test),	   LSK	   cells	   (***p=0.0009	   by	   unpaired	   t-­‐test),	  LSK	  CD150+CD48-­‐	   (**p=0.0014	   by	   Mann-­‐Whitney	   test)	   and	   LSK	  CD150+CD34-­‐	  (***p=0.0004	  by	  Mann-­‐Whitney	  test)	  cells.	  (D)	  Representative	  FACS	  plots	  of	  a	  cell	  cycle	  analysis	  of	  BM	  LSK	  cells.	  Cells	  were	  stained	  with	   DAPI	   and	   intracellular	   (ic)	   Ki67	   and	   analyzed	   by	   FACS.	   The	   different	   cell	   cycle	  phases	  are	  indicated	  in	  the	  scheme	  above.	  (E)	  Quantification	  of	  (D).	  Percentage	  of	  icKi67+	  BM	  LSK	  cells	  (G1	  +	  S	  +	  G2/M	  phase	  cells),	  obtained	   by	   FACS.	   Horizontal	   bars	   indicate	   mean	   values	   ±SD	   (**p=0.0022	   by	   paired	  t-­‐test).	  n=18	  per	  genotype.	  (F)	  Relative	  expression	  of	  p21,	  p27	  and	  p57	  mRNA	  in	  sorted	  CD150+	  LSK	  cells,	  analyzed	  by	  qPCR.	  Data	   are	  normalized	   for	  gapdh	   expression	   and	  presented	  as	  mean	  ±SD	   from	  individual	  mice.	  n=6-­‐7	  per	  genotype	  (***p=0.0007	  by	  unpaired	  t-­‐test).	  (G-­‐H)	   LRC-­‐assay.	   (G)	   Percentage	   of	   BrdU+	   cells	   (LRCsBrdU)	   present	   in	   the	   indicated	  
populations	   after	   16	   days	   of	   labeling,	   obtained	   by	   FACS.	   (H)	  Mean	   percentage	   ±SD	   of	  LRCsBrdU	   in	   the	   indicated	   populations	   after	   45	   days	   of	   chase	   phase.	   Total	   LSK	   cells	  (***p<0.0001);	   LSK	  CD150-­‐CD48+	   (***p<0.0001);	   LSK	  CD150+CD48+	   (***p=0.0006);	  LSK	  CD150+CD48-­‐	  (**p=0.0014);	  LSK	  CD150+CD34-­‐	  (*p=0.0350)	  LSK	  cells	  were	  analyzed	  by	  unpaired	  t-­‐test,	  n=7-­‐8	  per	  genotype.	  (I)	  Representative	  FACS	  plots	  showing	  the	  expression	  of	  c-­‐kit	  and	  Sca-­‐1	  on	  lin-­‐	  cells	  from	  Spl	  and	  PB.	  The	   frequencies	  of	  LK	  (orange	  box)	  and	  LSK	  cells	   (green	  box)	  are	  marked	  above	  plots	  (percentages	  of	  live	  leukocytes	  ±SD).	  n=24-­‐26	  per	  genotype.	  (J)	  Quantification	  of	  LK	  and	  LSK	  cells	  in	  Spl	  and	  in	  PB	  analyzed	  by	  FACS.	  Scale	  bars	  show	  mean	   cell	   counts	   ±SD	   (***p<0.0001;	   **p=0.0031	   by	  Mann-­‐Whitney	   test).	   n=25-­‐26	   per	  genotype.	  (K-­‐N)	   Multi-­‐lineage	   engraftment	   potential	   of	   PB	   cells	   isolated	   from	   K3+/+	   and	  K3-­‐/-­‐	  chimeras.	   Percentage	   donor-­‐derived	  whole	   leukocytes	   (CD45+)	   (K),	  myeloid	   cells	  (Gr-­‐1+,	   Mac-­‐1+,	   and	   Gr-­‐1+Mac-­‐1+)	   (L),	   B	   cells	   (B220+)	   (M),	   or	   T	   cells	   (CD3e+)	   (N)	   are	  shown	   from	   PB	   5,	   8,	   12	   and	   16	   weeks	   after	   transplantation.	   Data	   are	   plotted	   for	  individual	   recipients	   n=5	   for	   K3+/+	   (blue	   lines)	   and	   n=19	   for	   K3-­‐/-­‐	   (red	   lines)	   from	   3	  independent	   transplantation	   experiments.	   Significant	   differences	   in	   average	   lineage	  engraftment	   16	   weeks	   post	   transplantation	   are	   indicated	   (leukocytes:	   *p=0.0157,	  myeloid	   cells:	   **p=0.0085,	   B	   cells:	   **p=0.0028,	   T	   cells:	   **p=0.0008	   by	   Mann-­‐Whitney	  test).	  (O)	  Mobilization	  of	  LSK	  cells	  from	  K3+/+	  and	  K3-­‐/-­‐	  chimeras	  to	  the	  PB,	  shown	  as	  LSK	  cells	  per	  ml	  blood	  after	  G-­‐CSF	  or	  PBS	  treatment.	  Significance	  at	  day	  6	  is	   indicated	  (K3+/+	  vs.	  K3-­‐/-­‐	  with	  G-­‐CSF:	  ***p<0.0001,	  K3+/+	  vs.	  K3-­‐/-­‐	  with	  PBS:	  **p=0.0049	  by	  unpaired	  t-­‐test).	  n=3-­‐5	  per	  genotype.	  
Figure	  5:	  Premature	  exhaustion	  of	  K3-­‐/-­‐	  HSCs	  under	  hematopoietic	  stress	  (A)	  Analysis	  of	  radioprotection	  by	  donor	  K3+/+	  und	  K3-­‐/-­‐	  WBM	  cells	  in	  3	  rounds	  of	  serial	  BM	  transplantations.	  Kaplan-­‐Meier	  survival	  curve	  of	   the	  2nd	   generation,	  3rd	  generation	  and	   4th	   generation	   recipients	   are	   shown.	   Results	   are	   combined	   from	   9	   independent	  transplantation	  experiments.	  n=42-­‐55	  recipients	  per	  genotype	  (***p<0.0001	  by	  log-­‐rank	  test).	  (B)	   Blood	   cell	   counts	   of	   the	   2nd	   generation	   recipients	   transplanted	   with	   1000	   BM	  LSK	  CD150+	   cells	   sorted	   from	  K3+/+	   or	   K3-­‐/-­‐	   chimeras	  with	   5x106	   host-­‐type	  whole	   Spl	  cells.	   Percentages	   of	   donor-­‐derived	   whole	   leukocytes	   (CD45+),	   myeloid	   cells	   (Gr-­‐1+,	  
Mac-­‐1+,	  and	  Gr-­‐1+Mac-­‐1+),	  B	  cells	  (B220+),	  or	  T	  cells	  (CD3e+)	  in	  PB	  5	  and	  11	  weeks	  post	  transplantation	   are	   shown.	   Scale	   bars	   show	   the	   mean	   percent	   ±SD	   (***p<0.0001	   by	  Mann-­‐Whitney	  test).	  n=23-­‐28	  from	  4-­‐5	  independent	  experiments.	  (C)	   Percentage	   of	   donor-­‐derived	   HSPCs	   in	   BM	   of	   2nd	   generation	   recipients	   after	  11	  weeks,	  obtained	  by	  FACS.	  Horizontal	  bars	  indicate	  mean	  values	  ±SD	  (***p<0.0001	  by	  Mann-­‐Whitney	  test).	  n=23-­‐28	  from	  4-­‐5	  independent	  experiments.	  (D)	   Kaplan-­‐Meier	   survival	   curve	   showing	   response	   of	   K3fl/flRosa26Cre-­‐ERT2	   (n=10)	   and	  control	  mice	  to	  a	  sequential	  5-­‐FU	  treatment.	  Mice	  were	   treated	  with	  5-­‐FU	  weekly,	  and	  survival	  was	  monitored	  daily.	  Kindlin-­‐3	  gene	  deletion	  was	  induced	  by	  administration	  of	  tamoxifen	   (TAM)	   3	  months	   after	   transplantation	   and	   5	  weeks	   before	   5-­‐FU	   treatment.	  The	  control	  group	  contained	  K3fl/flRosa26Cre-­‐ERT2	  (w/o	  TAM	  n=7),	  wtRosa26Cre-­‐ERT2	  (with	  TAM	   n=6	   or	   w/o	   TAM	   n=5)	   and	   K3fl/fl	   (with	   TAM	   n=2	   or	   w/o	   TAM	   n=2)	   mice,	  (***p<0.0001	  by	  log-­‐rank	  test).	  
Figure	  6:	  Defects	  in	  K3-­‐/-­‐	  HSCs	  are	  cell	  autonomous	  	  (A)	  Representative	  FACS	  plots	  of	  PB	  from	  K3+/+	  and	  K3-­‐/-­‐	  mix-­‐chimeras	  4	  months	  after	  transplantation.	  Upper	  row	  shows	  whole	  leukocytes	  gated	  for	  CD45.2	  against	  CD45.1.	  In	  lower	  row	  lin-­‐	  cells	  of	  CD45.2+	  and	  CD45.1+	  populations	  are	  gated	  for	  c-­‐kit	  against	  Sca-­‐1.	  Gates	  for	  LK	  (right)	  and	  LSK	  cells	  (left)	  are	  shown.	  Numbers	  next	  to	  the	  gates	  represent	  the	   overall	   frequencies	   (percent	   of	   live	   PB	   leukocytes)	   ±SD	   from	   events	   in	   each	   gate,	  n=6-­‐8	  per	  genotype.	  	  (B)	  G-­‐CSF	  induced	  mobilization	  of	  BM	  LSK	  cells	  from	  K3+/+	  and	  K3-­‐/-­‐	  mix-­‐chimeras.	  MNCs	  from	  PB	  were	  analyzed	  by	  FACS	  for	  LSK	  cells.	  Histogram	  shows	  the	  mean	  number	  of	  LSK	  cells	  per	  ml	  PB	  ±SD.	  (**p<0.01	  and	  ***p<0.001	  by	  one-­‐??????????????????????????????multiple	  comparison	  test).	  (C-­‐D)	   LRC	   assay	   in	   K3+/+	   and	   K3-­‐/-­‐	   mix-­‐chimeras.	   (C)	   Percentage	   of	   LRCsBrdU	   in	  indicated	  populations	  after	  18	  days	  of	   labeling	  determined	  by	  FACS.	   (D)	  Percentage	  of	  LRCsBrdU	   in	   indicated	   populations	   after	   45-­‐50	   days	   of	   chase	   phase.	   Total	   LSK	  (**p=0.0073);	   LSK	  CD150-­‐CD48+	   (*p=0.0309);	   LSK	  CD150+CD48-­‐	   (**p=0.0017);	  LSK	  CD150+CD34-­‐	   (ns:	  p=0.0583)	   cells	   by	   paired	   t-­‐test.	   Scale	   bars	   show	   mean	  percentage	  ±SD,	  n=	  4	  per	  genotype.	  (E)	   5-­‐FU	   treatment	   (day	   0	   and	   7)	   of	   K3+/+	   and	  K3-­‐/-­‐	  mix-­‐chimeras.	   LSK	   cells	   from	  BM	  analyzed	  by	  FACS	  for	  percentage	  of	  CD45.1+	  and	  CD45.2+	  cells	  before	  and	  45	  days	  after	  first	   5-­‐FU	   injection.	   Histogram	   shows	   the	   mean	   percentage	   ±SD	   (***p<0.0001	   by	  
unpaired	  t-­‐test).	  n=9	  per	  genotype	  in	  2	  independent	  experiments.	  (F-­‐I)	   Results	   of	   a	   competitive	   repopulation	   assay	   with	   BM	   LSK	  CD150+CD45.2+	   cells	  FACS-­‐sorted	   from	   K3+/+	   and	   K3-­‐/-­‐	   mix-­‐chimeras.	   Each	   recipient	   received	   450	  LSK	  CD150+CD45.2+	   cells	   together	   with	   5x106	   host-­‐type	   whole	   Spl	   cells.	   Percent	  donor-­‐derived	   whole	   leukocytes	   (CD45+)	   (F),	   myeloid	   cells	   (Gr-­‐1+,	   Mac-­‐1+,	   and	  Gr-­‐1+Mac-­‐1+)	  (G),	  B	  cells	  (B220+)	  (H),	  or	  T	  cells	  (CD3e+)	  (I)	  from	  PB	  4,	  8	  and	  12	  weeks	  post	   transplantation	   are	   shown.	   Data	   are	   plotted	   for	   individual	   recipients	   K3+/+	   (blue	  solid	   lines)	  and	  K3-­‐/-­‐	   (red	   lines).	  Significant	  differences	   in	  average	   lineage	  engraftment	  are	   indicated	   (4	  weeks	   post	   transplantation:	   leukocytes	   (ns,	   p=0.8707)	   by	   unpaired	  t-­‐test;	   myeloid	   cells	   (**p=0.0093),	   B	   cells	   (*p=0.0337),	   T	   cells	   (**p=0.0074)	   by	  Mann-­‐Whitney	   test;	   8	   and	   12	  weeks	   post	   transplantation:	   leukocytes:	   ***p<0.0001	   by	  unpaired	  t-­‐test;	  myeloid,	  B	  and	  T	  cells:	  ***p<0.0001	  (or	  p=0.0006	  for	  myeloid	  cells	  after	  8	  weeks)	  by	  Mann-­‐Whitney	  test).	  n=14-­‐17	  from	  4	  independent	  experiments.	  (J)	  Percentage	  of	  donor-­‐derived	  HSPCs	  in	  BM	  of	  2nd	  generation	  recipients	  after	  12	  weeks	  obtained	   by	   FACS.	   Horizontal	   bars	   indicate	   mean	   values	   ±SD	   (***p<0.0001	   by	  Mann-­‐Whitney	  test).	  n=14-­‐17	  from	  4	  independent	  experiments.	  
Figure	   7:	   Kindlin-­‐3	   mediated	   activation	   of	   integrins	   is	   essential	   for	   activated	  
rather	  than	  quiescent	  HSCs	  (A-­‐D)	   Comparisons	   of	   the	   percentage	   of	   donor-­‐derived	   cells	   in	   the	   LK	   (A),	  LSK	  CD150-­‐CD48+	   (B),	   LSK	  CD150+CD48-­‐	   (C)	   and	   LSK	  CD150+CD48-­‐CD34-­‐	   (D)	  populations	  in	  the	  BM	  from	  K3+/+	  and	  K3-­‐/-­‐	  fetal	  liver	  mix-­‐chimeras	  1,	  3-­‐4	  and	  12	  months	  post	   transplantation.	   Significances	   between	  K3+/+	   and	  K-­‐/-­‐	  mix-­‐chimeras	   are	   indicated.	  Dots	  show	  the	  mean	  percentage	  ±SD	  (***p<0.001;	  ns,	  p>0,05	  by	  either	  unpaired	  t-­‐test	  or	  Mann-­‐Whitney	  test).	  n=4-­‐11	  per	  genotype	  and	  time	  point.	  (E)	  Comparisons	  of	  the	  percentage	  of	  donor-­‐derived	  cells	  in	  the	  indicated	  populations	  in	  the	  BM	   from	  K3+/+	   and	  K3-­‐/-­‐	   fetal	   liver	  mix-­‐chimeras	  3-­‐4	  months	  post	   transplantation.	  Histogram	   shows	   the	  mean	   percentage	   ±SD.	   (ns,	   p<0,05,	   **p<0.01	   and	   ***p<0.001	   by	  Repeated	  Measures	  ???????????????????????????????????????????????????.	  n=5-­‐11	  per	  genotype.	  (F-­‐I)	   Comparisons	   of	   the	   percentage	   of	   donor-­‐derived	   cells	   in	   the	   LK	   (F),	  LSK	  CD150-­‐CD48+	   (G),	   LSK	  CD150+CD48-­‐	   (H)	   and	   LSK	  CD150+CD48-­‐CD34-­‐	   (I)	  populations	   in	   the	   BM	   from	   wt-­‐Rosa26Cre-­‐ERT2	   (blue)	   and	   K3fl/flRosa26Cre-­‐ERT2	   (red)	  mix-­‐chimeras	   untreated	   (Ctrl.)	   or	   after	   treatments	   with	   tamoxifen	   (TAM	   PBS)	   or	  
tamoxifen	  and	  5-­‐FU	  (TAM	  5-­‐FU).	  Recipients	  were	  treated	  with	  tamoxifen	  3	  months	  after	  transplantation	  and	  5	  weeks	  before	  weekly	  5-­‐FU	  treatment.	  Histogram	  shows	  the	  mean	  percentage	   ±SD.	   (ns	   p>0,05,	   **p<0.01	   and	   ***p<0.001	   by	   either	   unpaired	   t-­‐test	   or	  Mann-­‐Whitney	  test).	  n=4-­‐6	  per	  genotype	  and	  treatment.	  (J)	  9EG7	  binding	  on	  BM	  LSK	  CD150-­‐CD48+	  and	  LSK	  CD150+CD48-­‐	  cells	  from	  100%	  K3+/+	  and	  K3-­‐/-­‐	  chimeras.	  Shown	  is	  the	  relative	  9EG7	  MFI	  (Geom	  mean	  FI).	  Error	  bars	  indicate	  +SD.	  (**p<0.01	  by	  paired	  t-­‐test).	  n=3	  per	  genotype.	  (K)	   Kaplan-­‐Meier	   survival	   curve	   of	   lethally	   irradiated	   recipients	   transplanted	   with	  1.5x104	   K3+/+	   or	   K3-­‐/-­‐	   LSK	   cells	   transduced	   with	   lentiviral	   expression	   constructs	   as	  indicated	   together	  with	  8.8x105	  WBM	  cells	   from	  a	  K3-­‐/-­‐	  100%	  chimera.	  n=5	   recipients	  per	  group.	  (L)	  FACS	  plots	  of	  PB	   from	  an	  LAD-­‐III	  patient	  (lower	  row)	  and	  a	  healthy	  child	  with	   the	  same	  age	  as	  control	  (upper	  row).	  Shown	  are	  MNC	  gated	  for	  CD34	  against	  CD45	  (left)	  and	  CD38	  against	  CD34	  (right).	  (M)	  CFU	  assay	  with	  blood	  MNC	  containing	  100	  CD34+	  cells	  (calculated	  according	  to	  the	  FACS	  frequencies)	  from	  an	  LAD-­‐III	  patient	  and	  healthy	  child.	  Shown	  are	  the	  numbers	  of	  colonies	   per	   blood	   MNC	   containing	   100	   CD34+	   cells.	   Two	   types	   of	   colonies	   were	  distinguished.	   BFU-­‐E	   (burst	   forming	   unit-­‐erythroid);	   CFU-­‐GM	   (colony	   forming	  unit-­‐granulocyte/macrophage).	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ABSTRACT 
Integrin-mediated activation of small GTPases polymerizes g-Actin into different Actin structures. Here 
we report that the g-Actin pools correlated with low nuclear MAL levels and MAL/SRF activities in αV 
single, intermediate in β1 single and high in αV,β1 double expressing cells. Integrin-mediated activation 
of MAL/SRF induced expression of the ubiquitin-like modifier interferon-stimulated gene 15 (ISG15) 
resulting in the ISGylation of integrins, Actin, Focal Adhesion and Actin binding proteins. The increased 
stability and/or activity of these proteins enhanced kidney fibroblast but also human breast cancer cell 
invasion and correlated with poor patient survival. Our findings show that integrin adhesions, MAL/SRF 
and ISG15 constitute a new autoregulatory feed-forward loop that precisely adjusts actin- and adhesion-
based functions required for cell spreading, migration and invasion. 
 
INTRODUCTION 
Integrin-mediated cell adhesion and signalling control numerous cellular processes, which are crucial for 
development, postnatal homeostasis and pathology. Integrin signalling is a multistep process that is 
initiated with integrin activation and ligand binding, followed by integrin clustering and the progressive 
assembly of signalling platforms consisting of adaptor, signalling/catalytic and cytoskeletal proteins. The 
first integrin-induced signalling platforms are small and unstable nascent adhesions (NAs), which 
eventually mature into large focal adhesions (FAs) that are connected to filamentous (f-) Actin. 
Integrin signalling induces both short- and long-term effects. The short-term effects consist of 
cytoskeletal rearrangements that allow cells to adopt their characteristic shape and initiate migration, 
and are caused by the activation of Rho family GTPases and actin-binding proteins (Danen et al., 2002). 
Long-term effects of integrin signalling result from changes in gene expression, which regulate cell 
proliferation and differentiation. Integrin-dependent regulation of gene expression is primarily thought 
to arise from cross talk with growth factor receptors (GFR) that increase the activity of mitogen 
activating protein (MAP) kinase pathways. A recent study, however, reported that β1-class integrins can 
change gene programs of mesenchymal stem cells involved in lineage commitment to bone, fat or 
cartilage by activating Rho GTPase signalling cascades, which result in the nuclear localization of the 
transcriptional co-activators Yes-associated protein (YAP) and transcriptional co-activator with PDZ-
binding motif (TAZ) (Tang et al., 2013). In addition to the control of YAP/TAZ, Rho family GTPases can 
also control gene transcription by releasing the association of the transcriptional co-activator 
Megakaryocyte Acute Leukemia protein (MAL; also known as MRTF-A or MKL1) from monomeric or 
globular (g-) Actin. Once g-Actin is assembled into Actin networks, free MAL translocates into the 
nucleus, where it associates with and activates the transcription factor Serum Response Factor (SRF), 
which regulates the expression of cytoskeletal proteins including Actin and Focal Adhesion proteins. 
Thus it is possible that integrin-mediated activation of Rho GTPases regulates cytoskeletal dynamics but 
also adhesion through effector proteins and the control of MAL`s nucleo-cytoplasmic shuttling in order 
to initiate target gene transcription. 
To test this hypothesis we investigated whether and which integrins regulate MAL/SRF-mediated gene 
expression. To achieve this goal, we used recently engineered cell lines that express Fibronectin (FN)-
binding integrins of the αV- (αVβ3, αVβ5) and/or β1-class (α5β1) that allowed us to assign stress fibre 
formation to αV-class integrins and myosin II activation and lamellipodia formation to α5β1 integrin 
(Schiller et al., 2013). We report that αV- and β1-class integrins synergize to regulate expression of 
MAL/SRF target genes. One new MAL/SRF target is the ubiquitn-like modifier Interferon-specific gene 15 
(ISG15), which becomes covalently attached to specific lysine residues of numerous known MAL/SRF 
target gene products including Vinculin, Talin and Eplin. ISG15 modifications are known and thought to 
negatively impact ubiquitination by a) inhibition of ubiquititin-specific E2 enzymes (Malakhova and 
Zhang, 2008; Okumura et al., 2008; Zou et al., 2005) and b) possible occupation of lysine residues also 
used by Ubiquitin through ISGylation . Thus it is possible that ISG15-linked proteins could be protected 
from proteasomal targeting (Liu et al., 2003). Our findings identify a new synergistic activity of 
fibronectin-binding integrins that controls cell invasion by regulating transcription and subsequent 
ISGylation. 
  
RESULTS 
FN bound α5β1 and αV-class integrins control f-Actin and nuclear MAL levels 
We generated immortalized fibroblast cell lines lacking the expression of all integrins (pan-knockouts, 
pKO) and re-expression of β1 and/or αV integrin cDNAs produced cells expressing αV- (pKO-αV), β1- 
(pKO-β1) or αV- and β1-class integrins (pKO-αV,β1) ((Schiller et al., 2013) Fig.S1A). When the three cell 
lines were seeded on FN-coated, circular micropatterns separated by non-adhesive polyethylene glycol, 
pKO-αV cells expressing the FN-binding αVβ3 and αVβ5 integrins preferentially formed large focal 
adhesions (FAs) that were shown with labelled phalloidin to be connected by thick radial stress fibres. In 
contrast, pKO-β1 cells expressing the FN-binding α5β1 integrin preferentially formed small, nascent 
adhesions (NAs), thin stress fibres and a dense subcortical actin network, and pKO-αV,β1 cells developed 
both large FAs and small NAs with thick and thin stress fibres and a dense subcortical actin meshwork 
(Fig.1A, B; Fig.S1A). To visualize non-polymerized Actin in the cytoplasm of the three cell lines, we 
stained the cells with fluorescently labelled DNaseI (Gabbiani et al., 1984; Heacock and Bamburg, 1983; 
Hitchcock, 1980). Surprisingly, we observed that also the cytoplasmic g-Actin pool was highest in pKO-
αV, intermediate in pKO-β1 and lowest in pKO-αV,β1 cells (Fig.1A, 1C). This finding was further 
confirmed by separating the cells into soluble (S, validated with GAPDH), nuclear (N) and cytoskeletal (C, 
validated with Vimentin) fractions and determining their β-Actin contents (Fig.1D). The experiment 
demonstrated that Actin contents in the soluble (representing g-Actin), cytoskeletal (representing f-
Actin) and nuclear fraction as well as the calculated g-/f-Actin ratios were significantly higher in pKO-αV 
cells compared to pKO-β1 and pKO-αV,β1 cells (Fig.1D-F). The increased Actin contents in all fractions of 
pKO-αV cells indicated that the total Actin levels are higher in pKO-αV cells compared to pKO-β1 and 
pKO-αV,β1 cells, which was indeed confirmed by western blotting and immunostaining of cells with anti-
β-Actin antibodies (Fig.S1B). To precisely determine the g-Actin levels in cytoplasm and nucleus, we 
performed precipitation assays with soluble and nuclear fractions using DNaseI coupled to beads and 
found significantly higher g-Actin contents in the cytoplasm and nucleus of pKO-αV compared to pKO-β1 
and pKO-αV,β1 cells (Fig.1G, H). FACS analysis excluded differences in nuclear size in our cell lines as 
cause for the different actin contents (Fig.S1C). 
Next we consulted our published whole cell proteome and phospho-proteome of pKO-αV, pKO-β1 and 
pKO-αV,β1 cells (Schiller et al., 2013) to evaluate whether a differential expression and activity of Actin 
sequestering, polymerizing and depolymerizing proteins either further aggravates or compensates for 
the different amounts of free g-Actin. Our analysis revealed significantly increased levels of Thymosin β4 
(Tβ4) and phosphoSer3-Cofilin in pKO-β1 cells (Fig. S1D-F) indicating that g-Actin is significantly more 
sequestered and f-Actin significantly less severed in pKO-β1 and pKO-αV,β1 cells compared to pKO-αV 
cells. 
The pool of g-Actin regulates nuclear translocation and activity of the transcriptional transactivator MAL, 
whose binding to the transcription factor SRF induces the expression of genes encoding “immediate-
early”, cytoskeletal and focal adhesion proteins. Therefore, the different free g-Actin levels in pKO-αV, 
pKO-β1 and pKO-αV,β1 cells suggested that their nuclear MAL levels should also be different. To test 
this hypothesis, we seeded the three cell lines on FN and immunostained them with specific rabbit 
polyclonal anti-MAL antibodies. The results revealed lowest nuclear MAL levels in pKO-αV, intermediate 
in pKO-β1 and highest in pKO-αV,β1 cells (Fig.1I, S1G). Importantly, treatment with Jasplankinolide, 
which diminishes free g-Actin by stabilizing Actin filaments, increased nuclear MAL in the three cell lines 
(Fig.1I, S1G). Conversely, treatment with Latrunculin A, which increases free g-Actin by disassembling f-
Actin, decreased nuclear MAL in the three cell lines (Fig.1I, S1G). Altogether these results show that FN-
binding integrin classes differentially regulate cellular g-/f-Actin content, which significantly influences 
nuclear levels of MAL. 
αV- and β1-class integrins cooperate to control SRF/MAL activity 
To test functional consequences of the different nuclear MAL contents in the three cell lines, we first 
measured SRF/MAL activity with SRF luciferase reporter assays. Whereas pKO-αV cells showed low SRF 
reporter activity, pKO-β1 cells displayed 4-fold higher and pKO-αV,β1 cells  ~10 fold higher SRF reporter 
activities. Importantly, Jasplankinolide treatment increased SRF activities to a similar extent in all three 
cell lines, while Latrunculin A (which had to be short due to cell lethality) showed as light opposite effect 
(Fig.2A). Treatment with serum (to induce nuclear translocation of MAL) or Leptomycine B (to inhibit 
nuclear export of MAL) increased SRF reporter activities in pKO-β1 and pKO-αV,β1 cells to a much higher 
extent as compared to pKO-αV cells (Fig.S2A, S2B). Expression of a dominant-negative MAL reduced SRF 
reporter activity to basal levels in the three cell lines (Fig.S2C), while overexpression of a g-Actin binding-
deficient MAL (∆N MAL, lacking the N-terminal G-actin binding motif) and a constitutive active mDia 
increased SRF/MAL induced luciferase activities to similar extents in the three cells (Fig.2B). 
To exclude that cell spreading defects (Connelly et al., 2010) caused the reduced nuclear MAL levels and 
SRF/MAL reporter activities in pKO-αV cells, we seeded the three cell lines  on FN-coated circular 
micropatterns with 28μm and 40μm diameters, respectively, and performed SRF reporter assays and 
immunostainings. The results of these experiments revealed that pKO-αV cells displayed similar SRF 
reporter activities and nuclear MAL levels on small and large FN-coated circular micropatterns, while 
pKO-β1 and pKO-αV,β1 cells increased SRF activities and nuclear MAL levels on 40µm sized 
micropatterns compared to 28µm sized micropatterns (Fig.2C-E) indicating that the reduced cell 
spreading of pKO-αV cells is not responsible for the reduced MAL/SRF activity. 
Next we performed experiments aimed at testing whether changes in the expression levels and/or 
activities of FN-binding integrin classes affect SRF reporter activity. First, Mn2+ treatment, which 
increases integrin activities, significantly elevated SRF reporter activity in all three cell lines, most 
prominently in pKO-β1 cells, intermediate in pKO-αV,β1 and lowest in pKO-αV cells (Fig.2F). Second, 
overexpression of αV- or β1-class integrins revealed that elevation of αV in pKO-αV did not change SRF 
activity, whereas elevation of β1 in pKO-β1 cells induced a small, significant increase of SRF activity and 
elevation of β1 in pKO-αV and αV in pKO-β1 cells induced a more prominent increase of SRF activity 
(Fig.2G). Similarly, overexpression of either αV or β1 in pKO-αV,β1 cells also significantly increased 
SRF/MAL activity. Third, pKO-αV,β1 cells were seeded on FN (bound by αV- and β1-class integrins), 
Vitronectin (VN) and Gelatin (both ligands bound by αV-class integrins only), treated with either anti-
α5β1 blocking antibodies or the αV-class specific small molecule inhibitor cilengitide and immunostained 
for MAL and assayed for SRF reporter activity (Fig.2H, 2I). The experiments showed that inhibition of 
α5β1 or αVβ3 Integrins on FN adherent pKO-αV,β1 cells significantly reduced nuclear MAL levels and 
SRF activities and hence phenocopied the pKO-αV cells indicating efficient activation of SRF requires the 
cooperation of both FN-binding integrin classes. Similarly, when pKO-αV,β1 cells were seeded on VN and 
Gelatin, respectively, they showed low nuclear MAL activity, which was not further decreased with the 
inhibition of α5β1 integrin. As expected, treatment of VN- or Gelatin-seeded pKO-αV,β1 cells with 
cilengitide blocked adhesion (Fig.2H). Finally, loss of the integrin activator proteins in FN-adherent 
fibroblasts double deficient for either Kindlin-1 and -2 or Talin-1 and -2 abolished SRF reporter activities 
(Fig.S2D). Altogether these results show that FN-binding integrin classes cooperate to activate SRF/MAL. 
αV- and β1-class integrins induce transcription of SRF/MAL target genes 
The high nuclear MAL content and SRF activity in pKO-αV,β1 cells suggest that MAL/SRF-induced gene 
transcription is controlled, at least in part, by integrins. To test this hypothesis, we compared published 
MAL/SRF transcriptomes (Balza and Misra, 2006; Cooper et al., 2007; Descot et al., 2009; Philippar et al., 
2004; Selvaraj and Prywes, 2004; Sun et al., 2006; Zhang et al., 2005) with the whole cell proteome of 
pKO-αV, pKO-β1 and pKO-αV,β1 cells (Schiller et al., 2013) and found a large number of MAL/SRF target 
genes including SRF and FA proteins such as Filamins, Vinculin, Talin, Eplin and integrins enriched in pKO-
β1 and pKO-αV,β1 cells (Table 1). The increased levels of SRF, Talin, Vinculin and Eplin (Lima1) mRNA 
and protein in pKO-β1 and pKO-αV,β1 cells were confirmed by qRT-PCR and western blotting (Fig.3A, 
3B).  
We also noted that ISG15 mRNA, dramatically down-regulated in SRF-deficient ES cells (Philippar et al., 
2004), was significantly elevated in pKO-αV,β1, intermediate in pKO-β1 cells and  low in pKO-αV cells 
(Fig.3A; Table 1). Western blotting confirmed high ISG15 levels in pKO-αV,β1, intermediate levels in 
pKO-β1 and low levels in pKO-αV cells but no secretion of ISG15 (Fig.3C, S3F). Similar results were 
obtained with immunostainings, which revealed ISG15 co-localisation with f-Actin fibres and the Actin 
cortex beneath membrane protrusions (Fig.3D) and with Paxillin in FAs of unroofed cells (Fig.3E). ISG15 
is an ubiquitin-like modifier, whose expression is induced by type I (α and β) interferons (Farrell et al., 
1979; Haas et al., 1987). ELISA and qRT-PCR excluded endogenous interferon α and β expression in pKO-
αV,β1 cells as cause for the high ISG15 levels. Importantly, however, poly I:C  treatment, which triggers 
endogenous interferon α and β expression, induced a strong ISG15 expression (Fig.S3A-E). To directly 
show that ISG15 and the FA protein Talin are new SRF/MAL target genes, we performed SRF and MAL 
chromatin-immunoprecipitation (CHIP) assays. SRF CHIPseq experiments performed in murine HL-1 cells 
(http://deepbase.sysu.edu.cn/index.php) identified potential SRF consensus binding sites (CArG box), 
which allowed designing primers to PCR amply the immunoprecipitaed DNA fragments (Fig.3F). The 
vinculin gene, as a known MAL/SRF target, and the gapdh gene not regulated by MAL/SRF were used as 
controls (Vartiainen et al., 2007) (Fig.3G, 3H). Immunoprecipitations of chromatin using either MAL or 
SRF antibodies resulted in a positive CHIP. In contrast, neither precipitation control rabbit IgG nor the 
gapdh gene resulted in a positive signal (Fig.3G, 3H).  
ISG15 is an ubiquitin-like modifier, which might compete with Ubiquitin at specific lysine residues and 
hence stabilize target proteins, modify the Ubiquitin E2 enzyme Ubc13 and Nedd4 leading to its 
inhibition, and alter the function of proteins by inducing or preventing the recruitment of binding 
partners (Jeon et al., 2009; Malakhova and Zhang, 2008; Takeuchi et al., 2005; Zou et al., 2005). Since 
protein levels of Talin and Eplin are higher in pKO-αV,β1 cells than predicted from their mRNA levels 
(Fig. 3A, 3B), we hypothesized that they might be modified with ISG15 and protected from degradation. 
To test this hypothesis we precipitated ISGylated proteins in pKO-αV,β1 cells with an ISG15-specific 
antibody and subsequently analysed them by mass spectrometry (Table S1). This analysis revealed a 
large number of focal adhesion and cytoskeletal proteins including Talin and Vinculin. These findings 
indicate that αV-class and α5β1 integrin-mediated SRF/MAL activation triggers the expression of 
SRF/MAL targets that include cytoskeletal proteins, integrins, focal adhesion proteins and ISG15, which 
modifies SRF/MAL targets to stabilize them and/or change their activity. 
αV- and β1-class integrin induced SRF/MAL activity and ISG15 levels to promote cell invasion 
MAL/SRF and ISG15 promote tumour cell invasion and are up-regulated in cancer (Desai et al., 2012; 
Kressner et al., 2013). To test whether the invasive properties of MAL and ISG15 are associated and 
triggered by β1 integrin-mediated adhesion we analysed integrin, nuclear MAL and ISG15 levels of the 
non-invasive MCF-7 and invasive MDA-MB-231 breast cancer cell lines. FACS analysis revealed 
significantly higher α5 and β1 levels and higher Integrin β1 activity (by probing 9EG7 antibody) on MDA-
MB-231 cells compared to MCF-7 cells (Fig.4A). The levels of αV integrin were significantly elevated in 
MCF-7 cells compared to MDA-MB-231 cells (Fig.4A). To test whether the high β1 integrin levels and 
activity are associated with high nuclear MAL activity in MDA-MB-231 cells we immunostained for f-
Actin and MAL, and investigated MAL/SRF activities. We observed that MCF7 cells formed tight cell-cell 
contacts with f-Actin accumulating at these sites and contained MAL in the cytoplasm and nucleus. In 
contrast, MDA-MB-231 were not adhering to each other, contained numerous stress fibres and almost 
the entire pool of MAL protein in the nucleus (Fig.4B, 4C). In line with high nuclear MAL levels, MDA-MB-
231 cells also displayed significantly higher SRF/MAL reporter activity (Fig.4D) expressed significantly 
higher levels of SRF/MAL target gene transcript levels (Fig.4E). The high levels of ISG15 resulted in an 
elevated ISGylation of target proteins in MDA-MB-231 compared to MCF-7 cells (Fig.4F). 
The invasive properties of MDA-MB-231 cells depend on the expression of MAL (Hu et al., 2011; 
Medjkane et al., 2009). To test whether ISG15 is required for SRF/MAL-induced cell invasion, we 
depleted ISG15 or overexpressed the de-ISGylase UBP43 in MCF-7 and MDA-MB-231 cells and 
performed invasion assays with a basement membrane model (Fig.4G, H). While MCF-7 cells were 
unable to invade through the basement membrane model, MDA-MB-231 cells efficiently moved through 
the membrane. siRNA-mediated depletion of ISG15 or overexpression of the de-ISGylase UBP43 almost 
completely prevented the invasion of MDA-MB-231 cells (Fig.4G, H). 
Next we tested whether high β1 integrin and ISG15 levels are prognostic markers for breast cancer 
patients. To this end, we consulted microarray data of breast cancer samples and correlated αV, β1 
integrins and ISG15 transcript levels with patient survival. The analyses revealed that patients with high 
expression of αV, β1 integrin or ISG15 displayed a significant increase in the hazardous ratio (HR) and p-
value compared to patients with low levels of either transcript (Fig.5A, 5B). Interestingly, patients with 
high levels of αV, β1 integrin and ISG15 transcripts in their cancer specimen show a significantly reduced 
survival rate compared to patients with low ISG15 levels (Fig.5C). To corroborate these in silico findings, 
we performed MAL and β1 integrin immunostainings of human breast cancer samples classified 
according to the Bloom-Richardson scale and modified by Elston and Ellis (1991) as grade 1 (G1), grade 2 
(G2), and grade 3 (G3). Hereby the grading system involves a semi-quantitative evaluation of three 
morphological features a) the percentage of tubule formation, b) the degree of nuclear pleomorphism 
and c) an accurate mitotic count using a defined field area. By the usage of a numerical scoring system, 
the overall grade is derived from a summation of individual scores for the three grades (Elston and Ellis, 
1991). (Fig.5D, 5E). Importantly to note, these patient biopsies also include normal healthy tissue next to 
pathologic malformations. In line with our findings, the overall expression of β1 integrin and nuclear 
MAL levels increased concomitantly from G1 to G2 and to G3 stage (Fig.5D, 5E, S5). Altogether our data 
show that integrin-mediated MAL/SRF/ISG15 signaling is elevated in cancer cell invasion in vitro and in 
vivo. 
  
DISCUSSION 
Tumour metastasis is initiated with the detachment of an individual tumour cell from a tumour cell 
aggregate followed by invasion into the surrounding tissue, entry into the circulation and finally 
settlement in a distant organ. The process of tumour cell invasion is critically dependent on the selection 
of tumour cells that are able to survive without tumour stroma, on the release of proteases that 
degrade and remodel the tumour- and tissue-derived ECM, and on cell adhesion molecules such as 
integrins (Hood and Cheresh, 2002). Integrins constitute the core components of the invasive machinery 
of tumour cells. They regulate the activity of small GTPases, Actin binding, bundling and modifying 
proteins to allow for cytoskeletal dynamics, membrane protrusions and invadopodia formation (Bishop 
and Hall, 2000; Hall, 2012; Hoshino et al., 2013; Murphy and Courtneidge, 2011). Since tumour cells 
express different types of integrins, it is unclear whether, and if yes, how they co-operate to achieve 
maximal efficiency in tissue invasion. The task of the present study was to define the integrin subfamily 
and the signalling pathways involved in tumour cell invasion. 
We have recently engineered a fibroblast-like cell line that allows expressing the FN-binding integrin 
αVβ3 and/or α5β1. These cell lines were used to demonstrate that αVβ3 and α5β1 integrins control 
actomyosin-based cell contractility in a cooperative manner. In the present study we also observed that 
cells expressing αVβ3 and α5β1 integrins (pKO-αV,β1 cells) most pronouncedly decrease their g-Actin 
pool, which results in the nuclear translocation of the g-Actin binding transcriptional transactivator MAL 
(also referred as MRTF-A). The consequences of the nuclear accumulation of MAL include binding to the 
transcription factor SRF and the transcription of MAL/SRF target genes, which comprise known genes 
such as Actin, Vinculin, Filamin, etc, as well as novel genes such as Talin, EPLIN and ISG15, which all 
contain functional CArG boxes that bind SRF and are required for responding to the active MAL/SRF 
complex. 
Our findings show that ISG15 is particularly highly elevated when αVβ3 and α5β1 bind FN. ISG15 is a 
ubiquitin like modifier protein and thought to be induced exquisitely by type I interferons (Farrell et al., 
1979; Haas et al., 1987). ISG15 is highly expressed in all tumours investigated so far 
(www.oncomine.org). Since the tumour stroma is infiltrated by immune cells it is believed that they are 
the source of interferon α/β production and hence the trigger for the high expression of ISG15 in cancer 
cells (van der Veen and Ploegh, 2012). While immune cell-derived interferon α/β strongly promotes 
expression of ISG15 in tumours it is unknown why ISG15 remains upregulated in tumour cells isolated 
and cultured ex vivo in the absence of immune cells and interferon α/β (Han et al., 2002; Hermeking et 
al., 1997; Lock et al., 2002). Based on our findings we propose that αVβ3/α5β1-induced nuclear 
translocation of MAL and activation of SRF are responsible for the high ISG15 transcription ex vivo. 
ISG15 is conjugated to proteins (ISGylation) in a multistep process that requires E1, E2 and E3 enzymes 
comparable to the protein-ubiquitination pathway (Haas et al., 1987; Lenschow et al., 2005; Loeb and 
Haas, 1992; Morales and Lenschow, 2013; Okumura et al., 2008; Yuan and Krug, 2001). Furthermore, a 
protease called Ubp43 removes ISG15 resulting in deISGylation of proteins (Malakhov et al., 2002). 
Protein ISG15lyation can alter protein function. Rac1 and MAPK, for example, dissociate from ISG15-
modified Filamin-B. This dissociation can terminate JNK signalling and inhibit apoptosis (Jeon et al., 
2009). It has also been shown that ISG15 modification can stabilize proteins either by ISGylation and 
inhibition of ubiquititn-specific E2 enzymes (Desai et al., 2006; Malakhova and Zhang, 2008; Okumura et 
al., 2008) or by competing with free ubiquitin for lysine residues on target proteins (Liu et al., 2003). 
Finally, ISGylation was shown to inhibit protein translation by either increasing the cap structure-binding 
activity of the ISGylated translational suppressor 4EHP (Okumura et al., 2007) or by down-regulating 
elF2α through ISGylation of dsRNA-dependent protein kinase (PKR) (Okumura et al., 2013).  
The expression of ISG15 is high in tumour cells in vivo and ex vivo indicating that ISG15 modification 
represents a tumour promoting and oncogenic function in primary tumours where interferon α/β levels 
are high as well as during and after invasion when interferon levels decrease. Hence, it is conceivable 
that αVβ3/α5β1 signalling kicks in to compensate low interferon levels and to sustain high ISG15 
expression. Our mass-spectrometry analysis of ISG15 modified protein (ISGylome) in pKO-αV,β1 cells 
revealed that numerous proteins including integrins, FA proteins (Talin, Vinculin, EPLIN, etc.) and Actin 
become ISGylated upon FN binding. We therefore, propose that αVβ3/α5β1 integrin-mediated signalling 
has two major consequences for tumour cell invasion; αVβ3/α5β1 integrins activate GTPases leading to 
polymerization of f-Actin networks and stress fibers, which are essential for membrane protrusions, cell 
contractility and adhesion reinforcement. In addition, the consumption of g-Actin for the f-Actin 
network formation results in liberation and nuclear translocation of MAL, binding to SRF and 
transcription of cytoskeletal, FA proteins and ISG15. ISG15 modifies integrins, FA proteins and Actin to 
increase their stability and/or improve their function (Fig. 6). This novel feed forward loop operates in 
fibroblasts as well as in invading cancer cells. The highly metastatic breast cancer cell line MDA-MB-231 
expressed significantly more α5β1, contained higher levels of nuclear MAL and ISG15 modified proteins, 
and performed significantly better in invasion assays than the non-metastatic MCF7 cell line. Most 
importantly, transcriptome analyses of breast cancer samples from large cohorts of patients revealed a 
statistically highly significant association between patient survival and high β1 integrin, MAL and ISG15 
levels. These findings indicate that the selection of tumour cells for high integrin levels in a tumour 
aggregate renders them independent of decreasing interferon and growth factor levels. This 
independence is facilitated with an increased strength of integrin signalling, which has the principal task 
in a metastasizing tumour cells to establish and maintain an efficient invasive machinery that 
compensates essential cues from the tumour stroma and eventually allows a long and harshly journey to 
distant and extraneous organ to succeed. 
  
EXPERIMENTAL PROCEDURES 
Isolation, immortalization, viral reconstitution and transfection of cell lines 
Mouse pKO fibroblasts and reconstituted pKO-αV, pKO- β1 and pKO-αV,β1 cell lines were generated 
from fibroblasts (floxed parental) derived from the kidney of 21-day-old male mice carrying floxed αV 
and β1 alleles (αV flox/flox, β1flox/flox), and constitutive β2 and β7 null alleles (β2−/−, β7−/−). Individual 
kidney fibroblast clones were immortalized by retroviral delivery of the SV40 large T. The immortalized 
floxed fibroblast clones were then retrovirally transduced with mouse αV and/or β1 integrin cDNAs and 
the endogenous floxed β1 and αV integrin loci were simultaneously deleted by adenoviral transduction 
of the Cre recombinase. Reconstituted cell lines were FACS sorted to obtain cell populations with 
comparable integrin surface levels to the parental cell clones(Schiller et al., 2013) or to have high or low 
integrin expression levels. Fibroblasts homozygous for floxed kindlin-1 and -2 or talin-1 or -2 genes were 
isolated from kidneys of 21-day-old double-floxed mice (whose generation will be described elsewhere), 
immortalized as described above and cloned. To obtain Kindlin-1 and -2 double-null or Talin-1 and -2 
double-null cells, the floxed kindlin alleles were removed by adenoviral Cre transduction. The breast 
cancer cell lines MDA-MB-231 and MCF-7 were purchased from ATCC (http://www.lgcstandards-
atcc.org/Products/Cells_and_Microorganisms/Cell_Lines.aspx?geo_country=de). 
 
Patient samples/biopsies 
For histological and immunostaining analysis, staged human breast cancer samples were kindly provided 
by Prof. Ferdinand Hofstädter, Institute of Pathology, 93053 Regensburg, Germany. 
 
Immunostainings and surface coating 
For immunofluorescence microscopy, cells were seeded on micropatterns or coated glass surfaces 
(Coating: 5 µg/ml Fibronectin (Calbiochem) or 1% Gelatin (Sigma) or 1% Collagen (Advanced BioMatrix) 
or 10 µg/ml Laminin (Roche) or 10 µg/ml Vitronectin (STEMCELL technologies) in PBS or 0.01% Poly-L-
lysine (Sigma)) in DMEM (GIBCO by Life Technologies) containing 10 % FCS at 37 °C, 5% CO2. For 
micropatterns the cell culture medium contained 0.5% FCS. After indicated time points the medium was 
soaked off, and cells were fixed with 3% PFA in PBS for 10 min at room temperature, washed with PBS, 
blocked with 1% BSA in PBS for 1 h at room temperature and then incubated with antibodies in a 
solution of 0.1% Triton X-100, 3% BSA in PBS. The fluorescent images were collected with a laser 
scanning confocal microscope (Leica SP5). For visualization g- and f-Actin structures, we followed a 
protocol published earlier (Small et al., 1999). H&E staining was performed according to standard 
procedures.  
 
Antibodies 
All antibodies are listed in Supplementary Information Table S3. 
 
Crosslinking 
Enrichment for focal-adhesion-associated proteins was achieved by shortly fixing the ventral cell cortex 
using DSP crosslinker (DTSP; Dithiobis[succinimidyl propionate]), followed by removal of non-crosslinked 
proteins and big organelles by stringent cell lysis and hydrodynamic sheer flow washing. 
 
Cell fractionation  
For cell fractionation a kit (ProteoExtract® Cytoskeleton Enrichment and Isolation Kit purchased from 
Millipore) was used according to the manufacturer´s instructions or a centrifugation-based method. For 
the centrifugation-based method to isolate the nuclei, cells were washed with PBS and harvest in a 
buffer containing 250 mM Sucrose, 10 mM HEPES and 1.5 mM EDTA. With the help of a syringe and a 
26Ga needle (Terumo) cells were opened further. After centrifugation the pellet (nuclei fraction) was 
washed 5 times with a buffer containing 20 mM Tris, 0.1 mM EDTA and 2 mM MgCl2. The pellet was 
resuspended in FACS buffer or staining solution for immunostaining. 
 
G-Actin-DNaseI pulldown 
DNaseI (Sigma-Aldrich) was covalently linked to CNBr-activated Sepharose beads (Sigma-Aldrich) at a 
concentration of 1 mg/ml according to the manufacturer´s protocol. BSA-Sepharose beads, which served 
as control, were prepared in the same way. For g-Actin pulldown 15µg protein lysate in RIPA buffer was 
incubated with 35µl of DNaseI- or BSA-coupled Sepharose beads in a volume of 300 µl over night at 4°C 
in an end-over-end-mixer. Next day, the beads were washed five times with cold wash buffer (1% NP-40, 
0.1 % SDS, 1mM DTT, 1mM PMSF in PBS). Beads were dried with a syringe and needle and SDS-sample 
buffer was added for subsequent western blot analysis. 
 
Constructs and transfections 
Constitutive active MAL (∆NMAL), dominant negative MAL (DN MAL: ∆N1B1 and ∆N∆C), SRF:MAL 
reporter constructs were provided by Prof. Guido Posern, Institute of Physiological Chemistry, 06114 
Halle, Germany. Constitutive active myc-mDia1 construct (myc-mDia1 FH1FH2) expression construct was 
amplified from an existing plasmid with forward primer 5’-gcc aag aat gaa atg gct tc-3’ and reverse 5’-tgc 
aga gct tct aga aga ct and the PCR product was cloned into the pCRII-TOPO vector and sequenced. The 
integrin αV-mCherry and integrin β1-mCherry were provided by Ralph Böttcher. The knockdown 
constructs for stable knockdown of murine ISG15 were purchased from Origene and the UBP43 
overexpression construct was purchased from Addgene. All transfections were carried out with 
Lipofectamine 2000 (Invitrogen through Life Technologies) according to the manufacturer’s instructions. 
 
SRF/MAL reporter assay  
Cells were plated on FN coated 12-well plates (6.0 x 105 cells per well) before transient transfection with 
0.5 µg of MAL/SRF reporter (p3DA.luc) reporter (Sotiropoulos et al., 1999), indicated expression plasmid 
and 25 ng thymidine kinase-driven renilla (Promega) for controlling transfection efficiency. The total 
amount of transfected plasmid DNA was kept constant at 1.5 µg per well by using pEGFP-C1 expression 
vector (Clontech). After 24h luciferase activity was analyzed with a Dual Luciferase reporter assay 
system (Promega). Jasplankinolide (100 nM, #420107-50UG from Merck Millipore) and Latrunculin A 
(500 nM, L5163 from Sigma) treatment was performed 3h prior to reporter read-out. 
 
Micropatterning 
Micropatterns were generated on PEG-coated glass coverslips with deep-ultraviolet lithography(Azioune 
et al., 2010). Glass coverslips were incubated in a 1 mM solution of a linear PEG, CH3–(O–CH2–CH2)43–
NH–CO–NH–CH2–CH2–CH2–Si(OEt)3 in dry toluene for 20 h at 80 °C under a nitrogen atmosphere. The 
substrates were removed, rinsed intensively with ethyl acetate, methanol and water, and dried with 
nitrogen. A pegylated glass coverslip and a chromium-coated quartz photomask (ML&C, Jena) were 
immobilized with vacuum onto a mask holder, which was immediately exposed to deep ultraviolet light 
using a low-pressure mercury lamp (NIQ 60/35 XL longlife lamp, quartz tube, 60 W from Heraeus 
Noblelight) at 5 cm distance for 7 min. The patterned substrates were subsequently incubated overnight 
with 100 μl of fibronectin (20 μg ml−1 in PBS) at 4 °C and washed once with PBS. 
 
FACS analysis 
For FACS analysis s suspension of fibroblasts was incubated for 1 h with primary antibodies on ice and 
then washed twice with FACS-PBS (3 mM EDTA, 2% FCS in PBS). Cell viability was assessed by propidium 
iodide staining. FACS analysis was carried out using a FACSCalibur Cytometer (BD Biosciences) and cell 
sorting with an AriaFACSII high-speed sorter (BD Biosciences), both equipped with FACS DiVa software 
(BD Biosciences). Purity of sorted cells was determined by post sort FACS analysis and typically exceeded 
95%. Data analysis was conducted using the FlowJo program (Version 9.4.10). 
 
Real-time PCR 
Total RNA from cells was extracted with RNeasy Mini extraction kit (Qiagen) following manufacturer’s 
instructions. cDNA was prepared with a  iScript cDNA Synthesis Kit (Biorad). Real Time PCR was 
performed with an iCycler (Biorad). Each sample was measured in triplicates and values were 
normalized to gapdh. PCR primers are listed in Supplementary Information Table S2. 
 
Mass spectrometry 
The mass spectrometry was performed and analyzed as previously described (Schiller et al., 2013). For 
the investigation of ISG15 target proteins, a Flag-murineISG15 construct was used for overexpression 
followed by a FLAG pulldown by using ANTI-FLAG® M2 Affinity Gel according to manufacturer´s 
instructions (Sigma, product #A2220), SDS PAGE gel electrophoresis and subsequent treatment for mass 
spectrometry analysis. 
 
Interferon ELISA 
Cells were plated on FN-coated tissue culture dishes for three days and the cells` supernatant was 
analyzed. To induce interferon production cells were transfected with 100 µg/ml Poly(I:C). ELISA for 
interferon α and interferon β secretion was performed with the VeriKineTM Mouse IFN-α and Mouse IFN-
β ELISA kit (PBL Interferon Source, product #42120 and #42400) according to manufacturer´s 
instructions. 
 
Invasion assay 
Invasion assay was purchased (Merck Millipore’s QCM™ Boyden chamber, 8 µm pore size) and 
performed according to manufacturer´s instructions 24 hours post-transfection with either shScr 
control, shISG15 or UBP43 constructs.  
 
CHIP 
For each immunoprecipitation, pKO-αV,β1 cells were used. Cross-linking, nuclei preparation and 
nuclease digestion of chromatin was performed according to manufacturer`s advice (SimpleCHIP 
Enzymatic Chromatin IP Kit (Magnetic Beads, #9003, Cell Signaling Technology). Then, 500 ml of 
chromatin was incubated overnight at 4°C with 1 to 50 dilution of anti-SRF (#5147; Cell Signaling 
Technology) or 30 µl home-made anti-MAL rabbit serum (#79). After washing of the 
Immunoprecipitated chromatin, the DNA– protein complexes were eluted with supplied CHIP elution 
buffer. Crosslinks were reversed overnight at 65°C, and DNA purified via columns also provided in the 
kit. Quantification was done by quantitative real-time PCR and is shown as the percentage of input 
chromatin. Gene-specific primers for amplification of immunoprecipitated DNA are listed in 
supplementary material Table S3. Primers for Gapdh and Srf were published previously (Vartiainen et al., 
2007). 
 
RNA interference 
Cells were infected with retroviral 29mer shISG15 expression constructs purchased from Origene 
(#TG502956). The pGFP-V-RS plasmid vector was created with an integrated turboGFP element to 
readily verify transfection efficiency and with a puromycine selection cassette to select for cells carrying 
integrations. 
 
Kaplan Meier analysis of gene expression microarray 
To analyze the prognostic value of integrin αV, integrin β1 and ISG15 gene the Kaplan-Meier plotter was 
used (http://kmplot.com/analysis/). The patient samples were split into two groups according to various 
quantile expressions of the proposed biomarker (low and high expression). The two patient cohorts 
were compared by a Kaplan-Meier survival plot, and the hazard ratio with 95% confidence intervals and 
logrank P value were calculated. 
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FIGURE AND TABLE LEGENDS 
Figure 1. FN bound α5β1 and αV-class integrins control f-Actin and nuclear MAL levels. (A) 
Superimposed picture (confocal stack) of indicated cell types immunostained for f-Actin (Phalloidin), g-
Actin (DNaseI) and DAPI plated on FN-coated glass surfaces. The intensity map shows the cytoplasmic 
distribution of g-Actin. Scale bar, 20 µm. (B, C) Quantification of cytoplasmic g-Actin by DNaseI (B) and f-
Actin fibres by Phalloidin (C) relative fluorescence intensities (n>20; 3 independent experiments). (D) 
Cell fractionation into soluble (S), nuclear (N) and cytoskeletal (C) components followed by western blot 
analysis with a β-Actin antibody. Antibodies against Vimentin and GAPDH confirm efficiency of 
subcellular protein fractionation (representative western blot of four independent experiments is 
shown). (E, F) Ratio of g-Actin versus GAPDH (E) and g-Actin versus f-Actin (F) of the indicated cell types 
is shown (n=4; 4 independent experiments). (G) Western blot analysis by Profilin and β-Actin antibody of 
g-Actin pulldown experiment with DNAseI- or BSA-coupled Sepharose beads (representative western 
blot of three independent experiments in technical duplicates is shown). (H) DNaseI-bound g-Actin in 
nuclear (N) and soluble (S) cell fraction was analysed (n=3; 3 independent experiments). (I) 
Immunostaining of indicated cell types plated on FN-coated glass coverslips and treated with DMSO 
(control), 100 nM Jasplankinolide (Jasp) and 500 nM Latrunculin A (LatA), respectively. The merged 
images display an overlay of Paxilin, MAL, f-Actin and nuclear staining (DAPI). Scale bar, 10 µm. All p-
values were calculated using a paired Students-t-test. 
Figure 2. αV-class integrins cooperate with α5β1 to induce SRF/MAL activity. (A) SRF-driven luciferase 
reporter activity in cells plated on FN and treated with DMSO, 100 nM Jasplankinolide (Jasp) or 500 nM 
Latrunculin A (LatA) (3 independent experiments). (B) SRF-driven luciferase reporter activity in cells 
plated on FN transfected with EGFP, a constitutive active (ca) MAL (∆N-MAL) or a ca mDia construct (4 
independent experiments). (C) SRF-driven luciferase reporter activity in cells plated on circular FN-
coated micropatterns with either 40 µm or 28 µm diameter (3 independent experiments). (D) Z-stacks of 
immunostained cells seeded on circular FN-coated micropatterns with indicated diameters. The cartoon 
on the left illustrates the position of the indicated stack. The merged picture displays an overlay of MAL 
(yellow), f-Actin (white) and nuclear staining (DAPI). Scale bar, 10 µm. (E) Quantification of nuclear 
fluorescence intensity for MAL from superimposed images shown in (D) (n=5). (F, G) SRF-driven 
luciferase reporter activity in indicated cells treated with Mn++ (n=5) (F) or transfected with the αV or β1 
Integrin (G) (n=4). (H) Immunostaining of pKO-αV,β1 cells plated on Fibronectin (FN), Vitronectin (VN) 
and Gelatin and untreated or treated with anti-α5β1 blocking antibodies or Cilengitide for MAL (red), f-
Actin (white) and nucleus (DAPI; green). The inserts show MAL in the different settings. Scale bar, 25 
µm. (I) SRF/MAL luciferase reporter activity (n=3) in pKO-αV,β1 cells plated on FN and untreated (n=15) 
or treated with anti-α5β1 blocking antibodies (n=22) or Cilengitide (n=27). All error bars represent 
+SEM. All p-values were calculated using a paired Students-t-test.   pKO-αV (green);  pKO-β1 
(orange);  pKO-αV,β1 (blue). 
Figure 3. αV- and β1-class integrins induce transcription of SRF/MAL target genes. 
(A) Quantitative realtime-PCR of the SRF/MAL target genes srf, talin, flnb, vcl, lima1 but also mrtf-a and 
isg15. mRNA levels are shown relative to GAPDH transcript levels (n>3; minimum of 3 independent RNA 
isolations, double blind). (B) Western blot analysis of SRF, Talin, Filamin B (FLN B), Vinculin (VCL), Lima1 
but also MAL (or MRTF-A). GAPDH was used to control protein loading. (C) Densitometric analysis of free 
ISG15 protein in the indicated cell lines (5 independent experiments). (D) Immunostaining for Paxillin 
(Pxn), ISG15, f-Actin and DAPI. Arrowheads indicate co-localization of f-Actin and ISG15. Scale bar, 10 
µm. (E) Immunostaining of ISG15, Paxillin, f-Actin and nucleus (DAPI) in FAs of cross-linked and unroofed 
indicated cells. The merged images display an overlay of ISG15, Paxillin, f-Actin and DAPI. Scale bar, 10 
µm. (F) Scheme to illustrate location of CArG boxes (SRF binding sites; Blue boxes) in isg15, vcl as control 
and tln-1 gene along Exons (Black boxes;). (G, H) Chromatin immunopreciptiation was performed with 
MAL, SRF or rabbit IgG antibody as control. Isg15, vcl, tln and gapdh as control CArG boxes were 
amplified by conventional PCR and visualized by agarose gel electrophoresis (G). Real-time PCR was 
performed from three independent chromatin preparations and IPs. Shown is the relative quantitation 
of isg15, vcl and tln relative to input chromatin (H). All error bars represent +SEM. All p-values were 
calculated using a paired Students-t-test.   pKO-αV (green);  pKO-β1 (orange);  pKO-αV,β1 (blue). 
Figure 4. αV- and β1-class Integrin induced SRF/MAL activity and ISG15 levels to promote 3D cell 
invasion. (A) FACS analysis of integrin α5, αV and β1 surface levels and β1 activity by 9EG7 staining MCF-
7 and MB231. (B, C) Immunostaining of non-invasive MCF-7 and highly invasive MB231 breast cancer 
cell lines seeded on FN (B). A representative example for threshold used for nuclear MAL 
quantification(C) is shown (In two independent experiment a minimum of 129 cells per cell line were 
analysed). The merged images display an overlay of MAL, f-Actin and nuclear staining (DAPI). Scale bar, 
10 µm. (D) SRF/MAL luciferase reporter assay of MCF-7 and MDA-MB-231 cells (n=3; three independent 
experiments). (E) Quantitative real-time PCR was performed for itgaV and SRF/MAL targets itgb1, isg15, 
srf, and lima1 but also for mrtf-a. Shown is the quantitation relative to gapdh (n=3, from 3 independent 
isolations, double blind). (F) Western blot of MDA-MB-231 and MCF-7 with ISG15 specific antibody. 
GAPDH was used to control loading. (G-H) FN-coated transwell cell invasion assay with MDA-MB-231 
and MCF-7 cells upon ISG15 knockdown, UBP43 overexpression or scrambled shRNA control (n=3; 3 
independent experiments). Immunostaining of transmigrated cell by Phalloidin and DAPI (G). 
Quantification of transmigrated cells compared to scrambled control (H). Scale bar, 100 µm. All error 
bars represent +SEM. All p-values were calculated using a paired Students-t-test.    pKO-αV (green);  
pKO-β1 (orange); and  pKO-αV,β1 (blue);  MCF-7 (white);   MB231 (black).  
Figure 5. αV- and β1-class integrin induced ISGylation of SRF/MAL targets results in bad breast cancer 
patient prognosis. (A, B) Kaplan Meier analysis indicates that breast cancer patients with high integrin 
β1 (A), or high ISG15 levels (B) die earlier. (C) Kaplan Meier analysis indicate bad patient outcome at high 
compared to low ISG15 transcript amounts by constant high α5 and β1 Integrin levels. (D) H/E staining 
of indicated breast cancer samples. Approximate area used for immunostaining (IF) is indicated. (E) 
Immunostaining of indicated patient samples for MAL, integrin β1 and f-Actin. The merged images 
display an overlay of MAL, integrin β1 and f-Actin and nuclear staining (DAPI). Scale bar, 50 µm.  
Figure 6. Model of how α5β1/αV-class integrins synergistically induce MAL/SRF, leading to multi-
layered protein ISGylation and enhanced 3D migration and invasion of tumour cells. Both, αV-class 
integrin induced RhoA/mDia and β1-class integrin induced Rac/WAVE/Arp2/3 activities are combined in 
FN-adherent pKO-αV,β1 cells leading to low g-Actin levels, the release and nuclear translocation of MAL, 
binding to SRF and transcription of target genes such as ISG15 and FA proteins. Production of ISG15 and 
its coupling machinery results in multi-layered protein ISGylation and subsequent stabilization of FA- 
and cytoskeletal-related proteins. Advanced cell migration properties leads to improved 3D migration 
and invasion of tumour cells.  
Table 1. Qualitative Comparison of SRF/MAL target genes to the proteome data of pKO-αV, pKO-β1 
and pKO-αV,β1 cells published in Schiller and Hermann et al., NCB, 2013. Data mining and comparison 
of seven different SRF/MAL target gene screening approaches were manually filtered for association 
with FA and actin functions and co-localization. A qualitative comparison with the pKO-cell proteome 
was performed. Data sources were cited by numbers: (1) Balza R. O. et al., JBC, 2006; (2) Philippar et al., 
MolCell, 2004; (3) Selvaraj A. et al., BMC, 2004; (4) Sun Q. et al., Genome Res, 2006; (5) Zhang S. X. et al., 
JBC, 2005; (6) Descot A. et al., MolCell, 2009; and (7) Cooper S. J. et al., Genome Res, 2007;   
enrichment in pKO-αV cells (green);  enrichment in pKO-β1 cells (orange); and  enrichment in pKO-
αV,β1 cells (blue);   not found in pKO-cell proteome list;   not enriched in the indicated cell type.  
SUPPLEMENTARY INFORMATION 
Figure S1. Different total Actin levels and distribution in pKO-αV, pKO-β1 and pKO-αV,β1 cells. (A) 
Immunostaining of indicated cell types for Paxillin and f-Actin plated for 90 minutes on circular FN-
coated micropatterns. The merged images display an overlay of Paxillin, f-Actin and nuclear (DAPI) 
staining. Scale bar, 25 µm. (B) Cell lysates were immunoblotted for total Actin. GAPDH was used as a 
loading control. Densitometric quantification of western blots (n=3) is depicted as fold changes below 
the corresponding blot with +/- SEM values. (C) FACS analysis of indicated cell types by propidium iodide 
staining to measure nuclear size. (D) Box plot of all actin modifying proteins (Schiller et al., 2013) in 
indicated cell lines classified into their effect on g-Actin pool: Neutral (black), decrease (blue), increase 
(yellow). Protein abundance is presented by Log2 ratios. Thymosin beta 4 (Tmsb4), Cofilin-1 (Cfl-1) and 
Advillin (Advil) were highlighted. (E) Log2 ratio of Tmsb4 expression in indicated cell lines (n=3; 3 
independent experiments). (F) Western blot of Cofilin and phospho-Cofilin (Ser3) (representative 
western blot of 4 independent experiments is shown). (G) Microscopy of indicated cells upon 
Latrunculin A (LatA) or Jasplankinolide (Jasp) treatment. DMSO was used as control. Dashed lines 
highlight lamellipodia and long protrusions caused by Jasp treatment. Scale bar, 20µm. 
Figure S2. αV-class integrins cooperate with α5β1 to induce SRF/MAL activity. (A-C) Reporter activity 
measurements of a SRF-driven firefly normalized to a thymidine kinase-driven renilla luciferase of cells 
plated on FN-coated culture dishes. Cells were starved and serum boosted with 40% FCS (A) and in (B) 
treated with Methanol (MeOH) as a control and Leptomycin B (LeptoB) to inhibit the nuclear export of 
MAL or (C) transfected with EGFP only or a dominant negative MAL (DN MAL) construct. (D) Reporter 
activity measurements of a SRF-driven firefly normalized to a thymidine kinase-driven renilla luciferase 
of Kindlin-1 and -2 or Talin-1 and -2 wild type (WT) and knockout cells (KO) seeded on FN. All error bars 
represent SEM and p-values were calculated using a paired Students-t-test.   pKO-αV (green);  pKO-
β1 (orange);  pKO-αV,β1 (blue); 
Figure S3. Type I interferon response independent but SRF/MAL dependent ISG15 transcription in 
pKO-αV, pKO-β1 and pKO-αV,β1 cells. (A-C) Quantitative real-time PCR of Interferon α (IFNα; A), 
Interferon β (IFNβ; B) and ISG15 upon 100µg/ml poly I:C stimulation (C) (n=3; 3 independent isolations). 
(D, E) ELISA-based quantification of IFNα (D) or IFNβ (E) levels in supernatants of indicated cells treated 
with Poly I:C. Error bars represent +SEM. p-values were calculated using a paired Students-t-test. (F)  
Western blot of free ISG15 in total cell lysate or supernatant of 72h cultured indicated cells. GAPDH was 
used to control protein loading. FN was used as a secreted protein control. Densitometric quantification 
of western blots (n>3; >3 independent experiments) is depicted as fold changes below the 
corresponding blot with +/- SEM values.  
Figure S5. αV- and β1-class integrin induced ISGylation of SRF/MAL targets results in bad breast cancer 
patient prognosis. Quantification of nuclear MAL in grade (G) 1 to G3 breast cancer sections (G1: n=10, 
G2: n=12, G3: n=20). 
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Gene Name Annotation Source
ACTA1 Skeletal alpha actin 1,2,6
ACTA2 Smooth muscle alpha actin 1,2,6
ACTC Alpha-cardiac actin 2
ACTC1 Actin, alpha cardiac muscle 1 1,5,6
ACTG Actin, cytoplasmic 2 2
ACTN1 Alpha-actinin-1 4
CAPZA3 F-actin-capping protein subunit alpha-3 4
CFL1 Cofilin, non-muscle isoform 4
CFL2 Cofilin2, muscle 1,4
DSTN Destrin, Actin-depolymerizing factor, ADF 4,6,7
ENAH, MENA Protein enabled homolog 1
EPLIN LIM domain and actin-binding protein 1 6
FBLN5 Fibulin-5 4
FHL1 Four and a half LIM domains protein 1 4,6
FHL2 Four and a half LIM domains protein 2 2,4
FLNA Filamin A 4
FLNC Filamin C 4
FNBP1 Formin-binding protein 1 1
IQGAP Ras GTPase-activating-like protein IQGAP1
ISG15 Interferon-induced 15kDa protein 2
ITGA1 Integrin alpha 1 7
ITGA5 Integrin alpha5 4,6
ITGA9 Integrin alpha 9 1,5
ITGB1 Integrin beta 1 1
ITGB1BP2 Integrin beta 1 binding protein 2 (melusin) 1,4,7
LPP LIM domain-containing preferred translocation partner in lipoma 2,6
MAP3K14 Mitogen-activated protein kinase kinase kinase 14 5,6
MAP3K4 Mitogen-activated protein kinase kinase kinase 4 5
MAPK10 Mitogen-activated protein kinase 10, JNK3 5
MYH11 Myosin heavy chain, smooth muscle isoform, SMMHC 7
MYH6 Myosin heavy chain, cardiac muscle alpha isoform, MyHC-alpha 1
MYH7 Myosin heavy chain, cardiac muscle beta isoform, MyHC-beta 1
MYH9 Non-muscle myosin heavy chain A, NMMHC-A, NMMHC-Iia 6,7
MYL3 Myosin light chain 1, slow-twitch muscle B/ventricular isoform, MLC1SB 1,5
MYL4 Myosin light chain 1, atrial/fetal isoform, MLC1A 1
MYL9 Myosin light chain 9, smooth muscle 1,5
PDLIM5 Enh, Enigma homolog 4
PDLIM7 Enigma 1,6
PFN1 Profilin-1 4
SRF Serum response factor 1,3
SVIL Supervillin 1,7
TLN Talin 4
TRIP6 Zyxin-related protein 1 4
VCL Vinculin 2,3,6,7
VIL1 Villin-1 6
ZYX Zyxin 3
SRF target genes Proteome 
Enriched
A p p e n d i x  | 221 
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Integrins are a large family of cell–
extracellular matrix (ECM) and cell–cell
adhesion molecules that regulate
development and tissue homeostasis by
controlling cell migration, survival,
proliferation and differentiation (Hynes,
2002). They are non-covalently associated
heterodimers consisting of a- and b-
subunits. On the cell surface, integrins
exist in a conformation with either high
(active) or low (inactive) ligand affinity.
Upon activation (inside-out signalling)
(Moser et al., 2009), integrins cluster and
form nascent focal adhesions, which
eventually mature into focal adhesions
(FAs) (outside-in signalling) (Legate et al.,
2009; Geiger and Yamada, 2011). Major
functions of integrins in FAs include their
ability to link the ECM to the actin
cytoskeleton and to fine tune growth
factor receptor signalling (Legate et al.,
2009).
Given that integrins lack intrinsic
enzymatic activity, their signalling crucially
depends on recruiting adaptor and signalling
proteins (Schiller et al., 2011). One of the best
described of these proteins is integrin-linked
kinase (ILK), which is directly recruited to b1
and b3 integrin cytoplasmic domains. Since
its discovery 15 years ago (Hannigan et al.,
1996), ILK has been shown to play crucial
roles in actin rearrangement, cell polarisation,
spreading, migration, proliferation and
survival (Legate et al., 2006). Despite its
predominant localisation in FAs, ILK has
also been shown to reside in cell–cell
adhesion sites, in centrosomes and in the
nucleus. Here, we summarise the functional
properties of ILK and highlight the recent
evidence demonstrating that ILK serves as a
scaffold protein rather than a kinase.
ILK and the Pinch–parvin complex
In vivo studies have revealed that ILK
is a ubiquitously expressed protein, whose
predominant function is to organise the
actin cytoskeleton during invertebrate and
vertebrate development and homeostasis. In
(See poster insert)
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Caenorhabditis elegans, the ILK orthologue
PAT-4 localises to integrins at muscle
attachment sites. Deletion of the pat-4
gene causes a ‘paralysed at two-fold-stage’
(PAT) phenotype that is characterised by
muscle detachment through defective
integrin–actin linkage and early lethality
(Mackinnon et al., 2002). In Drosophila
melanogaster, a germline deletion of ILK
leads to muscle detachment and lethality
(Zervas et al., 2001). Mice lacking ILK die
during the peri-implantation stage owing to
a failure to organise the F-actin cytoskeleton
in epiblast cells (Sakai et al., 2003). In
addition to the constitutive deletion, the
mouse ILK-encoding gene has been deleted
in several organs and cell types using the
Cre/loxP recombination system. The
outcome of these studies has been
extensively reviewed elsewhere (Rooney
and Streuli, 2011; Ho and Bendeck, 2009;
Hannigan et al., 2007; Wickstro¨m et al.,
2010b).
Structurally, ILK has three different
domains: five ankyrin repeats at the N-
terminus, followed by a pleckstrin
homology (PH)-like domain and a kinase-
like domain at the C-terminus (Chiswell
et al., 2008; Yang et al., 2009) (see poster).
Although ILK was shown to directly
interact with integrin cytoplasmic tails, it
appears that the recruitment of ILK to
integrins depends, at least in some cells, on
kindlin-2 (also known as Fermt2 and
Plekhc1) (Montanez et al., 2008; Chen
et al., 2008), a-parvin (Fukuda et al., 2009)
or paxillin (Nikolopoulos and Turner,
2001). Structural studies of ILK have
revealed, however, that the proposed
paxillin-interacting residues are buried
within a polypeptide fold and thus are not
directly accessible (Fukuda et al., 2009),
suggesting that these residues indirectly
contribute to paxillin binding. Before the
recruitment of ILK to FAs, ILK forms a
ternary complex with the two adaptor
proteins Pinch and parvin (termed the IPP
complex). Although it is not understood
how the IPP complex forms, its formation
ensures the stability of the individual
components and their faithful targeting to
the adhesion site (Zhang et al., 2002;
Fukuda et al., 2003a). Mammals have
two Pinch genes (Pinch-1 and Pinch-2;
also known as LIMS1 and LIMS2,
respectively), which encode proteins
consisting of five cysteine-rich, zinc-
binding LIM domains followed by a
nuclear export signal. The first LIM
domain of Pinch-1 and -2 binds to a
concave surface that extends from the
second to the fifth ankyrin repeat of ILK
(Chiswell et al., 2008; Yang et al., 2009)
(see poster). The three mammalian parvin
isoforms (a-, b- and c-parvin) are
composed of an N-terminal polypeptide
followed by two calponin homology (CH)
domains, the second of which binds to the
kinase-like domain of ILK (Tu et al., 2001;
Fukuda et al., 2009) (see poster). As ILK
can only bind one Pinch and one parvin
isoform at the same time (Chiswell et al.,
2008; Montanez et al., 2009), ILK is
capable of being part of several distinct
IPP complexes, each resulting in different
signalling outputs (see poster and below).
The parvin proteins can interact directly
with F-actin (Legate et al., 2006) or they
can recruit actin-binding proteins, such as
a-actinin – shown for b-parvin (Yamaji
et al., 2004) – or vinculin, an interaction
mediated through paxillin (Turner, 2000),
which has been shown for a- and c-parvin
(Yoshimi et al., 2006). In addition, they
control actin regulatory proteins such as
testicular protein kinase 1 (TESK1), which
can bind a-parvin and promote F-actin
polymerisation through phosphorylation of
cofilin (LaLonde et al., 2005). By contrast,
b-parvin regulates actin dynamics through
PAK-interactive exchange factor alpha (a-
PIX, encoded by ARHGEF6), a guanidine
exchange factor (GEF) for Rac1 and
Cdc42 (Mishima et al., 2004). Finally,
a-parvin has been shown to inhibit G-
proteins by recruiting Cdc42 GTPase-
activating protein (CdGAP, also known
as RHG31 and Kiaa1204, and encoded by
ARHGAP31) to FAs (LaLonde et al.,
2006), and to negatively regulate Rho-
associated protein kinase (ROCK)-driven
contractility in vascular smooth muscle
cells (Montanez et al., 2009).
Pinch-1 binds the Ras suppressor protein
1 (RSU1), which is important for integrin-
mediated cell adhesion and spreading
(Kadrmas et al., 2004; Ito et al., 2010).
RSU1 is a negative regulator of growth-
factor-induced Jun N-terminal kinase 1
(JNK1, also known as MAPK8)
(Kadrmas et al., 2004). Taken together
these findings suggest that the assembly of
distinct IPP complexes in a given cell,
together with the differential expression
patterns of Pinch and parvin isoforms,
provides a means for multiple alternative
signalling outputs (see poster).
Emerging functions of ILK
The most prominent subcellular
localisation of ILK is in integrin adhesion
sites. In recent years it has been reported
that ILK is also present in additional
subcellular regions and compartments
where it might exert integrin-independent
functions.
Functions in microtubule trafficking
networks
Keratinocytes, and probably other cells,
employ ILK to capture microtubule (MT)
tips to connect them to the cortical actin
network (see poster). ILK-mediated MT
capture occurs exclusively in nascent FAs
and is mediated by recruitment of the
large scaffold protein IQ-motif-containing
GTPase-activating protein 1 (IQGAP1)
(Wickstro¨m et al., 2010a). The capture of
MT tips can be achieved either directly
through binding of IQGAP1 to the MT tip
protein CLIP170 (cytoplasmic linker
protein 170; also known as CLIP1), or
indirectly through IQGAP1-mediated
recruitment of mammalian diaphanous
homolog 1 (mDia1; also known as DRF1),
which is also able to stabilise MTs. As both
IQGAP1 and mDia1 are also able to bind F-
actin, the ILK–IQGAP1–mDia1 complex
connects MTs with actin tracks at b1-
integrin-containing nascent adhesion sites
(Wickstro¨m et al., 2010a) (see poster).
Exocytotic carriers that are transported on
MT tracks require a switch from MT-based
to actin-based motility at the plasma
membrane to pass through the cortical F-
actin network and finally fuse with the
plasma membrane. Thus, the connection of
both networks by the ILK–IQGAP1–mDia1
complex at nascent adhesion sites is
essential for the exocytosis of caveolar
carriers (Wickstro¨m et al., 2010a).
Consequently, ILK not only contributes to
epithelial cell polarisation through actin
remodelling, but also through vesicular
trafficking and MT organisation.
Nuclear functions
Despite its prominent localisation in
different integrin adhesion sites, ILK has
also been observed in the nucleus of
several cell lines, including COS-1 cells
(Chun et al., 2005), MCF-7 cells (Acconcia
et al., 2007), HeLa cells and keratinocytes
(Nakrieko et al., 2008a) (see poster). The
nuclear function of ILK, however, is still
not well understood. In keratinocytes,
nuclear ILK has been shown to induce
DNA synthesis (Nakrieko et al., 2008a)
and, in MCF-7 cells, it has been found to
control the expression of the connector
enhancer of kinase suppressor of Ras3
(CNKSR3) gene (Acconcia et al., 2007). It
is known that CNKSR3 regulates the
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epithelial Na+ channel (ENaC) through
inhibition of the MAPK kinase MEK1
(Ziera et al., 2009). However, the
significance of ILK-regulated CNSKR3
expression is not understood.
It is also not well understood how ILK
translocates into the nucleus. For example,
it is not known whether the nuclear import
of ILK depends on its N-terminus
(Acconcia et al., 2007) or on a C-terminal
nuclear localisation signal (Chun et al.,
2005). The nuclear export of ILK requires
the kinase-like domain (Acconcia et al.,
2007; Nakrieko et al., 2008a) and is
apparently controlled by the nuclear
export factor CRM1, integrin-linked
kinase-associated serine and threonine
phosphatase 2C (ILKAP) and p21-
activated kinase 1 (PAK1) (Acconcia et
al., 2007; Nakrieko et al., 2008a).
Organisation of cell–cell contacts
ILK has been shown to serve as a scaffold
for promoting the formation of cell–cell
contacts (see poster) and the recruitment of
tight junction proteins (Vespa et al., 2003;
Vespa et al., 2005). Following treatment of
cultured keratinocytes with Ca2+, they
undergo differentiation. This process is
accompanied by the translocation of ILK
from FAs to cell–cell adhesion sites
(Vespa et al., 2003). This translocation is
known to require the N-terminal ankyrin
repeats (Vespa et al., 2003); however, it is
unclear whether Pinch-1 or -2 translocate
together with ILK. In contrast to these in
vitro findings, deletion of the Ilk gene
in mouse keratinocytes neither affects
cell–cell adhesion nor barrier function in
the epidermis, but severely impairs
keratinocyte migration on and adhesion to
the epidermal-dermal basal membrane
(BM), resulting in skin blistering,
epidermal hyperthickening and hair loss
(Lorenz et al., 2007; Nakrieko et al.,
2008b).
Centrosome functions
A proteomic search for new ILK-interacting
proteins identified a number of proteins,
including several centrosome- and mitotic-
spindle-associated proteins, such as a- and
b-tubulin, the tubulin-binding proteins
RUVBL1 and colonic and hepatic tumor
overexpressed gene protein (ch-TOG, also
known as CKAP5) (Dobreva et al., 2008)
(see poster). Although ILK probably binds
these proteins in an indirect manner
(Fielding et al., 2008), it colocalises with
them in centrosomes from interphase
and mitotic cells where it has an essential
role in controlling centrosome function
during mitotic spindle organisation and
centrosome clustering (Fielding et al.,
2008; Fielding et al., 2011). The
organisation of the mitotic spindle requires
the kinase Aurora A and the association of
ch-TOG with the centrosomal transforming
acidic coiled-coil-containing protein 3
(TACC3), which in turn promotes the
polymerisation and stabilisation of
centrosomal MTs (Barr and Gergely,
2007). In ILK-depleted cells, Aurora A
kinase, although active, is unable to
phosphorylate and thus activate TACC3,
resulting in disruption of mitotic spindles.
Similarly, the clustering of supernumerary
centrosomes in cancer cells is also achieved
by the TACC3–ch-TOG complex in an
ILK- and Aurora-A-dependent manner
(Fielding et al., 2011). ILK associates with
ch-TOG, but not with TACC3 or Aurora A.
Therefore, it is not clear how ILK supports
the phosphorylation of TACC3 by Aurora
A. Similarly, it is also unclear how ILK is
recruited to centrosomes. The centrosomal
localisation of ILK requires RUVBL1
expression and occurs without the known
ILK-binding partners, a-parvin and Pinch
(Fielding et al., 2008). Finally, it is also not
known why the treatment of cells with
QLT-0267, a small chemical compound that
binds to the ATP-binding site of ILK, is as
effective as siRNA-mediated depletion of
ILK in blocking the association of TACC3
with Aurora A (Fielding et al., 2008). The
mechanistic interpretation of this work is
based on the assumption that ILK acts as a
kinase, which has been disproved by genetic
and structural studies (see below). A
potential explanation for the inhibitory
effect of QLT-0267 could be an
impairment of the stability of ILK (see the
next section).
The kinase controversy
The experimental evidence that the kinase-
like domain of ILK lacks catalytic activity
is overwhelming (Wickstro¨m et al.,
2010b). Although ILK was initially
identified by Dedhar and colleagues as a
serine/threonine kinase (Hannigan et al.,
1996), it lacks several important motifs
that are conserved in most kinases (Hanks
et al., 1988) (see poster). Furthermore,
genetic studies in flies, worms and mice
have demonstrated that the putative kinase
activity is not required for development
and homeostasis (Zervas et al., 2001;
Mackinnon et al., 2002; Lange et al.,
2009). Despite this compelling evidence,
many papers have been and are still
published claiming that ILK is a bona
fide kinase, with only marginal evidence at
best.
The crystallisation of kinase-like domain
of ILK in complex with the CH domain of
a-parvin and its comparison to the kinase
domain of protein kinase A (PKA) has
provided a mechanistic explanation for why
the kinase function of ILK is not executed
(Fukuda et al., 2009). The catalytic activity
of a kinase depends on a coordinated
interplay of the N- and C-lobes and the
catalytic loop of the kinase domain with the
substrate and ATP. The N- and C-lobes and
the catalytic loop of ILK show major
differences to those of bona fide kinases
that render the ‘kinase’ of ILK non
functional: (1) The catalytic loop lacks
important acidic and positively charged
residues. The acidic residue (D166 in
PKA), which polarises the hydroxyl group
of the substrate and accepts its proton, is
replaced in ILK with the uncharged alanine
residue (A319) (Fukuda et al., 2009).
(2) The positively charged residue in
the catalytic loop (K168 in PKA),
which stabilises the intermediate state of
the phosphoryl transfer reaction by
neutralizing the negative charge of the c-
ATP phosphoryl group, is replaced in ILK
by N321 resulting in a misrouting of ATP to
the C-lobe. (3) In the N-lobe, the ATP-
binding p-loop captures ATP at a too great
distance from the active centre (10 A˚),
which precludes its movement towards the
catalytic loop, and the lysine residue K220
contacts the a- and c-ATP phosphoryl
groups instead of the a- and b-phosphoryl
groups resulting in an aberrant ATP
orientation. (4) Furthermore, the C-lobe of
ILK chelates ATP with only one instead of
the expected two metal ions. The metal ion
is bound by the aspartate residue (D339) of
the DVK motif of ILK (a DFG motif in
PKA), whereas the second potential metal-
binding residue (S324) remains unoccupied.
Another divergence from bona fide
kinases is the coordination of the c-ATP
phosphoryl-group by the lysine residue
(K341) of the DVK motif of the N-lobe,
which usually is mediated by the catalytic
loop (Fukuda et al., 2009). Nevertheless,
despite this structural evidence, dissenting
views are still expressed and the
controversy rages on (Hannigan et al.,
2011).
Thermodynamic and structural analysis
of ILK mutants has revealed that the
K220A and K220M mutations, previously
described as affecting kinase function,
destabilise the global ILK structure
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(Fukuda et al., 2011), thus reducing ILK
stability and the binding of interaction
partners such as a-parvin. This observation
provides an explanation for the severe
kidney defects observed in mice which
either lack a-parvin expression or carry
K220A or K220M mutations in ILK
(Lange et al., 2009).
Redefining the role of ILK in cancer
ILK is overexpressed in many types of
cancer, and it has been reported that its
depletion or inhibition with the small
molecule inhibitor QLT-0267 inhibits
anchorage-independent growth, cell cycle
progression and invasion (Hannigan et al.,
2005). The oncogenic effects of ILK have
been attributed for the most part to the
catalytic activity of the kinase domain
resulting in the activation of protein kinase
B (PKB, also known as Akt) and glycogen
synthase kinase-3 beta (GSK3b), which in
turn regulates the stability of proto-
oncogenic b-catenin (Hannigan et al.,
2005). The recent findings showing that
mammalian ILK lacks catalytic activity
and serves as a scaffold protein in FAs of
mammalian cells (Lange et al., 2009;
Fukuda et al., 2009) raise the question of
how ILK mediates its oncogenic potential
despite this functional twist.
One possibility is that ILK controls the
activity of oncogenes, such as PKB by
controlling their subcellular localisation.
For example, the ILK-binding partners a-
and b-parvin induce the recruitment of PKB
to the plasma membrane where PKB
mediates its oncogenic activity (Fukuda
et al., 2003b; Kimura et al., 2010). An
alternative possibility is that ILK and ILK-
interacting protein(s) regulate oncogenic
kinases by controlling the activity of
phosphatases. This has been shown for
Pinch-1, which binds to and inhibits
protein phosphatase 1a (PP1a) resulting in
sustained PKB phosphorylation and activity
(Eke et al., 2010). Consequently, reducing
the amounts of the IPP complex in FAs will
concomitantly result in an increased PP1a
activity and decreased PKB function. It is
also conceivable that ILK exerts its
oncogenic function through its ability to
cluster supernumerary centrosomes in
cancer cells, thereby preventing their
genomic instability and death (Fielding
et al., 2011). Finally, ILK might also
promote oncogenesis by regulating gene
expression in the nucleus or by modulating
the assembly of ECM proteins, as shown for
fibronectin (Wu et al., 1998), which has
been reported to affect cancer development
and invasion (Akiyama et al., 1995).
Outlook and perspectives
ILK research has been significantly
advanced in the past years by the
resolution the long-lasting debate
regarding the catalytic activity of ILK and
by identifying novel functions for ILK,
many of which occur outside of FAs.
However, most of the emerging functions
of ILK (e.g. in the nucleus, at cell–cell
adhesion sites and in the centrosome) have
only been studied in cultured cells thus far
and still await confirmation in vivo.
In addition, several basic functions of
ILK in FAs are still unresolved, including
the mechanism(s) of the recruitment of ILK
to FAs, the role of ILK in FA maturation
and as a potential stretch sensor (Bendig
et al., 2006), and the turnover and
modifications of ILK, to name a few.
Whether the recruitment of ILK to FAs
occurs through a direct association with the
integrin cytoplasmic domains or indirectly,
e.g. through binding to kindlins (Montanez
et al., 2008) or paxillin (Nikolopoulos and
Turner, 2001) is currently unclear. In this
regard, it is also not known whether ILK
binds or associates with all b-integrin
tails or whether this association is more
selective. A co-crystallisation of the kinase-
like domain of ILK with b-integrin tails
should help to answer some of these
questions. Similarly, a structural analysis
of the predicted PH domain of ILK would
clarify whether it adopts a classical PH fold,
as predicted in the original publication
(Hannigan et al., 1996), or a different
motif, whose function would then have to
be determined. Zebrafish studies point to a
stretch-sensing function for ILK in
cardiomyocytes (Bendig et al., 2006). This
observation raises the question of whether
mechanical stress sensing by ILK is
restricted to cardiomyocytes or whether it
also occurs in other cells, and of how ILK is
executing this function at the molecular
level. Finally, it will be important to re-
evaluate the role of ILK in cancer. Ideally,
these experiments should be performed in
an unbiased manner with tumour models in
mice (e.g. colon cancer and mammary
cancer models) that lack ILK expression,
and are complemented by sophisticated in
vitro studies with cells derived from the
tumours.
It is obvious that despite the rapid
progress in ILK research, many questions
are still unanswered. Recent advances in
imaging and proteomics combined with
genetics, cell biology and biochemistry
will make the years to come exciting for all
ILK aficionados.
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